GDC Terminology

Preferred Label : GDC Terminology;

NCIt synonyms : Genomics Data Commons Terminology;

NCIt definition : Terminology that supports the Genomic Data Commons (GDC).;

NCI Metathesaurus CUI : CL937332;

Details

Origin ID

C157711;

UMLS CUI

C4763808;

Semantic type(s)
- Intellectual Product [UMLS semantic type]
subset_includes_concept
- 0-30 Days [NCIt concept]
- 10-Deacetyltaxol [NCIt concept]
- 11C Topotecan [NCIt concept]
- 11D10 AluGel Anti-Idiotype Monoclonal Antibody [NCIt concept]
- 12-Allyldeoxoartemisinin [NCIt concept]
- 13-Deoxydoxorubicin [NCIt concept]
- 14C BMS-275183 [NCIt concept]
- 17beta-Hydroxysteroid Dehydrogenase Type 5 Inhibitor ASP9521 [NCIt concept]
- 2'-F-ara-deoxyuridine [NCIt concept]
- 2,6-Diaminopurine [NCIt concept]
- 2,6-Dimethoxyquinone [NCIt concept]
- 2-Deoxy-D-glucose [NCIt concept]
- 2-Ethylhydrazide [NCIt concept]
- 2-Fluoroadenine [NCIt concept]
- 2-Fluorofucose [NCIt concept]
- 2-Hydroxyestradiol [NCIt concept]
- 2-Hydroxyestrone [NCIt concept]
- 2-Hydroxyflutamide Depot [NCIt concept]
- 2-Methoxyestradiol [NCIt concept]
- 2-Methoxyestradiol Nanocrystal Colloidal Dispersion [NCIt concept]
- 2-Methoxyestrone [NCIt concept]
- 28S Ribosomal RNA to 18S Ribosomal RNA Ratio [NCIt concept]
- 3' Flank Mutation [NCIt concept]
- 3' Untranslated Region Mutation [NCIt concept]
- 3'-C-ethynylcytidine [NCIt concept]
- 3'-dA Phosphoramidate NUC-7738 [NCIt concept]
- 3-Dimensional Conformal Radiation Therapy [NCIt concept]
- 3-bromopyruvate-based Agent KAT-101 [NCIt concept]
- 3-bromopyruvate-based Agent KAT-201 [NCIt concept]
- 31-90 Days [NCIt concept]
- 4'-Iodo-4'-Deoxydoxorubicin [NCIt concept]
- 4-Nitroestrone 3-Methyl Ether [NCIt concept]
- 4-Thio-2-deoxycytidine [NCIt concept]
- 454 Sequencing [NCIt concept]
- 5' Flank Mutation [NCIt concept]
- 5' Untranslated Region Mutation [NCIt concept]
- 5-Aza-4'-thio-2'-deoxycytidine [NCIt concept]
- 5-Fluoro-2-Deoxycytidine [NCIt concept]
- 5-Hydroxyindoleacetic Acid Measurement [NCIt concept]
- 6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatases Isoform 3 Inhibitor ACT-PFK-158 [NCIt concept]
- 7-Cyanoquinocarcinol [NCIt concept]
- 7-Ethyl-10-Hydroxycamptothecin [NCIt concept]
- 7-Hydroxystaurosporine [NCIt concept]
- 8-Azaguanine [NCIt concept]
- 9-Ethyl 6-Mercaptopurine [NCIt concept]
- 91-180 Days [NCIt concept]
- 99mTc Bone Scintography [NCIt concept]
- 9H-Purine-6Thio-98D [NCIt concept]
- A1CF Gene [NCIt concept]
- A260 to A280 Ratio [NCIt concept]
- A2A/A2B Adenosine Receptor Antagonist INCB106385 [NCIt concept]
- A2AR Antagonist EXS21546 [NCIt concept]
- ABI SOLiD Sequencing [NCIt concept]
- ABI1 Gene [NCIt concept]
- ABL1 Gene [NCIt concept]
- ABL2 Gene [NCIt concept]
- AC Regimen [NCIt concept]
- AC-T Regimen [NCIt concept]
- ACACA Gene [NCIt concept]
- ACKR3 Gene [NCIt concept]
- ACSL3 Gene [NCIt concept]
- ACSL6 Gene [NCIt concept]
- ACSS2 Inhibitor MTB-9655 [NCIt concept]
- ACVR1 Gene [NCIt concept]
- ACVR2A Gene [NCIt concept]
- ADC TORL-4-500 [NCIt concept]
- ADH-1 [NCIt concept]
- AE37 Peptide/GM-CSF Vaccine [NCIt concept]
- AFDN Gene [NCIt concept]
- AFF1 Gene [NCIt concept]
- AFF3 Gene [NCIt concept]
- AFF4 Gene [NCIt concept]
- AIDS-Related Risk Factor [NCIt concept]
- AJCC Cancer Staging Manual [NCIt concept]
- AJCC Cancer Staging Manual 4th Edition [NCIt concept]
- AJCC Cancer Staging Manual 5th Edition [NCIt concept]
- AJCC Cancer Staging Manual 6th Edition [NCIt concept]
- AJCC Cancer Staging Manual 7th Edition [NCIt concept]
- AJCC Cancer Staging Manual 8th Edition [NCIt concept]
- AJCC v8 Clinical M Category [NCIt concept]
- AJCC v8 Clinical N Category [NCIt concept]
- AJCC v8 Clinical Stage [NCIt concept]
- AJCC v8 Clinical T Category [NCIt concept]
- AJCC v8 Pathologic M Category [NCIt concept]
- AJCC v8 Pathologic N Category [NCIt concept]
- AJCC v8 Pathologic Stage [NCIt concept]
- AJCC v8 Pathologic T Category [NCIt concept]
- AKAP9 Gene [NCIt concept]
- AKR1C3-activated Prodrug AST-3424 [NCIt concept]
- AKT 1/2 Inhibitor BAY1125976 [NCIt concept]
- AKT/RSK/S6K Inhibitor TAS0612 [NCIt concept]
- AKT1 Gene [NCIt concept]
- AKT2 Gene [NCIt concept]
- AKT3 Gene [NCIt concept]
- ALDH Inhibitor NYH817G and Mitochondrial Complex 1 Inhibitor NYH100P [NCIt concept]
- ALDH1/3 Inhibitor ABD-3001 [NCIt concept]
- ALDH2 Gene [NCIt concept]
- ALK Gene [NCIt concept]
- ALK Inhibitor [NCIt concept]
- ALK Inhibitor ASP3026 [NCIt concept]
- ALK Inhibitor NVL-655 [NCIt concept]
- ALK Inhibitor PLB 1003 [NCIt concept]
- ALK Inhibitor SY-3505 [NCIt concept]
- ALK Inhibitor TAE684 [NCIt concept]
- ALK-FAK Inhibitor CEP-37440 [NCIt concept]
- ALK-Positive Large B-Cell Lymphoma [NCIt concept]
- ALK/FAK/Pyk2 Inhibitor CT-707 [NCIt concept]
- ALK/ROS1 Inhibitor TGRX-326 [NCIt concept]
- ALK/ROS1 Inhibitor XZP-3621 [NCIt concept]
- ALK/TRK Inhibitor TSR-011 [NCIt concept]
- ALK/c-Met Inhibitor TQ-B3139 [NCIt concept]
- ALVAC gp100 Vaccine [NCIt concept]
- AMER1 Gene [NCIt concept]
- AMP KRAS Vaccine ELI-002 [NCIt concept]
- ANK1 Gene [NCIt concept]
- APC Gene [NCIt concept]
- APC8015F [NCIt concept]
- APE1/Ref-1 Redox Inhibitor APX3330 [NCIt concept]
- APIM-containing Peptide ATX-101 [NCIt concept]
- APOBEC3B Gene [NCIt concept]
- AQP1 Gene [NCIt concept]
- AR Antagonist BMS-641988 [NCIt concept]
- AR Gene [NCIt concept]
- ARAF Gene [NCIt concept]
- ARC Fusion Protein SL-279252 [NCIt concept]
- ARG1/ARG2 Inhibitor OATD-02 [NCIt concept]
- ARHGAP26 Gene [NCIt concept]
- ARHGAP5 Gene [NCIt concept]
- ARHGEF12 Gene [NCIt concept]
- ARID1A Gene [NCIt concept]
- ARID1B Gene [NCIt concept]
- ARID2 Gene [NCIt concept]
- ARNT Gene [NCIt concept]
- ASCII Encoding Version for Read Group QC [NCIt concept]
- ASO-STAT6-loaded PTGFRN-expressing Exosomes CDK-004 [NCIt concept]
- ASP4132 [NCIt concept]
- ASPSCR1 Gene [NCIt concept]
- ASXL1 Gene [NCIt concept]
- ASXL2 Gene [NCIt concept]
- ATAC-Seq [NCIt concept]
- ATF1 Gene [NCIt concept]
- ATIC Gene [NCIt concept]
- ATM Gene [NCIt concept]
- ATM Inhibitor M 3541 [NCIt concept]
- ATM Inhibitor SYH2051 [NCIt concept]
- ATM Kinase Inhibitor AZD0156 [NCIt concept]
- ATM Kinase Inhibitor AZD1390 [NCIt concept]
- ATM Kinase Inhibitor WSD-0628 [NCIt concept]
- ATM Kinase/DNA-PK Inhibitor XRD-0394 [NCIt concept]
- ATP1A1 Gene [NCIt concept]
- ATP2B3 Gene [NCIt concept]
- ATR Gene [NCIt concept]
- ATR Inhibitor ART0380 [NCIt concept]
- ATR Inhibitor ATG-018 [NCIt concept]
- ATR Inhibitor ATRN-119 [NCIt concept]
- ATR Inhibitor IMP9064 [NCIt concept]
- ATRX Gene [NCIt concept]
- AXIN1 Gene [NCIt concept]
- AXIN2 Gene [NCIt concept]
- AXL Inhibitor [NCIt concept]
- AXL Inhibitor DS-1205c [NCIt concept]
- AXL Inhibitor NTQ2494 [NCIt concept]
- AXL Inhibitor SLC-391 [NCIt concept]
- AXL Receptor Tyrosine Kinase/cMET Inhibitor BPI-9016M [NCIt concept]
- AXL/FLT3 Inhibitor TT-00973 [NCIt concept]
- AXL/FLT3/NTRK Inhibitor HH30134 [NCIt concept]
- AXL/FLT3/VEGFR2 Inhibitor KC1036 [NCIt concept]
- Abagovomab [NCIt concept]
- Abarelix [NCIt concept]
- Abdomen [NCIt concept]
- Abdominal (Mesenteric) Fibromatosis [NCIt concept]
- Abdominal Distension, CTCAE [NCIt concept]
- Abdominal Esophagus [NCIt concept]
- Abdominal Infection, CTCAE [NCIt concept]
- Abdominal Pain, CTCAE [NCIt concept]
- Abdominal Peritoneum [NCIt concept]
- Abdominal Soft Tissue Necrosis, CTCAE [NCIt concept]
- Abdominal Wall [NCIt concept]
- Abdominoperineal Resection [NCIt concept]
- Abducens Nerve Disorder, CTCAE [NCIt concept]
- Abemaciclib [NCIt concept]
- Abemaciclib Mesylate [NCIt concept]
- Abequolixron [NCIt concept]
- Abexinostat [NCIt concept]
- Abexinostat Tosylate [NCIt concept]
- Abiraterone [NCIt concept]
- Abiraterone Acetate [NCIt concept]
- Abiraterone Acetate/Niraparib [NCIt concept]
- Abiraterone Amorphous Solid Dispersion Formulation DST-2970 [NCIt concept]
- Abiraterone Decanoate [NCIt concept]
- Abiraterone Decanoate Depot [NCIt concept]
- Abituzumab [NCIt concept]
- Abivertinib Maleate Anhydrous [NCIt concept]
- Ablation Therapy [NCIt concept]
- Abnormal [NCIt concept]
- Abnormal Glucose Level Finding [NCIt concept]
- Abnormal Laboratory Test Result [NCIt concept]
- Absent [NCIt concept]
- Absolute Basophil Count [NCIt concept]
- Absolute Neutrophil Count [NCIt concept]
- Absorbable Gelatin Sponge [NCIt concept]
- Acai Berry Juice [NCIt concept]
- Acalabrutinib [NCIt concept]
- Acalisib [NCIt concept]
- Acasunlimab [NCIt concept]
- Acazicolcept [NCIt concept]
- Acceptor Splice Site SNP [NCIt concept]
- Accessory Nerve Disorder, CTCAE [NCIt concept]
- Accidental Building Fire Smoke Exposure [NCIt concept]
- Accidental Fire Smoke Exposure [NCIt concept]
- Accidental Forest Fire Smoke Exposure [NCIt concept]
- Accidental Grass Fire Smoke Exposure [NCIt concept]
- Accidental Vehicle Fire Smoke Exposure [NCIt concept]
- Aceglatone [NCIt concept]
- Acetabulum [NCIt concept]
- Acetaminophen [NCIt concept]
- Acetate [NCIt concept]
- Acetylcysteine [NCIt concept]
- Acetylglucosaminyltransferase V Inhibitor PhOx430 [NCIt concept]
- Acidosis, CTCAE [NCIt concept]
- Acimtamig [NCIt concept]
- Acinar Cell Adenoma [NCIt concept]
- Acinar Cell Carcinoma [NCIt concept]
- Acinar Cell Neoplasm [NCIt concept]
- Acitretin [NCIt concept]
- Acivicin [NCIt concept]
- Aclacinomycin B [NCIt concept]
- Aclarubicin [NCIt concept]
- Acodazole [NCIt concept]
- Acodazole Hydrochloride [NCIt concept]
- Acolbifene Hydrochloride [NCIt concept]
- Acoustic Nerve Disorder NOS, CTCAE [NCIt concept]
- Acquired Cystic Disease-Associated Renal Cell Carcinoma [NCIt concept]
- Acquired Immunodeficiency Syndrome [NCIt concept]
- Acquired Progressive Lymphangioma [NCIt concept]
- Acral Lentiginous Melanoma [NCIt concept]
- Acridine [NCIt concept]
- Acridine Carboxamide [NCIt concept]
- Acronine [NCIt concept]
- Actinium Ac 225 DOTATATE RYZ101 [NCIt concept]
- Actinium Ac 225 FPI-2059 [NCIt concept]
- Actinium Ac 225 Lintuzumab [NCIt concept]
- Actinium Ac 225 PSMA-I&T [NCIt concept]
- Actinium Ac 225 Vofatamab [NCIt concept]
- Actinium Ac 225-DOTA-Daratumumab [NCIt concept]
- Actinium Ac 225-DOTA-MTI-201 [NCIt concept]
- Actinium Ac 225-DOTA-anti-CEA Monoclonal Antibody M5A [NCIt concept]
- Actinium Ac 225-DOTA-h11B6 JNJ-69086420 [NCIt concept]
- Actinium Ac 225-FPI-1434 [NCIt concept]
- Actinium Ac-225 Anti-PSMA Monoclonal Antibody J591 [NCIt concept]
- Actinomycin C2 [NCIt concept]
- Actinomycin C3 [NCIt concept]
- Actinomycin F1 [NCIt concept]
- Activated Partial Thromboplastin Time Prolonged, CTCAE [NCIt concept]
- Activin Type 2B Receptor Fc Fusion Protein STM 434 [NCIt concept]
- Acute Basophilic Leukemia [NCIt concept]
- Acute Bilineal Leukemia [NCIt concept]
- Acute Biphenotypic Leukemia [NCIt concept]
- Acute Coronary Syndrome [NCIt concept]
- Acute Erythroid Leukemia [NCIt concept]
- Acute Kidney Injury, CTCAE [NCIt concept]
- Acute Leukemia [NCIt concept]
- Acute Leukemia of Ambiguous Lineage [NCIt concept]
- Acute Lymphoblastic Leukemia [NCIt concept]
- Acute Megakaryoblastic Leukemia [NCIt concept]
- Acute Monoblastic Leukemia [NCIt concept]
- Acute Monoblastic and Monocytic Leukemia [NCIt concept]
- Acute Monocytic Leukemia [NCIt concept]
- Acute Myeloid Leukemia [NCIt concept]
- Acute Myeloid Leukemia (Megakaryoblastic) with t(1;22)(p13.3;q13.1); RBM15-MKL1 [NCIt concept]
- Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome [NCIt concept]
- Acute Myeloid Leukemia Not Otherwise Specified [NCIt concept]
- Acute Myeloid Leukemia Post Cytotoxic Therapy [NCIt concept]
- Acute Myeloid Leukemia with CEBPA Mutation [NCIt concept]
- Acute Myeloid Leukemia with KMT2A Rearrangement [NCIt concept]
- Acute Myeloid Leukemia with Maturation [NCIt concept]
- Acute Myeloid Leukemia with Minimal Differentiation [NCIt concept]
- Acute Myeloid Leukemia with Multilineage Dysplasia [NCIt concept]
- Acute Myeloid Leukemia with NPM1 Mutation [NCIt concept]
- Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11 [NCIt concept]
- Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11 [NCIt concept]
- Acute Myeloid Leukemia with inv(3)(q21.3;q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM [NCIt concept]
- Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11 [NCIt concept]
- Acute Myeloid Leukemia with t(6;9)(p22.3;q34.1); DEK-NUP214 [NCIt concept]
- Acute Myeloid Leukemia with t(8;21)(q22; q22.1); RUNX1-RUNX1T1 [NCIt concept]
- Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A [NCIt concept]
- Acute Myeloid Leukemia without Maturation [NCIt concept]
- Acute Myeloid Leukemia, Myelodysplasia-Related [NCIt concept]
- Acute Myelomonocytic Leukemia [NCIt concept]
- Acute Myelomonocytic Leukemia with Abnormal Eosinophils [NCIt concept]
- Acute Panmyelosis with Myelofibrosis [NCIt concept]
- Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA [NCIt concept]
- Acute Renal Failure [NCIt concept]
- Acute Respiratory Distress Syndrome [NCIt concept]
- Acute Undifferentiated Leukemia [NCIt concept]
- Acyclic Nucleoside Phosphonate Prodrug ABI-1968 [NCIt concept]
- Ad-RTS-hIL-12 [NCIt concept]
- AdC68 Expressing PSA/PSMA/PSCA Vaccine PF-06755992 [NCIt concept]
- Adagloxad Simolenin [NCIt concept]
- Adagrasib [NCIt concept]
- Adakitug [NCIt concept]
- Adamantinoma [NCIt concept]
- Adamantinomatous Craniopharyngioma [NCIt concept]
- Adavosertib [NCIt concept]
- Additional Pathologic Findings [NCIt concept]
- Adebrelimab [NCIt concept]
- Adecatumumab [NCIt concept]
- Adenocarcinoma [NCIt concept]
- Adenocarcinoma In Situ [NCIt concept]
- Adenocarcinoma In Situ in Adenomatous Polyp [NCIt concept]
- Adenocarcinoma In Situ in Tubular Adenoma [NCIt concept]
- Adenocarcinoma In Situ in Tubulovillous Adenoma [NCIt concept]
- Adenocarcinoma In Situ in Villous Adenoma [NCIt concept]
- Adenocarcinoma In Situ in a Polyp [NCIt concept]
- Adenocarcinoma in Adenomatous Polyp [NCIt concept]
- Adenocarcinoma in Adenomatous Polyposis Coli [NCIt concept]
- Adenocarcinoma in Multiple Adenomatous Polyps [NCIt concept]
- Adenocarcinoma in Tubular Adenoma [NCIt concept]
- Adenocarcinoma in Tubulovillous Adenoma [NCIt concept]
- Adenocarcinoma in Villous Adenoma [NCIt concept]
- Adenocarcinoma with Apocrine Metaplasia [NCIt concept]
- Adenocarcinoma with Cartilaginous Metaplasia [NCIt concept]
- Adenocarcinoma with Cartilaginous and Osseous Metaplasia [NCIt concept]
- Adenocarcinoma with Neuroendocrine Differentiation [NCIt concept]
- Adenocarcinoma with Osseous Metaplasia [NCIt concept]
- Adenocarcinoma with Spindle Cell Metaplasia [NCIt concept]
- Adenocarcinoma with Squamous Metaplasia [NCIt concept]
- Adenoid Cystic Carcinoma [NCIt concept]
- Adenoma [NCIt concept]
- Adenomatoid Odontogenic Tumor [NCIt concept]
- Adenomatoid Tumor [NCIt concept]
- Adenomatous Polyp [NCIt concept]
- Adenomyoma [NCIt concept]
- Adenosarcoma [NCIt concept]
- Adenosine A2A Receptor Antagonist CS3005 [NCIt concept]
- Adenosine A2A Receptor Antagonist DZD2269 [NCIt concept]
- Adenosine A2A Receptor Antagonist ILB2109 [NCIt concept]
- Adenosine A2A Receptor Antagonist JNJ-86974680 [NCIt concept]
- Adenosine A2A Receptor Antagonist NIR178 [NCIt concept]
- Adenosine A2A Receptor Antagonist TT-10 [NCIt concept]
- Adenosine A2A Receptor Antagonist/Phosphodiesterase 10A PBF-999 [NCIt concept]
- Adenosine A2B Receptor Antagonist PBF-1129 [NCIt concept]
- Adenosine A2B Receptor Antagonist TT-4 [NCIt concept]
- Adenosine A2B Receptor Antagonist TT-702 [NCIt concept]
- Adenosine Receptor A2A/A2B Antagonist M1069 [NCIt concept]
- Adenosis [NCIt concept]
- Adenosquamous Carcinoma [NCIt concept]
- Adenovector-transduced AP1903-inducible MyD88/CD40-expressing Autologous PSMA-specific Prostate Cancer Vaccine BPX-201 [NCIt concept]
- Adenoviral Brachyury Vaccine ETBX-051 [NCIt concept]
- Adenoviral Cancer Vaccine PF-06936308 [NCIt concept]
- Adenoviral MUC1 Vaccine ETBX-061 [NCIt concept]
- Adenoviral PSA Vaccine ETBX-071 [NCIt concept]
- Adenoviral Transduced hIL-12-expressing Autologous Dendritic Cells INXN-3001 Plus Activator Ligand INXN-1001 [NCIt concept]
- Adenoviral Tumor-specific Neoantigen Priming Vaccine GAd-209-FSP [NCIt concept]
- Adenoviral Tumor-specific Neoantigen Priming Vaccine GRT-C901 [NCIt concept]
- Adenovirus 5 CEA/MUC1/Brachyury Vaccine Tri-Ad5 [NCIt concept]
- Adenovirus 5/F35-Human Guanylyl Cyclase C-PADRE [NCIt concept]
- Adenovirus Serotype 26-expressing HPV16 Vaccine JNJ-63682918 [NCIt concept]
- Adenovirus Serotype 26-expressing HPV18 Vaccine JNJ-63682931 [NCIt concept]
- Adenovirus-expressing TLR5/TLR5 Agonist Nanoformulation M-VM3 [NCIt concept]
- Adenovirus-mediated Human Interleukin-12 INXN-2001 Plus Activator Ligand INXN-1001 [NCIt concept]
- Aderbasib [NCIt concept]
- Adherent Culture [NCIt concept]
- Adipose Tissue [NCIt concept]
- Adjacent [NCIt concept]
- Adjuvant Generic [NCIt concept]
- Adjuvant Therapy [NCIt concept]
- Administered Treatment Clinical Trial Indicator [NCIt concept]
- Administration Professional [NCIt concept]
- Administrative and Specialized Secretary [NCIt concept]
- Adnexa [NCIt concept]
- Adnexal Carcinoma [NCIt concept]
- Adolescence [NCIt concept]
- Adopted Brother [NCIt concept]
- Adopted Daughter [NCIt concept]
- Adopted Sister [NCIt concept]
- Adopted Son [NCIt concept]
- Adoptive Father [NCIt concept]
- Adoptive Mother [NCIt concept]
- Adrenal Cortex [NCIt concept]
- Adrenal Cortical Adenoma [NCIt concept]
- Adrenal Cortical Carcinoma [NCIt concept]
- Adrenal Cortical Clear Cell Adenoma [NCIt concept]
- Adrenal Cortical Compact Cell Adenoma [NCIt concept]
- Adrenal Cortical Glomerulosa Cell Adenoma [NCIt concept]
- Adrenal Cortical Mixed Cell Adenoma [NCIt concept]
- Adrenal Cortical Neoplasm [NCIt concept]
- Adrenal Gland [NCIt concept]
- Adrenal Gland Myelolipoma [NCIt concept]
- Adrenal Gland Pheochromocytoma [NCIt concept]
- Adrenal Hormone Indicator [NCIt concept]
- Adrenal Insufficiency, CTCAE [NCIt concept]
- Adrenal Medulla [NCIt concept]
- Adrenal Rest Tumor [NCIt concept]
- Adrenocortical Insufficiency [NCIt concept]
- Adult Cardiac Cellular Rhabdomyoma [NCIt concept]
- Adult Cystic Nephroma [NCIt concept]
- Adult Cystic Teratoma [NCIt concept]
- Adult Extracardiac Rhabdomyoma [NCIt concept]
- Adult Granulosa Cell Tumor [NCIt concept]
- Adult Pleomorphic Rhabdomyosarcoma [NCIt concept]
- Adult Respiratory Distress Syndrome, CTCAE [NCIt concept]
- Adult T-Cell Leukemia/Lymphoma [NCIt concept]
- Adult Teratoma [NCIt concept]
- Adulthood [NCIt concept]
- Adverse Event [NCIt concept]
- Adverse Event Grade Code [NCIt concept]
- Aerosol Gemcitabine [NCIt concept]
- Aerosolized Aldesleukin [NCIt concept]
- Aerosolized Liposomal Rubitecan [NCIt concept]
- Afamitresgene Autoleucel [NCIt concept]
- Afatinib [NCIt concept]
- Afatinib Dimaleate [NCIt concept]
- Afeletecan Hydrochloride [NCIt concept]
- Affinity Enriched Genomic Library [NCIt concept]
- Affymetrix CEL Format [NCIt concept]
- Affymetrix Genome-Wide Human SNP Array 6.0 [NCIt concept]
- Afghanistan [NCIt concept]
- Afimoxifene [NCIt concept]
- After Hormone Therapy [NCIt concept]
- Afuresertib [NCIt concept]
- Agatolimod Sodium [NCIt concept]
- Age Data Obfuscated Indicator [NCIt concept]
- Age Started [NCIt concept]
- Age When Quit using Smokeless Tobacco after Regular Use [NCIt concept]
- Age at Last Exposure [NCIt concept]
- Age at Undescended Testis Correction [NCIt concept]
- Age in Days at Diagnosis [NCIt concept]
- Age in Years at Index Date [NCIt concept]
- Age in Years of Patient Relative at Cancer Diagnosis [NCIt concept]
- Age-Days [NCIt concept]
- Agent Orange Exposure [NCIt concept]
- Agent Unit of Measure [NCIt concept]
- Agerafenib [NCIt concept]
- Aggregated Somatic Variation Data [NCIt concept]
- Aggressive NK-Cell Leukemia [NCIt concept]
- Aggressive Osteoblastoma [NCIt concept]
- Aggressive Systemic Mastocytosis [NCIt concept]
- Agitation, CTCAE 5.0 [NCIt concept]
- Aglatimagene Besadenovec [NCIt concept]
- Agonistic Anti-OX40 Monoclonal Antibody INCAGN01949 [NCIt concept]
- Agonistic Anti-OX40 Monoclonal Antibody MEDI6469 [NCIt concept]
- Air-Liquid Interface Organoid [NCIt concept]
- Aircraft Smoke Exposure [NCIt concept]
- Akathisia, CTCAE [NCIt concept]
- Akkermansia muciniphila Probiotic [NCIt concept]
- Akt Inhibitor LY2780301 [NCIt concept]
- Akt Inhibitor MK2206 [NCIt concept]
- Akt Inhibitor SR13668 [NCIt concept]
- Akt-1 Antisense Oligonucleotide WGI-0301 [NCIt concept]
- Alacizumab Pegol [NCIt concept]
- Alanine Aminotransferase Increased, CTCAE [NCIt concept]
- Alanosine [NCIt concept]
- Albania [NCIt concept]
- Albumin Measurement [NCIt concept]
- Albumin-binding Cisplatin Prodrug BTP-114 [NCIt concept]
- Alcohol Consumption [NCIt concept]
- Alcohol Intolerance, CTCAE [NCIt concept]
- Alcohol Use History [NCIt concept]
- Alcoholic Beverage [NCIt concept]
- Alcoholic Liver Disease [NCIt concept]
- Aldesleukin [NCIt concept]
- Aldoxorubicin [NCIt concept]
- Alectinib [NCIt concept]
- Alefacept [NCIt concept]
- Alemtuzumab [NCIt concept]
- Alestramustine [NCIt concept]
- Aleukemic Chronic Lymphocytic Leukemia [NCIt concept]
- Aleukemic Leukemia [NCIt concept]
- Aleukemic Lymphoid Leukemia [NCIt concept]
- Alextatug [NCIt concept]
- Alflutinib Mesylate [NCIt concept]
- Algenpantucel-L [NCIt concept]
- Algeria [NCIt concept]
- Aligned Reads Index [NCIt concept]
- Aligned Sequence Read [NCIt concept]
- Alintegimod [NCIt concept]
- Alisertib [NCIt concept]
- Alitretinoin [NCIt concept]
- Alive [NCIt concept]
- Alkaline Phosphatase Increased, CTCAE [NCIt concept]
- Alkalosis, CTCAE [NCIt concept]
- Alkotinib [NCIt concept]
- Alkylating Agent-Related Acute Myeloid Leukemia [NCIt concept]
- Alkylating Agent-Related Myelodysplastic Syndrome [NCIt concept]
- AllPrep FFPE DNA Isolation [NCIt concept]
- AllPrep RNA Isolation [NCIt concept]
- Allele [NCIt concept]
- Allele-Specific Copy Number Segment Data [NCIt concept]
- Allergic Reaction [NCIt concept]
- Allergic Reaction, CTCAE [NCIt concept]
- Allergic Rhinitis, CTCAE [NCIt concept]
- Allitinib [NCIt concept]
- Allodepleted T Cell Immunotherapeutic ATIR101 [NCIt concept]
- Allogeneic Anti-B7-H3 CAR Gamma Delta T-cells QH104 [NCIt concept]
- Allogeneic Anti-BCMA CAR T Cells ALLO-605 [NCIt concept]
- Allogeneic Anti-BCMA CAR T Cells P-BCMA-ALLO1 [NCIt concept]
- Allogeneic Anti-BCMA CAR-transduced T-cells ALLO-715 [NCIt concept]
- Allogeneic Anti-BCMA-CAR T-cells PBCAR269A [NCIt concept]
- Allogeneic Anti-BCMA/CS1 Bispecific CAR-T Cells [NCIt concept]
- Allogeneic Anti-CD19 1XX-CAR T-cells FT819 [NCIt concept]
- Allogeneic Anti-CD19 CAR T-cells PBCAR19B [NCIt concept]
- Allogeneic Anti-CD19 CAR-NK Cells QN-019a [NCIt concept]
- Allogeneic Anti-CD19 CAR-gamma/delta T-cells QH103 [NCIt concept]
- Allogeneic Anti-CD19 Gamma-delta CAR-T Cells UTAA09 [NCIt concept]
- Allogeneic Anti-CD19 T-cells ThisCART19A [NCIt concept]
- Allogeneic Anti-CD19 Universal CAR-T Cells CTA101 [NCIt concept]
- Allogeneic Anti-CD19-CAR-CD28-IL-15-expressing Natural Killer T-cells [NCIt concept]
- Allogeneic Anti-CD19/CD22 CAR-BBz T-cells [NCIt concept]
- Allogeneic Anti-CD20 CAR T-cells LUCAR-20S [NCIt concept]
- Allogeneic Anti-CD20-CAR T-cells PBCAR20A [NCIt concept]
- Allogeneic Anti-CD20/CD22 Universal CAR-expressing T-lymphocytes UCART20x22 [NCIt concept]
- Allogeneic Anti-CD30 CAR-Epstein-Barr Virus-specific T-lymphocytes [NCIt concept]
- Allogeneic Anti-CD33 CAR NK Cells [NCIt concept]
- Allogeneic Anti-CD33 CAR T-cells VCAR33 [NCIt concept]
- Allogeneic Anti-CD33 CAR-NK Cells QN-023a [NCIt concept]
- Allogeneic Anti-CD38 DAR-T Cells STI-1492 [NCIt concept]
- Allogeneic Anti-CD5 CAR T Cells [NCIt concept]
- Allogeneic Anti-CD5-IL-15/IL-15sushi-safety Switch CAR T Cells [NCIt concept]
- Allogeneic Anti-CD7 CAR T Cells 4SCAR7U [NCIt concept]
- Allogeneic Anti-CD7 CAR-T Cells BEAM-201 [NCIt concept]
- Allogeneic Anti-CD70-CAR T-cells ALLO-316 [NCIt concept]
- Allogeneic Anti-CD70-CAR-IL-15-transduced Cord Blood-derived Natural Killer Cells [NCIt concept]
- Allogeneic Anti-HA-1 TCR-engineered T-cells TSC-100 [NCIt concept]
- Allogeneic Anti-HA-2 TCR-engineered T-cells TSC-101 [NCIt concept]
- Allogeneic Anti-NY-ESO-1-TCR-IL-15-transduced Cord Blood-derived Natural Killer Cells [NCIt concept]
- Allogeneic CAR T Cells CT0594CP [NCIt concept]
- Allogeneic CD16-expressing Natural Killer Cells CYNK-101 [NCIt concept]
- Allogeneic CD19-CAR CD45RA-negative T-cells [NCIt concept]
- Allogeneic CD19-OX40-CD3zeta-CAR-mbIL-15-expressing Natural Killer Cells NKX019 [NCIt concept]
- Allogeneic CD19/CD20-specific CAR-T Cells P-CD19CD20-ALLO1 [NCIt concept]
- Allogeneic CD19CAR-CD28-CD3-zeta-expressing T-lymphocytes [NCIt concept]
- Allogeneic CD20 CAR-grafted Gamma Delta T-cells ADI-001 [NCIt concept]
- Allogeneic CD22-specific Universal CAR-expressing T-lymphocytes UCART22 [NCIt concept]
- Allogeneic CD3- CD19- CD57+ NKG2C+ NK Cells FATE-NK100 [NCIt concept]
- Allogeneic CD8+ Leukemia-associated Antigens Specific T Cells NEXI-001 [NCIt concept]
- Allogeneic CRISPR-Cas9 Engineered Anti-CD19 CAR T-cells CTX112 [NCIt concept]
- Allogeneic CRISPR-Cas9 Engineered Anti-CD70 CAR-T Cells CTX130 [NCIt concept]
- Allogeneic CRISPR-edited Anti-BCMA CAR-T Cells CB-011 [NCIt concept]
- Allogeneic CRISPR-edited Anti-CD19 CAR T Cells PACE CART19 [NCIt concept]
- Allogeneic CRISPR-edited Anti-CD19 CAR T Cells PBLTT52CAR19 [NCIt concept]
- Allogeneic CRISPR-edited Anti-CD19 CAR-T Cells CB-010 [NCIt concept]
- Allogeneic CS1-specific Universal CAR-expressing T-lymphocytes UCARTCS1A [NCIt concept]
- Allogeneic Cellular Vaccine 1650-G [NCIt concept]
- Allogeneic Dendritic Secretomes [NCIt concept]
- Allogeneic EBV-transformed B-lymphoblastoid Cell Line Lysate-pulsed Autologous Dendritic Cell Vaccine KSD-101 [NCIt concept]
- Allogeneic GM-CSF-secreting Breast Cancer Vaccine SV-BR-1-GM [NCIt concept]
- Allogeneic GM-CSF-secreting Lethally Irradiated Prostate Cancer Vaccine [NCIt concept]
- Allogeneic GM-CSF-secreting Lethally Irradiated Whole Melanoma Cell Vaccine [NCIt concept]
- Allogeneic GM-CSF-secreting Tumor Vaccine PANC 10.05 pcDNA-1/GM-Neo [NCIt concept]
- Allogeneic GM-CSF-secreting Tumor Vaccine PANC 6.03 pcDNA-1/GM-Neo [NCIt concept]
- Allogeneic Gamma Delta T-cells GDKM-100 [NCIt concept]
- Allogeneic Gamma-delta T-lymphocytes TCB-008 [NCIt concept]
- Allogeneic Hematopoietic Stem Cell Transplantation [NCIt concept]
- Allogeneic Human Stem Cell-derived Pancreatic Islet Cells VX-880 [NCIt concept]
- Allogeneic Hypoimmune Anti-CD19 CAR T-cells SC291 [NCIt concept]
- Allogeneic IL13-Zetakine/HyTK-Expressing-Glucocorticoid Resistant Cytotoxic T Lymphocytes GRm13Z40-2 [NCIt concept]
- Allogeneic Invariant Natural Killer T-cells agenT-797 [NCIt concept]
- Allogeneic Irradiated Melanoma Cell Vaccine CSF470 [NCIt concept]
- Allogeneic Large Multivalent Immunogen Melanoma Vaccine LP2307 [NCIt concept]
- Allogeneic MUC1-C-specific CAR-T Cells P-MUC1C-ALLO1 [NCIt concept]
- Allogeneic Melanoma Vaccine AGI-101H [NCIt concept]
- Allogeneic NKG2D CAR Memory T-cells [NCIt concept]
- Allogeneic NKG2D-OX40-CD3zeta-CAR-mbIL-15-expressing Natural Killer Cells NKX101 [NCIt concept]
- Allogeneic Natural Killer Cell Line MG4101 [NCIt concept]
- Allogeneic Natural Killer Cell Line NK-92 [NCIt concept]
- Allogeneic Natural Killer Cells CHM 0201 [NCIt concept]
- Allogeneic Natural Killer Cells DVX201 [NCIt concept]
- Allogeneic Natural Killer Cells IDP-023 [NCIt concept]
- Allogeneic Natural Killer Cells PB103 [NCIt concept]
- Allogeneic Natural Killer Cells SAR445419 [NCIt concept]
- Allogeneic Nicotinamide-expanded Natural Killer Cells GDA-201 [NCIt concept]
- Allogeneic Plasmacytoid Dendritic Cells Expressing Lung Tumor Antigens PDC*lung01 [NCIt concept]
- Allogeneic Polymer-encapsulated IL-2-secreting Retinal Pigmented Epithelial Cells AVB-001 [NCIt concept]
- Allogeneic Renal Cell Carcinoma Vaccine MGN1601 [NCIt concept]
- Allogeneic Rituximab Conjugated Gamma Delta T-cells ACE1831 [NCIt concept]
- Allogeneic Third-party Suicide Gene-transduced Anti-HLA-DPB1*0401 CD4+ T-cells CTL 19 [NCIt concept]
- Allogeneic Variable Delta 1 Gamma-delta T-lymphocytes GDX012 [NCIt concept]
- Allogeneic iPSC-derived Anti-CD19-CAR/IL-15-expressing NK Cells CNTY-101 [NCIt concept]
- Allogeneic shRNA-based Anti-BCMA CAR T-cells CYAD-211 [NCIt concept]
- Allovectin-7 [NCIt concept]
- Almurtide [NCIt concept]
- Alobresib [NCIt concept]
- Alofanib [NCIt concept]
- Alomfilimab [NCIt concept]
- Alopecia, CTCAE [NCIt concept]
- Alpelisib [NCIt concept]
- Alpha Galactosylceramide [NCIt concept]
- Alpha Heavy Chain Disease [NCIt concept]
- Alpha V Beta 1 Inhibitor ATN-161 [NCIt concept]
- Alpha V Beta 8 Antagonist PF-06940434 [NCIt concept]
- Alpha-1 Antitrypsin Deficiency [NCIt concept]
- Alpha-Gal AGI-134 [NCIt concept]
- Alpha-PD1/IL2 Fusion Protein AWT020 [NCIt concept]
- Alpha-Thioguanine Deoxyriboside [NCIt concept]
- Alpha-fetoprotein Measurement [NCIt concept]
- Alpha-glucosidase Inhibitor [NCIt concept]
- Alpha-lactalbumin Breast Cancer Vaccine [NCIt concept]
- Alpha-lactalbumin-derived Synthetic Peptide-lipid Complex Alpha1H [NCIt concept]
- Alpha-tocopheryloxyacetic Acid [NCIt concept]
- Alrizomadlin [NCIt concept]
- Alsevalimab [NCIt concept]
- Altered Mental Status [NCIt concept]
- Altiratinib [NCIt concept]
- Altretamine [NCIt concept]
- Aluminum Exposure [NCIt concept]
- Alunacedase Alfa [NCIt concept]
- Alveolar Adenoma [NCIt concept]
- Alveolar Rhabdomyosarcoma [NCIt concept]
- Alveolar Ridge [NCIt concept]
- Alveolar Soft Part Sarcoma [NCIt concept]
- Alvespimycin [NCIt concept]
- Alvespimycin Hydrochloride [NCIt concept]
- Alvocidib [NCIt concept]
- Alvocidib Hydrochloride [NCIt concept]
- Alvocidib Prodrug TP-1287 [NCIt concept]
- Amatuximab [NCIt concept]
- Ambamustine [NCIt concept]
- Ambazone [NCIt concept]
- Amber [NCIt concept]
- Amblyomin-X [NCIt concept]
- Amcasertib [NCIt concept]
- Amcenestrant [NCIt concept]
- Amdizalisib [NCIt concept]
- Amelanotic Melanoma [NCIt concept]
- Ameloblastic Carcinoma [NCIt concept]
- Ameloblastic Fibro-Odontoma [NCIt concept]
- Ameloblastic Fibro-Odontosarcoma [NCIt concept]
- Ameloblastic Fibrodentinoma [NCIt concept]
- Ameloblastic Fibrodentinosarcoma [NCIt concept]
- Ameloblastic Fibroma [NCIt concept]
- Ameloblastic Fibrosarcoma [NCIt concept]
- Ameloblastoma [NCIt concept]
- American Indian or Alaska Native [NCIt concept]
- Ametantrone [NCIt concept]
- Ametumumab [NCIt concept]
- Amifostine [NCIt concept]
- Amino Acid Injection [NCIt concept]
- Aminocamptothecin [NCIt concept]
- Aminocamptothecin Colloidal Dispersion [NCIt concept]
- Aminoflavone Prodrug AFP464 [NCIt concept]
- Aminolevulinic Acid Intravenous Formulation SONALA-001 [NCIt concept]
- Aminopterin [NCIt concept]
- Aminopterin Sodium [NCIt concept]
- Amivantamab [NCIt concept]
- Amivantamab and Recombinant Human Hyaluronidase [NCIt concept]
- Amnesia, CTCAE [NCIt concept]
- Amniotic Fluid [NCIt concept]
- Amolimogene Bepiplasmid [NCIt concept]
- Amonafide L-Malate [NCIt concept]
- Amosite Asbestos [NCIt concept]
- Ampulla of Vater [NCIt concept]
- Ampulla of Vater Pancreatobiliary Type Adenocarcinoma [NCIt concept]
- Ampullary Noninvasive Pancreatobiliary Papillary Neoplasm with High Grade Dysplasia [NCIt concept]
- Ampullary Noninvasive Pancreatobiliary Papillary Neoplasm with Low Grade Dysplasia [NCIt concept]
- Ampullary Noninvasive Papillary Neoplasm, Pancreatobiliary Type [NCIt concept]
- Amredobresib [NCIt concept]
- Amrubicin [NCIt concept]
- Amrubicin Hydrochloride [NCIt concept]
- Amsacrine [NCIt concept]
- Amsacrine Lactate [NCIt concept]
- Amsilarotene [NCIt concept]
- Amustaline [NCIt concept]
- Amustaline Dihydrochloride [NCIt concept]
- Amuvatinib [NCIt concept]
- Amuvatinib Hydrochloride [NCIt concept]
- Anakinra [NCIt concept]
- Anal Canal [NCIt concept]
- Anal Canal Cloacogenic Carcinoma [NCIt concept]
- Anal Carcinoma [NCIt concept]
- Anal Fistula, CTCAE [NCIt concept]
- Anal Glands Adenocarcinoma [NCIt concept]
- Anal Hemorrhage, CTCAE [NCIt concept]
- Anal Intraepithelial Neoplasia 3 [NCIt concept]
- Anal Mucositis, CTCAE [NCIt concept]
- Anal Necrosis, CTCAE [NCIt concept]
- Anal Pain, CTCAE [NCIt concept]
- Anal Sphincter [NCIt concept]
- Anal Stenosis, CTCAE [NCIt concept]
- Anal Transitional Zone [NCIt concept]
- Anal Ulcer, CTCAE [NCIt concept]
- Analysis Metadata [NCIt concept]
- Analyte Type [NCIt concept]
- Anaphylaxis, CTCAE [NCIt concept]
- Anaplasia Descriptor [NCIt concept]
- Anaplasia Indicator [NCIt concept]
- Anaplastic (Malignant) Meningioma [NCIt concept]
- Anaplastic Astrocytoma [NCIt concept]
- Anaplastic Astrocytoma, IDH-Wildtype [NCIt concept]
- Anaplastic Ependymoma [NCIt concept]
- Anaplastic Ganglioglioma [NCIt concept]
- Anaplastic Large Cell Lymphoma [NCIt concept]
- Anaplastic Large Cell Lymphoma, ALK-Negative [NCIt concept]
- Anaplastic Large Cell Lymphoma, ALK-Positive [NCIt concept]
- Anaplastic Lesion [NCIt concept]
- Anaplastic Lymphoma [NCIt concept]
- Anaplastic Medulloblastoma [NCIt concept]
- Anaplastic Oligoastrocytoma [NCIt concept]
- Anaplastic Oligodendroglioma [NCIt concept]
- Anaplastic Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted [NCIt concept]
- Anaplastic Pleomorphic Xanthoastrocytoma [NCIt concept]
- Anastrozole [NCIt concept]
- Anatomic Site for Involved Surgical Margin [NCIt concept]
- Anatomic Site of Maximum Tumor Bulk [NCIt concept]
- Anatomic Site or Organ with Contiguous Invasion [NCIt concept]
- Anaxirone [NCIt concept]
- Anbalcabtagene Autoleucel [NCIt concept]
- Anbenitamab [NCIt concept]
- Ancient DNA Isolation [NCIt concept]
- Ancient Schwannoma [NCIt concept]
- Ancitabine [NCIt concept]
- Ancitabine Hydrochloride [NCIt concept]
- Andecaliximab [NCIt concept]
- Andorra [NCIt concept]
- Androgen Antagonist APC-100 [NCIt concept]
- Androgen Excess [NCIt concept]
- Androgen Receptor Antagonist BAY 1161116 [NCIt concept]
- Androgen Receptor Antagonist TAS3681 [NCIt concept]
- Androgen Receptor Antagonist TQB3720 [NCIt concept]
- Androgen Receptor Antagonist TRC253 [NCIt concept]
- Androgen Receptor Antisense Oligonucleotide AZD5312 [NCIt concept]
- Androgen Receptor Antisense Oligonucleotide EZN-4176 [NCIt concept]
- Androgen Receptor Degrader AC176 [NCIt concept]
- Androgen Receptor Degrader CC-94676 [NCIt concept]
- Androgen Receptor Degrader RO7656594 [NCIt concept]
- Androgen Receptor Downregulator AZD3514 [NCIt concept]
- Androgen Receptor Inhibitor ONCT-534 [NCIt concept]
- Androgen Receptor Ligand-binding Domain-encoding Plasmid DNA Vaccine MVI-118 [NCIt concept]
- Androgen Receptor/Glucocorticoid Receptor Antagonist CB-03-10 [NCIt concept]
- Andrographolide [NCIt concept]
- Androstane Steroid HE3235 [NCIt concept]
- Anemia [NCIt concept]
- Anemia, CTCAE [NCIt concept]
- Anetumab Ravtansine [NCIt concept]
- Aneuploidy [NCIt concept]
- Ang2/VEGF-Binding Peptides-Antibody Fusion Protein CVX-241 [NCIt concept]
- Angiocentric Glioma [NCIt concept]
- Angiocentric Immunoproliferative Lesion [NCIt concept]
- Angiofibroma [NCIt concept]
- Angiogenesis Inhibitor JI-101 [NCIt concept]
- Angiokeratoma [NCIt concept]
- Angioleiomyoma [NCIt concept]
- Angiolipoma [NCIt concept]
- Angiomatoid Fibrous Histiocytoma [NCIt concept]
- Angiomatous Meningioma [NCIt concept]
- Angiomyofibroblastoma [NCIt concept]
- Angiomyolipoma [NCIt concept]
- Angiomyosarcoma [NCIt concept]
- Angiomyxoma [NCIt concept]
- Angiopoietin-2-specific Fusion Protein PF-04856884 [NCIt concept]
- Angiosarcoma [NCIt concept]
- Angola [NCIt concept]
- Anguilla [NCIt concept]
- Anhydrous Enol-oxaloacetate [NCIt concept]
- Anhydrovinblastine [NCIt concept]
- Aniline Mustard [NCIt concept]
- Animal Allergy [NCIt concept]
- Animal Producer [NCIt concept]
- Ankle Fracture, CTCAE [NCIt concept]
- Ankle Joint [NCIt concept]
- Ann Arbor B Symptoms Indicator [NCIt concept]
- Ann Arbor Clinical Stage [NCIt concept]
- Ann Arbor Clinical Stage I [NCIt concept]
- Ann Arbor Clinical Stage II [NCIt concept]
- Ann Arbor Clinical Stage III [NCIt concept]
- Ann Arbor Clinical Stage IV [NCIt concept]
- Ann Arbor Extranodal Involvement Indicator [NCIt concept]
- Ann Arbor Pathologic Stage [NCIt concept]
- Ann Arbor Pathologic Stage I [NCIt concept]
- Ann Arbor Pathologic Stage II [NCIt concept]
- Ann Arbor Pathologic Stage III [NCIt concept]
- Ann Arbor Pathologic Stage IV [NCIt concept]
- Annamycin [NCIt concept]
- Annamycin Liposomal [NCIt concept]
- Annonaceous Acetogenins [NCIt concept]
- Annotated Somatic Variation Data [NCIt concept]
- Anorectal [NCIt concept]
- Anorectal Infection, CTCAE [NCIt concept]
- Anorexia, CTCAE [NCIt concept]
- Anorgasmia, CTCAE [NCIt concept]
- Ansamitomicin P-3 [NCIt concept]
- Antacid Preparation [NCIt concept]
- Antecubital Fossa [NCIt concept]
- Anterior Mediastinum [NCIt concept]
- Anterior Surface of the Epiglottis [NCIt concept]
- Anterior Wall of the Bladder [NCIt concept]
- Anterior Wall of the Nasopharynx [NCIt concept]
- Anthramycin [NCIt concept]
- Anthrapyrazole [NCIt concept]
- Anti c-KIT Antibody-drug Conjugate LOP628 [NCIt concept]
- Anti-4-1BB/5T4 Bispecific Antibody ALG.APV-527 [NCIt concept]
- Anti-4-1BB/PD-L1 Bispecific Antibody PM1003 [NCIt concept]
- Anti-5T4 Antibody-Drug Conjugate PF-06263507 [NCIt concept]
- Anti-5T4 Antibody-drug Conjugate ASN004 [NCIt concept]
- Anti-5T4 Antibody-drug Conjugate SYD1875 [NCIt concept]
- Anti-A33 Monoclonal Antibody KRN330 [NCIt concept]
- Anti-A5B1 Integrin Monoclonal Antibody PF-04605412 [NCIt concept]
- Anti-ACTR/4-1BB/CD3zeta-Viral Vector-transduced Autologous T-Lymphocytes ACTR087 [NCIt concept]
- Anti-AG7 Antibody Drug Conjugate AbGn-107 [NCIt concept]
- Anti-AGS-16 Monoclonal Antibody AGS-16M18 [NCIt concept]
- Anti-AGS-5 Antibody-Drug Conjugate ASG-5ME [NCIt concept]
- Anti-AGS-8 Monoclonal Antibody AGS-8M4 [NCIt concept]
- Anti-ALK-1 Monoclonal Antibody GT90001 [NCIt concept]
- Anti-ALPP/ALPPL2/MMAE ADC SGN-ALPV [NCIt concept]
- Anti-ANG2 Monoclonal Antibody MEDI-3617 [NCIt concept]
- Anti-B7-H3 Antibody DS-5573a [NCIt concept]
- Anti-B7-H3 Antibody-drug Conjugate BAT8009 [NCIt concept]
- Anti-B7-H3 Antibody-drug Conjugate HS-20093 [NCIt concept]
- Anti-B7-H3 Antibody-drug Conjugate MHB088C [NCIt concept]
- Anti-B7-H3 CAR T Cells TAA06 [NCIt concept]
- Anti-B7-H3/CD28 Bispecific Antibody XmAb808 [NCIt concept]
- Anti-B7-H4 Antibody-drug Conjugate SGN-B7H4V [NCIt concept]
- Anti-B7-H4 Antibody-drug Conjugate XMT-1660 [NCIt concept]
- Anti-B7-H4 Monoclonal Antibody NC762 [NCIt concept]
- Anti-B7-H4/ TOP1i Antibody-drug Conjugate AZD8205 [NCIt concept]
- Anti-B7-H4/Anti-4-1BB Bispecific Antibody CLN-418 [NCIt concept]
- Anti-B7-H4/Anti-CD3 Bispecific Antibody GEN1047 [NCIt concept]
- Anti-B7-H4/Anti-CD3 Bispecific Antibody PF-07260437 [NCIt concept]
- Anti-B7-H6/Anti-CD3 Bispecific Antibody BI 765049 [NCIt concept]
- Anti-B7H7 Monoclonal Antibody HBM1020 [NCIt concept]
- Anti-BAFFR Monoclonal Antibody ESG206 [NCIt concept]
- Anti-BCMA Antibody SEA-BCMA [NCIt concept]
- Anti-BCMA Antibody-drug Conjugate AMG 224 [NCIt concept]
- Anti-BCMA CAR-NK Cells [NCIt concept]
- Anti-BCMA SparX Protein Plus BCMA-directed Anti-TAAG ARC T-cells CART-ddBCMA [NCIt concept]
- Anti-BCMA/Alpha-amanitin Antibody-drug Conjugate HDP-101 [NCIt concept]
- Anti-BCMA/Anti-CD3 Bispecific Antibody EMB-06 [NCIt concept]
- Anti-BCMA/Anti-CD3 Bispecific Antibody REGN5459 [NCIt concept]
- Anti-BCMA/Anti-CD3 Bispecific Antibody WVT078 [NCIt concept]
- Anti-BCMA/Anti-CD3 T-cell Engaging Bispecific Antibody ABBV-383 [NCIt concept]
- Anti-BCMA/Anti-GPRC5D CAR-T Cells BMS-986453 [NCIt concept]
- Anti-BCMA/Anti-GPRC5D CAR-T Cells OriC321 [NCIt concept]
- Anti-BCMA/CD38/CD3 Trispecific Antibody ISB 2001 [NCIt concept]
- Anti-BCMA/PBD ADC MEDI2228 [NCIt concept]
- Anti-BTLA Monoclonal Antibody HFB200603 [NCIt concept]
- Anti-BTN3A Agonistic Monoclonal Antibody ICT01 [NCIt concept]
- Anti-C-met Monoclonal Antibody SAIT301 [NCIt concept]
- Anti-CA19-9 Monoclonal Antibody 5B1 [NCIt concept]
- Anti-CA6-DM4 Immunoconjugate SAR566658 [NCIt concept]
- Anti-CAIX CAR T Cells [NCIt concept]
- Anti-CALRmut/Anti-CD3 Bispecific Antibody JNJ-88549968 [NCIt concept]
- Anti-CCR7 Antibody-drug Conjugate JBH492 [NCIt concept]
- Anti-CCR7 Monoclonal Antibody CAP-100 [NCIt concept]
- Anti-CCR8 Monoclonal Antibody BAY3375968 [NCIt concept]
- Anti-CCR8 Monoclonal Antibody BMS-986340 [NCIt concept]
- Anti-CCR8 Monoclonal Antibody CM369 [NCIt concept]
- Anti-CCR8 Monoclonal Antibody GS-1811 [NCIt concept]
- Anti-CCR8 Monoclonal Antibody LM-108 [NCIt concept]
- Anti-CCR8 Monoclonal Antibody S-531011 [NCIt concept]
- Anti-CCR8 Monoclonal Antibody SRF114 [NCIt concept]
- Anti-CCR8 Monoclonal Antibody ZL-1218 [NCIt concept]
- Anti-CD117/Amanitin Antibody-drug Conjugate MGTA-117 [NCIt concept]
- Anti-CD122 Humanized Monoclonal Antibody Mik-Beta-1 [NCIt concept]
- Anti-CD123 Monoclonal Antibody CSL360 [NCIt concept]
- Anti-CD123 Monoclonal Antibody KHK2823 [NCIt concept]
- Anti-CD123-Pyrrolobenzodiazepine Dimer Antibody Drug Conjugate SGN-CD123A [NCIt concept]
- Anti-CD123/Anti-CD3 Bispecific DART Molecule MGD024 [NCIt concept]
- Anti-CD123/CD16A Bispecific Antibody AFM28 [NCIt concept]
- Anti-CD123/CD3 BiTE Antibody SAR440234 [NCIt concept]
- Anti-CD123/CD3 Bispecific Antibody APVO436 [NCIt concept]
- Anti-CD123/CD3 Bispecific Antibody JNJ-63709178 [NCIt concept]
- Anti-CD123/Kinesin Spindle Protein Inhibitor Antibody-drug Conjugate VIP943 [NCIt concept]
- Anti-CD123/TOP1i Antibody-drug Conjugate AZD9829 [NCIt concept]
- Anti-CD137 Agonistic Monoclonal Antibody ADG106 [NCIt concept]
- Anti-CD137 Agonistic Monoclonal Antibody ADG206 [NCIt concept]
- Anti-CD137 Agonistic Monoclonal Antibody AGEN2373 [NCIt concept]
- Anti-CD137 Agonistic Monoclonal Antibody CTX-471 [NCIt concept]
- Anti-CD137 Agonistic Monoclonal Antibody EU101 [NCIt concept]
- Anti-CD137 Agonistic Monoclonal Antibody YH004 [NCIt concept]
- Anti-CD137 Monoclonal Antibody PE0116 [NCIt concept]
- Anti-CD137/Anti-FAP Bispecific Antibody BI 765179 [NCIt concept]
- Anti-CD137/PD-L1 Bispecific Antibody AP203 [NCIt concept]
- Anti-CD137/PD-L1 Bispecific Antibody FS222 [NCIt concept]
- Anti-CD147 Monoclonal Antibody DS-1471 [NCIt concept]
- Anti-CD157 Monoclonal Antibody MEN1112 [NCIt concept]
- Anti-CD163 Monoclonal Antibody OR2805 [NCIt concept]
- Anti-CD19 Antibody-T-cell Receptor-expressing T-cells ET019003 [NCIt concept]
- Anti-CD19 Antibody-drug Conjugate IKS03 [NCIt concept]
- Anti-CD19 Antibody-drug Conjugate SGN-CD19B [NCIt concept]
- Anti-CD19 CAR T Cells AT101 [NCIt concept]
- Anti-CD19 Cord Blood-derived CAR-NK Cells [NCIt concept]
- Anti-CD19 Monoclonal Antibody DI-B4 [NCIt concept]
- Anti-CD19 Monoclonal Antibody MDX-1342 [NCIt concept]
- Anti-CD19 iCAR NK Cells [NCIt concept]
- Anti-CD19-Glucosteroid Receptor Modulator ADC ABBV-31 [NCIt concept]
- Anti-CD19/Anti-CD20/Anti-CD22 CAR-T Cells LCAR-AIO [NCIt concept]
- Anti-CD19/Anti-CD22 Bispecific Immunotoxin DT2219ARL [NCIt concept]
- Anti-CD19/Anti-CD3/Anti-CD2 Trispecific Antibody PIT565 [NCIt concept]
- Anti-CD19/Anti-CD3/Anti-CD28 Trispecific Antibody CC312 [NCIt concept]
- Anti-CD19/CD20/CD22/CD30 CAR-T Cells [NCIt concept]
- Anti-CD19/CD22 CAR NK Cells [NCIt concept]
- Anti-CD19/CD28 Bispecific Antibody RO7443904 [NCIt concept]
- Anti-CD19/CD3 BiTE Antibody AMG 562 [NCIt concept]
- Anti-CD19/CD3 Bispecific Antibody AZD0486 [NCIt concept]
- Anti-CD19/CD3 Bispecific Antibody CN201 [NCIt concept]
- Anti-CD19/CD3 Bispecific Antibody GNR-084 [NCIt concept]
- Anti-CD19/CD3 T-cell Engaging Bispecific Antibody CLN-978 [NCIt concept]
- Anti-CD19/CD3 Tetravalent Antibody AFM11 [NCIt concept]
- Anti-CD1d/Vdelta2 Gamma Delta T-cell Engaging Bispecific Antibody LAVA-051 [NCIt concept]
- Anti-CD20 Antibody-drug Conjugate MRG001 [NCIt concept]
- Anti-CD20 Antibody-drug Conjugate TRS005 [NCIt concept]
- Anti-CD20 Monoclonal Antibody B001 [NCIt concept]
- Anti-CD20 Monoclonal Antibody BAT4306F [NCIt concept]
- Anti-CD20 Monoclonal Antibody MIL62 [NCIt concept]
- Anti-CD20 Monoclonal Antibody PRO131921 [NCIt concept]
- Anti-CD20 Monoclonal Antibody TL011 [NCIt concept]
- Anti-CD20-engineered Toxin Body MT-3724 [NCIt concept]
- Anti-CD20/Anti-CD22 CAR T-cells [NCIt concept]
- Anti-CD20/Anti-CD3 Bispecific Antibody MBS303 [NCIt concept]
- Anti-CD20/CD3 Bispecific Antibody EX103 [NCIt concept]
- Anti-CD20/CD3 Bispecific Antibody JS203 [NCIt concept]
- Anti-CD20/CD37 Monoclonal Antibody Combination PSB202 [NCIt concept]
- Anti-CD20/anti-CD3 Bispecific Antibody CM355 [NCIt concept]
- Anti-CD200R1 Monoclonal Antibody 23ME-00610 [NCIt concept]
- Anti-CD205 Antibody-drug Conjugate OBT076 [NCIt concept]
- Anti-CD22 ADC TRPH-222 [NCIt concept]
- Anti-CD22-CAR m971-BBz Lentiviral Vector-transduced Autologous T Lymphocytes CRG-022 [NCIt concept]
- Anti-CD22/Anti-CD28 Bispecific Antibody REGN5837 [NCIt concept]
- Anti-CD226 Agonist Antibody LY3435151 [NCIt concept]
- Anti-CD228/4-1BB Bispecific Agent SGN-BB228 [NCIt concept]
- Anti-CD228/MMAE Antibody-drug Conjugate SGN-CD228A [NCIt concept]
- Anti-CD24 Monoclonal Antibody ATG-031 [NCIt concept]
- Anti-CD25 Monoclonal Antibody BA1106 [NCIt concept]
- Anti-CD25-IL-2 Monoclonal Antibody AU-007 [NCIt concept]
- Anti-CD26 Monoclonal Antibody YS110 [NCIt concept]
- Anti-CD27 Monoclonal Antibody GEN1053/BNT313 [NCIt concept]
- Anti-CD27L Antibody-Drug Conjugate AMG 172 [NCIt concept]
- Anti-CD3 Immunotoxin A-dmDT390-bisFv(UCHT1) [NCIt concept]
- Anti-CD3/Anti-5T4 Bispecific Antibody GEN1044 [NCIt concept]
- Anti-CD3/Anti-BCMA Bispecific Antibody TQB2934 [NCIt concept]
- Anti-CD3/Anti-CD20 Trifunctional Bispecific Monoclonal Antibody FBTA05 [NCIt concept]
- Anti-CD3/Anti-Claudin18.2 Bispecific Antibody IBI389 [NCIt concept]
- Anti-CD3/Anti-GUCY2C Bispecific Antibody PF-07062119 [NCIt concept]
- Anti-CD3/CD19/CD20 Trispecific Antibody 1A46 [NCIt concept]
- Anti-CD3/CD38 Bispecific Monoclonal Antibody AMG 424 [NCIt concept]
- Anti-CD3/CD38 Bispecific Monoclonal Antibody IGM-2644 [NCIt concept]
- Anti-CD3/CD7-Ricin Toxin A Immunotoxin [NCIt concept]
- Anti-CD30 Monoclonal Antibody MDX-1401 [NCIt concept]
- Anti-CD30 Monoclonal Antibody XmAb2513 [NCIt concept]
- Anti-CD30/CD3 Bispecific Antibody GEN3017 [NCIt concept]
- Anti-CD30/DM1 Antibody-drug Conjugate F0002 [NCIt concept]
- Anti-CD32B Monoclonal Antibody BI-1206 [NCIt concept]
- Anti-CD33 Antibody-drug Conjugate IMGN779 [NCIt concept]
- Anti-CD33 Monoclonal Antibody BI 836858 [NCIt concept]
- Anti-CD33 Monoclonal Antibody-DM4 Conjugate AVE9633 [NCIt concept]
- Anti-CD33/CD123/CD70 DARPin CD3 Engager MP0533 [NCIt concept]
- Anti-CD33/CD3 Bispecific Antibody GEM 333 [NCIt concept]
- Anti-CD33/CD3 Bispecific Antibody JNJ-67571244 [NCIt concept]
- Anti-CD352 Antibody-drug Conjugate SGN-CD352A [NCIt concept]
- Anti-CD37 MMAE Antibody-drug Conjugate AGS67E [NCIt concept]
- Anti-CD37 Monoclonal Antibody BI 836826 [NCIt concept]
- Anti-CD38 Antibody-drug Conjugate STI-6129 [NCIt concept]
- Anti-CD38 Monoclonal Antibody CID-103 [NCIt concept]
- Anti-CD38 Monoclonal Antibody SAR442085 [NCIt concept]
- Anti-CD38 Monoclonal Antibody SG301 [NCIt concept]
- Anti-CD38/Anti-CD47 Bispecific Antibody ISB 1442 [NCIt concept]
- Anti-CD38/CD28xCD3 Tri-specific Monoclonal Antibody SAR442257 [NCIt concept]
- Anti-CD38/CD3 Bispecific Monoclonal Antibody GBR 1342 [NCIt concept]
- Anti-CD38/CD3 Bispecific Monoclonal Antibody XmAb18968 [NCIt concept]
- Anti-CD39 Antibody/TGF-beta RII Ectodomain Fusion Protein ES014 [NCIt concept]
- Anti-CD39 Monoclonal Antibody AB598 [NCIt concept]
- Anti-CD39 Monoclonal Antibody IPH5201 [NCIt concept]
- Anti-CD39 Monoclonal Antibody JS019 [NCIt concept]
- Anti-CD39 Monoclonal Antibody PUR001 [NCIt concept]
- Anti-CD39 Monoclonal Antibody TTX-030 [NCIt concept]
- Anti-CD40 Agonist Antibody YH003 [NCIt concept]
- Anti-CD40 Agonist Monoclonal Antibody CDX-1140 [NCIt concept]
- Anti-CD40 Agonist Monoclonal Antibody MIL97 [NCIt concept]
- Anti-CD40 Monoclonal Antibody Chi Lob 7/4 [NCIt concept]
- Anti-CD40/Anti-mesothelin Bispecific Antibody ABBV-428 [NCIt concept]
- Anti-CD44 Monoclonal Antibody RO5429083 [NCIt concept]
- Anti-CD45 Monoclonal Antibody AHN-12 [NCIt concept]
- Anti-CD46 Antibody-drug Conjugate FOR46 [NCIt concept]
- Anti-CD47 ADC SGN-CD47M [NCIt concept]
- Anti-CD47 Monoclonal Antibody AO-176 [NCIt concept]
- Anti-CD47 Monoclonal Antibody CC-90002 [NCIt concept]
- Anti-CD47 Monoclonal Antibody HMPL-A83 [NCIt concept]
- Anti-CD47 Monoclonal Antibody IMC-002 [NCIt concept]
- Anti-CD47 Monoclonal Antibody MIL95 [NCIt concept]
- Anti-CD47 Monoclonal Antibody SHR-1603 [NCIt concept]
- Anti-CD47 Monoclonal Antibody STI-6643 [NCIt concept]
- Anti-CD47 Monoclonal Antibody ZL-1201 [NCIt concept]
- Anti-CD47/Anti-HER2 Bispecific Antibody IMM2902 [NCIt concept]
- Anti-CD47/Anti-PD-L1 Bispecific Antibody 6MW3211 [NCIt concept]
- Anti-CD47/Anti-PD-L1 Bispecific Antibody PF-07257876 [NCIt concept]
- Anti-CD47/Anti-mesothelin Bispecific Antibody NI-1801 [NCIt concept]
- Anti-CD47/CD20 Bispecific Antibody IMM0306 [NCIt concept]
- Anti-CD48/MMAE Antibody-drug Conjugate SGN-CD48A [NCIt concept]
- Anti-CD52 Monoclonal Antibody ALLO-647 [NCIt concept]
- Anti-CD7 CAR T Cells BT-007 [NCIt concept]
- Anti-CD7 CAR T Cells SenL-T7 [NCIt concept]
- Anti-CD7 CAR-T Cells RD13-02 [NCIt concept]
- Anti-CD70 Antibody-Drug Conjugate MDX-1203 [NCIt concept]
- Anti-CD70 Antibody-drug Conjugate PRO1160 [NCIt concept]
- Anti-CD70 Antibody-drug Conjugate SGN-CD70A [NCIt concept]
- Anti-CD70 CAR-expressing T Lymphocytes [NCIt concept]
- Anti-CD70 Monoclonal Antibody IMM40H [NCIt concept]
- Anti-CD70 Monoclonal Antibody MDX-1411 [NCIt concept]
- Anti-CD70 Monoclonal Antibody SEA-CD70 [NCIt concept]
- Anti-CD71/vcMMAE Probody-drug Conjugate CX-2029 [NCIt concept]
- Anti-CD73 Monoclonal Antibody BMS-986179 [NCIt concept]
- Anti-CD73 Monoclonal Antibody HB0045 [NCIt concept]
- Anti-CD73 Monoclonal Antibody HLX23 [NCIt concept]
- Anti-CD73 Monoclonal Antibody IBI325 [NCIt concept]
- Anti-CD73 Monoclonal Antibody JAB-BX102 [NCIt concept]
- Anti-CD73 Monoclonal Antibody NZV930 [NCIt concept]
- Anti-CD73 Monoclonal Antibody PT199 [NCIt concept]
- Anti-CD73 Monoclonal Antibody Sym024 [NCIt concept]
- Anti-CD74 Antibody-drug Conjugate STRO-001 [NCIt concept]
- Anti-CD79b CAR T Cells [NCIt concept]
- Anti-CD8b Antibody/IL-2 Mutein Fusion Protein AB248 [NCIt concept]
- Anti-CD93 Monoclonal Antibody DCBY02 [NCIt concept]
- Anti-CD93 Monoclonal Antibody DCSZ11 [NCIt concept]
- Anti-CD98 Monoclonal Antibody IGN523 [NCIt concept]
- Anti-CDH17/Anti-CD3 Bispecific Antibody ARB202 [NCIt concept]
- Anti-CDH3/MSLN BiTE Antibody AMG 305 [NCIt concept]
- Anti-CDH6 Antibody-drug Conjugate HKT288 [NCIt concept]
- Anti-CEA BiTE Monoclonal Antibody AMG211 [NCIt concept]
- Anti-CEA/Anti-4-1BB Bispecific Antibody BGB-B167 [NCIt concept]
- Anti-CEA/Anti-CD3 Bispecific Antibody BA1202 [NCIt concept]
- Anti-CEA/Anti-CEACAM6 Antibody-drug Conjugate EBC-129 [NCIt concept]
- Anti-CEA/Anti-DTPA-In (F6-734) Bispecific Antibody [NCIt concept]
- Anti-CEA/Anti-HSG Bispecific Monoclonal Antibody TF2 [NCIt concept]
- Anti-CEACAM1 Monoclonal Antibody CM-24 [NCIt concept]
- Anti-CEACAM5 ADC SGN-CEACAM5C [NCIt concept]
- Anti-CEACAM5 Antibody-drug Conjugate M9140 [NCIt concept]
- Anti-CEACAM6 AFAIKL2 Antibody Fragment/Jack Bean Urease Immunoconjugate L-DOS47 [NCIt concept]
- Anti-CFH Monoclonal Antibody GT103 [NCIt concept]
- Anti-CLDN18.2 Antibody-drug Conjugate TQB2103 [NCIt concept]
- Anti-CLDN18.2 CAR T Cells LY011 [NCIt concept]
- Anti-CLDN18.2 CAR-T Cells AZD6422 [NCIt concept]
- Anti-CLDN18.2 Heavy Chain Antibody Fc Fusion Protein DR30303 [NCIt concept]
- Anti-CLDN18.2 Monoclonal Antibody ZL-1211 [NCIt concept]
- Anti-CLDN18.2/Anti-CD3 Bispecific Antibody ASP2138 [NCIt concept]
- Anti-CLDN18.2/CD47 Bispecific Antibody SG1906 [NCIt concept]
- Anti-CLDN6 Antibody-drug Conjugate DS-9606a [NCIt concept]
- Anti-CLDN6 CAR T-cells [NCIt concept]
- Anti-CLDN6 Monoclonal Antibody ASP1650 [NCIt concept]
- Anti-CLDN6/CD3 BiTE Antibody AMG 794 [NCIt concept]
- Anti-CLDN6/CD3 Bispecific Antibody SAIL66 [NCIt concept]
- Anti-CLL1-PBD ADC DCLL9718S [NCIt concept]
- Anti-CLL1/Anti-CD33 CAR-T Cells LCAR-AMDR [NCIt concept]
- Anti-CSF1 Monoclonal Antibody PD-0360324 [NCIt concept]
- Anti-CSF1R Monoclonal Antibody AMB-05X [NCIt concept]
- Anti-CSF1R Monoclonal Antibody IMC-CS4 [NCIt concept]
- Anti-CTLA-4 Monoclonal Antibody ADU-1604 [NCIt concept]
- Anti-CTLA-4 Monoclonal Antibody IBI310 [NCIt concept]
- Anti-CTLA-4 Monoclonal Antibody KD6001 [NCIt concept]
- Anti-CTLA-4 Monoclonal Antibody REGN4659 [NCIt concept]
- Anti-CTLA-4 Monoclonal Antibody XTX101 [NCIt concept]
- Anti-CTLA-4 Monoclonal Antibody YH001 [NCIt concept]
- Anti-CTLA-4 Monoclonal Antibody-IL-15/IL-15Ra Fusion Protein JK08 [NCIt concept]
- Anti-CTLA-4 Probody BMS-986288 [NCIt concept]
- Anti-CTLA-4/Anti-PD-1 Monoclonal Antibody Combination BCD-217 [NCIt concept]
- Anti-CTLA-4/OX40 Bispecific Antibody ATOR-1015 [NCIt concept]
- Anti-CTLA4 Antibody Fc Fusion Protein KN044 [NCIt concept]
- Anti-CTLA4 Monoclonal Antibody BMS-986218 [NCIt concept]
- Anti-CXCR4 Monoclonal Antibody PF-06747143 [NCIt concept]
- Anti-Claudin 18.2 Antibody-drug Conjugate EO-3021 [NCIt concept]
- Anti-Claudin 18.2 Antibody-drug Conjugate JS107 [NCIt concept]
- Anti-Claudin 18.2 Antibody-drug Conjugate SKB315 [NCIt concept]
- Anti-Claudin 18.2 Antibody-drug Conjugate SOT102 [NCIt concept]
- Anti-Claudin-18.2 Monoclonal Antibody NBL-015 [NCIt concept]
- Anti-Claudin-18.2 Monoclonal Antibody SPX-101 [NCIt concept]
- Anti-Claudin18.2 ADC CMG901 [NCIt concept]
- Anti-Claudin18.2 Antibody-drug Conjugate IBI343 [NCIt concept]
- Anti-Claudin18.2 CAR T Cells IBI345 [NCIt concept]
- Anti-Claudin18.2 CAR T Cells LCAR-C18S [NCIt concept]
- Anti-Claudin18.2 CAR-T Cells IM92 [NCIt concept]
- Anti-Claudin18.2/Anti-4-1BB Bispecific Antibody PM1032 [NCIt concept]
- Anti-Claudin18.2/Anti-CD3 Bispecific Antibody QLS31905 [NCIt concept]
- Anti-Claudin18.2/Anti-CD47 Bispecific Antibody PT886 [NCIt concept]
- Anti-DDR1 Monoclonal Antibody PRTH-101 [NCIt concept]
- Anti-DKK1 Monoclonal Antibody BHQ880 [NCIt concept]
- Anti-DKK1 Monoclonal Antibody JS015 [NCIt concept]
- Anti-DLK-1 Antibody-drug Conjugate ADCT-701 [NCIt concept]
- Anti-DLL3 ADC ZL-1310 [NCIt concept]
- Anti-DLL3/Anti-CD47 Bispecific Antibody PT217 [NCIt concept]
- Anti-DLL3/CD3 Bispecific Antibody BI 764532 [NCIt concept]
- Anti-DLL3/CD3 Bispecific Antibody QLS31904 [NCIt concept]
- Anti-DLL3/CD3/CD137 Trispecific Antibody RG6524 [NCIt concept]
- Anti-DLL3/DLL3/CD3 Trispecific Antibody ZG006 [NCIt concept]
- Anti-DLL4 Monoclonal Antibody MEDI0639 [NCIt concept]
- Anti-DLL4/Anti-VEGF-A Bispecific Antibody CTX-009 [NCIt concept]
- Anti-DR5 Agonist Monoclonal Antibody TRA-8 [NCIt concept]
- Anti-DR5 Agonistic Antibody DS-8273a [NCIt concept]
- Anti-DR5 Agonistic Monoclonal Antibody IGM-8444 [NCIt concept]
- Anti-DR5 Agonistic Monoclonal Antibody INBRX-109 [NCIt concept]
- Anti-Denatured Collagen Monoclonal Antibody TRC093 [NCIt concept]
- Anti-EDB Antibody-drug Conjugate PYX-201 [NCIt concept]
- Anti-EGFR Antibody-drug Conjugate ABBV-637 [NCIt concept]
- Anti-EGFR Antibody-drug Conjugate CPO301 [NCIt concept]
- Anti-EGFR Antibody-drug Conjugate MRG003 [NCIt concept]
- Anti-EGFR Gamma Delta T-cell Engaging Bispecific Antibody SGN-EGFRd2 [NCIt concept]
- Anti-EGFR Monoclonal Antibody CPGJ 602 [NCIt concept]
- Anti-EGFR Monoclonal Antibody EMD 55900 [NCIt concept]
- Anti-EGFR Monoclonal Antibody GC1118 [NCIt concept]
- Anti-EGFR Monoclonal Antibody GT-MAB 5.2-GEX [NCIt concept]
- Anti-EGFR Monoclonal Antibody Mixture MM-151 [NCIt concept]
- Anti-EGFR Monoclonal Antibody SCT200 [NCIt concept]
- Anti-EGFR Monoclonal Antibody SYN004 [NCIt concept]
- Anti-EGFR Monoclonal Antibody ZZ06 [NCIt concept]
- Anti-EGFR/Anti-4-1BB Bispecific Antibody HLX35 [NCIt concept]
- Anti-EGFR/CD16A Bispecific Antibody AFM24 [NCIt concept]
- Anti-EGFR/DM1 Antibody-drug Conjugate AVID100 [NCIt concept]
- Anti-EGFR/HER2/HER3 Monoclonal Antibody Mixture Sym013 [NCIt concept]
- Anti-EGFR/LGR5 Bispecific Antibody MCLA-158 [NCIt concept]
- Anti-EGFR/anti-CD3 Tumor Protease-activated T-cell Engager JANX008 [NCIt concept]
- Anti-EGFR/anti-HER3 Antibody-drug Conjugate BL-B01D1 [NCIt concept]
- Anti-EGFR/c-MET/c-MET Trispecific Antibody GB263T [NCIt concept]
- Anti-EGFR/c-Met Bispecific Antibody CKD-702 [NCIt concept]
- Anti-EGFR/c-Met/TOP1i ADC AZD9592 [NCIt concept]
- Anti-EGFRvIII Antibody Drug Conjugate AMG 595 [NCIt concept]
- Anti-EGFRvIII Immunotoxin MR1-1 [NCIt concept]
- Anti-EGFRvIII-CAR-CD3/EGFR BiTE-transduced Autologous T-lymphocytes CARv3-TEAM-E [NCIt concept]
- Anti-EGFRvIII/CD3 Bispecific Antibody RO7428731 [NCIt concept]
- Anti-EGFRvIII/CD3 Bispecific Antibody hEGFRvIII:CD3 bi-scFv [NCIt concept]
- Anti-EGP-2 Immunotoxin MOC31-PE [NCIt concept]
- Anti-ENPP3 Antibody-Drug Conjugate AGS-16C3F [NCIt concept]
- Anti-ENPP3/Anti-CD3 Bispecific Antibody XmAb819 [NCIt concept]
- Anti-ENPP3/MMAF Antibody-Drug Conjugate AGS-16M8F [NCIt concept]
- Anti-ETBR/MMAE Antibody-Drug Conjugate DEDN6526A [NCIt concept]
- Anti-Ep-CAM Monoclonal Antibody ING-1 [NCIt concept]
- Anti-EpCAM Monoclonal Antibody AM-928 [NCIt concept]
- Anti-EpCAM/Anti-4-1BB Bispecific Antibody BNT314 [NCIt concept]
- Anti-EpCAM/Anti-CD3 Bispecific Antibody A-337 [NCIt concept]
- Anti-EpCAM/Anti-CD3 Bispecific Antibody BA3182 [NCIt concept]
- Anti-EpCAM/Anti-CD3 Bispecific Antibody M701 [NCIt concept]
- Anti-EphA2 Antibody-directed Liposomal Docetaxel Prodrug MM-310 [NCIt concept]
- Anti-EphA2 Monoclonal Antibody DS-8895a [NCIt concept]
- Anti-EphA2 Monoclonal Antibody-MMAF Immunoconjugate MEDI-547 [NCIt concept]
- Anti-ErbB2/Anti-ErbB3 Bispecific Monoclonal Antibody MM-111 [NCIt concept]
- Anti-ErbB3 Monoclonal Antibody AV-203 [NCIt concept]
- Anti-ErbB3 Monoclonal Antibody CDX-3379 [NCIt concept]
- Anti-ErbB3 Monoclonal Antibody REGN1400 [NCIt concept]
- Anti-FAP Antibody-drug Conjugate OMTX705 [NCIt concept]
- Anti-FGFR3 Antibody-drug Conjugate LY3076226 [NCIt concept]
- Anti-FGFR4 Monoclonal Antibody U3-1784 [NCIt concept]
- Anti-FLT3 Antibody-drug Conjugate AGS62P1 [NCIt concept]
- Anti-FLT3 Monoclonal Antibody 4G8-SDIEM [NCIt concept]
- Anti-FLT3 Monoclonal Antibody IMC-EB10 [NCIt concept]
- Anti-FLT3/CD3 Bispecific Antibody CLN-049 [NCIt concept]
- Anti-FOLR1 CoStAR-expressing Autologous Tumor-infiltrating Lymphocytes ITIL-306 [NCIt concept]
- Anti-FOXP3 Antisense Oligonucleotide AZD8701 [NCIt concept]
- Anti-FRa Antibody-drug Conjugate AZD5335 [NCIt concept]
- Anti-FRa/DM21 ADC IMGN151 [NCIt concept]
- Anti-FRalpha/Exatecan ADC PRO1184 [NCIt concept]
- Anti-Factor Bb Monoclonal Antibody NM8074 [NCIt concept]
- Anti-GARP Monoclonal Antibody DS-1055a [NCIt concept]
- Anti-GARP Monoclonal Antibody HLX60 [NCIt concept]
- Anti-GARP Monoclonal Antibody JYB1907 [NCIt concept]
- Anti-GARP/PD-L1 Bispecific Antibody BPB-101 [NCIt concept]
- Anti-GCC Antibody-Drug Conjugate TAK-164 [NCIt concept]
- Anti-GD2 Monoclonal Antibody BCD-245 [NCIt concept]
- Anti-GD2 Monoclonal Antibody MORAb-028 [NCIt concept]
- Anti-GD2 Monoclonal Antibody hu14.18K322A [NCIt concept]
- Anti-GD3 Antibody-drug Conjugate PF-06688992 [NCIt concept]
- Anti-GDF15 Monoclonal Antibody AV-380 [NCIt concept]
- Anti-GITR Agonistic Monoclonal Antibody ASP1951 [NCIt concept]
- Anti-GITR Agonistic Monoclonal Antibody BMS-986156 [NCIt concept]
- Anti-GITR AgonisticMonoclonal Antibody REGN6569 [NCIt concept]
- Anti-GITR Monoclonal Antibody GWN 323 [NCIt concept]
- Anti-GITR Monoclonal Antibody MK-4166 [NCIt concept]
- Anti-GPC3 CAR T-lymphocytes AZD5851 [NCIt concept]
- Anti-GPC3/Anti-CD3 Bispecific Antibody CM350 [NCIt concept]
- Anti-GPC3/TCR Nanobody SAR444200 [NCIt concept]
- Anti-GPR20/DXd Antibody-drug Conjugate DS-6157a [NCIt concept]
- Anti-GPRC5D/anti-CD3 Bispecific Antibody LBL-034 [NCIt concept]
- Anti-GRP78 Monoclonal Antibody PAT-SM6 [NCIt concept]
- Anti-GUCY2C CAR-T Cells [NCIt concept]
- Anti-Ganglioside GM2 Monoclonal Antibody BIW-8962 [NCIt concept]
- Anti-Globo H Monoclonal Antibody OBI-888 [NCIt concept]
- Anti-Globo H/MMAE Antibody-drug Conjugate OBI 999 [NCIt concept]
- Anti-Glypican 3/CD3 Bispecific Antibody ERY974 [NCIt concept]
- Anti-GnRH Vaccine PEP223 [NCIt concept]
- Anti-HA Epitope Monoclonal Antibody MEDI8852 [NCIt concept]
- Anti-HB-EGF Monoclonal Antibody KHK2866 [NCIt concept]
- Anti-HBEGF Monoclonal Antibody U3-1565 [NCIt concept]
- Anti-HER2 ADC BB-1701 [NCIt concept]
- Anti-HER2 Antibody Conjugated Natural Killer Cells ACE1702 [NCIt concept]
- Anti-HER2 Antibody-drug Conjugate BAT8001 [NCIt concept]
- Anti-HER2 Antibody-drug Conjugate BAT8010 [NCIt concept]
- Anti-HER2 Antibody-drug Conjugate BL-M07D1 [NCIt concept]
- Anti-HER2 Antibody-drug Conjugate DB-1303 [NCIt concept]
- Anti-HER2 Antibody-drug Conjugate DP303c [NCIt concept]
- Anti-HER2 Antibody-drug Conjugate IBI354 [NCIt concept]
- Anti-HER2 Antibody-drug Conjugate JSKN003 [NCIt concept]
- Anti-HER2 Antibody-drug Conjugate MEDI4276 [NCIt concept]
- Anti-HER2 Bispecific Antibody KM257 [NCIt concept]
- Anti-HER2 Bispecific Antibody TQB2930 [NCIt concept]
- Anti-HER2 Bispecific Antibody-drug Conjugate ZW49 [NCIt concept]
- Anti-HER2 GSPT1 Degrader ORM-5029 [NCIt concept]
- Anti-HER2 Immune Stimulator-antibody Conjugate NJH395 [NCIt concept]
- Anti-HER2 Molecule AIP-303 [NCIt concept]
- Anti-HER2 Monoclonal Antibody B002 [NCIt concept]
- Anti-HER2 Monoclonal Antibody BAT1006 [NCIt concept]
- Anti-HER2 Monoclonal Antibody BAY2701438 [NCIt concept]
- Anti-HER2 Monoclonal Antibody HLX22 [NCIt concept]
- Anti-HER2 Monoclonal Antibody QL1209 [NCIt concept]
- Anti-HER2-DM1 ADC B003 [NCIt concept]
- Anti-HER2-DM1 Antibody-drug Conjugate GQ1001 [NCIt concept]
- Anti-HER2-STING Agonist ADC XMT-2056 [NCIt concept]
- Anti-HER2-vc0101 ADC PF-06804103 [NCIt concept]
- Anti-HER2/4-1BB Bispecific Antibody YH32367 [NCIt concept]
- Anti-HER2/Anti-CD3 Bispecific Antibody M802 [NCIt concept]
- Anti-HER2/Anti-CD3 Bispecific Monoclonal Antibody GBR 1302 [NCIt concept]
- Anti-HER2/Anti-PD-1 Bispecific Antibody SSGJ-705 [NCIt concept]
- Anti-HER2/Auristatin Payload Antibody-drug Conjugate XMT-1522 [NCIt concept]
- Anti-HER2/CD3/CD28 Tri-specific Antibody SAR443216 [NCIt concept]
- Anti-HER2/CD3/XTEN Protease-activated T-cell Engager AMX-818 [NCIt concept]
- Anti-HER2/HER2 Bispecific ADC KM501 [NCIt concept]
- Anti-HER2/PBD-MA Antibody-drug Conjugate DHES0815A [NCIt concept]
- Anti-HER2/Topoisomerase I Inhibitor ADC TQB2102 [NCIt concept]
- Anti-HER3 Antibody-drug Conjugate SHR-A2009 [NCIt concept]
- Anti-HER3 Antibody-drug Conjugate YL202 [NCIt concept]
- Anti-HER3 Monoclonal Antibody GSK2849330 [NCIt concept]
- Anti-HER3 Monoclonal Antibody SIBP-03 [NCIt concept]
- Anti-HER3/Topoisomerase I Inhibitor Antibody-drug Conjugate DB-1310 [NCIt concept]
- Anti-HGF Monoclonal Antibody TAK-701 [NCIt concept]
- Anti-HGF Monoclonal Antibody YYB101 [NCIt concept]
- Anti-HIF-1alpha LNA Antisense Oligonucleotide EZN-2968 [NCIt concept]
- Anti-HIV-1 Lentiviral Vector-expressing sh5/C46 Cal-1 [NCIt concept]
- Anti-HLA-A2-MAGE-A4/Anti-CD3 Bispecific Antibody RO7444973 [NCIt concept]
- Anti-HLA-A2-WT1/Anti-CD3 T-cell Engaging Bispecific Antibody RO7283420 [NCIt concept]
- Anti-HLA-DR Monoclonal Antibody IMMU-114 [NCIt concept]
- Anti-HLA-G Antibody TTX-080 [NCIt concept]
- Anti-HLA-G/CD3 Bispecific Antibody JNJ-78306358 [NCIt concept]
- Anti-HPV16 TCR-engineered T-cells CRTE7A2-01 [NCIt concept]
- Anti-ICOS Agonist Monoclonal Antibody BMS-986226 [NCIt concept]
- Anti-ICOS Monoclonal Antibody MEDI-570 [NCIt concept]
- Anti-IGF-1R Recombinant Monoclonal Antibody BIIB022 [NCIt concept]
- Anti-IGFBP2 Plasmid DNA Vaccine AST-201 [NCIt concept]
- Anti-IGSF8 Monoclonal Antibody GV20-0251 [NCIt concept]
- Anti-IL-11 Monoclonal Antibody 9MW3811 [NCIt concept]
- Anti-ILT2 Monoclonal Antibody AGEN1571 [NCIt concept]
- Anti-ILT2 Monoclonal Antibody BND-22 [NCIt concept]
- Anti-ILT2/Anti-ILT4 Monoclonal Antibody NGM707 [NCIt concept]
- Anti-ILT4 Monoclonal Antibody MK-4830 [NCIt concept]
- Anti-Integrin Monoclonal Antibody-DM4 Immunoconjugate IMGN388 [NCIt concept]
- Anti-KAAG1 Antibody-Drug Conjugate ADCT-901 [NCIt concept]
- Anti-KIR Monoclonal Antibody IPH 2101 [NCIt concept]
- Anti-KIR3DL3 Monoclonal Antibody NPX267 [NCIt concept]
- Anti-KLK2 CAR-T Cells JNJ-75229414 [NCIt concept]
- Anti-KLK2/CD3 Bispecific Antibody JNJ-78278343 [NCIt concept]
- Anti-KSP/Anti-VEGF siRNAs ALN-VSP02 [NCIt concept]
- Anti-LAG-3 Monoclonal Antibody GLS-012 [NCIt concept]
- Anti-LAG-3 Monoclonal Antibody HLX26 [NCIt concept]
- Anti-LAG-3 Monoclonal Antibody LBL-007 [NCIt concept]
- Anti-LAG-3 Monoclonal Antibody TQB2223 [NCIt concept]
- Anti-LAG-3/Anti-PD-L1 Bispecific Antibody IBI323 [NCIt concept]
- Anti-LAG-3/PD-1 Bispecific Antibody INCA32459 [NCIt concept]
- Anti-LAG-3/PD-L1 Bispecific Antibody FS118 [NCIt concept]
- Anti-LAG-3/TIGIT Bispecific Antibody ZGGS15 [NCIt concept]
- Anti-LAIR1 Monoclonal Antibody NC525 [NCIt concept]
- Anti-LAIR1 Monoclonal Antibody NGM438 [NCIt concept]
- Anti-LAMP1 Antibody-drug Conjugate SAR428926 [NCIt concept]
- Anti-LGR5 Monoclonal Antibody BNC101 [NCIt concept]
- Anti-LILRB Monoclonal Antibody ADA-011 [NCIt concept]
- Anti-LILRB2 Monoclonal Antibody BMS-986406 [NCIt concept]
- Anti-LILRB2 Monoclonal Antibody IO-108 [NCIt concept]
- Anti-LILRB2 Monoclonal Antibody OR502 [NCIt concept]
- Anti-LILRB4 Monoclonal Antibody IO-202 [NCIt concept]
- Anti-LILRB4 Monoclonal Antibody NGM831 [NCIt concept]
- Anti-LIV-1 Antibody-drug Conjugate BRY812 [NCIt concept]
- Anti-Lewis B/Lewis Y Monoclonal Antibody GNX102 [NCIt concept]
- Anti-Ly6E Antibody-Drug Conjugate RG 7841 [NCIt concept]
- Anti-MAGE-A4 T-cell Receptor/Anti-CD3 scFv Fusion Protein IMC-C103C [NCIt concept]
- Anti-MET x MET Antibody Drug Conjugate REGN5093-M114 [NCIt concept]
- Anti-MICA/MICB Monoclonal Antibody CLN-619 [NCIt concept]
- Anti-MSLN CAR-T Cells LCAR-M23 [NCIt concept]
- Anti-MUC1 Monoclonal Antibody BTH1704 [NCIt concept]
- Anti-MUC1/EGFR Bispecific Antibody Drug Conjugate M1231 [NCIt concept]
- Anti-MUC16/Anti-CD3 Bispecific Antibody LBL-033 [NCIt concept]
- Anti-MUC16/CD28 Bispecific Antibody REGN5668 [NCIt concept]
- Anti-MUC16/MMAE Antibody-Drug Conjugate DMUC4064A [NCIt concept]
- Anti-Melanin Monoclonal Antibody PTI-6D2 [NCIt concept]
- Anti-Met Monoclonal Antibody Mixture Sym015 [NCIt concept]
- Anti-Met/EGFR Monoclonal Antibody LY3164530 [NCIt concept]
- Anti-NKG2A Monoclonal Antibody BMS-986315 [NCIt concept]
- Anti-NKG2A Monoclonal Antibody Sym025 [NCIt concept]
- Anti-NRP1 Antibody ASP1948 [NCIt concept]
- Anti-NY-ESO-1 Immunotherapeutic GSK-2241658A [NCIt concept]
- Anti-NY-ESO1/LAGE-1A TCR/scFv Anti-CD3 IMCnyeso [NCIt concept]
- Anti-NaPi2b Antibody-drug Conjugate XMT-1592 [NCIt concept]
- Anti-Nucleolin Aptamer AS1411 [NCIt concept]
- Anti-OFA Immunotherapeutic BB-MPI-03 [NCIt concept]
- Anti-OX40 Agonist Monoclonal Antibody BAT6026 [NCIt concept]
- Anti-OX40 Agonist Monoclonal Antibody BGB-A445 [NCIt concept]
- Anti-OX40 Agonist Monoclonal Antibody HFB301001 [NCIt concept]
- Anti-OX40 Agonist Monoclonal Antibody YH-002 [NCIt concept]
- Anti-OX40 Antibody BMS 986178 [NCIt concept]
- Anti-OX40 Hexavalent Agonist Antibody INBRX-106 [NCIt concept]
- Anti-OX40 Monoclonal Antibody GSK3174998 [NCIt concept]
- Anti-OX40/CD137 Bispecific Antibody FS120 [NCIt concept]
- Anti-PD-1 Antibody AI-025/Anti-CTLA-4 Antibody ONC-392 Combination Formulation AI-061 [NCIt concept]
- Anti-PD-1 Fusion Protein AMP-224 [NCIt concept]
- Anti-PD-1 Monoclonal Antibody 609A [NCIt concept]
- Anti-PD-1 Monoclonal Antibody BAT1306 [NCIt concept]
- Anti-PD-1 Monoclonal Antibody BAT1308 [NCIt concept]
- Anti-PD-1 Monoclonal Antibody GNR-051 [NCIt concept]
- Anti-PD-1 Monoclonal Antibody MEDI0680 [NCIt concept]
- Anti-PD-1 Monoclonal Antibody MW11 [NCIt concept]
- Anti-PD-1 Monoclonal Antibody OSE-279 [NCIt concept]
- Anti-PD-1 Monoclonal Antibody PE0105 [NCIt concept]
- Anti-PD-1 Monoclonal Antibody QL1604 [NCIt concept]
- Anti-PD-1 Monoclonal Antibody SHR-1901 [NCIt concept]
- Anti-PD-1 Monoclonal Antibody SYN125 [NCIt concept]
- Anti-PD-1 Monoclonal Antibody Sym021 [NCIt concept]
- Anti-PD-1 Monoclonal Antibody TY101 [NCIt concept]
- Anti-PD-1 siRNA PH-762 [NCIt concept]
- Anti-PD-1-IL-15 Prodrug Fusion Molecule ASKG915 [NCIt concept]
- Anti-PD-1/Anti-4-1BB Bispecific Antibody IBI-319 [NCIt concept]
- Anti-PD-1/Anti-CD3 Bispecific Antibody ONO-4685 [NCIt concept]
- Anti-PD-1/Anti-PD-L1 Bispecific Antibody IBI318 [NCIt concept]
- Anti-PD-1/Anti-TGF-beta Bifunctional Fusion Protein TQB2868 [NCIt concept]
- Anti-PD-1/Anti-TGFbRII Bispecific Antibody INCA33890 [NCIt concept]
- Anti-PD-1/Anti-TIGIT Bispecific Antibody IBI321 [NCIt concept]
- Anti-PD-1/Anti-TIM-3 Bispecific Antibody AZD7789 [NCIt concept]
- Anti-PD-1/Anti-TIM-3 Bispecific Antibody LB1410 [NCIt concept]
- Anti-PD-1/Anti-VEGF Bispecific Antibody JS207 [NCIt concept]
- Anti-PD-1/CD47 Infusion Protein HX009 [NCIt concept]
- Anti-PD-1/IL-2 Bispecific Antibody Fusion Protein IBI363 [NCIt concept]
- Anti-PD-1/LAG-3 Bispecific Antibody AK129 [NCIt concept]
- Anti-PD-1/LAG-3 Bispecific Antibody EMB-02 [NCIt concept]
- Anti-PD-1/TGF-beta RII Bifunctional Fusion Protein JS201 [NCIt concept]
- Anti-PD-1/TGFbRII Fusion Protein LBL-015 [NCIt concept]
- Anti-PD-L1 Antibody-drug Conjugate SGN-PDL1V [NCIt concept]
- Anti-PD-L1 Antibody/IL-15 Fusion Protein IGM-7354 [NCIt concept]
- Anti-PD-L1 Monoclonal Antibody FAZ053 [NCIt concept]
- Anti-PD-L1 Monoclonal Antibody GR1405 [NCIt concept]
- Anti-PD-L1 Monoclonal Antibody LP002 [NCIt concept]
- Anti-PD-L1 Monoclonal Antibody MDX-1105 [NCIt concept]
- Anti-PD-L1 Monoclonal Antibody RC98 [NCIt concept]
- Anti-PD-L1/4-1BB Bispecific Antibody QLF31907 [NCIt concept]
- Anti-PD-L1/Anti-4-1BB Bispecific Antibody ABL503 [NCIt concept]
- Anti-PD-L1/Anti-CD47 Bispecific Antibody BAT7104 [NCIt concept]
- Anti-PD-L1/Anti-CD47 Bispecific Monoclonal Antibody LB101 [NCIt concept]
- Anti-PD-L1/Anti-LAG-3 Bispecific Antibody ABL501 [NCIt concept]
- Anti-PD-L1/Anti-OX40 Bispecific Antibody EMB-09 [NCIt concept]
- Anti-PD-L1/Anti-TGF-beta Bifunctional Fusion Protein TQB2858 [NCIt concept]
- Anti-PD-L1/Anti-TIGIT Bispecific Antibody PM1022 [NCIt concept]
- Anti-PD-L1/Anti-VEGF Bispecific Antibody Fusion Protein B1962 [NCIt concept]
- Anti-PD-L1/Anti-VEGF-A Bispecific Antibody PM8002 [NCIt concept]
- Anti-PD-L1/CD137 Bispecific Antibody MCLA-145 [NCIt concept]
- Anti-PD-L1/CD27 Bispecific Antibody CDX-527 [NCIt concept]
- Anti-PD-L1/Claudin18.2 Bispecific Antibody Q-1802 [NCIt concept]
- Anti-PD-L1/IL-15 Fusion Protein KD033 [NCIt concept]
- Anti-PD-L1/IL-15 Fusion Protein SIM0237 [NCIt concept]
- Anti-PD-L1/PD-L2 Bispecific Antibody IMGS-001 [NCIt concept]
- Anti-PD-L1/TGF-beta Bispecific Antibody Y101D [NCIt concept]
- Anti-PD-L1/TGFbetaRII Fusion Protein 6MW3511 [NCIt concept]
- Anti-PD-L1/TGFbetaRII Fusion Protein BJ-005 [NCIt concept]
- Anti-PD-L1/TIM-3 Bispecific Antibody LY3415244 [NCIt concept]
- Anti-PD1/IL-15 Fusion Protein SAR445877 [NCIt concept]
- Anti-PKN3 siRNA Atu027 [NCIt concept]
- Anti-PLGF Monoclonal Antibody TB-403 [NCIt concept]
- Anti-PR1/HLA-A2 Monoclonal Antibody Hu8F4 [NCIt concept]
- Anti-PRAME Immunotherapeutic GSK2302032A [NCIt concept]
- Anti-PRAME T-cell Receptor/Anti-CD3 scFv Fusion Protein IMC-F106C [NCIt concept]
- Anti-PRL-3 Monoclonal Antibody PRL3-zumab [NCIt concept]
- Anti-PSCA Monoclonal Antibody AGS-1C4D4 [NCIt concept]
- Anti-PSMA Antibody-drug Conjugate ARX517 [NCIt concept]
- Anti-PSMA Gamma Delta T-cell Engaging Bispecific Antibody LAVA-1207 [NCIt concept]
- Anti-PSMA Monoclonal Antibody MLN591-DM1 Immunoconjugate MLN2704 [NCIt concept]
- Anti-PSMA Monoclonal Antibody-MMAE Conjugate [NCIt concept]
- Anti-PSMA/Anti-CD28 Bispecific Antibody JNJ-87189401 [NCIt concept]
- Anti-PSMA/Anti-CD3 T-cell Engaging Bispecific Antibody TNB-585 [NCIt concept]
- Anti-PSMA/CD3 Bispecific Antibody CCW702 [NCIt concept]
- Anti-PSMA/CD3 Bispecific Antibody REGN4336 [NCIt concept]
- Anti-PSMA/CD3 Monoclonal Antibody MOR209/ES414 [NCIt concept]
- Anti-PSMA/CD3 Protease-activated T-cell Engager JANX007 [NCIt concept]
- Anti-PSMA/PBD ADC MEDI3726 [NCIt concept]
- Anti-PVR Monoclonal Antibody NTX-1088 [NCIt concept]
- Anti-PVRIG Monoclonal Antibody COM701 [NCIt concept]
- Anti-PVRIG Monoclonal Antibody GSK4381562 [NCIt concept]
- Anti-PVRIG Monoclonal Antibody JS009 [NCIt concept]
- Anti-PVRIG Monoclonal Antibody NM1F [NCIt concept]
- Anti-Progranulin Monoclonal Antibody AG01 [NCIt concept]
- Anti-RANKL Monoclonal Antibody GB-223 [NCIt concept]
- Anti-RANKL Monoclonal Antibody HS-20090 [NCIt concept]
- Anti-ROR1 Antibody-drug Conjugate CS5001 [NCIt concept]
- Anti-ROR1/Anti-CD3 Bispecific Antibody EMB-07 [NCIt concept]
- Anti-ROR1/CD3 T-cell Engager NVG-111 [NCIt concept]
- Anti-ROR1/PNU-159682 Derivative Antibody-drug Conjugate NBE-002 [NCIt concept]
- Anti-S15 Monoclonal Antibody NC318 [NCIt concept]
- Anti-SEZ6 Antibody-drug Conjugate ABBV-706 [NCIt concept]
- Anti-SIRP Monoclonal Antibody ELA026 [NCIt concept]
- Anti-SIRP-alpha Antibody BR105 [NCIt concept]
- Anti-SIRPa Monoclonal Antibody ADU-1805 [NCIt concept]
- Anti-SIRPa Monoclonal Antibody BI 765063 [NCIt concept]
- Anti-SIRPa Monoclonal Antibody BI 770371 [NCIt concept]
- Anti-SIRPa Monoclonal Antibody DS-1103 [NCIt concept]
- Anti-SIRPa Monoclonal Antibody LM-101 [NCIt concept]
- Anti-SIRPalpha Monoclonal Antibody BYON4228 [NCIt concept]
- Anti-STEAP1 CAR T-cells [NCIt concept]
- Anti-STn Antibody-drug Conjugate SGN-STNV [NCIt concept]
- Anti-Senl-h19 CAR T Cells [NCIt concept]
- Anti-Siglec-15 Monoclonal Antibody PYX-106 [NCIt concept]
- Anti-TAG-72 Monoclonal Antibody scFV CC-49/218 [NCIt concept]
- Anti-TCR Vb6/Vb10/IL-2 Antibody Fusion Protein STAR0602 [NCIt concept]
- Anti-TF Antibody-drug Conjugate MRG004A [NCIt concept]
- Anti-TF Monoclonal Antibody ALT-836 [NCIt concept]
- Anti-TGF-beta 1/Anti-COX-2 siRNAs STP707 [NCIt concept]
- Anti-TGF-beta Monoclonal Antibody SAR-439459 [NCIt concept]
- Anti-TGF-beta RII Monoclonal Antibody IMC-TR1 [NCIt concept]
- Anti-TIGIT Antibody/TGFbeta-RII Fusion Protein AK130 [NCIt concept]
- Anti-TIGIT Bispecific Antibody BMS-986442 [NCIt concept]
- Anti-TIGIT Monoclonal Antibody ASP8374 [NCIt concept]
- Anti-TIGIT Monoclonal Antibody BAT6005 [NCIt concept]
- Anti-TIGIT Monoclonal Antibody BAT6021 [NCIt concept]
- Anti-TIGIT Monoclonal Antibody COM902 [NCIt concept]
- Anti-TIGIT Monoclonal Antibody PM1021 [NCIt concept]
- Anti-TIGIT Monoclonal Antibody SGN-TGT [NCIt concept]
- Anti-TIGIT Monoclonal Antibody TAB006 [NCIt concept]
- Anti-TIGIT/Anti-PD-L1 Bispecific Antibody HB0036 [NCIt concept]
- Anti-TIGIT/Anti-PD-L1 Bispecific Antibody HLX301 [NCIt concept]
- Anti-TIGIT/Anti-PVRIG Bispecific Antibody PM1009 [NCIt concept]
- Anti-TIGIT/Anti-PVRIG Bispecific Antibody SIM0348 [NCIt concept]
- Anti-TIM-3 Antibody BMS-986258 [NCIt concept]
- Anti-TIM-3 Monoclonal Antibody BC3402 [NCIt concept]
- Anti-TIM-3 Monoclonal Antibody Sym023 [NCIt concept]
- Anti-TIM-3 Monoclonal Antibody TQB2618 [NCIt concept]
- Anti-TIM3 Monoclonal Antibody LY3321367 [NCIt concept]
- Anti-TIM3 Monoclonal Antibody SHR-1702 [NCIt concept]
- Anti-TNFR2 Monoclonal Antibody BI-1808 [NCIt concept]
- Anti-TNFR2 Monoclonal Antibody HFB200301 [NCIt concept]
- Anti-TNFR2 Monoclonal Antibody NBL-020 [NCIt concept]
- Anti-TNFR2 Monoclonal Antibody SIM1811-03 [NCIt concept]
- Anti-TRAILR2/CDH17 Tetravalent Bispecific Antibody BI 905711 [NCIt concept]
- Anti-TREM1 Agonistic Monoclonal Antibody PY159 [NCIt concept]
- Anti-TREM2 Monoclonal Antibody PY314 [NCIt concept]
- Anti-TROP-2/MMAE Antibody-drug Conjugate LCB84 [NCIt concept]
- Anti-TROP-2/Topoisomerase Inhibitor ADC MHB036C [NCIt concept]
- Anti-TROP2 Antibody-drug Conjugate BAT8003 [NCIt concept]
- Anti-TROP2 Antibody-drug Conjugate BAT8008 [NCIt concept]
- Anti-TROP2 Antibody-drug Conjugate BIO-106 [NCIt concept]
- Anti-TROP2 Antibody-drug Conjugate BL-M02D1 [NCIt concept]
- Anti-TROP2 Monoclonal Antibody-Tub196 Conjugate JS108 [NCIt concept]
- Anti-TROP2-CAR-IL-15-transduced Cord Blood-derived Natural Killer Cells [NCIt concept]
- Anti-TWEAK Monoclonal Antibody RG7212 [NCIt concept]
- Anti-TYRP1/CD3 T-cell Engager RO7293583 [NCIt concept]
- Anti-Tissue Factor Monoclonal Antibody MORAb-066 [NCIt concept]
- Anti-Tumor Necrosis Factor Therapy [NCIt concept]
- Anti-VEGF Anticalin PRS-050-PEG40 [NCIt concept]
- Anti-VEGF Monoclonal Antibody hPV19 [NCIt concept]
- Anti-VEGF/ANG2 Nanobody BI 836880 [NCIt concept]
- Anti-VEGF/TGF-beta 1 Fusion Protein HB-002T [NCIt concept]
- Anti-VEGF/TGF-beta Bispecific Antibody Fusion Protein ZGGS18 [NCIt concept]
- Anti-VEGFC Monoclonal Antibody VGX-100 [NCIt concept]
- Anti-VEGFR2 Monoclonal Antibody MSB0254 [NCIt concept]
- Anti-VEGFR3 Monoclonal Antibody IMC-3C5 [NCIt concept]
- Anti-VISTA Monoclonal Antibody HMBD-002 [NCIt concept]
- Anti-VISTA Monoclonal Antibody KVA12123 [NCIt concept]
- Anti-VISTA Monoclonal Antibody SNS-101 [NCIt concept]
- Anti-VISTA Monoclonal Antibody W0180 [NCIt concept]
- Anti-VSIG4 Monoclonal Antibody EU103 [NCIt concept]
- Anti-alpha5beta1 Integrin Antibody MINT1526A [NCIt concept]
- Anti-angiopoietin Monoclonal Antibody AMG 780 [NCIt concept]
- Anti-c-KIT Monoclonal Antibody CDX 0158 [NCIt concept]
- Anti-c-Met ADC ABBV-400 [NCIt concept]
- Anti-c-Met Antibody-drug Conjugate BYON3521 [NCIt concept]
- Anti-c-Met Antibody-drug Conjugate HTI-1066 [NCIt concept]
- Anti-c-Met Antibody-drug Conjugate TR1801 [NCIt concept]
- Anti-c-Met Monoclonal Antibody ARGX-111 [NCIt concept]
- Anti-c-Met Monoclonal Antibody HLX55 [NCIt concept]
- Anti-c-Met/EGFR/VEGF Trispecific Antibody TAVO412 [NCIt concept]
- Anti-c-Met/MMAE ADC MYTX-011 [NCIt concept]
- Anti-c-Met/MMAE ADC RC108 [NCIt concept]
- Anti-c-fms Monoclonal Antibody AMG 820 [NCIt concept]
- Anti-claudin 18.2 Antibody-drug Conjugate CPO102 [NCIt concept]
- Anti-claudin 18.2 Antibody-drug Conjugate LM-302 [NCIt concept]
- Anti-claudin 18.2 Monoclonal Antibody M108 [NCIt concept]
- Anti-claudin 18.2 Monoclonal Antibody MIL93 [NCIt concept]
- Anti-claudin-1 Monoclonal Antibody ALE.C04 [NCIt concept]
- Anti-claudin18.2 Monoclonal Antibody AB011 [NCIt concept]
- Anti-claudin18.2 Monoclonal Antibody ASKB589 [NCIt concept]
- Anti-claudin18.2 Monoclonal Antibody LM-102 [NCIt concept]
- Anti-dectin-2 Agonist Monoclonal Antibody BDC-3042 [NCIt concept]
- Anti-folate Receptor Alpha Antibody-drug Conjugate AMT-151 [NCIt concept]
- Anti-fucosyl-GM1 Monoclonal Antibody BMS-986012 [NCIt concept]
- Anti-galectin-9 Monoclonal Antibody LYT-200 [NCIt concept]
- Anti-gpA33/CD3 Monoclonal Antibody MGD007 [NCIt concept]
- Anti-gremlin-1 Monoclonal Antibody TST003 [NCIt concept]
- Anti-hepcidin Monoclonal Antibody LY2787106 [NCIt concept]
- Anti-human GITR Monoclonal Antibody AMG 228 [NCIt concept]
- Anti-human GITR Monoclonal Antibody TRX518 [NCIt concept]
- Anti-integrin Beta-1 Monoclonal Antibody OS2966 [NCIt concept]
- Anti-integrin Beta-6/MMAE Antibody-drug Conjugate SGN-B6A [NCIt concept]
- Anti-interleukin-1 Beta Monoclonal Antibody AK114 [NCIt concept]
- Anti-interleukin-1 Beta Monoclonal Antibody FL-101 [NCIt concept]
- Anti-interleukin-13 Receptor Alpha 2 CAR T Cells YYB-103 [NCIt concept]
- Anti-latent TGFb1 Monoclonal Antibody RO7496353 [NCIt concept]
- Anti-mesothelin Antibody-drug Conjugate BMS-986148 [NCIt concept]
- Anti-mesothelin-Pseudomonas Exotoxin 24 Cytolytic Fusion Protein LMB-100 [NCIt concept]
- Anti-mesothelin/MMAE Antibody-Drug Conjugate DMOT4039A [NCIt concept]
- Anti-mesothelin/MMAE Antibody-drug Conjugate RC88 [NCIt concept]
- Anti-mucin-1/PE Immunoconjugate BM7PE [NCIt concept]
- Anti-mutant Calreticulin Monoclonal Antibody INCA033989 [NCIt concept]
- Anti-nectin-4 Antibody-drug Conjugate 9MW2821 [NCIt concept]
- Anti-nectin-4 Antibody-drug Conjugate ADRX-0706 [NCIt concept]
- Anti-netrin-1 Monoclonal Antibody NP137 [NCIt concept]
- Anti-nf-P2X7 Antibody Ointment BIL-010t [NCIt concept]
- Anti-prolactin Receptor Antibody LFA102 [NCIt concept]
- Anti-survivin T-cell Receptor/Anti-CD3 Bispecific Therapeutic ABBV-184 [NCIt concept]
- Anti-tissue Factor Antibody-drug Conjugate XB002 [NCIt concept]
- Antiandrogen Therapy [NCIt concept]
- Antiangiogenic Drug Combination TL-118 [NCIt concept]
- Antibody ROSE12 [NCIt concept]
- Antibody STING Drug Conjugate TAK-500 [NCIt concept]
- Antibody receptor-Trap Fusion Protein IMM2520 [NCIt concept]
- Antibody-Drug Conjugate DFRF4539A [NCIt concept]
- Antibody-drug Conjugate ABBV-011 [NCIt concept]
- Antibody-drug Conjugate AMT-116 [NCIt concept]
- Antibody-drug Conjugate Anti-TIM-1-vcMMAE CDX-014 [NCIt concept]
- Antibody-drug Conjugate DB-1305 [NCIt concept]
- Antibody-drug Conjugate MEDI7247 [NCIt concept]
- Antibody-drug Conjugate PF-06647263 [NCIt concept]
- Antibody-drug Conjugate PF-06664178 [NCIt concept]
- Antibody-drug Conjugate RC118 [NCIt concept]
- Antibody-drug Conjugate SC-002 [NCIt concept]
- Antibody-drug Conjugate SC-004 [NCIt concept]
- Antibody-drug Conjugate SC-005 [NCIt concept]
- Antibody-drug Conjugate SC-006 [NCIt concept]
- Antibody-drug Conjugate SC-007 [NCIt concept]
- Antibody-drug Conjugate SHR-A1904 [NCIt concept]
- Antibody-drug Conjugate SHR-A1912 [NCIt concept]
- Antibody-drug Conjugate SHR-A1921 [NCIt concept]
- Antibody-drug Conjugate SHR-A2102 [NCIt concept]
- Antibody-drug Conjugate TORL-1-23 [NCIt concept]
- Antibody-drug Conjugate TORL-2-307-ADC [NCIt concept]
- Antibody-drug Conjugate YL201 [NCIt concept]
- Anticonvulsant Therapy [NCIt concept]
- Antigen [NCIt concept]
- Antigen KI-67 [NCIt concept]
- Antigen-presenting Cells-expressing HPV16 E6/E7 SQZ-PBMC-HPV [NCIt concept]
- Antigen-presenting Cells-expressing HPV16 E6/E7/CD86/mbIL-2/mbIL-12 SQZ-eAPC-HPV [NCIt concept]
- Antigua and Barbuda [NCIt concept]
- Antimetabolite FF-10502 [NCIt concept]
- Antineoplastic Vaccine [NCIt concept]
- Antineoplastic Vaccine GV-1301 [NCIt concept]
- Antineoplaston A10 [NCIt concept]
- Antineoplaston AS2-1 [NCIt concept]
- Antisense Oligonucleotide GTI-2040 [NCIt concept]
- Antisense Oligonucleotide ION537 [NCIt concept]
- Antisense Oligonucleotide QR-313 [NCIt concept]
- Antitumor B Key Active Component-alpha [NCIt concept]
- Antiviral Agent TGN-S11 [NCIt concept]
- Antrodia cinnamomea Supplement [NCIt concept]
- Antroquinonol Capsule [NCIt concept]
- Antrum [NCIt concept]
- Antrum Pylori [NCIt concept]
- Anus [NCIt concept]
- Anvatabart Opadotin [NCIt concept]
- Anxiety [NCIt concept]
- Anxiety, CTCAE 5.0 [NCIt concept]
- Anzurstobart [NCIt concept]
- Aorta [NCIt concept]
- Aortic Body [NCIt concept]
- Aortic Injury, CTCAE [NCIt concept]
- Aortic Valve Disease, CTCAE [NCIt concept]
- Aorticopulmonary Paraganglioma [NCIt concept]
- Apalutamide [NCIt concept]
- Apatorsen [NCIt concept]
- Apaziquone [NCIt concept]
- Apex of the Prostate [NCIt concept]
- Aphidicoline Glycinate [NCIt concept]
- Aphonia, CTCAE [NCIt concept]
- Apilimod Dimesylate Capsule [NCIt concept]
- Apitolisib [NCIt concept]
- Apnea, CTCAE [NCIt concept]
- Apocrine Adenoma [NCIt concept]
- Apocrine Carcinoma [NCIt concept]
- Apocrine Hidrocystoma [NCIt concept]
- Apolizumab [NCIt concept]
- Apomab [NCIt concept]
- Apomine [NCIt concept]
- Apoptosis Inducer BZL101 [NCIt concept]
- Apoptosis Inducer GCS-100 [NCIt concept]
- Apoptosis Inducer MPC-2130 [NCIt concept]
- Appendage of the Uterus [NCIt concept]
- Appendicitis Perforated, CTCAE [NCIt concept]
- Appendicitis, CTCAE [NCIt concept]
- Appendix [NCIt concept]
- Appendix Tubular Carcinoid [NCIt concept]
- Apricoxib [NCIt concept]
- Aprinocarsen [NCIt concept]
- Aprutumab [NCIt concept]
- Aprutumab Ixadotin [NCIt concept]
- Aqueous Humor [NCIt concept]
- Arabinoxylan Compound MGN3 [NCIt concept]
- Arachnoiditis, CTCAE [NCIt concept]
- Aranose [NCIt concept]
- Archexin [NCIt concept]
- Architect, Planner, Surveyor and Designer [NCIt concept]
- Archive [NCIt concept]
- Arcitumomab [NCIt concept]
- Area Under Curve [NCIt concept]
- Arfolitixorin [NCIt concept]
- Argentina [NCIt concept]
- Arginase-1 Long Peptide Vaccine [NCIt concept]
- Arginine Butyrate [NCIt concept]
- Arm [NCIt concept]
- Armed Forces Occupation, Other Rank [NCIt concept]
- Armenia [NCIt concept]
- Arnebia Indigo Jade Pearl Topical Cream [NCIt concept]
- Array Design Format [NCIt concept]
- Arrhythmia [NCIt concept]
- Arsenic Exposure [NCIt concept]
- Arsenic Trioxide [NCIt concept]
- Arsenic Trioxide Capsule Formulation ORH 2014 [NCIt concept]
- Artemether Sublingual Spray [NCIt concept]
- Artemisinin Dimer [NCIt concept]
- Arterial Injury, CTCAE [NCIt concept]
- Arteriovenous Malformation/Hemangioma [NCIt concept]
- Arteritis Infective, CTCAE [NCIt concept]
- Artery [NCIt concept]
- Artesunate [NCIt concept]
- Arthralgia, CTCAE [NCIt concept]
- Arthritis [NCIt concept]
- Arthritis, CTCAE [NCIt concept]
- Artist [NCIt concept]
- Artistic, Cultural and Culinary Associate Professional [NCIt concept]
- Aruba [NCIt concept]
- Arugula Seed Powder [NCIt concept]
- Aryl Hydrocarbon Receptor Antagonist BAY2416964 [NCIt concept]
- Aryl Hydrocarbon Receptor Inhibitor IK-175 [NCIt concept]
- Asaley [NCIt concept]
- Asbestos Body [NCIt concept]
- Asbestos Exposure [NCIt concept]
- Asbestos Exposure Mineral Type Indicator [NCIt concept]
- Ascending Colon [NCIt concept]
- Asciminib [NCIt concept]
- Ascites Drainage [NCIt concept]
- Ascites Fluid Sample [NCIt concept]
- Ascites, CTCAE [NCIt concept]
- Ascrinvacumab [NCIt concept]
- Ashwagandha Root Powder Extract [NCIt concept]
- Asian [NCIt concept]
- Askin Tumor [NCIt concept]
- Aspacytarabine [NCIt concept]
- Asparaginase [NCIt concept]
- Asparaginase Erwinia chrysanthemi [NCIt concept]
- Aspartate Aminotransferase Increased, CTCAE [NCIt concept]
- Aspirate [NCIt concept]
- Aspiration, CTCAE [NCIt concept]
- Aspirin [NCIt concept]
- Assay Color Channel Name [NCIt concept]
- Assay Plate Identifier [NCIt concept]
- Assay Plate Well Identifier [NCIt concept]
- Assembler [NCIt concept]
- Astatine At 211 Anti-CD38 Monoclonal Antibody OKT10-B10 [NCIt concept]
- Astatine At 211 Anti-CD45 Monoclonal Antibody BC8-B10 [NCIt concept]
- Astatine At 211 F(ab')2 MX35 [NCIt concept]
- Asthma [NCIt concept]
- Astroblastoma, MN1-Altered [NCIt concept]
- Astrocytic Tumor [NCIt concept]
- Astrocytoma [NCIt concept]
- Astrocytoma, IDH-Mutant, Grade 2 [NCIt concept]
- Astrocytoma, IDH-Mutant, Grade 3 [NCIt concept]
- Astrocytoma, IDH-Mutant, Grade 4 [NCIt concept]
- Astuprotimut-R [NCIt concept]
- Asulacrine [NCIt concept]
- Asulacrine Isethionate [NCIt concept]
- Asunercept [NCIt concept]
- Asystole, CTCAE 5.0 [NCIt concept]
- At 211 Monoclonal Antibody 81C6 [NCIt concept]
- Atamestane [NCIt concept]
- Atamparib [NCIt concept]
- Ataxia Telangiectasia Syndrome [NCIt concept]
- Ataxia, CTCAE 5.0 [NCIt concept]
- Atelectasis, CTCAE [NCIt concept]
- Atezolizumab [NCIt concept]
- Atezolizumab and Recombinant Human Hyaluronidase [NCIt concept]
- Atiprimod [NCIt concept]
- Atiprimod Dihydrochloride [NCIt concept]
- Atiprimod Dimaleate [NCIt concept]
- Atorvastatin Calcium [NCIt concept]
- Atorvastatin Sodium [NCIt concept]
- Atrasentan Hydrochloride [NCIt concept]
- Atrial Fibrillation [NCIt concept]
- Atrial Fibrillation, CTCAE [NCIt concept]
- Atrial Flutter, CTCAE [NCIt concept]
- Atrioventricular Block Complete, CTCAE [NCIt concept]
- Atrioventricular Block First Degree, CTCAE [NCIt concept]
- Attenuated Listeria monocytogenes ANZ-100 [NCIt concept]
- Attenuated Measles Virus Encoding SCD Transgene TMV-018 [NCIt concept]
- Atuveciclib [NCIt concept]
- Atypical Adenoma [NCIt concept]
- Atypical Adenomatous Lung Hyperplasia [NCIt concept]
- Atypical Burkitt/Burkitt-Like Lymphoma [NCIt concept]
- Atypical Choroid Plexus Papilloma [NCIt concept]
- Atypical Chronic Myeloid Leukemia [NCIt concept]
- Atypical Fibroxanthoma [NCIt concept]
- Atypical Lipomatous Tumor/Well Differentiated Liposarcoma [NCIt concept]
- Atypical Meningioma [NCIt concept]
- Atypical Mitotic Figures [NCIt concept]
- Atypical Polypoid Adenomyoma [NCIt concept]
- Atypical Teratoid/Rhabdoid Tumor [NCIt concept]
- Audencel [NCIt concept]
- Aumolertinib [NCIt concept]
- Aunt [NCIt concept]
- Auranofin [NCIt concept]
- Aurora A Kinase Inhibitor JAB-2485 [NCIt concept]
- Aurora A Kinase Inhibitor LY3295668 [NCIt concept]
- Aurora A Kinase Inhibitor LY3295668 Erbumine [NCIt concept]
- Aurora A Kinase Inhibitor MK5108 [NCIt concept]
- Aurora A Kinase Inhibitor VIC-1911 [NCIt concept]
- Aurora A Kinase/Tyrosine Kinase Inhibitor ENMD-2076 [NCIt concept]
- Aurora B Serine/Threonine Kinase Inhibitor TAK-901 [NCIt concept]
- Aurora B/C Kinase Inhibitor GSK1070916A [NCIt concept]
- Aurora B/VEGFR/FGFR Inhibitor AL8326 [NCIt concept]
- Aurora Kinase Inhibitor AMG 900 [NCIt concept]
- Aurora Kinase Inhibitor BI 811283 [NCIt concept]
- Aurora Kinase Inhibitor MLN8054 [NCIt concept]
- Aurora Kinase Inhibitor PF-03814735 [NCIt concept]
- Aurora Kinase Inhibitor SNS-314 [NCIt concept]
- Aurora Kinase Inhibitor TTP607 [NCIt concept]
- Aurora Kinase/FLT3 Inhibitor EP0042 [NCIt concept]
- Aurora Kinase/VEGFR2 Inhibitor CYC116 [NCIt concept]
- Australia [NCIt concept]
- Austria [NCIt concept]
- Author, Journalist and Linguist [NCIt concept]
- Autogene Cevumeran [NCIt concept]
- Autoimmune Atrophic Chronic Gastritis [NCIt concept]
- Autoimmune Disorder, CTCAE [NCIt concept]
- Autoimmune Lymphoproliferative Syndrome [NCIt concept]
- Autologous ACTR-CD16-CD28-expressing T-lymphocytes ACTR707 [NCIt concept]
- Autologous AFP Specific T Cell Receptor Transduced T Cells C-TCR055 [NCIt concept]
- Autologous ALPG/ALPP-targeted Anti-MSLN CAR-Fas/PTPN2 shRNA-miR-expressing T-lymphocytes AB-1015 [NCIt concept]
- Autologous AXL-targeted CAR T-cells CCT301-38 [NCIt concept]
- Autologous Alpha-PNE Switchable CAR-T Cells CLBR001 [NCIt concept]
- Autologous Alpha-PNE Switchable CAR-T Cells CLBR001 and CD19-specific Adapter Molecule SWI019 [NCIt concept]
- Autologous Anti-BCMA CAR T-cells MCARH125 [NCIt concept]
- Autologous Anti-BCMA CAR T-cells PHE885 [NCIt concept]
- Autologous Anti-BCMA CAR T-cells spCART-269 [NCIt concept]
- Autologous Anti-BCMA CAR-transduced T-cells KITE-585 [NCIt concept]
- Autologous Anti-BCMA CD8+ CAR T-cells Descartes-11 [NCIt concept]
- Autologous Anti-BCMA-CAR Expressing Stem Memory T-cells P-BCMA-101 [NCIt concept]
- Autologous Anti-BCMA-CAR-4-1BB-CD3zeta-expressing Memory T-lymphocytes bb21217 [NCIt concept]
- Autologous Anti-BCMA-CAR-4-1BB-CD3zeta-expressing T-cells C-CAR088 [NCIt concept]
- Autologous Anti-BCMA-CAR-expressing CD4+/CD8+ T-lymphocytes FCARH143 [NCIt concept]
- Autologous Anti-CD123 CAR-T Cells [NCIt concept]
- Autologous Anti-CD19 CAR T-cells 19(T2)28z1xx [NCIt concept]
- Autologous Anti-CD19 CAR T-cells IM19 [NCIt concept]
- Autologous Anti-CD19 CAR TCR-zeta/4-1BB-transduced T-lymphocytes huCART19 [NCIt concept]
- Autologous Anti-CD19 CAR Vector-transduced T Cells pCAR-19B [NCIt concept]
- Autologous Anti-CD19 CAR-4-1BB-CD3zeta-expressing T-cells CNCT19 [NCIt concept]
- Autologous Anti-CD19 CAR-CD28 T-cells ET019002 [NCIt concept]
- Autologous Anti-CD19 CAR-CD3zeta-4-1BB-expressing T-cells PZ01 [NCIt concept]
- Autologous Anti-CD19 CAR-IL-18-expressing T-lymphocytes [NCIt concept]
- Autologous Anti-CD19 CAR-T Cells CABA-201 [NCIt concept]
- Autologous Anti-CD19 CAR-T Cells GC019F [NCIt concept]
- Autologous Anti-CD19 CAR-expressing T Lymphocytes [NCIt concept]
- Autologous Anti-CD19 CAR-expressing T-lymphocytes CLIC-1901 [NCIt concept]
- Autologous Anti-CD19 CAR-expressing T-lymphocytes IC19/1563 [NCIt concept]
- Autologous Anti-CD19 CAR-expressing T-lymphocytes UF-KURE19 [NCIt concept]
- Autologous Anti-CD19 Chimeric Antigen Receptor T-cells SJCAR19 [NCIt concept]
- Autologous Anti-CD19 DASH CAR-T Cells [NCIt concept]
- Autologous Anti-CD19 T-cell Receptor T cells ET190L1 [NCIt concept]
- Autologous Anti-CD19 TAC-T cells TAC01-CD19 [NCIt concept]
- Autologous Anti-CD19/CD20 Bispecific CAR-T Cells IMPT-314 [NCIt concept]
- Autologous Anti-CD19/CD20 Bispecific Nanobody-based CAR-T cells [NCIt concept]
- Autologous Anti-CD19/CD20 CAR-T Cells KITE-363 [NCIt concept]
- Autologous Anti-CD19/CD22 CAR T-cells AUTO3 [NCIt concept]
- Autologous Anti-CD19CAR-4-1BB-CD3zeta-EGFRt-expressing CD4+/CD8+ Central Memory T-lymphocytes JCAR014 [NCIt concept]
- Autologous Anti-CD19CAR-HER2t/CD22CAR-EGFRt-expressing T-cells [NCIt concept]
- Autologous Anti-CD1a CAR T Cells OC-1 [NCIt concept]
- Autologous Anti-CD20 CAR T-cells C-CAR066 [NCIt concept]
- Autologous Anti-CD20 CAR Transduced CD4/CD8 Enriched T-cells MB-CART20.1 [NCIt concept]
- Autologous Anti-CD20CAR-CD28-4-1BB-CD3zeta T-lymphocytes MB-106 [NCIt concept]
- Autologous Anti-CD22 CAR-4-1BB-TCRz-transduced T-lymphocytes CART22-65s [NCIt concept]
- Autologous Anti-CD22 CAR-expressing T-cells SCRI-CAR22v2 [NCIt concept]
- Autologous Anti-CD30 CAR T Cells HSP-CAR30 [NCIt concept]
- Autologous Anti-CD4 CAR T-cells LB1901 [NCIt concept]
- Autologous Anti-CD5 CAR Monocytes MT-101 [NCIt concept]
- Autologous Anti-CD7 CAR T Cells PA3-17 [NCIt concept]
- Autologous Anti-CD7 CAR T-cells SENL101 [NCIt concept]
- Autologous Anti-CD7-CAR-CD28zeta T-cells [NCIt concept]
- Autologous Anti-CD79a/anti-CD20 CAR T-cells bbT369 [NCIt concept]
- Autologous Anti-CD79b CAR-T Cells JV-213 [NCIt concept]
- Autologous Anti-CDH17 CAR-T Cells CHM-2101 [NCIt concept]
- Autologous Anti-CEA CAR/HLA-A*02-gated Inhibitory Receptor/B2M shRNA-expressing T-lymphocytes A2B530 [NCIt concept]
- Autologous Anti-CLDN18.2 TAC T-cells TAC01-CLDN18.2 [NCIt concept]
- Autologous Anti-CLL-1-CAR T-lymphocytes KITE-222 [NCIt concept]
- Autologous Anti-CSPG4 CAR-iC9-expressing T-lymphocytes [NCIt concept]
- Autologous Anti-Claudin18.2 CAR T-cells LB1908 [NCIt concept]
- Autologous Anti-DLL3 CAR-T Cells LB2102 [NCIt concept]
- Autologous Anti-EBV CAR T Cells BRG01 [NCIt concept]
- Autologous Anti-EGFR CAR-transduced CXCR 5-modified T-lymphocytes [NCIt concept]
- Autologous Anti-EGFR/Anti-IL13Ralpha2 CAR T-cells [NCIt concept]
- Autologous Anti-EGFRvIII synNotch Receptor-induced Anti-EphA2/IL-13Ralpha2 CAR-T Cells [NCIt concept]
- Autologous Anti-FLT3 CAR T Cells AMG 553 [NCIt concept]
- Autologous Anti-FLT3 CAR T Cells TAA05 [NCIt concept]
- Autologous Anti-GFRa4 CAR-TCR-zeta-4-1BB-expressing T-cells [NCIt concept]
- Autologous Anti-GPC2-CAR T-cells [NCIt concept]
- Autologous Anti-GPC3 CAR T Cells BOXR1030 [NCIt concept]
- Autologous Anti-GPC3-CAR T-lymphocytes Ori-C101 [NCIt concept]
- Autologous Anti-GPRC5D CAR-T Cells BMS-986393 [NCIt concept]
- Autologous Anti-GPRC5D-CAR-4-1BB-expressing T-cells MCARH109 [NCIt concept]
- Autologous Anti-HER2 CAR Macrophages CT-0508 [NCIt concept]
- Autologous Anti-HER2 CAR T-cells CCT303-406 [NCIt concept]
- Autologous Anti-HER2 CAR-CD28 T Cells [NCIt concept]
- Autologous Anti-HER2 CAR-T Cells [NCIt concept]
- Autologous Anti-HLA-A*02/AFP TCRm-expressing T-cells ET140202 [NCIt concept]
- Autologous Anti-HLA-A*0201/AFP CAR T-cells ET1402L1 [NCIt concept]
- Autologous Anti-HLA-G CAR-T Cells IVS-3001 [NCIt concept]
- Autologous Anti-ICAM-1-CAR-CD28-4-1BB-CD3zeta-expressing T-cells AIC100 [NCIt concept]
- Autologous Anti-KK-LC-1 TCR-expressing T-cells [NCIt concept]
- Autologous Anti-LGR5 CAR-T Cells CNA3103 [NCIt concept]
- Autologous Anti-MAGE-A1 TCR-engineered T-cells TSC-204-A0201 [NCIt concept]
- Autologous Anti-MAGE-A1 TCR-engineered T-cells TSC-204-C0702 [NCIt concept]
- Autologous Anti-MART-1 F5 TCR Tumor Infiltrating Lymphocytes [NCIt concept]
- Autologous Anti-MSLN CAR/HLA-A*02-gated Inhibitory Receptor/B2M shRNA-expressing T-lymphocytes A2B694 [NCIt concept]
- Autologous Anti-NKG2DL/Anti-CLDN18.2 Bispecific CAR-T Cells KD-496 [NCIt concept]
- Autologous Anti-NY-ESO-1 TCR/CD8alpha-expressing T-cells GSK3901961 [NCIt concept]
- Autologous Anti-NY-ESO-1 TCR/dnTGF-BRII-expressing T-cells GSK3845097 [NCIt concept]
- Autologous Anti-PD-1 Antibody-activated Tumor-infiltrating Lymphocytes [NCIt concept]
- Autologous Anti-PD-L1-armored Anti-CD22 CAR T Cells [NCIt concept]
- Autologous Anti-PRAME TCR/CD8alphabeta-expressing T-cells IMA203CD8 [NCIt concept]
- Autologous Anti-PSMA CAR-T Cells P-PSMA-101 [NCIt concept]
- Autologous Anti-PSMA CAR/CD2/dnTGF-BRII/PD-1:CD28 Switch Receptor-expressing T-cells TmPSMA-02 [NCIt concept]
- Autologous Anti-ROR1 CAR T-cells LYL797 [NCIt concept]
- Autologous Anti-ROR1 CAR-T Cells BMS-986403 [NCIt concept]
- Autologous Anti-ROR1 CAR-T Cells ONCT-808 [NCIt concept]
- Autologous Anti-ROR1 CAR-mbIL15-Safety Switch/Intrinsic PD-1 Blockade T-cells PRGN-3007 [NCIt concept]
- Autologous Anti-Siglec-6 CAR-T Cells [NCIt concept]
- Autologous Anti-TM4SF1 CAR-T Cells [NCIt concept]
- Autologous Anti-glypican-3 CAR-IL-15-iC9-expressing T-lymphocytes [NCIt concept]
- Autologous Anti-gp100:154-162 TCR Tumor Infiltrating Lymphocytes [NCIt concept]
- Autologous Anti-kappa Light Chain CAR-CD28-expressing T-lymphocytes [NCIt concept]
- Autologous Anti-mesothelin CAR-IL-7-CCL19-expressing T-lymphocytes TAK-103 [NCIt concept]
- Autologous Anti-mesothelin CAR-T Cells UCLM802 [NCIt concept]
- Autologous Anti-mesothelin KIR-CAR-transduced T-cells SynKIR-110 [NCIt concept]
- Autologous Anti-mesothelin T-cell Receptor Fusion Construct/PD-1:CD28 Switch Receptor-expressing T-cells TC-510 [NCIt concept]
- Autologous B-cell/Monocyte-presenting HER2/neu Antigen Vaccine BVAC-B [NCIt concept]
- Autologous B7-H3/EGFR806/HER2/IL13-zetakine CAR-expressing CD4+/CD8+ T-cells SC-CAR4BRAIN [NCIt concept]
- Autologous BAFF-expressing CAR T Cells LMY-920 [NCIt concept]
- Autologous BCMA-targeted CAR T Cells CC-98633 [NCIt concept]
- Autologous BCMA-targeted CAR T Cells LCAR-B4822M [NCIt concept]
- Autologous BCMA/TACI-targeted Trimeric APRIL-based CAR T Cells [NCIt concept]
- Autologous Bispecific BCMA/CD19-targeted CAR-T Cells GC012F [NCIt concept]
- Autologous Bispecific CD19/CD22-targeted CAR-T Cells GC022 [NCIt concept]
- Autologous Bone Marrow-derived CD34/CXCR4-positive Stem Cells AMR-001 [NCIt concept]
- Autologous CAR T Cells KITE-197 [NCIt concept]
- Autologous CAR T Cells U87 [NCIt concept]
- Autologous CAR-T Cells B4T2-001 [NCIt concept]
- Autologous CAR-mbIL15-Safety Switch T-cells PRGN-3005 [NCIt concept]
- Autologous CAR-mbIL15-Safety Switch T-cells PRGN-3006 [NCIt concept]
- Autologous CD123-4SCAR-expressing T-cells 4SCAR123 [NCIt concept]
- Autologous CD19 CAR-expressing CD4+/CD8+ T-cells MB-CART19.1 [NCIt concept]
- Autologous CD19-CD8-CD28-CAR-mbIL15-HER1t T Cells [NCIt concept]
- Autologous CD19-targeted CAR T Cells CC-97540 [NCIt concept]
- Autologous CD19-targeted CAR-T Cells GC007F [NCIt concept]
- Autologous CD19/PD-1 Bispecific CAR-T Cells [NCIt concept]
- Autologous CD20-4SCAR-expressing T-cells 4SCAR20 [NCIt concept]
- Autologous CD22-4SCAR-expressing T-cells 4SCAR22 [NCIt concept]
- Autologous CD38-4SCAR-expressing T-cells 4SCAR38 [NCIt concept]
- Autologous CLTX-targeted CAR T-lymphocytes CHM 1101 [NCIt concept]
- Autologous CMV-pp65-LAMP mRNA Loaded Monocyte Vaccine MT-201-GBM [NCIt concept]
- Autologous CRISPR-edited Anti-CD19 CAR T Cells XYF19 [NCIt concept]
- Autologous Clonal Neoantigen T Cells ATL001 [NCIt concept]
- Autologous Cytokine-induced Killer Cells/Vaccinia Virus DD-CDSR CRX100 [NCIt concept]
- Autologous Deep IL-15 Primed T-cells TRQ15-01 [NCIt concept]
- Autologous Dendritic Cell Vaccine ACT2001 [NCIt concept]
- Autologous Engineered TCR-T Cells KSH01 [NCIt concept]
- Autologous Engineered TCR-T Cells KSX01 [NCIt concept]
- Autologous Enhanced NY-ESO-1 TCR Engineered T-cells GSK4427296 [NCIt concept]
- Autologous FRa-4SCAR-expressing T-cells 4SCAR-FRa [NCIt concept]
- Autologous GCC-targeting CAR T Cells GCC19CART [NCIt concept]
- Autologous Gamma Delta T-cell Receptor-expressing T-cells TEG002 [NCIt concept]
- Autologous Gene-modified Gamma Delta T-cells [NCIt concept]
- Autologous Gene-modified PD-1-positive T-lymphocytes Sc610 [NCIt concept]
- Autologous Gene-modified PD-1-positive T-lymphocytes ScTIL210 [NCIt concept]
- Autologous Genetically-modified MAGE-A4 C1032 CD8alpha T Cells [NCIt concept]
- Autologous HBV-specific TCR-expressing T-lymphocytes SCG101 [NCIt concept]
- Autologous HER2-CAR-modified Adenovirus-specific Cytotoxic T-lymphocytes [NCIt concept]
- Autologous HER2-targeted Dual-switch CAR-T Cells BPX-603 [NCIt concept]
- Autologous HPV16 E7-specific HLA-A*02:01-restricted TCR Gene Engineered Lymphocytes KITE-439 [NCIt concept]
- Autologous HPV16/HPV18/Survivin-specific CD8+ T-cells NEXI-003 [NCIt concept]
- Autologous Heat-Shock Protein 70 Peptide Vaccine AG-858 [NCIt concept]
- Autologous Hematopoietic Stem Cell Transplantation [NCIt concept]
- Autologous IL-12/Multi-targeted Primed T-cells RPTR 168 [NCIt concept]
- Autologous Interleukin-15-armored Anti-glypican-3 CAR-iC9-expressing T-lymphocytes [NCIt concept]
- Autologous LMP1/LMP2/EBNA1-specific HLA-A02:01/24:02/11:01-restricted TCR-expressing T-lymphocytes YT-E001 [NCIt concept]
- Autologous MAGE-A3/A6-specific TCR Gene-engineered Lymphocytes KITE-718 [NCIt concept]
- Autologous MAGE-C2-specific HLA-A2-restricted TCR T-lymphocytes [NCIt concept]
- Autologous MCPyV-specific HLA-A02-restricted TCR-transduced CD4+ and CD8+ T-cells FH-MCVA2TCR [NCIt concept]
- Autologous MG7-pulsed Dendritic Cell Vaccine [NCIt concept]
- Autologous Memory Cytokine-enriched Natural Killer Cells [NCIt concept]
- Autologous Mesenchymal Stem Cells Apceth_101 [NCIt concept]
- Autologous Mesothelin-specific Human mRNA CAR-transfected PBMCs MCY-M11 [NCIt concept]
- Autologous Monocyte-derived Lysate-pulsed Dendritic Cell Vaccine PV-001-DC [NCIt concept]
- Autologous Multi-lineage Potential Cells [NCIt concept]
- Autologous Multiple Antigen-specific T-cells MASE-T [NCIt concept]
- Autologous NKG2D CAR T Cells KD-025 [NCIt concept]
- Autologous NKG2D CAR T-cells CYAD-02 [NCIt concept]
- Autologous NKG2D CAR-CD3zeta-DAP10-expressing T-Lymphocytes CYAD-01 [NCIt concept]
- Autologous Natural Killer Cells SNK01 [NCIt concept]
- Autologous Nectin-4/FAP-targeted CAR-T Cells [NCIt concept]
- Autologous Neoantigen-specific T-lymphocytes GEN-011 [NCIt concept]
- Autologous Orthogonal IL-2Rbeta-expressing Anti-CD19 CAR T-cells SYNCAR-001 [NCIt concept]
- Autologous Ovarian Cancer-specific Antigens-pulsed Dendritic Cells Cellgram-DC [NCIt concept]
- Autologous PD-1 Nanobody-expressing Anti-MSLN CAR T-cells [NCIt concept]
- Autologous PD-1-knockout Tumor-infiltrating Lymphocytes IOV-4001 [NCIt concept]
- Autologous PD1-knockout CD19-specific CAR T-cells BRL-201 [NCIt concept]
- Autologous PRAME-targeting TCR-engineered T-cells IMA203 [NCIt concept]
- Autologous Pancreatic Adenocarcinoma Lysate and mRNA-loaded Dendritic Cell Vaccine [NCIt concept]
- Autologous Peripheral Blood Lymphocytes from Ibrutinib-treated Chronic Lymphocytic Leukemia Patients IOV-2001 [NCIt concept]
- Autologous Polyclonal Tumor Infiltrating Lymphocytes LYL845 [NCIt concept]
- Autologous Prostate Cancer Antigen-expressing Dendritic Cell Vaccine BPX-101 [NCIt concept]
- Autologous Prostate Cancer-specific Antigens-pulsed Dendritic Cells Cellgram-DC-PC [NCIt concept]
- Autologous Prostate Stem Cell Antigen-specific CAR T Cells BPX-601 [NCIt concept]
- Autologous ROR2-targeted CAR T-cells CCT301-59 [NCIt concept]
- Autologous Rapamycin-resistant Th1/Tc1 Cells RAPA-201 [NCIt concept]
- Autologous TAAs-loaded Autologous Dendritic Cells AV-GBM-1 [NCIt concept]
- Autologous TCR-engineered T-cells IMA201 [NCIt concept]
- Autologous TCR-engineered T-cells IMA202 [NCIt concept]
- Autologous TCRm-expressing T-cells ET140203 [NCIt concept]
- Autologous TP53 R175H Mutant-specific HLA-A*02:01-restricted TCR Gene Engineered T-lymphocytes NT-175 [NCIt concept]
- Autologous TROP2-CAR-transduced PD-1-positive T Cells T60c [NCIt concept]
- Autologous Tetravalent Dendritic Cell Vaccine MIDRIX4-LUNG [NCIt concept]
- Autologous Total Tumor mRNA and CMV-pp65-flLAMP mRNA Loaded Liposome Vaccine [NCIt concept]
- Autologous Tumor Cells/Bacillus Calmette-Guerin/Formalin-based Vaccine [NCIt concept]
- Autologous Tumor Infiltrating Lymphocytes C-TIL051 [NCIt concept]
- Autologous Tumor Infiltrating Lymphocytes C-TIL052A [NCIt concept]
- Autologous Tumor Infiltrating Lymphocytes GT101 [NCIt concept]
- Autologous Tumor Infiltrating Lymphocytes GT201 [NCIt concept]
- Autologous Tumor Infiltrating Lymphocytes HV-101 [NCIt concept]
- Autologous Tumor Infiltrating Lymphocytes ITIL-168 [NCIt concept]
- Autologous Tumor Infiltrating Lymphocytes LM103 [NCIt concept]
- Autologous Tumor Infiltrating Lymphocytes LN-145 [NCIt concept]
- Autologous Tumor Infiltrating Lymphocytes LN-145-S1 [NCIt concept]
- Autologous Tumor Infiltrating Lymphocytes MDA-TIL [NCIt concept]
- Autologous Tumor Infiltrating Lymphocytes TBio-4101 [NCIt concept]
- Autologous Tumor Vaccine Plus Polysaccharide-derived Delta Inulin Adjuvant [NCIt concept]
- Autologous Tumor-infiltrating Lymphocytes HS-IT101 [NCIt concept]
- Autologous Universal CAR-expressing T-lymphocytes UniCAR02-T [NCIt concept]
- Autologous Vaccine-enhanced Ex Vivo Activated Cancer Neoantigens-specific T-cells TVI-Brain-1 [NCIt concept]
- Autologous WT1-directed CRISPR/Cas9-engineered TCR-T Cells NTLA-5001 [NCIt concept]
- Autologous dnTGF-BRII-armored Anti-GPC3 CAR T-cells AZD5851 [NCIt concept]
- Autologous mbIL-12-expressing Tumor Infiltrating Lymphocytes GT202 [NCIt concept]
- Autologous-Autologous Tandem Hematopoietic Stem Cell Transplantation [NCIt concept]
- Autonomic Nervous System [NCIt concept]
- Autopsy [NCIt concept]
- Autotaxin Inhibitor IOA-289 [NCIt concept]
- Avadomide [NCIt concept]
- Avadomide Hydrochloride [NCIt concept]
- Avapritinib [NCIt concept]
- Avascular Necrosis [NCIt concept]
- Avascular Necrosis, CTCAE [NCIt concept]
- Avdoralimab [NCIt concept]
- Avelumab [NCIt concept]
- Average Number Cigarettes Smoked a Day [NCIt concept]
- Average Number of Alcoholic Drinks per Day [NCIt concept]
- Average Number of Days per Week One Drinks Alcohol [NCIt concept]
- Average Number of Exercise Days per Week [NCIt concept]
- Average Number of Times per Day Subject Uses Tobacco [NCIt concept]
- Average Read Length [NCIt concept]
- Average Sequence Insert Size [NCIt concept]
- Aviscumine [NCIt concept]
- Avotaciclib [NCIt concept]
- Axalimogene Filolisbac [NCIt concept]
- Axatilimab [NCIt concept]
- Axicabtagene Ciloleucel [NCIt concept]
- Axilla [NCIt concept]
- Axillary Lymph Node [NCIt concept]
- Axillary Tail of the Breast [NCIt concept]
- Axitinib [NCIt concept]
- Axl/Mer Inhibitor INCB081776 [NCIt concept]
- Axl/Mer Inhibitor PF-07265807 [NCIt concept]
- Axl/Mer/CSF1R Inhibitor Q702 [NCIt concept]
- Azacitidine [NCIt concept]
- Azapicyl [NCIt concept]
- Azaribine [NCIt concept]
- Azaserine [NCIt concept]
- Azathioprine [NCIt concept]
- Azenosertib [NCIt concept]
- Azerbaijan [NCIt concept]
- Azercabtagene Zapreleucel [NCIt concept]
- Azimexon [NCIt concept]
- Azintuxizumab Vedotin [NCIt concept]
- Aziridinylbenzoquinone RH1 [NCIt concept]
- Azoospermia, CTCAE [NCIt concept]
- Azotomycin [NCIt concept]
- Azurin:50-77 Cell Penetrating Peptide p28 [NCIt concept]
- B Acute Lymphoblastic Leukemia [NCIt concept]
- B Lymphoblastic Leukemia/Lymphoma with t(12;21)(p13.2;q22.1); ETV6-RUNX1 [NCIt concept]
- B Lymphoblastic Leukemia/Lymphoma with t(1;19)(q23;p13.3); TCF3-PBX1 [NCIt concept]
- B Lymphoblastic Leukemia/Lymphoma with t(5;14)(q31.1;q32.3); IL3-IGH [NCIt concept]
- B Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1 [NCIt concept]
- B Lymphoblastic Leukemia/Lymphoma with t(v;11q23.3); KMT2A Rearranged [NCIt concept]
- B Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified [NCIt concept]
- B Lymphoblastic Lymphoma [NCIt concept]
- B-Cell Antigen Receptor Complex-Associated Protein Alpha Chain [NCIt concept]
- B-Cell Genotyping Assay [NCIt concept]
- B-Cell Lymphoma 6 Protein [NCIt concept]
- B-Cell Prolymphocytic Leukemia [NCIt concept]
- B-Cell Receptor CD22 [NCIt concept]
- B-Lymphocyte Antigen CD19 [NCIt concept]
- B-Lymphocyte Antigen CD20 [NCIt concept]
- B-Raf/VEGFR-2 Inhibitor RAF265 [NCIt concept]
- B-Symptoms [NCIt concept]
- B2M Gene [NCIt concept]
- B7H3/CD3-targeting T-cell Engaging Molecule TAK-280 [NCIt concept]
- BAI File [NCIt concept]
- BAP1 Gene [NCIt concept]
- BAP1 Tumor Predisposition Syndrome [NCIt concept]
- BARD1 Gene [NCIt concept]
- BC-819 Plasmid/Polyethylenimine Complex [NCIt concept]
- BCG Solution [NCIt concept]
- BCG Tokyo-172 Strain Solution [NCIt concept]
- BCG Vaccine [NCIt concept]
- BCL10 Gene [NCIt concept]
- BCL11A Gene [NCIt concept]
- BCL11B Gene [NCIt concept]
- BCL2 Gene [NCIt concept]
- BCL2 Inhibitor VOB560 [NCIt concept]
- BCL2L12 Gene [NCIt concept]
- BCL3 Gene [NCIt concept]
- BCL6 Degrader BMS-986458 [NCIt concept]
- BCL6 Gene [NCIt concept]
- BCL7A Gene [NCIt concept]
- BCL9 Gene [NCIt concept]
- BCL9L Gene [NCIt concept]
- BCLAF1 Gene [NCIt concept]
- BCMA x CD3 T-cell Engaging Antibody CC-93269 [NCIt concept]
- BCMA-CD19 Compound CAR T Cells [NCIt concept]
- BCMA-specific Universal CAR-expressing T-lymphocytes LCAR-BCX [NCIt concept]
- BCMA-targeted LCAR-BCDR Cells [NCIt concept]
- BCMA/CD3e Tri-specific T-cell Activating Construct HPN217 [NCIt concept]
- BCOR Gene [NCIt concept]
- BCORL1 Gene [NCIt concept]
- BCR Biotab Format [NCIt concept]
- BCR Gene [NCIt concept]
- BCR Signaling Pathway Inhibitor DZD8586 [NCIt concept]
- BCR-ABL Inhibitor HS-10382 [NCIt concept]
- BCR-ABL Inhibitor TGRX-678 [NCIt concept]
- BD2-selective BET Inhibitor NUV-868 [NCIt concept]
- BEBT-908 Free Base [NCIt concept]
- BEDPE Format [NCIt concept]
- BET Bromodomain Inhibitor ZEN-3694 [NCIt concept]
- BET Inhibitor ABBV-744 [NCIt concept]
- BET Inhibitor BAY1238097 [NCIt concept]
- BET Inhibitor FT-1101 [NCIt concept]
- BET Inhibitor GSK2820151 [NCIt concept]
- BET Inhibitor INCB054329 [NCIt concept]
- BET Inhibitor INCB057643 [NCIt concept]
- BET Inhibitor JAB-8263 [NCIt concept]
- BET Inhibitor RO6870810 [NCIt concept]
- BET Inhibitor TQB3617 [NCIt concept]
- BET-bromodomain Inhibitor ODM-207 [NCIt concept]
- BET/CBP/p300 Inhibitor EP31670 [NCIt concept]
- BF-200 Gel Formulation [NCIt concept]
- BG8 IHC Staining Method [NCIt concept]
- BGT226 Maleate [NCIt concept]
- BH3 Mimetic ABT-737 [NCIt concept]
- BIRC3 Gene [NCIt concept]
- BIRC6 Gene [NCIt concept]
- BL22 Immunotoxin [NCIt concept]
- BLM Gene [NCIt concept]
- BMP5 Gene [NCIt concept]
- BMPR1A Gene [NCIt concept]
- BMS-184476 [NCIt concept]
- BMS-188797 [NCIt concept]
- BMS-214662 [NCIt concept]
- BMS-275183 [NCIt concept]
- BP-Cx1-Platinum Complex BP-C1 [NCIt concept]
- BR96-Doxorubicin Immunoconjugate [NCIt concept]
- BRAF Gene [NCIt concept]
- BRAF Inhibitor [NCIt concept]
- BRAF Inhibitor ARQ 736 [NCIt concept]
- BRAF Inhibitor BGB-3245 [NCIt concept]
- BRAF Inhibitor PF-07799933 [NCIt concept]
- BRAF V600E Degrader CFT1946 [NCIt concept]
- BRAF V600E Inhibitor HLX208 [NCIt concept]
- BRAF(V600E) Kinase Inhibitor ABM-1310 [NCIt concept]
- BRAF(V600E) Kinase Inhibitor RO5212054 [NCIt concept]
- BRAF585-614 (V600E) Peptide [NCIt concept]
- BRAFV600/PI3K Inhibitor ASN003 [NCIt concept]
- BRCA1 Gene [NCIt concept]
- BRCA2 Gene [NCIt concept]
- BRD1 Gene [NCIt concept]
- BRD3 Gene [NCIt concept]
- BRD4 Gene [NCIt concept]
- BRD4 Inhibitor PLX2853 [NCIt concept]
- BRD4 Inhibitor PLX51107 [NCIt concept]
- BRD4 Protein Degrader RNK05047 [NCIt concept]
- BRD9 Degrader CFT8634 [NCIt concept]
- BRD9 Degrader FHD-609 [NCIt concept]
- BRG1/BRM Inhibitor FHD-286 [NCIt concept]
- BRIP1 Gene [NCIt concept]
- BTBD18 Gene [NCIt concept]
- BTG1 Gene [NCIt concept]
- BTK Degrader ABBV-101 [NCIt concept]
- BTK Degrader AC0676 [NCIt concept]
- BTK Degrader BGB-16673 [NCIt concept]
- BTK Degrader HSK29116 [NCIt concept]
- BTK Degrader NX-2127 [NCIt concept]
- BTK Degrader NX-5948 [NCIt concept]
- BTK Gene [NCIt concept]
- BTK Inhibitor ABBV-992 [NCIt concept]
- BTK Inhibitor CT-1530 [NCIt concept]
- BTK Inhibitor DTRMWXHS-12 [NCIt concept]
- BTK Inhibitor GB5121 [NCIt concept]
- BTK Inhibitor HMPL-760 [NCIt concept]
- BTK Inhibitor HZ-A-018 [NCIt concept]
- BTK Inhibitor JNJ-64264681 [NCIt concept]
- BTK Inhibitor LP-168 [NCIt concept]
- BTK Inhibitor TL-895 [NCIt concept]
- BTK Inhibitor TQB3702 [NCIt concept]
- BTK Inhibitor TT-01488 [NCIt concept]
- BUB1B Gene [NCIt concept]
- BXQ-350 Nanovesicle Formulation [NCIt concept]
- Babaodan Capsule [NCIt concept]
- Bacillus Calmette-Guerin Substrain Connaught Live Antigen [NCIt concept]
- Bacillus Calmette-Guerin Substrain Danish 1331 Live Antigen [NCIt concept]
- Back [NCIt concept]
- Back Pain, CTCAE 5.0 [NCIt concept]
- Bacterial Colonization [NCIt concept]
- Bacterial Type III Secretion-based Agent T3P-Y058-739 [NCIt concept]
- Bacteroides fragilis [NCIt concept]
- Bactobolin [NCIt concept]
- Bafetinib [NCIt concept]
- Bafisontamab [NCIt concept]
- Bahamas [NCIt concept]
- Bahrain [NCIt concept]
- Balixafortide [NCIt concept]
- Balloon Cell Melanoma [NCIt concept]
- Balloon Cell Nevus [NCIt concept]
- Balstilimab [NCIt concept]
- Baltaleucel-T [NCIt concept]
- Bangladesh [NCIt concept]
- Banoxantrone [NCIt concept]
- Bapotulimab [NCIt concept]
- Barasertib [NCIt concept]
- Barbados [NCIt concept]
- Bardoxolone [NCIt concept]
- Bardoxolone Methyl [NCIt concept]
- Barecetamab [NCIt concept]
- Baricitinib [NCIt concept]
- Barrett Esophagus [NCIt concept]
- Basal Cell Adenoma [NCIt concept]
- Basal Cell Carcinoma [NCIt concept]
- Basal Cell Neoplasm [NCIt concept]
- Basaloid Carcinoma [NCIt concept]
- Basaloid Squamous Cell Carcinoma [NCIt concept]
- Base Edited Natural Killer Cells NK510 [NCIt concept]
- Base Mismatch Proportion Data [NCIt concept]
- Base of Tongue [NCIt concept]
- Base of the Prostate [NCIt concept]
- Basiliximab-IR700 RM-1995 [NCIt concept]
- Basophilic Adenocarcinoma [NCIt concept]
- Basroparib [NCIt concept]
- Batabulin [NCIt concept]
- Batabulin Sodium [NCIt concept]
- Batimastat [NCIt concept]
- Batiraxcept [NCIt concept]
- Batoprotafib [NCIt concept]
- Bavdegalutamide [NCIt concept]
- Bavituximab [NCIt concept]
- Bazedoxifene [NCIt concept]
- Bazlitoran [NCIt concept]
- Bcl-2 Inhibitor ABBV-453 [NCIt concept]
- Bcl-2 Inhibitor ABBV-623 [NCIt concept]
- Bcl-2 Inhibitor BCL201 [NCIt concept]
- Bcl-2 Inhibitor LOXO-338 [NCIt concept]
- Bcl-2 Inhibitor LP-108 [NCIt concept]
- Bcl-2 Inhibitor TQB3909 [NCIt concept]
- Bcl-2 Inhibitor ZN-d5 [NCIt concept]
- Bcl-2/Bcl-XL Inhibitor LP-118 [NCIt concept]
- Bcl-XL Proteolysis Targeting Chimera DT2216 [NCIt concept]
- Bcl-Xs Adenovirus Vaccine [NCIt concept]
- Beauvericin [NCIt concept]
- Becatecarin [NCIt concept]
- Beckwith-Wiedemann Syndrome [NCIt concept]
- Becotatug [NCIt concept]
- Bee Venom Allergy [NCIt concept]
- Beer [NCIt concept]
- Befotertinib [NCIt concept]
- Behcet Syndrome [NCIt concept]
- Belagenpumatucel-L [NCIt concept]
- Belantamab Mafodotin [NCIt concept]
- Belapectin [NCIt concept]
- Belarus [NCIt concept]
- Belgium [NCIt concept]
- Belimumab [NCIt concept]
- Belinostat [NCIt concept]
- Belize [NCIt concept]
- Belotecan Hydrochloride [NCIt concept]
- Belrestotug [NCIt concept]
- Belvarafenib [NCIt concept]
- Belzupacap Sarotalocan [NCIt concept]
- Belzutifan [NCIt concept]
- Bemarituzumab [NCIt concept]
- Bemcentinib [NCIt concept]
- Bempegaldesleukin [NCIt concept]
- Benaxibine [NCIt concept]
- Bendamustine [NCIt concept]
- Bendamustine Hydrochloride [NCIt concept]
- Bendamustine-containing Nanoparticle-based Formulation RXDX-107 [NCIt concept]
- Benign Adrenal Cortical Neoplasm [NCIt concept]
- Benign Cellular Infiltrate [NCIt concept]
- Benign Epithelial Neoplasm [NCIt concept]
- Benign Gastrointestinal Stromal Tumor [NCIt concept]
- Benign Hemangioendothelioma [NCIt concept]
- Benign Hemangiopericytoma [NCIt concept]
- Benign Leydig Cell Tumor [NCIt concept]
- Benign Mesenchymoma [NCIt concept]
- Benign Muscle Neoplasm [NCIt concept]
- Benign Myoepithelioma [NCIt concept]
- Benign Neoplasm [NCIt concept]
- Benign Odontogenic Neoplasm [NCIt concept]
- Benign Phyllodes Tumor [NCIt concept]
- Benign Prostatic Hyperplasia [NCIt concept]
- Benign Sertoli Cell Tumor [NCIt concept]
- Benign Skin Appendage Neoplasm [NCIt concept]
- Benign Soft Tissue Neoplasm [NCIt concept]
- Benign Stromal Tumor [NCIt concept]
- Benign Sweat Gland Neoplasm [NCIt concept]
- Benign Synovial Neoplasm [NCIt concept]
- Benign Teratoma [NCIt concept]
- Benign Thymoma [NCIt concept]
- Benin [NCIt concept]
- Benmelstobart [NCIt concept]
- Benzaldehyde Dimethane Sulfonate [NCIt concept]
- Benzene Exposure [NCIt concept]
- Benzoylphenylurea [NCIt concept]
- Berberine Chloride [NCIt concept]
- Bermekimab [NCIt concept]
- Bermuda [NCIt concept]
- Bersanlimab [NCIt concept]
- Berubicin Hydrochloride [NCIt concept]
- Berzosertib [NCIt concept]
- Best Overall Response [NCIt concept]
- Beta Alethine [NCIt concept]
- Beta Tubulin Polymerization Inhibitor CCI-001 [NCIt concept]
- Beta-2 Microglobulin Measurement [NCIt concept]
- Beta-Carotene [NCIt concept]
- Beta-Glucan [NCIt concept]
- Beta-Glucan MM-10-001 [NCIt concept]
- Beta-Thioguanine Deoxyriboside [NCIt concept]
- Beta-catenin Antagonist ST316 [NCIt concept]
- Beta-catenin Inhibitor FOG-001 [NCIt concept]
- Beta-elemene [NCIt concept]
- Beta-lapachone Prodrug ARQ 761 [NCIt concept]
- Betaglucin Gel [NCIt concept]
- Betifisolimab [NCIt concept]
- Betulinic Acid [NCIt concept]
- Bevacizumab [NCIt concept]
- Bevacizumab/Carboplatin/Paclitaxel Regimen [NCIt concept]
- Bexarotene [NCIt concept]
- Bexirestrant [NCIt concept]
- Bexmarilimab [NCIt concept]
- Bezuclastinib [NCIt concept]
- Bhutan [NCIt concept]
- Bi-Sialidase Fusion Protein E-602 [NCIt concept]
- Bicalutamide [NCIt concept]
- Bifunctional TGF-beta Antagonist/IL-15 Protein Complex HCW9218 [NCIt concept]
- Biguanide Antidiabetic Agent [NCIt concept]
- Bilateral [NCIt concept]
- Bilateral Modified Radical Neck Dissection [NCIt concept]
- Bile Duct [NCIt concept]
- Bile Duct Adenocarcinoma [NCIt concept]
- Bile Duct Adenoma [NCIt concept]
- Bile Duct Carcinoma [NCIt concept]
- Bile Duct Intraductal Papillary Neoplasm [NCIt concept]
- Bile Duct Intraductal Papillary Neoplasm, High Grade [NCIt concept]
- Bile Duct Intraductal Papillary Neoplasm, Low Grade [NCIt concept]
- Bile Duct Mucinous Cystic Neoplasm [NCIt concept]
- Bile Duct Mucinous Cystic Neoplasm with an Associated Invasive Carcinoma [NCIt concept]
- Bile Duct Stenosis, CTCAE [NCIt concept]
- Biliary Anastomotic Leak, CTCAE [NCIt concept]
- Biliary Fistula, CTCAE [NCIt concept]
- Biliary System Disorder [NCIt concept]
- Biliary Tract [NCIt concept]
- Biliary Tract Infection, CTCAE [NCIt concept]
- Billion Cells per Liter [NCIt concept]
- Bimiralisib [NCIt concept]
- Binary Alignment Map [NCIt concept]
- Binetrakin [NCIt concept]
- Binimetinib [NCIt concept]
- Bintrafusp Alfa [NCIt concept]
- Biochemical Assessment Indicator [NCIt concept]
- Biochemical Evidence of Disease [NCIt concept]
- Biochemical Evidence of Disease without Structural Correlate [NCIt concept]
- Biological Brother [NCIt concept]
- Biological Father [NCIt concept]
- Biological Grandchild [NCIt concept]
- Biological Grandfather [NCIt concept]
- Biological Grandmother [NCIt concept]
- Biological Grandparent [NCIt concept]
- Biological Maternal Aunt [NCIt concept]
- Biological Maternal Cousin [NCIt concept]
- Biological Maternal Grandfather [NCIt concept]
- Biological Maternal Grandmother [NCIt concept]
- Biological Maternal Uncle [NCIt concept]
- Biological Mother [NCIt concept]
- Biological Niece [NCIt concept]
- Biological Parent [NCIt concept]
- Biological Paternal Aunt [NCIt concept]
- Biological Paternal Cousin [NCIt concept]
- Biological Paternal Grandfather [NCIt concept]
- Biological Paternal Grandmother [NCIt concept]
- Biological Paternal Uncle [NCIt concept]
- Biological Sibling [NCIt concept]
- Biological Sister [NCIt concept]
- Biological Son [NCIt concept]
- Biomarker Positive Malignant Neoplasm [NCIt concept]
- Biopsy [NCIt concept]
- Biopsy with Histologic Confirmation [NCIt concept]
- Biospecimen [NCIt concept]
- Biospecimen Collection Chronology [NCIt concept]
- Biospecimen Collection Method [NCIt concept]
- Biospecimen Collection by Other Surgical Resection Method [NCIt concept]
- Biospecimen Core Resource Identifier [NCIt concept]
- Biospecimen Data Supplement [NCIt concept]
- Biospecimen Growth Rate [NCIt concept]
- Biospecimen Laterality [NCIt concept]
- Biospecimen Portion Creation Date Time [NCIt concept]
- Biospecimen Portion Number [NCIt concept]
- Biospecimen Sequence Number [NCIt concept]
- Biospecimen Type [NCIt concept]
- Biospecimen Volume [NCIt concept]
- Biospecimen on a Slide [NCIt concept]
- Biphasic Mesothelioma [NCIt concept]
- Biphasic Synovial Sarcoma [NCIt concept]
- Biphenotypic Sinonasal Sarcoma [NCIt concept]
- Biphosphonate [NCIt concept]
- Birabresib [NCIt concept]
- Birinapant [NCIt concept]
- Biropepimut-S [NCIt concept]
- Birt-Hogg-Dube Syndrome [NCIt concept]
- Birth Country [NCIt concept]
- Birth Year [NCIt concept]
- Bisantrene [NCIt concept]
- Bisantrene Hydrochloride [NCIt concept]
- Bisnafide [NCIt concept]
- Bisnafide Dimesylate [NCIt concept]
- Bispecific Antibody 2B1 [NCIt concept]
- Bispecific Antibody AGEN1223 [NCIt concept]
- Bispecific Antibody ASP1002 [NCIt concept]
- Bispecific Antibody JNJ-70218902 [NCIt concept]
- Bispecific Antibody MDX-H210 [NCIt concept]
- Bispecific Antibody MDX447 [NCIt concept]
- Bispecific Antibody QLF3108 [NCIt concept]
- Bispecific CD80-lgG4Fc-IL-2v Fusion Protein GI-101 [NCIt concept]
- Bispecific CD80-lgG4Fc-IL-2v Fusion Protein GI-102 [NCIt concept]
- Bispecific Ligand-drug Conjugate CBP-1018 [NCIt concept]
- Bispecific Ligand-drug Conjugate CBP-1019 [NCIt concept]
- Bispecific Monoclonal Antibody ASP2074 [NCIt concept]
- Bisthianostat [NCIt concept]
- Bisulfite Sequencing [NCIt concept]
- Bivalent BRD4 Inhibitor AZD5153 [NCIt concept]
- Bizalimogene Ralaplasmid [NCIt concept]
- Bizarre Leiomyoma [NCIt concept]
- Bizaxofusp [NCIt concept]
- Bizelesin [NCIt concept]
- Black Cohosh [NCIt concept]
- Black Raspberry Nectar [NCIt concept]
- Black or African American [NCIt concept]
- Blacksmith, Toolmaker and Related Trades Worker [NCIt concept]
- Bladder [NCIt concept]
- Bladder Anastomotic Leak, CTCAE [NCIt concept]
- Bladder Carcinoma [NCIt concept]
- Bladder Infection, CTCAE [NCIt concept]
- Bladder Neck [NCIt concept]
- Bladder Perforation, CTCAE 5.0 [NCIt concept]
- Bladder Spasm, CTCAE 5.0 [NCIt concept]
- Bladder Trigone [NCIt concept]
- Blast Count [NCIt concept]
- Blastic Plasmacytoid Dendritic Cell Neoplasm [NCIt concept]
- Blastoma [NCIt concept]
- Bleomycin [NCIt concept]
- Bleomycin A2 [NCIt concept]
- Bleomycin B2 [NCIt concept]
- Bleomycin Sulfate [NCIt concept]
- Blinatumomab [NCIt concept]
- Blinded Clinical Study [NCIt concept]
- Bloating, CTCAE [NCIt concept]
- Blood [NCIt concept]
- Blood Antidiuretic Hormone Abnormal, CTCAE [NCIt concept]
- Blood Bilirubin Increased, CTCAE [NCIt concept]
- Blood Cancer-Derived Blood Specimen [NCIt concept]
- Blood Cancer-Derived Blood Specimen, Post-Treatment [NCIt concept]
- Blood Cancer-Derived Bone Marrow Specimen [NCIt concept]
- Blood Cancer-Derived Bone Marrow Specimen, Post-Treatment [NCIt concept]
- Blood Clot [NCIt concept]
- Blood Corticotrophin Decreased, CTCAE [NCIt concept]
- Blood Gonadotrophin Abnormal, CTCAE [NCIt concept]
- Blood Prolactin Abnormal, CTCAE [NCIt concept]
- Blood Sample [NCIt concept]
- Blood Test Range Lower Limit of Normal [NCIt concept]
- Blood Test Range Upper Limit of Normal [NCIt concept]
- Blood Urea Nitrogen Measurement [NCIt concept]
- Blood Vessel [NCIt concept]
- Blood Vessel Neoplasm [NCIt concept]
- Blood and Lymphatic System Disorders - Other, Specify, CTCAE [NCIt concept]
- Blue [NCIt concept]
- Blue Nevus [NCIt concept]
- Blueberry Powder Supplement [NCIt concept]
- Blurred Vision, CTCAE [NCIt concept]
- Boanmycin Hydrochloride [NCIt concept]
- Bocodepsin Besylate [NCIt concept]
- Boditrectinib [NCIt concept]
- Body [NCIt concept]
- Body Height [NCIt concept]
- Body Mass Index [NCIt concept]
- Body Odor, CTCAE [NCIt concept]
- Body Surface Area [NCIt concept]
- Body of Stomach [NCIt concept]
- Body of the Pancreas [NCIt concept]
- Body of the Penis [NCIt concept]
- Bolivia, Plurinational State of [NCIt concept]
- Bomedemstat [NCIt concept]
- Bone [NCIt concept]
- Bone Infection, CTCAE [NCIt concept]
- Bone Marrow [NCIt concept]
- Bone Marrow Aspirate [NCIt concept]
- Bone Marrow Hypocellular, CTCAE [NCIt concept]
- Bone Marrow Malignant Cell Indicator [NCIt concept]
- Bone Marrow Sample [NCIt concept]
- Bone Marrow-Derived Fibroblasts [NCIt concept]
- Bone Marrow-Derived Mononuclear Cells [NCIt concept]
- Bone Neoplasm [NCIt concept]
- Bone Pain, CTCAE 5.0 [NCIt concept]
- Bone of the Extremity [NCIt concept]
- Borderline Ovarian Brenner Tumor [NCIt concept]
- Borderline Ovarian Clear Cell Adenofibroma [NCIt concept]
- Borderline Ovarian Clear Cell Tumor [NCIt concept]
- Borderline Ovarian Endometrioid Adenofibroma [NCIt concept]
- Borderline Ovarian Endometrioid Tumor/Atypical Proliferative Ovarian Endometrioid Tumor [NCIt concept]
- Borderline Ovarian Mucinous Adenofibroma [NCIt concept]
- Borderline Ovarian Serous Adenofibroma [NCIt concept]
- Borderline Ovarian Serous Surface Papillary Tumor [NCIt concept]
- Borderline Ovarian Serous Tumor-Micropapillary Variant/Non-Invasive Low Grade Ovarian Serous Carcinoma [NCIt concept]
- Borderline Papillary Cystadenoma [NCIt concept]
- Borderline Papillary Mucinous Cystadenoma [NCIt concept]
- Borderline Papillary Serous Cystadenoma [NCIt concept]
- Borderline Phyllodes Tumor [NCIt concept]
- Borderline Serous Cystadenoma [NCIt concept]
- Borofalan (10B) [NCIt concept]
- Boronophenylalanine-Fructose Complex [NCIt concept]
- Bortezomib [NCIt concept]
- Boserolimab [NCIt concept]
- Bosnia and Herzegovina [NCIt concept]
- Bosutinib [NCIt concept]
- Bosutinib Monohydrate [NCIt concept]
- Botanical Agent BEL-X-HG [NCIt concept]
- Botanical Agent LEAC-102 [NCIt concept]
- Botensilimab [NCIt concept]
- Botryoid-Type Embryonal Rhabdomyosarcoma [NCIt concept]
- Botswana [NCIt concept]
- Bovine Cartilage [NCIt concept]
- Bowen Disease of the Skin [NCIt concept]
- Brachial Plexopathy, CTCAE 5.0 [NCIt concept]
- Brachytherapy [NCIt concept]
- Brachyury-expressing Yeast Vaccine GI-6301 [NCIt concept]
- Brain [NCIt concept]
- Brain Stem [NCIt concept]
- Brain Ventricle [NCIt concept]
- Branchial Cleft Remnant [NCIt concept]
- Branchioma [NCIt concept]
- Brazil [NCIt concept]
- Breast [NCIt concept]
- Breast Adenomyoepithelioma [NCIt concept]
- Breast Atrophy, CTCAE [NCIt concept]
- Breast Atypical Medullary Carcinoma [NCIt concept]
- Breast Cancer pTis (DCIS) TNM Finding v8 [NCIt concept]
- Breast Cancer pTis (LCIS) TNM Finding v6 and v7 [NCIt concept]
- Breast Cancer pTis (Paget) TNM Finding v8 [NCIt concept]
- Breast Carcinoma [NCIt concept]
- Breast Carcinoma with Chondroid Metaplasia [NCIt concept]
- Breast Carcinoma with Osseous Metaplasia [NCIt concept]
- Breast Ductal Carcinoma [NCIt concept]
- Breast Ductal Carcinoma In Situ [NCIt concept]
- Breast Ductal Carcinoma In Situ and Invasive Lobular Carcinoma [NCIt concept]
- Breast Ductal Carcinoma In Situ and Lobular Carcinoma [NCIt concept]
- Breast Ductal Carcinoma In Situ and Lobular Carcinoma In Situ [NCIt concept]
- Breast Ductal Carcinoma In Situ, Comedo Type [NCIt concept]
- Breast Ductal Carcinoma In Situ, Cribriform Pattern [NCIt concept]
- Breast Ductal Carcinoma In Situ, High Grade [NCIt concept]
- Breast Ductal Carcinoma In Situ, Solid Type [NCIt concept]
- Breast Fibroadenoma [NCIt concept]
- Breast Giant Fibroadenoma [NCIt concept]
- Breast Implant-Associated Anaplastic Large Cell Lymphoma [NCIt concept]
- Breast Infection, CTCAE [NCIt concept]
- Breast Inflammatory Carcinoma [NCIt concept]
- Breast Intracanalicular Fibroadenoma [NCIt concept]
- Breast Intracystic Papillary Carcinoma [NCIt concept]
- Breast Intracystic Papilloma [NCIt concept]
- Breast Intraductal Papilloma [NCIt concept]
- Breast Lobular Carcinoma [NCIt concept]
- Breast Lobular Carcinoma In Situ [NCIt concept]
- Breast Medullary Carcinoma [NCIt concept]
- Breast Micropapillary Ductal Carcinoma In Situ [NCIt concept]
- Breast Mixed Ductal and Lobular Carcinoma [NCIt concept]
- Breast Paget Disease [NCIt concept]
- Breast Paget Disease and Intraductal Carcinoma [NCIt concept]
- Breast Paget Disease with Invasive Ductal Carcinoma [NCIt concept]
- Breast Paget Disease without Invasive Carcinoma [NCIt concept]
- Breast Pain, CTCAE 5.0 [NCIt concept]
- Breast Papillary Ductal Carcinoma In Situ [NCIt concept]
- Breast Papillary Ductal Carcinoma In Situ with Invasion [NCIt concept]
- Breast Pericanalicular Fibroadenoma [NCIt concept]
- Breast Pleomorphic Lobular Carcinoma In Situ [NCIt concept]
- Breast Scirrhous Carcinoma [NCIt concept]
- Breast Secretory Carcinoma [NCIt concept]
- Breast Solid Papillary Carcinoma [NCIt concept]
- Breflate [NCIt concept]
- Brenner Tumor [NCIt concept]
- Brentuximab [NCIt concept]
- Brentuximab Vedotin [NCIt concept]
- Brequinar [NCIt concept]
- Brequinar Sodium [NCIt concept]
- Breslow Thickness [NCIt concept]
- Briciclib Sodium [NCIt concept]
- Brigatinib [NCIt concept]
- Brigimadlin [NCIt concept]
- Brilanestrant [NCIt concept]
- Brimonidine Tartrate Nanoemulsion OCU-300 [NCIt concept]
- Briquilimab [NCIt concept]
- Brivanib [NCIt concept]
- Brivanib Alaninate [NCIt concept]
- Brivudine [NCIt concept]
- Brivudine Phosphoramidate [NCIt concept]
- Broad Ligament [NCIt concept]
- Broad-Spectrum Human Papillomavirus Vaccine V505 [NCIt concept]
- Broccoli Sprout/Broccoli Seed Extract Supplement [NCIt concept]
- Bromacrylide [NCIt concept]
- Bromebric Acid [NCIt concept]
- Bromocriptine Mesylate [NCIt concept]
- Bronchial Fistula, CTCAE [NCIt concept]
- Bronchial Infection, CTCAE [NCIt concept]
- Bronchial Mixed Squamous Cell and Glandular Papilloma [NCIt concept]
- Bronchial Obstruction, CTCAE [NCIt concept]
- Bronchial Stricture, CTCAE [NCIt concept]
- Bronchiole [NCIt concept]
- Bronchitis [NCIt concept]
- Bronchopleural Fistula, CTCAE [NCIt concept]
- Bronchopulmonary Hemorrhage, CTCAE [NCIt concept]
- Bronchospasm, CTCAE [NCIt concept]
- Bronchus [NCIt concept]
- Brontictuzumab [NCIt concept]
- Brostacillin Hydrochloride [NCIt concept]
- Brostallicin [NCIt concept]
- Brother [NCIt concept]
- Brother-in-law [NCIt concept]
- Brown [NCIt concept]
- Broxuridine [NCIt concept]
- Bruceanol A [NCIt concept]
- Bruceanol B [NCIt concept]
- Bruceanol C [NCIt concept]
- Bruceanol D [NCIt concept]
- Bruceanol E [NCIt concept]
- Bruceanol F [NCIt concept]
- Bruceanol G [NCIt concept]
- Bruceanol H [NCIt concept]
- Bruceantin [NCIt concept]
- Bruising, CTCAE [NCIt concept]
- Brunei Darussalam [NCIt concept]
- Bryostatin 1 [NCIt concept]
- Buccal Cell Sample [NCIt concept]
- Buccal Mucosa [NCIt concept]
- Buccal Mucosal Resection [NCIt concept]
- Budigalimab [NCIt concept]
- Budotitane [NCIt concept]
- Bufalin [NCIt concept]
- Buffy Coat [NCIt concept]
- Building Finisher and Related Trades Worker [NCIt concept]
- Building Frame and Related Trades Worker [NCIt concept]
- Building and Housekeeping Supervisor [NCIt concept]
- Bulgaria [NCIt concept]
- Bullous Dermatitis, CTCAE [NCIt concept]
- Buparlisib [NCIt concept]
- Burixafor [NCIt concept]
- Burixafor Hydrobromide [NCIt concept]
- Burkina Faso [NCIt concept]
- Burkitt Leukemia [NCIt concept]
- Burkitt Lymphoma [NCIt concept]
- Burkitt Lymphoma Clinical Variant Indicator [NCIt concept]
- Burn, CTCAE [NCIt concept]
- Burning Oil Smoke Exposure [NCIt concept]
- Burning Tree Smoke Exposure [NCIt concept]
- Burning Waste Smoke Exposure [NCIt concept]
- Burning Wood Smoke Exposure [NCIt concept]
- Burosumab [NCIt concept]
- Burundi [NCIt concept]
- Buserelin [NCIt concept]
- Bushen Culuan Decoction [NCIt concept]
- Bushen-Jianpi Decoction [NCIt concept]
- Business Services Agent [NCIt concept]
- Business Services and Administration Manager [NCIt concept]
- Busulfan [NCIt concept]
- Buthionine Sulfoximine [NCIt concept]
- Buttock [NCIt concept]
- Buttock Pain, CTCAE 5.0 [NCIt concept]
- C-Reactive Protein Measurement [NCIt concept]
- C-VISA BikDD:Liposome [NCIt concept]
- C-myb Antisense Oligonucleotide G4460 [NCIt concept]
- CA-125 Antigen [NCIt concept]
- CA19-9 Antigen [NCIt concept]
- CACNA1D Gene [NCIt concept]
- CAIX Inhibitor DTP348 [NCIt concept]
- CAIX Inhibitor SLC-0111 [NCIt concept]
- CALB2 Gene [NCIt concept]
- CALR Gene [NCIt concept]
- CAMTA1 Gene [NCIt concept]
- CANT1 Gene [NCIt concept]
- CAR NK Cells SZ003 [NCIt concept]
- CAR T-Cells AMG 119 [NCIt concept]
- CAR-NK Cells SZ011 [NCIt concept]
- CARD11 Gene [NCIt concept]
- CARD11-BCL10-MALT1 Complex Inhibitor XL114 [NCIt concept]
- CARS1 Gene [NCIt concept]
- CASP8 Gene [NCIt concept]
- CBFA2T2 Gene [NCIt concept]
- CBFA2T3 Gene [NCIt concept]
- CBFB Gene [NCIt concept]
- CBL Gene [NCIt concept]
- CBL-B Inhibitor HST-1011 [NCIt concept]
- CBL-B Inhibitor NX-1607 [NCIt concept]
- CBL-B Inhibitor-treated Autologous Tumor-infiltrating Lymphocytes DeTIL-0255 [NCIt concept]
- CBLB Gene [NCIt concept]
- CBLC Gene [NCIt concept]
- CBP/beta-catenin Modulator E7386 [NCIt concept]
- CBP/p300 Bromodomain Inhibitor AUR-107 [NCIt concept]
- CBP/p300 Bromodomain Inhibitor FT-7051 [NCIt concept]
- CCDC6 Gene [NCIt concept]
- CCNB1IP1 Gene [NCIt concept]
- CCNC Gene [NCIt concept]
- CCND1 Gene [NCIt concept]
- CCND2 Gene [NCIt concept]
- CCND3 Gene [NCIt concept]
- CCNE1 Gene [NCIt concept]
- CCR2 Antagonist CCX872-B [NCIt concept]
- CCR2 Antagonist PF-04136309 [NCIt concept]
- CCR2/CCR5 Antagonist BMS-813160 [NCIt concept]
- CCR4 Gene [NCIt concept]
- CCR7 Gene [NCIt concept]
- CD11b Agonist GB1275 [NCIt concept]
- CD122-selective IL-2/Anti-CD25 Antibody-like Fusion Protein ANV419 [NCIt concept]
- CD123-CD33 Compound CAR T Cells [NCIt concept]
- CD123-specific Targeting Module TM123 [NCIt concept]
- CD137/Nectin-4 Bispecific-targeting Agent BT7480 [NCIt concept]
- CD137/PSMA/HSA Trispecific-targeting Agent CB 307 [NCIt concept]
- CD15 Antigen [NCIt concept]
- CD19-expressing Oncolytic Virus CF33 [NCIt concept]
- CD19-specific Adapter Molecule SWI019 [NCIt concept]
- CD19R(EQ)-CD28-CD3zeta-EGFRt-expressing T-lymphocytes [NCIt concept]
- CD19x22 Bicistronic CAR T-cells [NCIt concept]
- CD20-CD19 Compound CAR T Cells [NCIt concept]
- CD20/CD47 Bispecific Fusion Protein CPO107 [NCIt concept]
- CD200 Activation Receptor Ligand hP1A8 [NCIt concept]
- CD209 Gene [NCIt concept]
- CD274 Gene [NCIt concept]
- CD28 Gene [NCIt concept]
- CD3 Complex [NCIt concept]
- CD3-activating CD19 Bi-specific Antibody A-319 [NCIt concept]
- CD371-specific/YSNVz/IL-18 CAR T Cells [NCIt concept]
- CD4 Expressing Cell Count [NCIt concept]
- CD4 Expressing Cell Nadir [NCIt concept]
- CD4 Lymphocytes Decreased, CTCAE [NCIt concept]
- CD4-specific Telomerase Peptide Vaccine UCPVax [NCIt concept]
- CD44 Targeted Agent SPL-108 [NCIt concept]
- CD44v6-specific CAR T-cells [NCIt concept]
- CD47 Antagonist AUR103 Calcium [NCIt concept]
- CD47/SIRPa Blocking Agent TQB2928 [NCIt concept]
- CD73 Inhibitor ATG-037 [NCIt concept]
- CD73 Inhibitor LY3475070 [NCIt concept]
- CD73 Inhibitor ORIC-533 [NCIt concept]
- CD74 Gene [NCIt concept]
- CD79A Gene [NCIt concept]
- CD79B Gene [NCIt concept]
- CD8 Enriched Young Autologous Tumor-infiltrating Lymphocytes [NCIt concept]
- CD80-Fc Fusion Protein FPT155 [NCIt concept]
- CD80-Fc Fusion Protein KM602 [NCIt concept]
- CD99 Gene [NCIt concept]
- CDC7 Inhibitor SGR-2921 [NCIt concept]
- CDC7 Inhibitor TQB3824 [NCIt concept]
- CDC7 Kinase Inhibitor BMS-863233 [NCIt concept]
- CDC7 Kinase Inhibitor LY3143921 Hydrate [NCIt concept]
- CDC7 Kinase Inhibitor NMS-1116354 [NCIt concept]
- CDC73 Gene [NCIt concept]
- CDH1 Gene [NCIt concept]
- CDH10 Gene [NCIt concept]
- CDH11 Gene [NCIt concept]
- CDH17 Gene [NCIt concept]
- CDK Inhibitor AT7519 [NCIt concept]
- CDK Inhibitor R547 [NCIt concept]
- CDK Inhibitor SNS-032 [NCIt concept]
- CDK1/2/4 Inhibitor AG-024322 [NCIt concept]
- CDK12 Gene [NCIt concept]
- CDK2 Inhibitor ARTS-021 [NCIt concept]
- CDK2 Inhibitor BLU-222 [NCIt concept]
- CDK2 Inhibitor INX-315 [NCIt concept]
- CDK2/4/6 Inhibitor PF-07224826 [NCIt concept]
- CDK2/4/6 Inhibitor RGT-419B [NCIt concept]
- CDK2/4/6 Inhibitor SYH2043 [NCIt concept]
- CDK2/4/6/FLT3 Inhibitor FN-1501 [NCIt concept]
- CDK4 Gene [NCIt concept]
- CDK4 Inhibitor BGB-43395 [NCIt concept]
- CDK4 Inhibitor P1446A-05 [NCIt concept]
- CDK4 Inhibitor PF-07220060 [NCIt concept]
- CDK4/6 Inhibition [NCIt concept]
- CDK4/6 Inhibitor BPI-1178 [NCIt concept]
- CDK4/6 Inhibitor BPI-16350 [NCIt concept]
- CDK4/6 Inhibitor CS3002 [NCIt concept]
- CDK4/6 Inhibitor FCN-437 [NCIt concept]
- CDK4/6 Inhibitor GLR2007 [NCIt concept]
- CDK4/6 Inhibitor HS-10342 [NCIt concept]
- CDK4/6 Inhibitor PRT3645 [NCIt concept]
- CDK4/6 Inhibitor QLS12004 [NCIt concept]
- CDK4/6 Inhibitor SPH4336 [NCIt concept]
- CDK4/6 Inhibitor TQB3303 [NCIt concept]
- CDK4/6 Inhibitor TQB3616 [NCIt concept]
- CDK4/6 Inhibitor XZP-3287 [NCIt concept]
- CDK6 Gene [NCIt concept]
- CDK7 Inhibitor LY3405105 [NCIt concept]
- CDK7 Inhibitor LY3405105 Besylate [NCIt concept]
- CDK7 Inhibitor Q901 [NCIt concept]
- CDK7 Inhibitor SY-5609 [NCIt concept]
- CDK7 Inhibitor TY-2699a [NCIt concept]
- CDK8/19 Inhibitor SEL 120 [NCIt concept]
- CDK9 Inhibitor AZD4573 [NCIt concept]
- CDK9 Inhibitor GFH009 [NCIt concept]
- CDK9 Inhibitor KB-0742 [NCIt concept]
- CDK9 Inhibitor PRT2527 [NCIt concept]
- CDKN1A Gene [NCIt concept]
- CDKN1B Gene [NCIt concept]
- CDKN2A Gene [NCIt concept]
- CDKN2C Gene [NCIt concept]
- CDX2 Gene [NCIt concept]
- CEA-MUC-1-TRICOM Vaccine CV301 [NCIt concept]
- CEA-targeting Agent RG6123 [NCIt concept]
- CEBPA Gene [NCIt concept]
- CEBPA-targeting saRNA MTL-CEBPA Liposome [NCIt concept]
- CENP-E Inhibitor GSK-923295A [NCIt concept]
- CEP164 Gene [NCIt concept]
- CEP170B Gene [NCIt concept]
- CEP43 Gene [NCIt concept]
- CEP89 Gene [NCIt concept]
- CHCHD7 Gene [NCIt concept]
- CHD2 Gene [NCIt concept]
- CHD4 Gene [NCIt concept]
- CHEK2 Gene [NCIt concept]
- CHGA Gene [NCIt concept]
- CHIC2 Gene [NCIt concept]
- CHK1 Inhibitor MK-8776 [NCIt concept]
- CHK1 Inhibitor PF-477736 [NCIt concept]
- CHOP Regimen [NCIt concept]
- CHP-NY-ESO-1 Peptide Vaccine IMF-001 [NCIt concept]
- CHST11 Gene [NCIt concept]
- CIC Gene [NCIt concept]
- CIITA Gene [NCIt concept]
- CK1 Alpha Degrader CC-91633 [NCIt concept]
- CK1alpha/CDK7/CDK9 Inhibitor BTX-A51 [NCIt concept]
- CK2-targeting Synthetic Peptide CIGB-300 [NCIt concept]
- CL 246738 [NCIt concept]
- CLEC12A-targeting CCR/Anti-ADGRE2 CAR T Cells ADCLEC.syn1 [NCIt concept]
- CLIP1 Gene [NCIt concept]
- CLK Inhibitor CTX-712 [NCIt concept]
- CLP1 Gene [NCIt concept]
- CLTC Gene [NCIt concept]
- CLTCL1 Gene [NCIt concept]
- CNBD1 Gene [NCIt concept]
- CNBP Gene [NCIt concept]
- CNOT3 Gene [NCIt concept]
- CNTNAP2 Gene [NCIt concept]
- CNTRL Gene [NCIt concept]
- COL1A1 Gene [NCIt concept]
- COL2A1 Gene [NCIt concept]
- COL3A1 Gene [NCIt concept]
- COX-2 Inhibitor ECP-1014 [NCIt concept]
- COX6C Gene [NCIt concept]
- CPK Increased, CTCAE [NCIt concept]
- CREB1 Gene [NCIt concept]
- CREB3L1 Gene [NCIt concept]
- CREB3L2 Gene [NCIt concept]
- CREBBP Gene [NCIt concept]
- CRL4-CRBN Modulator KPG-818 [NCIt concept]
- CRLF2 Gene [NCIt concept]
- CRNKL1 Gene [NCIt concept]
- CRTC1 Gene [NCIt concept]
- CRTC3 Gene [NCIt concept]
- CSF1R Gene [NCIt concept]
- CSF1R Inhibitor HMPL-653 [NCIt concept]
- CSF1R Inhibitor PLX73086 [NCIt concept]
- CSF3R Gene [NCIt concept]
- CSMD3 Gene [NCIt concept]
- CT2584 [NCIt concept]
- CT2584 Mesylate [NCIt concept]
- CTCF Gene [NCIt concept]
- CTDP1 Gene [NCIt concept]
- CTNNA2 Gene [NCIt concept]
- CTNNB1 Gene [NCIt concept]
- CTNND1 Gene [NCIt concept]
- CTNND2 Gene [NCIt concept]
- CTPS1 Inhibitor STP938 [NCIt concept]
- CUL3 Gene [NCIt concept]
- CUX1 Gene [NCIt concept]
- CXC Chemokine Receptor 2 Antagonist AZD5069 [NCIt concept]
- CXCR1/2 Inhibitor RP72 [NCIt concept]
- CXCR1/2 Inhibitor SX-682 [NCIt concept]
- CXCR2 Antagonist QBM076 [NCIt concept]
- CXCR4 Antagonist USL311 [NCIt concept]
- CXCR4 Gene [NCIt concept]
- CXCR4 Inhibitor Q-122 [NCIt concept]
- CXCR4 Peptide Antagonist LY2510924 [NCIt concept]
- CXCR4-modified Anti-BCMA CAR T Cells [NCIt concept]
- CXCR4/E-selectin Antagonist GMI-1359 [NCIt concept]
- CYL-02 Plasmid DNA [NCIt concept]
- CYLD Gene [NCIt concept]
- CYP11A1 Inhibitor ODM-209 [NCIt concept]
- CYP17 Lyase Inhibitor ASN001 [NCIt concept]
- CYP17/Androgen Receptor Inhibitor ODM 204 [NCIt concept]
- CYP17/CYP11B2 Inhibitor LAE001 [NCIt concept]
- CYP2C8 Gene [NCIt concept]
- CYSLTR2 Gene [NCIt concept]
- Cabazitaxel [NCIt concept]
- Cabiralizumab [NCIt concept]
- Cabo Verde [NCIt concept]
- Cabozantinib [NCIt concept]
- Cabozantinib S-malate [NCIt concept]
- Cactinomycin [NCIt concept]
- Cadmium Exposure [NCIt concept]
- Cadonilimab [NCIt concept]
- Caffeic Acid Phenethyl Ester [NCIt concept]
- Calaspargase Pegol [NCIt concept]
- Calcifying Cystic Odontogenic Tumor [NCIt concept]
- Calcifying Epithelial Odontogenic Tumor [NCIt concept]
- Calcifying Nested Stromal-Epithelial Tumor [NCIt concept]
- Calcitriol [NCIt concept]
- Calcium Channel Blocker [NCIt concept]
- Calcium Measurement [NCIt concept]
- Calcium Release-activated Channels Inhibitor RP4010 [NCIt concept]
- Calcium Saccharate [NCIt concept]
- Calculus bovis/Moschus/Olibanum/Myrrha Capsule [NCIt concept]
- Caldonirimab [NCIt concept]
- Calf [NCIt concept]
- Calicheamicin Gamma 1I [NCIt concept]
- Cambodia [NCIt concept]
- Cameroon [NCIt concept]
- Camidanlumab Tesirine [NCIt concept]
- Camizestrant [NCIt concept]
- Camonsertib [NCIt concept]
- Camoteskimab [NCIt concept]
- Camptothecin [NCIt concept]
- Camptothecin Analogue TLC388 [NCIt concept]
- Camptothecin Sodium [NCIt concept]
- Camptothecin-20(S)-O-Propionate Hydrate [NCIt concept]
- Camrelizumab [NCIt concept]
- Camsirubicin [NCIt concept]
- Canada [NCIt concept]
- Canakinumab [NCIt concept]
- Cancell [NCIt concept]
- Cancer Antigen 72-4 Measurement [NCIt concept]
- Cancer Cell Metabolism Modulator OMT-111 [NCIt concept]
- Cancer Cellularity Measurement [NCIt concept]
- Cancer Control [NCIt concept]
- Cancer Detection Method [NCIt concept]
- Cancer Model Distributor Reference Identifier [NCIt concept]
- Cancer Peptide Vaccine S-588410 [NCIt concept]
- Cancer Screening [NCIt concept]
- Cancer-Related Death [NCIt concept]
- Candida Antigen Extract Patch VDMN-21 [NCIt concept]
- Candidiasis [NCIt concept]
- Canerpaturev [NCIt concept]
- Canertinib Dihydrochloride [NCIt concept]
- Canfosfamide [NCIt concept]
- Canfosfamide Hydrochloride [NCIt concept]
- Cannabidiol [NCIt concept]
- Cantrixil [NCIt concept]
- Cantuzumab Ravtansine [NCIt concept]
- Capecitabine [NCIt concept]
- Capecitabine Rapidly Disintegrating Tablet [NCIt concept]
- Capillary [NCIt concept]
- Capillary Hemangioma [NCIt concept]
- Capillary Leak Syndrome, CTCAE [NCIt concept]
- Capivasertib [NCIt concept]
- Capmatinib [NCIt concept]
- Capsase-9-PP2A Interaction Inhibitor PEP-010 [NCIt concept]
- Captopril [NCIt concept]
- Car, Van and Motorcycle Driver [NCIt concept]
- Caracemide [NCIt concept]
- Carbendazim [NCIt concept]
- Carbetimer [NCIt concept]
- Carbogen [NCIt concept]
- Carbon C 14-pamiparib [NCIt concept]
- Carbon Monoxide Diffusing Capacity Decreased, CTCAE [NCIt concept]
- Carboplatin [NCIt concept]
- Carboplatin/Paclitaxel [NCIt concept]
- Carboplatin/Paclitaxel Regimen [NCIt concept]
- Carboquone [NCIt concept]
- Carboxyamidotriazole [NCIt concept]
- Carboxyamidotriazole Orotate [NCIt concept]
- Carboxyphenyl Retinamide [NCIt concept]
- Carboxyphthalato-1,2-diaminocyclohexaneplatinum [NCIt concept]
- Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5 [NCIt concept]
- Carcinoid Tumor of Uncertain Malignant Potential [NCIt concept]
- Carcinoma [NCIt concept]
- Carcinoma In Situ [NCIt concept]
- Carcinoma In Situ in a Polyp [NCIt concept]
- Carcinoma Simplex [NCIt concept]
- Carcinoma ex Pleomorphic Adenoma [NCIt concept]
- Carcinoma in a Polyp [NCIt concept]
- Carcinomatosis [NCIt concept]
- Carcinosarcoma [NCIt concept]
- Cardiac Arrest, CTCAE [NCIt concept]
- Cardiac Disorders - Other, Specify, CTCAE [NCIt concept]
- Cardiac Troponin I Increased, CTCAE [NCIt concept]
- Cardiac Troponin T Increased, CTCAE [NCIt concept]
- Cardiovascular Disorder [NCIt concept]
- Carfilzomib [NCIt concept]
- Caricotamide/Tretazicar [NCIt concept]
- Carina [NCIt concept]
- Carlumab [NCIt concept]
- Carmofur [NCIt concept]
- Carmustine [NCIt concept]
- Carmustine Implant [NCIt concept]
- Carmustine Sustained-Release Implant Wafer [NCIt concept]
- Carmustine in Ethanol [NCIt concept]
- Carotid Body [NCIt concept]
- Carotid Body Paraganglioma [NCIt concept]
- Carotuximab [NCIt concept]
- Cartilage [NCIt concept]
- Carubicin [NCIt concept]
- Carubicin Hydrochloride [NCIt concept]
- Carzelesin [NCIt concept]
- Carzinophilin [NCIt concept]
- Cashier and Ticket Clerk [NCIt concept]
- Cat Allergy [NCIt concept]
- Cataract [NCIt concept]
- Cataract, CTCAE 5.0 [NCIt concept]
- Catequentinib Hydrochloride [NCIt concept]
- Catheter Related Infection, CTCAE [NCIt concept]
- Cationic Liposome-Encapsulated Paclitaxel [NCIt concept]
- Cationic Peptide Cream Cypep-1 [NCIt concept]
- Catumaxomab [NCIt concept]
- Cauda Equina [NCIt concept]
- Cause of Death [NCIt concept]
- Cavernous Hemangioma [NCIt concept]
- Cavernous Lymphangioma [NCIt concept]
- Cavrotolimod [NCIt concept]
- Cayman Islands [NCIt concept]
- Cecal Hemorrhage, CTCAE [NCIt concept]
- Cecal Infection, CTCAE [NCIt concept]
- Cecum [NCIt concept]
- Cedazuridine [NCIt concept]
- Cedazuridine/Azacitidine Combination Agent ASTX030 [NCIt concept]
- Cedefingol [NCIt concept]
- Cediranib [NCIt concept]
- Cediranib Maleate [NCIt concept]
- Celecoxib [NCIt concept]
- Celiac Disease [NCIt concept]
- Cell [NCIt concept]
- Cell Count [NCIt concept]
- Cell Culture [NCIt concept]
- Cell Culture Image [NCIt concept]
- Cell Cycle Checkpoint/DNA Repair Antagonist IC83 [NCIt concept]
- Cell Line [NCIt concept]
- Cell Line-Derived Xenograft [NCIt concept]
- Cells per Milliliter [NCIt concept]
- Cellular Angiofibroma [NCIt concept]
- Cellular Blue Nevus [NCIt concept]
- Cellular Ependymoma [NCIt concept]
- Cellular Fibroma [NCIt concept]
- Cellular Leiomyoma [NCIt concept]
- Cellular Schwannoma [NCIt concept]
- Cellularity Measurement [NCIt concept]
- Cemacabtagene Ansegedleucel [NCIt concept]
- Cemadotin [NCIt concept]
- Cemadotin Hydrochloride [NCIt concept]
- Cemento-Osseous Dysplasia [NCIt concept]
- Cemento-Ossifying Fibroma [NCIt concept]
- Cementoblastoma [NCIt concept]
- Cemiplimab [NCIt concept]
- Cemsidomide [NCIt concept]
- Cenersen [NCIt concept]
- Cenisertib [NCIt concept]
- Centigray [NCIt concept]
- Centimeter [NCIt concept]
- Centipeda minima Decoction [NCIt concept]
- Central African Republic [NCIt concept]
- Central Lung Parenchyma Tumor [NCIt concept]
- Central Nervous System [NCIt concept]
- Central Nervous System Embryonal Tumor with Rhabdoid Features [NCIt concept]
- Central Nervous System Embryonal Tumor, Not Otherwise Specified [NCIt concept]
- Central Nervous System Germinoma [NCIt concept]
- Central Nervous System Infectious Disorder [NCIt concept]
- Central Nervous System Lymphoma [NCIt concept]
- Central Nervous System Medulloepithelioma [NCIt concept]
- Central Nervous System Necrosis, CTCAE [NCIt concept]
- Central Nervous System Solitary Fibrous Tumor, Grade 1 [NCIt concept]
- Central Nervous System Solitary Fibrous Tumor, Grade 2 [NCIt concept]
- Central Nervous System Solitary Fibrous Tumor, Grade 3 [NCIt concept]
- Central Neurocytoma [NCIt concept]
- Central Odontogenic Fibroma [NCIt concept]
- Central Portion of the Breast [NCIt concept]
- Central Zone of Prostate [NCIt concept]
- Centroblastic Lymphoma [NCIt concept]
- Ceralasertib [NCIt concept]
- Ceramide Nanoliposome [NCIt concept]
- Cerdulatinib [NCIt concept]
- Cerebellar Liponeurocytoma [NCIt concept]
- Cerebellar Sarcoma [NCIt concept]
- Cerebellum [NCIt concept]
- Cereblon Modulator BTX-1188 [NCIt concept]
- Cereblon Modulator SP-3164 [NCIt concept]
- Cereblon Modulator TQB3820 [NCIt concept]
- Cerebral Cortex [NCIt concept]
- Cerebral Hemisphere [NCIt concept]
- Cerebral Meninges [NCIt concept]
- Cerebrospinal Fluid [NCIt concept]
- Cerebrospinal Fluid Leakage, CTCAE [NCIt concept]
- Cerebrovascular Disorder [NCIt concept]
- Cergutuzumab Amunaleukin [NCIt concept]
- Ceritinib [NCIt concept]
- Ceruminous Adenocarcinoma [NCIt concept]
- Ceruminous Adenoma [NCIt concept]
- Cervical Adenocarcinoma Admixed with Neuroendocrine Carcinoma [NCIt concept]
- Cervical Carcinoma [NCIt concept]
- Cervical Esophagus [NCIt concept]
- Cervical Lymph Node [NCIt concept]
- Cervical Mucinous Adenocarcinoma, Intestinal-Type [NCIt concept]
- Cervical Spine [NCIt concept]
- Cervical Squamotransitional Carcinoma [NCIt concept]
- Cervical Villoglandular Adenocarcinoma [NCIt concept]
- Cervicitis Infection, CTCAE [NCIt concept]
- Cervix Uteri [NCIt concept]
- Cesalin [NCIt concept]
- Cetrelimab [NCIt concept]
- Cetuximab [NCIt concept]
- Cetuximab Sarotalocan Sodium [NCIt concept]
- Cetuximab-loaded Ethylcellulose Polymeric Nanoparticles Decorated with Octreotide (SY) [NCIt concept]
- Cevipabulin [NCIt concept]
- Cevipabulin Fumarate [NCIt concept]
- Cevipabulin Succinate [NCIt concept]
- Cevostamab [NCIt concept]
- ChAdOx1-PSA/PAP/STEAP1/5T4 Prostate Cancer Vaccine ChAdOx1-PCAQ [NCIt concept]
- ChIP-Seq [NCIt concept]
- ChIP-Seq Antibody Name [NCIt concept]
- ChIP-Seq Target Name [NCIt concept]
- Chad [NCIt concept]
- Chaparrin [NCIt concept]
- Chaparrinone [NCIt concept]
- Checkpoint Kinase Inhibitor AZD7762 [NCIt concept]
- Checkpoint Kinase Inhibitor XL844 [NCIt concept]
- Cheilitis, CTCAE [NCIt concept]
- Chemical Exposure [NCIt concept]
- Chemical Exposure Type Indicator [NCIt concept]
- Chemical Lysis DNA Extraction [NCIt concept]
- Chemical and Photographic Products Plant and Machine Operator [NCIt concept]
- Chemoembolization [NCIt concept]
- Chemoprotection [NCIt concept]
- Chemotherapeutic Cycle Number [NCIt concept]
- Chemotherapy [NCIt concept]
- Chest [NCIt concept]
- Chest Pain - Cardiac, CTCAE [NCIt concept]
- Chest Wall [NCIt concept]
- Chest Wall Pain, CTCAE 5.0 [NCIt concept]
- ChiNing Decoction [NCIt concept]
- Child Care Worker and Teachers' Aide [NCIt concept]
- Child Relation [NCIt concept]
- Child-Pugh Class A [NCIt concept]
- Child-Pugh Class A5 [NCIt concept]
- Child-Pugh Class A6 [NCIt concept]
- Child-Pugh Class B [NCIt concept]
- Child-Pugh Class B7 [NCIt concept]
- Child-Pugh Class B8 [NCIt concept]
- Child-Pugh Class B9 [NCIt concept]
- Child-Pugh Class C [NCIt concept]
- Child-Pugh Class C10 [NCIt concept]
- Child-Pugh Class C11 [NCIt concept]
- Child-Pugh Class C12 [NCIt concept]
- Child-Pugh Clinical Classification [NCIt concept]
- Childhood [NCIt concept]
- Childhood Astrocytic Tumor [NCIt concept]
- Childhood Malignant Liver Neoplasm [NCIt concept]
- Childhood Nasal Type Extranodal NK/T-Cell Lymphoma [NCIt concept]
- Children's Oncology Group Liver Tumor Staging System [NCIt concept]
- Children's Oncology Group Neuroblastoma Risk Group Staging System [NCIt concept]
- Children's Oncology Group Renal Cancer Staging System [NCIt concept]
- Children's Oncology Group Retinoblastoma Risk Group Staging System [NCIt concept]
- Chile [NCIt concept]
- Chills, CTCAE [NCIt concept]
- Chimeric Monoclonal Antibody 81C6 [NCIt concept]
- Chimerism [NCIt concept]
- China [NCIt concept]
- Chk1 Inhibitor GDC-0425 [NCIt concept]
- Chk1 Inhibitor GDC-0575 [NCIt concept]
- Chk1 Inhibitor LY2880070 [NCIt concept]
- Chk1 Inhibitor PEP07 [NCIt concept]
- Chk1 Inhibitor SRA737 [NCIt concept]
- Chk2 Inhibitor PHI-101 [NCIt concept]
- Chlamydial Infection [NCIt concept]
- Chlorambucil [NCIt concept]
- Chlorodihydropyrimidine [NCIt concept]
- Chloroquine [NCIt concept]
- Chloroquinoxaline Sulfonamide [NCIt concept]
- Chlorotoxin [NCIt concept]
- Chlorotoxin (EQ)-CD28-CD3zeta-CD19t-expressing CAR T-lymphocytes [NCIt concept]
- Chlorozotocin [NCIt concept]
- Cholangiocarcinoma [NCIt concept]
- Cholecystitis, CTCAE 5.0 [NCIt concept]
- Cholelithiasis [NCIt concept]
- Cholesterol High, CTCAE [NCIt concept]
- Choline [NCIt concept]
- Choline Kinase Alpha Inhibitor TCD-717 [NCIt concept]
- Chondroblastic Osteosarcoma [NCIt concept]
- Chondroblastoma [NCIt concept]
- Chondroid Chordoma [NCIt concept]
- Chondroid Lipoma [NCIt concept]
- Chondroid Syringoma [NCIt concept]
- Chondroma [NCIt concept]
- Chondromatosis [NCIt concept]
- Chondromyxoid Fibroma [NCIt concept]
- Chondrosarcoma [NCIt concept]
- Chordoid Glioma [NCIt concept]
- Chordoid Meningioma [NCIt concept]
- Chordoma [NCIt concept]
- Choriocarcinoma [NCIt concept]
- Choriocarcinoma Combined with Other Germ Cell Elements [NCIt concept]
- Choriogonadotropin Measurement [NCIt concept]
- Choroid [NCIt concept]
- Choroid Plexus Carcinoma [NCIt concept]
- Choroid Plexus Papilloma [NCIt concept]
- Chromium Exposure [NCIt concept]
- Chromogranin A Measurement [NCIt concept]
- Chromogranin B Measurement [NCIt concept]
- Chromomycin A3 [NCIt concept]
- Chromophobe Renal Cell Carcinoma [NCIt concept]
- Chromosomal Rearrangement [NCIt concept]
- Chromosomal Translocation [NCIt concept]
- Chromosome [NCIt concept]
- Chromosome Arm [NCIt concept]
- Chromosome Band [NCIt concept]
- Chronic Eosinophilic Leukemia, Not Otherwise Specified [NCIt concept]
- Chronic Fatigue Syndrome [NCIt concept]
- Chronic Hepatitis [NCIt concept]
- Chronic Intestinal Cryptosporidiosis [NCIt concept]
- Chronic Kidney Disease [NCIt concept]
- Chronic Kidney Disease, CTCAE [NCIt concept]
- Chronic Kidney Disease, Stage 5 [NCIt concept]
- Chronic Leukemia [NCIt concept]
- Chronic Lymphocytic Leukemia [NCIt concept]
- Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma [NCIt concept]
- Chronic Lymphoproliferative Disorder of NK-Cells [NCIt concept]
- Chronic Monocytic Leukemia [NCIt concept]
- Chronic Myeloid Leukemia, BCR-ABL1 Positive [NCIt concept]
- Chronic Myeloid Leukemia, Philadelphia Chromosome Positive, BCR-ABL1 Positive [NCIt concept]
- Chronic Myelomonocytic Leukemia [NCIt concept]
- Chronic Neutrophilic Leukemia [NCIt concept]
- Chronic Obstructive Pulmonary Disease [NCIt concept]
- Chronic Pancreatitis [NCIt concept]
- Chronic Phase Primary Myelofibrosis [NCIt concept]
- Chronic Renal Failure [NCIt concept]
- Chronic Systemic Steroid Use [NCIt concept]
- Chrysanthemum morifolium/Ganoderma lucidum/Glycyrrhiza glabra/Isatis indigotica/Panax pseudoginseng/Rabdosia rubescens/Scutellaria baicalensis/Serona repens Supplement [NCIt concept]
- Chylothorax, CTCAE [NCIt concept]
- Cibisatamab [NCIt concept]
- Cidan Herbal Capsule [NCIt concept]
- Ciforadenant [NCIt concept]
- Cifurtilimab [NCIt concept]
- Cigar [NCIt concept]
- Cigar Smoke Exposure [NCIt concept]
- Cigarette [NCIt concept]
- Cigarette Smoke Exposure [NCIt concept]
- Cilengitide [NCIt concept]
- Ciliary Body [NCIt concept]
- Ciliary Body Benign Medulloepithelioma [NCIt concept]
- Ciliary Body Benign Teratoid Medulloepithelioma [NCIt concept]
- Ciliary Body Teratoid Medulloepithelioma [NCIt concept]
- Ciltacabtagene Autoleucel [NCIt concept]
- Cimetidine [NCIt concept]
- Cinacalcet Hydrochloride [NCIt concept]
- Cinobufagin [NCIt concept]
- Cinobufotalin [NCIt concept]
- Cinrebafusp Alfa [NCIt concept]
- Cintirorgon [NCIt concept]
- Cintredekin Besudotox [NCIt concept]
- Circulating Cell-Free DNA [NCIt concept]
- Circulating Endothelial Cell Count [NCIt concept]
- Circulating Tumor Cell Count [NCIt concept]
- Circumferential Resection Margin [NCIt concept]
- Cirrhosis [NCIt concept]
- Cisplatin [NCIt concept]
- Cisplatin Liposomal [NCIt concept]
- Cisplatin Micelle Formulation HA132 [NCIt concept]
- Cisplatin-E Therapeutic Implant [NCIt concept]
- Cisplatin/Docetaxel Regimen [NCIt concept]
- Cisplatin/Fluorouracil Regimen [NCIt concept]
- Cisplatin/Gemcitabine Regimen [NCIt concept]
- Cisplatin/Pemetrexed Regimen [NCIt concept]
- Cisplatin/Vinblastine/Cell Penetration Enhancer Formulation INT230-6 [NCIt concept]
- Citarinostat [NCIt concept]
- Citatuzumab Bogatox [NCIt concept]
- Cixutumumab [NCIt concept]
- Cladribine [NCIt concept]
- Clanfenur [NCIt concept]
- Clarithromycin [NCIt concept]
- Clark Level Finding [NCIt concept]
- Clark Level I [NCIt concept]
- Clark Level II [NCIt concept]
- Clark Level III [NCIt concept]
- Clark Level IV [NCIt concept]
- Clark Level V [NCIt concept]
- Classic Medulloblastoma [NCIt concept]
- Clavicle [NCIt concept]
- Clear Cell Adenocarcinoma [NCIt concept]
- Clear Cell Adenofibroma [NCIt concept]
- Clear Cell Adenoma [NCIt concept]
- Clear Cell Chondrosarcoma [NCIt concept]
- Clear Cell Cystadenofibroma [NCIt concept]
- Clear Cell Ependymoma [NCIt concept]
- Clear Cell Hepatocellular Carcinoma [NCIt concept]
- Clear Cell Hidradenoma [NCIt concept]
- Clear Cell Meningioma [NCIt concept]
- Clear Cell Neoplasm [NCIt concept]
- Clear Cell Odontogenic Carcinoma [NCIt concept]
- Clear Cell Papillary Cystadenoma [NCIt concept]
- Clear Cell Renal Cell Carcinoma [NCIt concept]
- Clear Cell Sarcoma of Soft Tissue [NCIt concept]
- Clear Cell Sarcoma of the Kidney [NCIt concept]
- Client Information Worker [NCIt concept]
- Clifutinib [NCIt concept]
- Clifutinib Besylate [NCIt concept]
- Clincal Data Supplement [NCIt concept]
- Clinical Assessment Indicator [NCIt concept]
- Clinical Center Type Acronym [NCIt concept]
- Clinical Data [NCIt concept]
- Clinical Distant Metastasis ENSAT Staging Finding v7 [NCIt concept]
- Clinical Finding Detected by Imaging [NCIt concept]
- Clinical Trial Agent [NCIt concept]
- Clinical Trial Censoring [NCIt concept]
- Clinical and Biochemical Assessments Indicator [NCIt concept]
- Clioquinol [NCIt concept]
- Clitoris [NCIt concept]
- Clivatuzumab [NCIt concept]
- Clodronate Disodium [NCIt concept]
- Clodronic Acid [NCIt concept]
- Clofarabine [NCIt concept]
- Clomesone [NCIt concept]
- Clomiphene [NCIt concept]
- Clomiphene Citrate [NCIt concept]
- Clonal Hematopoiesis [NCIt concept]
- Clonality [NCIt concept]
- Closed [NCIt concept]
- Clostridium Novyi-NT Spores [NCIt concept]
- Clostridium difficile Infection [NCIt concept]
- CoREST Inhibitor TNG260 [NCIt concept]
- Coal Dust Exposure [NCIt concept]
- Coal Smoke Exposure [NCIt concept]
- Coal-Burining Indoor Stove or Fireplace Smoke Exposure [NCIt concept]
- Cobimetinib [NCIt concept]
- Cobolimab [NCIt concept]
- Cobomarsen [NCIt concept]
- Coccidioidomycosis [NCIt concept]
- Cochlear Nerve [NCIt concept]
- Codrituzumab [NCIt concept]
- Coenzyme Q10 [NCIt concept]
- Cofetuzumab Pelidotin [NCIt concept]
- Cognitive Disturbance, CTCAE 5.0 [NCIt concept]
- Cohesive Pattern [NCIt concept]
- Cohort Level Copy Number Scores [NCIt concept]
- Coke Oven Emission Exposure [NCIt concept]
- Colchicine-Site Binding Agent ABT-751 [NCIt concept]
- Cold Contaminant-free Iobenguane I-131 [NCIt concept]
- Colitis, CTCAE [NCIt concept]
- Collecting Duct Carcinoma [NCIt concept]
- College Completion [NCIt concept]
- Colloidal Gold-Bound Tumor Necrosis Factor [NCIt concept]
- Colombia [NCIt concept]
- Colon [NCIt concept]
- Colon Adenocarcinoma [NCIt concept]
- Colon Polyp [NCIt concept]
- Colonic Fistula, CTCAE [NCIt concept]
- Colonic Hemorrhage, CTCAE [NCIt concept]
- Colonic Mucosa [NCIt concept]
- Colonic Obstruction, CTCAE [NCIt concept]
- Colonic Perforation, CTCAE [NCIt concept]
- Colonic Stenosis, CTCAE [NCIt concept]
- Colonic Ulcer, CTCAE [NCIt concept]
- Colonoscopy [NCIt concept]
- Colorectal Cancer Peptide Vaccine PolyPEPI1018 [NCIt concept]
- Colorectal Carcinoma [NCIt concept]
- Colorectal Serrated Adenocarcinoma [NCIt concept]
- Colorectal Tumor-Associated Peptides Vaccine IMA910 [NCIt concept]
- Coltuximab Ravtansine [NCIt concept]
- Columnar Cell Variant Thyroid Gland Papillary Carcinoma [NCIt concept]
- Columnar Mucosa Indicator [NCIt concept]
- Combination Estrogen/Progestin Hormonal Contraception [NCIt concept]
- Combination Radiotherapy [NCIt concept]
- Combined Carcinoid and Adenocarcinoma [NCIt concept]
- Combined Hepatocellular Carcinoma and Cholangiocarcinoma [NCIt concept]
- Combined Lung Large Cell Neuroendocrine Carcinoma [NCIt concept]
- Combined Lung Small Cell Carcinoma [NCIt concept]
- Combined Lung Small Cell Carcinoma and Lung Adenocarcinoma [NCIt concept]
- Combined Nucleotide Variation Profile [NCIt concept]
- Combretastatin [NCIt concept]
- Combretastatin A-1 [NCIt concept]
- Combretastatin A1 Diphosphate [NCIt concept]
- Comedo-Type Adenocarcinoma [NCIt concept]
- Comma Separated Values Format [NCIt concept]
- Commensal Bacterial Strain Formulation BMC128 [NCIt concept]
- Commensal Bacterial Strain Formulation VE800 [NCIt concept]
- Commissioned Armed Forces Officer [NCIt concept]
- Commissure of the Lip [NCIt concept]
- Common Acute Lymphoblastic Leukemia [NCIt concept]
- Common Bile Duct [NCIt concept]
- Common Carotid Artery [NCIt concept]
- Common Iliac Lymph Node [NCIt concept]
- Common Variable Immunodeficiency [NCIt concept]
- Comorbid Condition [NCIt concept]
- Comorbidity [NCIt concept]
- Comorbidity Diagnostic Method [NCIt concept]
- Comoros [NCIt concept]
- Comparative Genomic Hybridization [NCIt concept]
- Complete Genomics Sequencing [NCIt concept]
- Complete Hydatidiform Mole [NCIt concept]
- Complete Remission [NCIt concept]
- Complete Response Unconfirmed [NCIt concept]
- Complete Tumor Cell Necrosis [NCIt concept]
- Complex Epithelial Neoplasm [NCIt concept]
- Complex Odontoma [NCIt concept]
- Complication [NCIt concept]
- Composite Gangliocytoma/Neuroma and Neuroendocrine Tumor [NCIt concept]
- Composite Lymphoma [NCIt concept]
- Composition [NCIt concept]
- Compound Kushen Injection [NCIt concept]
- Compound Nevus [NCIt concept]
- Compound Odontoma [NCIt concept]
- Computed Tomography [NCIt concept]
- Conatumumab [NCIt concept]
- Conbercept [NCIt concept]
- Concentrated Lingzhi Mushroom Extract [NCIt concept]
- Concentration [NCIt concept]
- Concentration Impairment, CTCAE [NCIt concept]
- Concordant Bone Marrow Histology [NCIt concept]
- Concurrent Chemoradiation [NCIt concept]
- Condition or Disease under Study [NCIt concept]
- Conditionally Reprogrammed Cells [NCIt concept]
- Conduction Disorder, CTCAE [NCIt concept]
- Confusion, CTCAE 5.0 [NCIt concept]
- Congenital Melanocytic Nevus [NCIt concept]
- Congenital Mesoblastic Nephroma [NCIt concept]
- Congenital Peribronchial Myofibroblastic Tumor [NCIt concept]
- Congenital, Familial and Genetic Disorders - Other, Specify, CTCAE [NCIt concept]
- Congestive Heart Failure [NCIt concept]
- Congo [NCIt concept]
- Congo, the Democratic Republic of the [NCIt concept]
- Conjunctiva [NCIt concept]
- Conjunctivitis Infective, CTCAE [NCIt concept]
- Conjunctivitis, CTCAE [NCIt concept]
- Connective Tissue [NCIt concept]
- Connective Tissue Disorder [NCIt concept]
- Connective and Soft Tissue [NCIt concept]
- Consent Exemption for Use of Post-mortem Samples [NCIt concept]
- Consent Waiver [NCIt concept]
- Consistent Pathology Review Indicator [NCIt concept]
- Consolidation Therapy [NCIt concept]
- Constipation, CTCAE [NCIt concept]
- Constrictive Pericarditis [NCIt concept]
- Continuous Oxygen Administration [NCIt concept]
- Control Analyte [NCIt concept]
- Conventional Osteosarcoma [NCIt concept]
- Conventional Radiotherapy [NCIt concept]
- Conversion Mutation [NCIt concept]
- Convincing Image Source [NCIt concept]
- Cook Islands [NCIt concept]
- Cooking-Related Smoke Exposure [NCIt concept]
- Cooks and Food Preparation Workers [NCIt concept]
- Copanlisib [NCIt concept]
- Copanlisib Hydrochloride [NCIt concept]
- Copper Cu 64-ATSM [NCIt concept]
- Copper Cu 67 SAR-bisPSMA [NCIt concept]
- Copper Cu 67 SAR-bombesin [NCIt concept]
- Copper Cu 67 Ucasareotide Dasaroxetan [NCIt concept]
- Copper Exposure [NCIt concept]
- Copper Gluconate [NCIt concept]
- Copy Number [NCIt concept]
- Copy Number Estimate [NCIt concept]
- Copy Number Polymorphism [NCIt concept]
- Copy Number Segment Data [NCIt concept]
- Cord Blood Derived CAR T-Cells [NCIt concept]
- Cord Blood-derived Expanded Natural Killer Cells PNK-007 [NCIt concept]
- Cordycepin [NCIt concept]
- Cordycepin Triphosphate [NCIt concept]
- Core Biopsy [NCIt concept]
- Core Histone Macro-H2A [NCIt concept]
- Core Histone Macro-H2A.1 [NCIt concept]
- Core Histone Macro-H2A.2 [NCIt concept]
- Coriolus Versicolor Extract [NCIt concept]
- Cornea [NCIt concept]
- Corneal Infection, CTCAE [NCIt concept]
- Corneal Ulcer, CTCAE [NCIt concept]
- Coronary Artery Disease [NCIt concept]
- Corpus Uteri [NCIt concept]
- Corrected Undescended Testis Laterality [NCIt concept]
- Corticorelin Acetate [NCIt concept]
- Cortisone Acetate [NCIt concept]
- Cosibelimab [NCIt concept]
- Cositecan [NCIt concept]
- Costa Rica [NCIt concept]
- Cote d'Ivoire [NCIt concept]
- Cotsiranib [NCIt concept]
- Cough, CTCAE [NCIt concept]
- Country of Residence at Enrollment [NCIt concept]
- Cousin [NCIt concept]
- Cowden Syndrome [NCIt concept]
- CpG Oligodeoxynucleotide GNKG168 [NCIt concept]
- CpG-STAT3 siRNA CAS3/SS3 [NCIt concept]
- Cranial Nerve [NCIt concept]
- Cranial Nerve Infection, CTCAE [NCIt concept]
- Craniopharyngeal Duct [NCIt concept]
- Craniopharyngioma [NCIt concept]
- Craniotomy [NCIt concept]
- Creatinine Increased, CTCAE [NCIt concept]
- Creatinine Measurement [NCIt concept]
- Crelosidenib [NCIt concept]
- Crenigacestat [NCIt concept]
- Crenolanib [NCIt concept]
- Crenolanib Besylate [NCIt concept]
- Cribriform Carcinoma [NCIt concept]
- Cribriform Pattern [NCIt concept]
- Crizotinib [NCIt concept]
- Croatia [NCIt concept]
- Crocidolite Asbestos [NCIt concept]
- Crohn Disease [NCIt concept]
- Crolibulin [NCIt concept]
- Cross-Contaminated Read Fraction [NCIt concept]
- Crude Oil Exposure [NCIt concept]
- Cryopreservation [NCIt concept]
- Cryosurgery [NCIt concept]
- Cryptococcal Meningitis [NCIt concept]
- Cryptococcosis [NCIt concept]
- Cryptogenic Organizing Pneumonia [NCIt concept]
- Cryptophycin [NCIt concept]
- Cryptophycin 52 [NCIt concept]
- Crystalline Genistein Formulation AXP107-11 [NCIt concept]
- Cuba [NCIt concept]
- Cudarolimab [NCIt concept]
- Curacao [NCIt concept]
- Curcumin [NCIt concept]
- Curcumin/Doxorubicin-encapsulating Nanoparticle IMX-110 [NCIt concept]
- Cure [NCIt concept]
- Current Biospecimen Weight [NCIt concept]
- Current Every Day Smoker [NCIt concept]
- Current Hormonal Contraceptive User [NCIt concept]
- Current Reformed Smoker Within Past 15 Years [NCIt concept]
- Current Reformed Smoker, More than 15 Years [NCIt concept]
- Current Reformed Smoker, Years Unknown [NCIt concept]
- Current Smoker [NCIt concept]
- Current Smoking Frequency [NCIt concept]
- Current Some Day Smoker [NCIt concept]
- Cusatuzumab [NCIt concept]
- Cushingoid, CTCAE [NCIt concept]
- Custirsen Sodium [NCIt concept]
- Cutaneous Mastocytosis [NCIt concept]
- Cutaneous Merkel Cell Carcinoma [NCIt concept]
- Cutaneous Nodular Melanoma [NCIt concept]
- Cx43 Agonistic Monoclonal Antibody ALMB-0168 [NCIt concept]
- CyberKnife [NCIt concept]
- Cyclin-dependent Kinase 8/19 Inhibitor BCD 115 [NCIt concept]
- Cyclodisone [NCIt concept]
- Cycloleucine [NCIt concept]
- Cyclopentenyl Cytosine [NCIt concept]
- Cyclophosphamide [NCIt concept]
- Cyclophosphamide Anhydrous [NCIt concept]
- Cyclosporine [NCIt concept]
- Cylindroma [NCIt concept]
- Cyproterone [NCIt concept]
- Cyproterone Acetate [NCIt concept]
- Cyprus [NCIt concept]
- Cyst [NCIt concept]
- Cystadenocarcinoma [NCIt concept]
- Cystadenofibroma [NCIt concept]
- Cystadenoma [NCIt concept]
- Cystectomy [NCIt concept]
- Cystic Hygroma [NCIt concept]
- Cystic Partially Differentiated Kidney Nephroblastoma [NCIt concept]
- Cystic Teratoma [NCIt concept]
- Cystic Tumor of the Atrioventricular Node [NCIt concept]
- Cystitis Noninfective, CTCAE [NCIt concept]
- Cystoscopy [NCIt concept]
- Cytarabine [NCIt concept]
- Cytarabine Monophosphate Prodrug MB07133 [NCIt concept]
- Cytochlor [NCIt concept]
- Cytogenetic Abnormality [NCIt concept]
- Cytogenetic Analysis [NCIt concept]
- Cytokeratin-5 Staining Method [NCIt concept]
- Cytokeratin-6 Staining Method [NCIt concept]
- Cytokine Release Syndrome, CTCAE [NCIt concept]
- Cytokine-based Biologic Agent IRX-2 [NCIt concept]
- Cytologic Atypia [NCIt concept]
- Cytology [NCIt concept]
- Cytomegaloviral Infection [NCIt concept]
- Cytoplasmic Immunoglobulin [NCIt concept]
- Cytotoxic Agent-LAT1 Substrate QBS10072S [NCIt concept]
- Czechia [NCIt concept]
- D-methionine Formulation MRX-1024 [NCIt concept]
- DAB389 Epidermal Growth Factor [NCIt concept]
- DACH Polymer Platinate AP5346 [NCIt concept]
- DACH-Platin Micelle NC-4016 [NCIt concept]
- DAXX Gene [NCIt concept]
- DCAF12L2 Gene [NCIt concept]
- DCC Gene [NCIt concept]
- DCTN1 Gene [NCIt concept]
- DDB2 Gene [NCIt concept]
- DDIT3 Gene [NCIt concept]
- DDR1-2/VEGFR2-3/PDGFRalpha-beta Inhibitor ICP-033 [NCIt concept]
- DDR2 Gene [NCIt concept]
- DDX10 Gene [NCIt concept]
- DDX3X Gene [NCIt concept]
- DDX5 Degrader FL118 [NCIt concept]
- DDX5 Gene [NCIt concept]
- DDX6 Gene [NCIt concept]
- DEK Gene [NCIt concept]
- DGCR8 Gene [NCIt concept]
- DGK-alpha Inhibitor GS-9911 [NCIt concept]
- DGKalpha Inhibitor BAY 2862789 [NCIt concept]
- DHA-Paclitaxel [NCIt concept]
- DHEA Mustard [NCIt concept]
- DHODH Inhibitor JNJ-74856665 [NCIt concept]
- DHODH Inhibitor RP7214 [NCIt concept]
- DI-Leu16-IL2 Immunocytokine [NCIt concept]
- DICER1 Gene [NCIt concept]
- DLCO % REF [NCIt concept]
- DLL3/CD3e Tri-specific T-cell Activating Construct HPN328 [NCIt concept]
- DM4-Conjugated Anti-Cripto Monoclonal Antibody BIIB015 [NCIt concept]
- DNA [NCIt concept]
- DNA Interference Oligonucleotide PNT2258 [NCIt concept]
- DNA Methylation Analysis [NCIt concept]
- DNA Methylation Array [NCIt concept]
- DNA Minor Groove Binding Agent SG2000 [NCIt concept]
- DNA Plasmid Encoding Human IL-12 phIL12 [NCIt concept]
- DNA Plasmid Vaccine ITI-1001 [NCIt concept]
- DNA Plasmid-encoding Interleukin-12 INO-9012/PSA/PSMA DNA Plasmids INO-5150 Formulation INO-5151 [NCIt concept]
- DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine MEDI0457 [NCIt concept]
- DNA Polymerase Theta Inhibitor ART6043 [NCIt concept]
- DNA Polymerase Theta Inhibitor GSK4524101 [NCIt concept]
- DNA Repair Inhibiting Oligonucleotide [NCIt concept]
- DNA Vaccine VB10.16 [NCIt concept]
- DNA-PK inhibitor AZD7648 [NCIt concept]
- DNA-PK/PI3K-delta Inhibitor BR101801 [NCIt concept]
- DNA-PK/TOR Kinase Inhibitor CC-115 [NCIt concept]
- DNA-dependent Protein Kinase Inhibitor VX-984 [NCIt concept]
- DNAJB1 Gene [NCIt concept]
- DNM2 Gene [NCIt concept]
- DNMT1 Inhibitor NTX-301 [NCIt concept]
- DNMT1 Mixed-Backbone Antisense Oligonucleotide MG 98 [NCIt concept]
- DNMT3A Gene [NCIt concept]
- DNTT Gene [NCIt concept]
- DOT1L Gene [NCIt concept]
- DPPG2-based Thermosensitive Liposomes Encapsulating Doxorubicin DPPG2-TSL-DOX [NCIt concept]
- DPT/BCG/Measles/Serratia/Pneumococcus Vaccine [NCIt concept]
- DPT/Typhoid/Staphylococcus aureus/Paratyphoid A/Paratyphoid B Vaccine [NCIt concept]
- DPX-E7 HPV Vaccine [NCIt concept]
- DR5-targeting Tetrameric Nanobody Agonist TAS266 [NCIt concept]
- DRD2 Antagonist/ClpP Agonist ONC206 [NCIt concept]
- DROSHA Gene [NCIt concept]
- DTRMWXHS-12/Everolimus/Pomalidomide Combination Agent DTRM-555 [NCIt concept]
- DUX4L1 Gene [NCIt concept]
- Dabrafenib [NCIt concept]
- Dabrafenib Mesylate [NCIt concept]
- Dacarbazine [NCIt concept]
- Dacetuzumab [NCIt concept]
- Daclizumab [NCIt concept]
- Dacomitinib [NCIt concept]
- Dactinomycin [NCIt concept]
- Dactolisib [NCIt concept]
- Dactolisib Tosylate [NCIt concept]
- Daily Drinker [NCIt concept]
- Dairy or Lactose Intolerance Allergy [NCIt concept]
- Dalantercept [NCIt concept]
- Dalmitamig [NCIt concept]
- Dalnicastobart [NCIt concept]
- Dalotuzumab [NCIt concept]
- Dalpiciclib [NCIt concept]
- Dalutrafusp Alfa [NCIt concept]
- Danburstotug [NCIt concept]
- Daniquidone [NCIt concept]
- Danusertib [NCIt concept]
- Danvatirsen [NCIt concept]
- Danvilostomig [NCIt concept]
- Daporinad [NCIt concept]
- Daratumumab [NCIt concept]
- Daratumumab and Hyaluronidase-fihj [NCIt concept]
- Dargistotug [NCIt concept]
- Darinaparsin [NCIt concept]
- Darleukin [NCIt concept]
- Darolutamide [NCIt concept]
- Daromun [NCIt concept]
- Darovasertib [NCIt concept]
- Dasatinib [NCIt concept]
- Dasminapant [NCIt concept]
- Data Analysis Workflow Name [NCIt concept]
- Data Analysis Workflow URL [NCIt concept]
- Data Analysis Workflow Version [NCIt concept]
- Data Release [NCIt concept]
- Database and Network Professional [NCIt concept]
- Date of Diagnosis [NCIt concept]
- Date of First Enrollment into Study [NCIt concept]
- Date of Recurrence [NCIt concept]
- Datopotamab Deruxtecan [NCIt concept]
- Daughter [NCIt concept]
- Daughter-in-law [NCIt concept]
- Daunorubicin [NCIt concept]
- Daunorubicin Citrate [NCIt concept]
- Daunorubicin Hydrochloride [NCIt concept]
- Davamotecan Pegadexamer [NCIt concept]
- Davoceticept [NCIt concept]
- Davutamig [NCIt concept]
- Dazostinag Disodium [NCIt concept]
- Dead [NCIt concept]
- Death Certificate [NCIt concept]
- Death NOS, CTCAE [NCIt concept]
- Death Neonatal, CTCAE [NCIt concept]
- Death Related to Adverse Event [NCIt concept]
- Death without Remission [NCIt concept]
- Deceased Family Member [NCIt concept]
- Decitabine [NCIt concept]
- Decitabine and Cedazuridine [NCIt concept]
- Dedifferentiated Chondrosarcoma [NCIt concept]
- Dedifferentiated Chordoma [NCIt concept]
- Dedifferentiated Liposarcoma [NCIt concept]
- Deep (Aggressive) Angiomyxoma [NCIt concept]
- Deep Fibrous Histiocytoma [NCIt concept]
- Deep Gray Matter [NCIt concept]
- Deep Lesion [NCIt concept]
- Deep Parotidectomy [NCIt concept]
- Deep Vein Thrombosis [NCIt concept]
- Defactinib [NCIt concept]
- Defactinib Hydrochloride [NCIt concept]
- Deferoxamine [NCIt concept]
- Deferoxamine Mesylate [NCIt concept]
- Defosbarasertib [NCIt concept]
- Degarelix [NCIt concept]
- Degarelix Acetate [NCIt concept]
- Dehydration, CTCAE [NCIt concept]
- Delanzomib [NCIt concept]
- Delayed Orgasm, CTCAE [NCIt concept]
- Delayed Puberty, CTCAE [NCIt concept]
- Deletion Mutation [NCIt concept]
- Delins Mutation [NCIt concept]
- Delirium, CTCAE [NCIt concept]
- Delolimogene Mupadenorepvec [NCIt concept]
- Delusions, CTCAE [NCIt concept]
- Demcizumab [NCIt concept]
- Demecolcine [NCIt concept]
- Demplatin Pegraglumer [NCIt concept]
- Dendrimer-conjugated Bcl-2/Bcl-XL Inhibitor AZD0466 [NCIt concept]
- Dendritic Cell Tumor, Not Otherwise Specified [NCIt concept]
- Dendritic Cell Vaccine [NCIt concept]
- Dendritic Cell-Autologous Lung Tumor Vaccine [NCIt concept]
- Dendritic Cell-targeting Lentiviral Vector ID-LV305 [NCIt concept]
- Denenicokin [NCIt concept]
- Denfivontinib [NCIt concept]
- Denfivontinib Hydrochloride [NCIt concept]
- Dengue Virus Adjuvant PV-001-DV [NCIt concept]
- Denibulin [NCIt concept]
- Denibulin Hydrochloride [NCIt concept]
- Denifanstat [NCIt concept]
- Denileukin Diftitox [NCIt concept]
- Denintuzumab Mafodotin [NCIt concept]
- Denmark [NCIt concept]
- Denosumab [NCIt concept]
- Dental Caries, CTCAE [NCIt concept]
- Dentinogenic Ghost Cell Tumor [NCIt concept]
- Denys-Drash Syndrome [NCIt concept]
- Deoxycytidine Kinase Inhibitor TRE-515 [NCIt concept]
- Depatuxizumab [NCIt concept]
- Depatuxizumab Mafodotin [NCIt concept]
- Depressed Level of Consciousness, CTCAE [NCIt concept]
- Depression [NCIt concept]
- Depression, CTCAE [NCIt concept]
- Depth of Tumor Invasion [NCIt concept]
- Derazantinib [NCIt concept]
- Derived Cell Line [NCIt concept]
- Dermal [NCIt concept]
- Dermal Nevus [NCIt concept]
- Dermatitis Radiation, CTCAE [NCIt concept]
- Dermatofibrosarcoma Protuberans [NCIt concept]
- Dermatomyositis [NCIt concept]
- Dermoid Cyst [NCIt concept]
- Descending Colon [NCIt concept]
- Deslorelin [NCIt concept]
- Deslorelin Acetate [NCIt concept]
- Desmoid Fibromatosis [NCIt concept]
- Desmoplastic Fibroma [NCIt concept]
- Desmoplastic Infantile Astrocytoma [NCIt concept]
- Desmoplastic Infantile Ganglioglioma [NCIt concept]
- Desmoplastic Melanoma [NCIt concept]
- Desmoplastic Mesothelioma [NCIt concept]
- Desmoplastic Small Round Cell Tumor [NCIt concept]
- Desmoplastic/Nodular Medulloblastoma [NCIt concept]
- Detalimogene Voraplasmid [NCIt concept]
- Detirelix [NCIt concept]
- Detorubicin [NCIt concept]
- Deutenzalutamide [NCIt concept]
- Deuteporfin [NCIt concept]
- Device Related Infection, CTCAE [NCIt concept]
- Devimistat [NCIt concept]
- Dexamethasone [NCIt concept]
- Dexamethasone Phosphate [NCIt concept]
- Dexamethasone Sodium Phosphate [NCIt concept]
- Dexanabinol [NCIt concept]
- Dexrazoxane [NCIt concept]
- Dexrazoxane Hydrochloride [NCIt concept]
- Dezaguanine [NCIt concept]
- Dezaguanine Mesylate [NCIt concept]
- Dezapelisib [NCIt concept]
- Diabetes Is Controlled by Diet [NCIt concept]
- Diabetes Is Controlled by Insulin [NCIt concept]
- Diabetes Mellitus [NCIt concept]
- Diabetes Therapy [NCIt concept]
- Diabetic Neuropathy [NCIt concept]
- Diacylglycerol Kinase Zeta Inhibitor ASP1570 [NCIt concept]
- Diacylglycerol Kinase Zeta Inhibitor BAY2965501 [NCIt concept]
- Diacylglycerol Kinase Zeta Inhibitor BGB-30813 [NCIt concept]
- Diagnosis Pathologically Confirmed Indicator [NCIt concept]
- Diagnostic Imaging [NCIt concept]
- Diagnostic Method [NCIt concept]
- Diagnostic Radiology [NCIt concept]
- Diagnostic Slide [NCIt concept]
- Dianhydrogalactitol [NCIt concept]
- Diaphragm [NCIt concept]
- Diarrhea, CTCAE [NCIt concept]
- Diarylsulfonylurea Compound ILX-295501 [NCIt concept]
- Diazepinomicin [NCIt concept]
- Diaziquone [NCIt concept]
- Diazooxonorleucine [NCIt concept]
- Dibrospidium Chloride [NCIt concept]
- Dichloroallyl Lawsone [NCIt concept]
- Dicycloplatin [NCIt concept]
- Didox [NCIt concept]
- Dienogest [NCIt concept]
- Diesel Exhaust Exposure [NCIt concept]
- Diet [NCIt concept]
- Diethylnorspermine [NCIt concept]
- Differential Gene Expression Level Analysis [NCIt concept]
- Differentiated Anti-BCMA Autologous CAR T Cells ARI0002h [NCIt concept]
- Differentiated Retinoblastoma [NCIt concept]
- Differentiating Neuroblastoma [NCIt concept]
- Diffuse [NCIt concept]
- Diffuse Astrocytoma [NCIt concept]
- Diffuse Astrocytoma, IDH-Wildtype [NCIt concept]
- Diffuse Centroblastic-Centrocytic Lymphoma [NCIt concept]
- Diffuse Cutaneous Mastocytosis [NCIt concept]
- Diffuse Intraductal Papillomatosis [NCIt concept]
- Diffuse Large B-Cell Lymphoma [NCIt concept]
- Diffuse Large B-Cell Lymphoma Arising in HHV8-Positive Multicentric Castleman Disease [NCIt concept]
- Diffuse Large B-Cell Lymphoma Associated with Chronic Inflammation [NCIt concept]
- Diffuse Large B-Cell Lymphoma, Not Otherwise Specified [NCIt concept]
- Diffuse Leptomeningeal Glioneuronal Tumor [NCIt concept]
- Diffuse Lesion [NCIt concept]
- Diffuse Malignant Lymphoma [NCIt concept]
- Diffuse Midline Glioma, H3 K27M-Mutant [NCIt concept]
- Diffuse Mixed Cell Lymphoma [NCIt concept]
- Diffuse Pattern [NCIt concept]
- Diffuse Pediatric-Type High Grade Glioma, H3-Wildtype and IDH-Wildtype [NCIt concept]
- Diffuse Retinoblastoma [NCIt concept]
- Diffuse Sclerosing Variant Thyroid Gland Papillary Carcinoma [NCIt concept]
- Diffuse Type Adenocarcinoma [NCIt concept]
- Digestive System Mixed Adenoneuroendocrine Carcinoma [NCIt concept]
- Digital Papillary Adenocarcinoma [NCIt concept]
- Digital Papillary Adenoma [NCIt concept]
- Digitoxin [NCIt concept]
- Digoxin [NCIt concept]
- Dihydro-5-Azacytidine [NCIt concept]
- Dihydrolenperone [NCIt concept]
- Dihydroorotate Dehydrogenase Inhibitor AG-636 [NCIt concept]
- Diindolylmethane [NCIt concept]
- Dilation and Curettage [NCIt concept]
- Dilpacimab [NCIt concept]
- Dimethylmyleran [NCIt concept]
- Dinaciclib [NCIt concept]
- Dinutuximab [NCIt concept]
- Dioscorea nipponica Makino Extract DNE3 [NCIt concept]
- Diphencyprone [NCIt concept]
- Diploidy [NCIt concept]
- Direct Mixed Photon and Electron Field [NCIt concept]
- Discordant Bone Marrow Histology [NCIt concept]
- Disease Grade Qualifier [NCIt concept]
- Disease Involvement Site [NCIt concept]
- Disease Progression [NCIt concept]
- Disease Progression Evidence [NCIt concept]
- Disease Recurrence Evidence [NCIt concept]
- Disease Response [NCIt concept]
- Disease or Disorder [NCIt concept]
- Disinfectant Exposure [NCIt concept]
- Disitamab Vedotin [NCIt concept]
- Disseminated Intravascular Coagulation, CTCAE [NCIt concept]
- Distal [NCIt concept]
- Distal Pancreatectomy [NCIt concept]
- Distance of Closest Surgical Margin [NCIt concept]
- Distant Lymph Node [NCIt concept]
- Distant Metastasis [NCIt concept]
- Distant Site Receiving Treatment [NCIt concept]
- Distantly Metastatic Malignant Neoplasm [NCIt concept]
- Disufenton Sodium [NCIt concept]
- Ditiocarb [NCIt concept]
- Divarasib [NCIt concept]
- Diverticulitis [NCIt concept]
- Divorced [NCIt concept]
- Dizziness, CTCAE 5.0 [NCIt concept]
- Djibouti [NCIt concept]
- Docetaxel [NCIt concept]
- Docetaxel Anhydrous [NCIt concept]
- Docetaxel Depot Formulation NZ-DTX [NCIt concept]
- Docetaxel Emulsion ANX-514 [NCIt concept]
- Docetaxel Formulation CKD-810 [NCIt concept]
- Docetaxel Lipid Microspheres [NCIt concept]
- Docetaxel Nanoparticle CPC634 [NCIt concept]
- Docetaxel Polymeric Micelles [NCIt concept]
- Docetaxel-PNP [NCIt concept]
- Docetaxel-loaded Nanopharmaceutical CRLX301 [NCIt concept]
- Docetaxel/Ritonavir [NCIt concept]
- Docetaxel/Vandetanib Regimen [NCIt concept]
- Dociparstat sodium [NCIt concept]
- Document Version Identifier [NCIt concept]
- Dodekin [NCIt concept]
- Dog Allergy [NCIt concept]
- Dolastatin 10 [NCIt concept]
- Dolastatin 15 [NCIt concept]
- Domatinostat [NCIt concept]
- Dome of the Bladder [NCIt concept]
- Dome-Shaped Lesion [NCIt concept]
- Domestic Partnership [NCIt concept]
- Domestic, Hotel and Office Cleaner and Helper [NCIt concept]
- Dominica [NCIt concept]
- Dominican Republic [NCIt concept]
- Domvanalimab [NCIt concept]
- Donafenib [NCIt concept]
- Donor Splice Site SNP [NCIt concept]
- Dopamine-Secreting [NCIt concept]
- Dordaviprone [NCIt concept]
- Dose [NCIt concept]
- Dose Frequency [NCIt concept]
- Dostarlimab [NCIt concept]
- Double Recombinant Vaccinia Virus VV-GMCSF-Lact [NCIt concept]
- Double-Expressor Lymphoma [NCIt concept]
- Dovitinib [NCIt concept]
- Dovitinib Lactate [NCIt concept]
- Down Syndrome [NCIt concept]
- Doxazosin [NCIt concept]
- Doxercalciferol [NCIt concept]
- Doxifluridine [NCIt concept]
- Doxorubicin [NCIt concept]
- Doxorubicin Hydrochloride [NCIt concept]
- Doxorubicin Prodrug L-377,202 [NCIt concept]
- Doxorubicin Prodrug/Prodrug-activating Biomaterial SQ3370 [NCIt concept]
- Doxorubicin-Eluting Beads [NCIt concept]
- Doxorubicin-HPMA Conjugate [NCIt concept]
- Doxorubicin-Magnetic Targeted Carrier Complex [NCIt concept]
- Doxorubicin-loaded EGFR-targeting Nanocells [NCIt concept]
- Dresbuxelimab [NCIt concept]
- Drinker [NCIt concept]
- Drinking Status [NCIt concept]
- Dromostanolone Propionate [NCIt concept]
- Drozitumab [NCIt concept]
- Dry Eye, CTCAE [NCIt concept]
- Dry Mouth, CTCAE [NCIt concept]
- Dry Skin, CTCAE [NCIt concept]
- Dual IGF-1R/InsR Inhibitor BMS-754807 [NCIt concept]
- Dual-activating Polyvalent STING Agonist ONM-501 [NCIt concept]
- Dual-target CAR T Cells C-4-29 [NCIt concept]
- Dual-target CAR-T Cells BGT007 [NCIt concept]
- Dubermatinib [NCIt concept]
- Duborimycin [NCIt concept]
- Dulanermin [NCIt concept]
- Duligotuzumab [NCIt concept]
- Duodenal Fistula, CTCAE [NCIt concept]
- Duodenal Hemorrhage, CTCAE [NCIt concept]
- Duodenal Infection, CTCAE [NCIt concept]
- Duodenal Obstruction, CTCAE [NCIt concept]
- Duodenal Perforation, CTCAE [NCIt concept]
- Duodenal Stenosis, CTCAE [NCIt concept]
- Duodenal Ulcer, CTCAE [NCIt concept]
- Duodenum [NCIt concept]
- Dupilumab [NCIt concept]
- Durvalumab [NCIt concept]
- Dusigitumab [NCIt concept]
- Dust Exposure [NCIt concept]
- Duvelisib [NCIt concept]
- Duvortuxizumab [NCIt concept]
- Dynemicin [NCIt concept]
- Dynemicin A [NCIt concept]
- Dysarthria, CTCAE [NCIt concept]
- Dysembryoplastic Neuroepithelial Tumor [NCIt concept]
- Dysesthesia, CTCAE [NCIt concept]
- Dysgeusia, CTCAE [NCIt concept]
- Dyslipidemia [NCIt concept]
- Dysmenorrhea, CTCAE [NCIt concept]
- Dyspareunia, CTCAE [NCIt concept]
- Dyspepsia, CTCAE [NCIt concept]
- Dysphagia, CTCAE [NCIt concept]
- Dysphasia, CTCAE [NCIt concept]
- Dysplasia [NCIt concept]
- Dysplasia Degree [NCIt concept]
- Dysplasia Negative [NCIt concept]
- Dysplastic Cerebellar Gangliocytoma [NCIt concept]
- Dysplastic Nevus [NCIt concept]
- Dyspnea, CTCAE [NCIt concept]
- E2F1 Pathway Activator ARQ 171 [NCIt concept]
- EBF1 Gene [NCIt concept]
- EBNA-1 inhibitor VK-2019 [NCIt concept]
- EBP Inhibitor DSP-0390 [NCIt concept]
- EBV Immortalized Lymphocytes [NCIt concept]
- EBV Infection [NCIt concept]
- EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified [NCIt concept]
- EBV-Related Lymphoproliferative Disorder [NCIt concept]
- ECOG Performance Status [NCIt concept]
- ECOG Performance Status 0 [NCIt concept]
- ECOG Performance Status 1 [NCIt concept]
- ECOG Performance Status 2 [NCIt concept]
- ECOG Performance Status 3 [NCIt concept]
- ECOG Performance Status 4 [NCIt concept]
- ECOG Performance Status 5 [NCIt concept]
- ECT204 Transgene-transduced Autologous T Cells ECT204 [NCIt concept]
- ECT2L Gene [NCIt concept]
- EED Gene [NCIt concept]
- EED Inhibitor APG-5918 [NCIt concept]
- EED Inhibitor BR1733 [NCIt concept]
- EED Inhibitor MAK683 [NCIt concept]
- EGFR Antagonist Hemay022 [NCIt concept]
- EGFR Antisense DNA BB-401 [NCIt concept]
- EGFR Exon 20 Insertion Inhibitor BLU-451 [NCIt concept]
- EGFR Gene [NCIt concept]
- EGFR Inhibitor ERAS-801 [NCIt concept]
- EGFR Inhibitor NRC-2694 [NCIt concept]
- EGFR Inhibitor NRC-2694 Dihydrochloride [NCIt concept]
- EGFR Inhibitor NRC-2694 Hydrochloride [NCIt concept]
- EGFR Inhibitor PD-168393 [NCIt concept]
- EGFR Inhibitor TY-9591 [NCIt concept]
- EGFR Inhibitor WJ13404 [NCIt concept]
- EGFR Inhibitor XZP-5809 [NCIt concept]
- EGFR Inhibitor XZP-5809 Tartrate [NCIt concept]
- EGFR Mutant-selective Inhibitor BBT-176 [NCIt concept]
- EGFR Mutant-selective Inhibitor BLU-701 [NCIt concept]
- EGFR Mutant-selective Inhibitor BPI-361175 [NCIt concept]
- EGFR Mutant-selective Inhibitor FWD1509 MsOH [NCIt concept]
- EGFR Mutant-selective Inhibitor H002 [NCIt concept]
- EGFR Mutant-selective Inhibitor HS-10375 [NCIt concept]
- EGFR Mutant-selective Inhibitor NX-019 [NCIt concept]
- EGFR Mutant-selective Inhibitor QLH11811 [NCIt concept]
- EGFR Mutant-selective Inhibitor TQB3804 [NCIt concept]
- EGFR Mutant-selective Inhibitor YK-029A [NCIt concept]
- EGFR Mutant-specific Inhibitor CK-101 [NCIt concept]
- EGFR Mutant-specific Inhibitor ZN-e4 [NCIt concept]
- EGFR T790M Antagonist BPI-15086 [NCIt concept]
- EGFR Tri-specific Natural Killer Cell Engager DF9001 [NCIt concept]
- EGFR-targeted IL-2/IL-10 Dual Cytokine Fusion Protein DK210 (EGFR) [NCIt concept]
- EGFR/CD3-targeting T-cell Engaging Molecule TAK-186 [NCIt concept]
- EGFR/EGFRvIII Inhibitor CM93 [NCIt concept]
- EGFR/EGFRvIII Inhibitor WSD0922-FU [NCIt concept]
- EGFR/HER1/HER2 Inhibitor PKI166 [NCIt concept]
- EGFR/HER2 Inhibitor ABT-101 [NCIt concept]
- EGFR/HER2 Inhibitor AV-412 [NCIt concept]
- EGFR/HER2 Inhibitor ORIC-114 [NCIt concept]
- EGFR/HER2 Inhibitor TAS2940 [NCIt concept]
- EGFR/HER2 Kinase Inhibitor TAK-285 [NCIt concept]
- EGFR/HER2 Mutant-selective Inhibitor BAY2927088 [NCIt concept]
- EGFR/HER2 Mutant-selective Inhibitor HS-10376 [NCIt concept]
- EGFR/HER2 Mutant-selective Inhibitor STX-721 [NCIt concept]
- EGFR/VEGFR/RET Inhibitor HA121-28 [NCIt concept]
- EGb761 [NCIt concept]
- EIF1AX Gene [NCIt concept]
- EIF3E Gene [NCIt concept]
- EIF4A2 Gene [NCIt concept]
- ELF3 Gene [NCIt concept]
- ELF4 Gene [NCIt concept]
- ELK4 Gene [NCIt concept]
- ELL Gene [NCIt concept]
- ELN Adverse-Risk Category [NCIt concept]
- ELN Favorable-Risk Category [NCIt concept]
- ELN Gene [NCIt concept]
- ELN Intermediate-Risk Category [NCIt concept]
- EML4 Gene [NCIt concept]
- ENPP1 Inhibitor RBS2418 [NCIt concept]
- ENPP1 Inhibitor SR-8541A [NCIt concept]
- ENSAT Stage I Adrenal Cortical Carcinoma [NCIt concept]
- ENSAT Stage II Adrenal Cortical Carcinoma [NCIt concept]
- ENSAT Stage III Adrenal Cortical Carcinoma [NCIt concept]
- ENSAT Stage IV Adrenal Cortical Carcinoma [NCIt concept]
- EP Regimen [NCIt concept]
- EP2/EP4 Antagonist TPST-1495 [NCIt concept]
- EP300 Gene [NCIt concept]
- EP4 Antagonist DT-9081 [NCIt concept]
- EP4 Antagonist INV-1120 [NCIt concept]
- EP4 Antagonist ONO-4578 [NCIt concept]
- EPAS1 Gene [NCIt concept]
- EPCAM Gene [NCIt concept]
- EPHA3 Gene [NCIt concept]
- EPHA7 Gene [NCIt concept]
- EPS15 Gene [NCIt concept]
- ER Alpha-targeting Chimeric Protein Degrader AC682 [NCIt concept]
- ERBB2 Gene [NCIt concept]
- ERBB3 Gene [NCIt concept]
- ERBB4 Gene [NCIt concept]
- ERC1 Gene [NCIt concept]
- ERCC2 Gene [NCIt concept]
- ERCC3 Gene [NCIt concept]
- ERCC4 Gene [NCIt concept]
- ERCC5 Gene [NCIt concept]
- ERG Gene [NCIt concept]
- ERK 1/2 Inhibitor ASTX029 [NCIt concept]
- ERK Inhibitor CC-90003 [NCIt concept]
- ERK Inhibitor MK-8353 [NCIt concept]
- ERK1/2 Inhibitor D3S-002 [NCIt concept]
- ERK1/2 Inhibitor ERAS-007 [NCIt concept]
- ERK1/2 Inhibitor HH2710 [NCIt concept]
- ERK1/2 Inhibitor JSI-1187 [NCIt concept]
- ERK1/2 Inhibitor KO-947 [NCIt concept]
- ERa36 Modulator Icaritin [NCIt concept]
- ESR1 Gene [NCIt concept]
- ESR1 Peptides/GM-CSF/Montanide ISA Vaccine [NCIt concept]
- ETNK1 Gene [NCIt concept]
- ETV1 Gene [NCIt concept]
- ETV4 Gene [NCIt concept]
- ETV5 Gene [NCIt concept]
- ETV6 Gene [NCIt concept]
- EWSR1 Gene [NCIt concept]
- EXT1 Gene [NCIt concept]
- EXT2 Gene [NCIt concept]
- EZH1/2 Inhibitor HH2853 [NCIt concept]
- EZH2 Gene [NCIt concept]
- EZH2 Inhibitor PF-06821497 [NCIt concept]
- EZH2 Inhibitor SHR2554 [NCIt concept]
- EZR Gene [NCIt concept]
- Ear [NCIt concept]
- Ear Pain, CTCAE [NCIt concept]
- Ear and Labyrinth Disorders - Other, Specify, CTCAE [NCIt concept]
- Ebvaciclib [NCIt concept]
- Eccrine Carcinoma [NCIt concept]
- Eccrine Hidrocystoma [NCIt concept]
- Echinomycin [NCIt concept]
- Eciskafusp Alfa [NCIt concept]
- Ecromeximab [NCIt concept]
- Ectocervix [NCIt concept]
- Ectomesenchymoma [NCIt concept]
- Ectopic Pregnancy [NCIt concept]
- Ecuador [NCIt concept]
- Eczema [NCIt concept]
- Edatrexate [NCIt concept]
- Edelfosine [NCIt concept]
- Edema Cerebral, CTCAE [NCIt concept]
- Edema Face, CTCAE [NCIt concept]
- Edema Limbs, CTCAE [NCIt concept]
- Edema Trunk, CTCAE [NCIt concept]
- Edetic Acid [NCIt concept]
- Edicotinib [NCIt concept]
- Edodekin alfa [NCIt concept]
- Edotecarin [NCIt concept]
- Edralbrutinib [NCIt concept]
- Edrecolomab [NCIt concept]
- Education Level [NCIt concept]
- Efatutazone [NCIt concept]
- Efatutazone Dihydrochloride [NCIt concept]
- Effusion [NCIt concept]
- Efgivanermin Alfa [NCIt concept]
- Efizonerimod [NCIt concept]
- Eflornithine [NCIt concept]
- Eflornithine Hydrochloride [NCIt concept]
- Eftilagimod Alpha [NCIt concept]
- Eftozanermin Alfa [NCIt concept]
- Eg5 Kinesin-Related Motor Protein Inhibitor 4SC-205 [NCIt concept]
- Eg5 Kinesin-Related Motor Protein Inhibitor ARQ 621 [NCIt concept]
- Eganelisib [NCIt concept]
- Egg Allergy [NCIt concept]
- Egypt [NCIt concept]
- Eicosapentaenoic Acid [NCIt concept]
- Eighth [NCIt concept]
- Ejaculation Disorder, CTCAE [NCIt concept]
- Ejection Fraction Decreased, CTCAE [NCIt concept]
- El Salvador [NCIt concept]
- Elacestrant [NCIt concept]
- Elacytarabine [NCIt concept]
- Elagolix [NCIt concept]
- Elapsed Time Between Clamping and Freezing [NCIt concept]
- Elapsed Time Between Excision and Freezing [NCIt concept]
- Elastofibroma [NCIt concept]
- Elbasvir/Grazoprevir [NCIt concept]
- Elbow Joint [NCIt concept]
- Electrical Fire Smoke Exposure [NCIt concept]
- Electrical and Electronic Equipment Mechanics, Installers, and Repairers [NCIt concept]
- Electrocardiogram QT Corrected Interval Prolonged, CTCAE [NCIt concept]
- Electronic Cigarette [NCIt concept]
- Electronic Cigarette Smoke Exposure [NCIt concept]
- Electronic File Content Type [NCIt concept]
- Electronics and Telecommunications Installer and Repairer [NCIt concept]
- Electrotechnology Engineer [NCIt concept]
- Elenestinib [NCIt concept]
- Elesclomol [NCIt concept]
- Elesclomol Sodium [NCIt concept]
- Elevated Expression [NCIt concept]
- Elevated Test Result [NCIt concept]
- Elgemtumab [NCIt concept]
- Elimusertib [NCIt concept]
- Elinafide [NCIt concept]
- Elisidepsin [NCIt concept]
- Elliptinium [NCIt concept]
- Elliptinium Acetate [NCIt concept]
- Elmustine [NCIt concept]
- Elongation Mutation [NCIt concept]
- Elotuzumab [NCIt concept]
- Elpamotide [NCIt concept]
- Elraglusib [NCIt concept]
- Elranatamab [NCIt concept]
- Elsamitrucin [NCIt concept]
- Eltanexor [NCIt concept]
- Eltrapuldencel-T [NCIt concept]
- Eluvixtamab [NCIt concept]
- Elzovantinib [NCIt concept]
- Emactuzumab [NCIt concept]
- Emapalumab [NCIt concept]
- Emavusertib [NCIt concept]
- Embolic Agent [NCIt concept]
- Embolic Bead [NCIt concept]
- Embolization Therapy [NCIt concept]
- Embryonal Carcinoma [NCIt concept]
- Embryonal Rhabdomyosarcoma [NCIt concept]
- Embryonal Tumor with Multilayered Rosettes [NCIt concept]
- Embryonal Tumor with Multilayered Rosettes, C19MC-Altered [NCIt concept]
- Embryonic Fluid [NCIt concept]
- Embryonic Tissue [NCIt concept]
- Emepepimut-S [NCIt concept]
- Emerfetamab [NCIt concept]
- Emfizatamab [NCIt concept]
- Emibetuzumab [NCIt concept]
- Emidurdar [NCIt concept]
- Emilumenib [NCIt concept]
- Emilumenib Succinate [NCIt concept]
- Emirodatamab [NCIt concept]
- Emitefur [NCIt concept]
- Emofolin Sodium [NCIt concept]
- Empesertib [NCIt concept]
- Emvododstat [NCIt concept]
- Emzadirib [NCIt concept]
- Enadenotucirev [NCIt concept]
- Enadenotucirev-expressing Anti-CD40 Agonistic Monoclonal Antibody NG-350A [NCIt concept]
- Enadenotucirev-expressing FAP/CD3 Bispecific FAP-TAc NG-641 [NCIt concept]
- Enasidenib [NCIt concept]
- Enasidenib Mesylate [NCIt concept]
- Enavatuzumab [NCIt concept]
- Enbezotinib [NCIt concept]
- Encapsulated Rapamycin [NCIt concept]
- Encapsulated Variant Thyroid Gland Papillary Carcinoma [NCIt concept]
- Encelimab [NCIt concept]
- Encephalitis Infection, CTCAE [NCIt concept]
- Encephalomyelitis Infection, CTCAE [NCIt concept]
- Encephalopathy [NCIt concept]
- Encephalopathy, CTCAE 5.0 [NCIt concept]
- Enchondroma [NCIt concept]
- Enclomiphene [NCIt concept]
- Enclomiphene Citrate [NCIt concept]
- Encorafenib [NCIt concept]
- End of Consolidation Therapy Occurrence Indicator [NCIt concept]
- End of Treatment Course 1 Occurrence Indicator [NCIt concept]
- End of Treatment Course 2 Occurrence Indicator [NCIt concept]
- End of Treatment Course Occurrence Indicator [NCIt concept]
- Endemic Burkitt Lymphoma [NCIt concept]
- Endocarditis Infective, CTCAE [NCIt concept]
- Endocervical Adenocarcinoma, Usual-Type [NCIt concept]
- Endocervical Polyp [NCIt concept]
- Endocervix [NCIt concept]
- Endocrine Disorders - Other, Specify, CTCAE [NCIt concept]
- Endocrine Gland [NCIt concept]
- Endolaryngeal Excision [NCIt concept]
- Endometrial Atypical Hyperplasia/Endometrioid Intraepithelial Neoplasia [NCIt concept]
- Endometrial Carcinoma [NCIt concept]
- Endometrial Endometrioid Adenocarcinoma, Ciliated Variant [NCIt concept]
- Endometrial Endometrioid Adenocarcinoma, Secretory Variant [NCIt concept]
- Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation [NCIt concept]
- Endometrial Polyp [NCIt concept]
- Endometrial Stromal Nodule [NCIt concept]
- Endometrioid Adenocarcinoma [NCIt concept]
- Endometrioid Stromal Sarcoma [NCIt concept]
- Endometriosis [NCIt concept]
- Endometrium [NCIt concept]
- Endophthalmitis, CTCAE [NCIt concept]
- Endorectal Tumor Resection [NCIt concept]
- Endosalpingiosis [NCIt concept]
- Endoscopic Biopsy [NCIt concept]
- Endoscopic Mucosal Resection [NCIt concept]
- Endoscopic Procedure [NCIt concept]
- Endothelin Receptor Type A Antagonist YM598 [NCIt concept]
- Endoxifen Hydrochloride [NCIt concept]
- Enfortumab Vedotin [NCIt concept]
- Engineered Human Umbilical Vein Endothelial Cells AB-205 [NCIt concept]
- Engineered IL-12 Prodrug WTX-330 [NCIt concept]
- Engineered IL-12 Variant/Aluminum Hydroxide Complex ANK-101 [NCIt concept]
- Engineered IL-2 Prodrug WTX-124 [NCIt concept]
- Engineered Interferon Alpha-2b Prodrug JZP898 [NCIt concept]
- Engineered Interferon ORB-011 [NCIt concept]
- Engineered Red Blood Cells Co-expressing 4-1BBL and IL-15TP RTX-240 [NCIt concept]
- Engineered Red Blood Cells Expressing 4-1BBL/IL-12 RTX-224 [NCIt concept]
- Engineered Red Blood Cells Expressing HPV16 E7/4-1BBL/IL-12 RTX-321 [NCIt concept]
- Engineered Toxin Body Targeting CD38 TAK-169 [NCIt concept]
- Engineered Toxin Body Targeting CTLA-4 MT-8421 [NCIt concept]
- Engineered Toxin Body Targeting HER2 MT-5111 [NCIt concept]
- Engineered Toxin Body Targeting PD-L1 MT-6402 [NCIt concept]
- Engineers [NCIt concept]
- Eniluracil/5-FU Combination Tablet [NCIt concept]
- Enitociclib [NCIt concept]
- Enlonstobart [NCIt concept]
- Enloplatin [NCIt concept]
- Enneking High Surgical Grade [NCIt concept]
- Enneking Low Surgical Grade [NCIt concept]
- Enneking Metastasis [NCIt concept]
- Enneking Metastasis M0 [NCIt concept]
- Enneking Metastasis M1 [NCIt concept]
- Enneking Stage IA [NCIt concept]
- Enneking Stage IB [NCIt concept]
- Enneking Stage IIA [NCIt concept]
- Enneking Stage IIB [NCIt concept]
- Enneking Stage III [NCIt concept]
- Enneking Staging System [NCIt concept]
- Enneking Surgical Grade [NCIt concept]
- Enneking Tumor Type [NCIt concept]
- Enoblituzumab [NCIt concept]
- Enobosarm [NCIt concept]
- Enoticumab [NCIt concept]
- Enpromate [NCIt concept]
- Enristomig [NCIt concept]
- Ensartinib [NCIt concept]
- Ensituximab [NCIt concept]
- Enteric-Coated TRPM8 Agonist D-3263 Hydrochloride [NCIt concept]
- Enterochromaffin-Like Cell Neuroendocrine Tumor G1 [NCIt concept]
- Enterococcus gallinarum Strain MRx0518 [NCIt concept]
- Enterocolitis Infectious, CTCAE [NCIt concept]
- Enterocolitis, CTCAE [NCIt concept]
- Enteroglucagonoma [NCIt concept]
- Enteropathy-Associated T-Cell Lymphoma [NCIt concept]
- Enterovesical Fistula, CTCAE [NCIt concept]
- Entinostat [NCIt concept]
- Entolimod [NCIt concept]
- Entospletinib [NCIt concept]
- Entrectinib [NCIt concept]
- Enucleation [NCIt concept]
- Envafolimab [NCIt concept]
- Enzalutamide [NCIt concept]
- Enzastaurin [NCIt concept]
- Enzastaurin Hydrochloride [NCIt concept]
- Eosinophil Count [NCIt concept]
- Eosinophilic Granuloma [NCIt concept]
- Epacadostat [NCIt concept]
- Epacmarstobart [NCIt concept]
- Epcoritamab [NCIt concept]
- Ependymoma [NCIt concept]
- EphA2-targeting Bicycle Toxin Conjugate BT5528 [NCIt concept]
- Epididymis [NCIt concept]
- Epidural Spinal Canal Space [NCIt concept]
- Epinephrine-Secreting [NCIt concept]
- Epipodophyllotoxin Analog GL331 [NCIt concept]
- Epipodophyllotoxin-Related Myelodysplastic Syndrome [NCIt concept]
- Epipropidine [NCIt concept]
- Epirubicin [NCIt concept]
- Epirubicin Hydrochloride [NCIt concept]
- Epistaxis, CTCAE [NCIt concept]
- Epithelial Neoplasm [NCIt concept]
- Epithelial Synovial Sarcoma [NCIt concept]
- Epithelial-Myoepithelial Carcinoma [NCIt concept]
- Epithelioid Cell Melanoma [NCIt concept]
- Epithelioid Cell Nevus [NCIt concept]
- Epithelioid Cell Type Gastrointestinal Stromal Tumor [NCIt concept]
- Epithelioid Glioblastoma [NCIt concept]
- Epithelioid Hemangioendothelioma [NCIt concept]
- Epithelioid Hemangioma [NCIt concept]
- Epithelioid Leiomyosarcoma [NCIt concept]
- Epithelioid Malignant Peripheral Nerve Sheath Tumor [NCIt concept]
- Epithelioid Mesothelioma [NCIt concept]
- Epithelioid Sarcoma [NCIt concept]
- Epithelioid Trophoblastic Tumor [NCIt concept]
- Epitinib Succinate [NCIt concept]
- Epitiostanol [NCIt concept]
- Epitrochlear Lymph Node [NCIt concept]
- Epitrochlear Region [NCIt concept]
- Epothilone KOS-1584 [NCIt concept]
- Epratuzumab [NCIt concept]
- Epratuzumab-cys-tesirine [NCIt concept]
- Eprenetapopt [NCIt concept]
- Epstein-Barr Virus Test [NCIt concept]
- Epstein-Barr Virus gp350-ferritin Nanoparticle Vaccine with Saponin-based Adjuvant [NCIt concept]
- Equatorial Guinea [NCIt concept]
- Equecabtagene Autoleucel [NCIt concept]
- Equivocal [NCIt concept]
- Eragidomide [NCIt concept]
- Eramkafusp Alfa [NCIt concept]
- Erastin Analogue PRLX 93936 [NCIt concept]
- Erbulozole [NCIt concept]
- Erdafitinib [NCIt concept]
- Erectile Dysfunction, CTCAE [NCIt concept]
- Eribulin [NCIt concept]
- Eribulin Mesylate [NCIt concept]
- Eritrea [NCIt concept]
- Erlotinib [NCIt concept]
- Erlotinib Hydrochloride [NCIt concept]
- Ertumaxomab [NCIt concept]
- Eryaspase [NCIt concept]
- Erythema Multiforme, CTCAE [NCIt concept]
- Erythrocyte Sedimentation Rate Measurement [NCIt concept]
- Erythroderma, CTCAE [NCIt concept]
- Erythroleukemia [NCIt concept]
- Erzotabart [NCIt concept]
- Escherichia coli Infection [NCIt concept]
- Esophageal Anastomotic Leak, CTCAE [NCIt concept]
- Esophageal Carcinoma [NCIt concept]
- Esophageal Columnar Dysplasia [NCIt concept]
- Esophageal Columnar Dysplasia Degree [NCIt concept]
- Esophageal Columnar Metaplasia Indicator [NCIt concept]
- Esophageal Columnar Mucosa Goblet Cell Indicator [NCIt concept]
- Esophageal Fistula, CTCAE [NCIt concept]
- Esophageal Hemorrhage, CTCAE [NCIt concept]
- Esophageal High Grade Intraepithelial Neoplasia [NCIt concept]
- Esophageal Infection, CTCAE [NCIt concept]
- Esophageal Mucosa [NCIt concept]
- Esophageal Necrosis, CTCAE [NCIt concept]
- Esophageal Obstruction, CTCAE [NCIt concept]
- Esophageal Pain, CTCAE [NCIt concept]
- Esophageal Perforation, CTCAE [NCIt concept]
- Esophageal Stenosis, CTCAE [NCIt concept]
- Esophageal Ulcer, CTCAE [NCIt concept]
- Esophageal Varices Hemorrhage, CTCAE 5.0 [NCIt concept]
- Esophagitis, CTCAE [NCIt concept]
- Esophagus [NCIt concept]
- Esorubicin [NCIt concept]
- Esorubicin Hydrochloride [NCIt concept]
- Esperamicin A1 [NCIt concept]
- Essential Thrombocythemia [NCIt concept]
- Essiac [NCIt concept]
- Esterified Estrogens [NCIt concept]
- Estimated Read Error due to Contamination [NCIt concept]
- Estonia [NCIt concept]
- Estradiol Valerate [NCIt concept]
- Estramustine [NCIt concept]
- Estramustine Phosphate Sodium [NCIt concept]
- Estrogen Only Hormone Replacement Therapy [NCIt concept]
- Estrogen Receptor Agonist GTx-758 [NCIt concept]
- Estrogen Receptor Degrader AC699 [NCIt concept]
- Estrogen/Progesterone Hormone Replacement Therapy [NCIt concept]
- Estrogens, Conjugated [NCIt concept]
- Eswatini [NCIt concept]
- Etalocib [NCIt concept]
- Etanercept [NCIt concept]
- Etanidazole [NCIt concept]
- Etaracizumab [NCIt concept]
- Etarotene [NCIt concept]
- Etevritamab [NCIt concept]
- Ethanol Ablation Therapy [NCIt concept]
- Ethaselen [NCIt concept]
- Ethinyl Estradiol [NCIt concept]
- Ethiodized Oil [NCIt concept]
- Ethiopia [NCIt concept]
- Ethmoid Sinus [NCIt concept]
- Ethnic Group [NCIt concept]
- Ethyleneimine [NCIt concept]
- Ethylnitrosourea [NCIt concept]
- Etidronate-Cytarabine Conjugate MBC-11 [NCIt concept]
- Etigilimab [NCIt concept]
- Etirinotecan Pegol [NCIt concept]
- Etoglucid [NCIt concept]
- Etoposide [NCIt concept]
- Etoposide Phosphate [NCIt concept]
- Etoposide Toniribate [NCIt concept]
- Etoprine [NCIt concept]
- Etoricoxib [NCIt concept]
- Etrumadenant [NCIt concept]
- Ets-family Transcription Factor Inhibitor TK216 [NCIt concept]
- Euphoria, CTCAE 5.0 [NCIt concept]
- Eurestobart [NCIt concept]
- European LeukemiaNet Risk Classification [NCIt concept]
- Evalstotug [NCIt concept]
- Event [NCIt concept]
- Everolimus [NCIt concept]
- Everolimus Tablets for Oral Suspension [NCIt concept]
- Every Hour [NCIt concept]
- Every Other Day [NCIt concept]
- Every Twenty-Four Hours [NCIt concept]
- Evexomostat [NCIt concept]
- Evofosfamide [NCIt concept]
- Evorpacept [NCIt concept]
- Evunzekibart [NCIt concept]
- Ewing Sarcoma [NCIt concept]
- Ex Vivo-expanded Allogeneic Gamma 9 Delta 2 T-cells [NCIt concept]
- Ex Vivo-expanded Autologous T Cells IMA101 [NCIt concept]
- Exarafenib [NCIt concept]
- Exatecan Mesylate [NCIt concept]
- Exatecan Mesylate Anhydrous [NCIt concept]
- Excel Open XML Format [NCIt concept]
- Excisional Biopsy [NCIt concept]
- Exemestane [NCIt concept]
- Exemption from Informed Consent for Research [NCIt concept]
- Exercised Five or More Days per Week [NCIt concept]
- Exercised One to Two Days per Week [NCIt concept]
- Exercised Three to Four Days per Week [NCIt concept]
- Exicorilant [NCIt concept]
- Exisulind [NCIt concept]
- Exlinkibart [NCIt concept]
- Exon Mutation [NCIt concept]
- Exon RNA Measurement [NCIt concept]
- Exon of Interest Number [NCIt concept]
- Exoresection [NCIt concept]
- Exostosis, CTCAE 5.0 [NCIt concept]
- Expanded Next Generation Cancer Model [NCIt concept]
- Experiment Metadata [NCIt concept]
- Experiment Name [NCIt concept]
- Experimental Method [NCIt concept]
- Exposure Duration [NCIt concept]
- Exposure Duration Years [NCIt concept]
- Exposure Duration in Hours per Day [NCIt concept]
- Exposure Source Indicator [NCIt concept]
- Expression Negative [NCIt concept]
- Extended Release Flucytosine [NCIt concept]
- Extended Release Metformin Hydrochloride [NCIt concept]
- Extended-Release MetAP2 Inhibitor APL-1501 [NCIt concept]
- Extended-release Onapristone [NCIt concept]
- Extensible Markup Language [NCIt concept]
- Extensive Extracapsular Extention [NCIt concept]
- External [NCIt concept]
- External Acoustic Meatus [NCIt concept]
- External Beam Radiation Therapy [NCIt concept]
- External Ear [NCIt concept]
- External Ear Pain, CTCAE 5.0 [NCIt concept]
- External Iliac Lymph Node [NCIt concept]
- External Lip [NCIt concept]
- External Lower Lip [NCIt concept]
- External Upper Lip [NCIt concept]
- Extra-Adrenal Paraganglioma [NCIt concept]
- Extraabdominal Fibromatosis [NCIt concept]
- Extracapsular Extension Present Indicator [NCIt concept]
- Extracapsular Extent Indicator [NCIt concept]
- Extracompartmental Tumor [NCIt concept]
- Extracutaneous Mastocytoma [NCIt concept]
- Extrahepatic Bile Duct [NCIt concept]
- Extramammary Paget Disease [NCIt concept]
- Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue [NCIt concept]
- Extranodal Tumor Extension Absent [NCIt concept]
- Extraocular Muscle Paresis, CTCAE [NCIt concept]
- Extraocular Nodule Size [NCIt concept]
- Extraosseous Plasmacytoma [NCIt concept]
- Extrapyramidal Disorder, CTCAE [NCIt concept]
- Extrascleral Extension of Uveal Melanoma [NCIt concept]
- Extraskeletal Myxoid Chondrosarcoma [NCIt concept]
- Extrathyroid Extent Indicator [NCIt concept]
- Extravascular Matrix Loops [NCIt concept]
- Extraventricular Neurocytoma [NCIt concept]
- Eye [NCIt concept]
- Eye Color [NCIt concept]
- Eye Disorders - Other, Specify, CTCAE [NCIt concept]
- Eye Infection, CTCAE [NCIt concept]
- Eye Pain, CTCAE 5.0 [NCIt concept]
- Eyebrow [NCIt concept]
- Eyelid [NCIt concept]
- Eyelid Function Disorder, CTCAE [NCIt concept]
- Ezabenlimab [NCIt concept]
- Ezobresib [NCIt concept]
- Ezurpimtrostat [NCIt concept]
- F16-IL2 Fusion Protein [NCIt concept]
- FACT Complex-targeting Curaxin CBL0137 [NCIt concept]
- FAK Inhibitor GSK2256098 [NCIt concept]
- FAK Inhibitor PF-00562271 [NCIt concept]
- FAK Inhibitor VS-4718 [NCIt concept]
- FAK/ALK/ROS1 Inhibitor APG-2449 [NCIt concept]
- FAM131B Gene [NCIt concept]
- FAM135B Gene [NCIt concept]
- FAM47C Gene [NCIt concept]
- FANCA Gene [NCIt concept]
- FANCC Gene [NCIt concept]
- FANCD2 Gene [NCIt concept]
- FANCE Gene [NCIt concept]
- FANCF Gene [NCIt concept]
- FANCG Gene [NCIt concept]
- FAP/4-1BB-targeting DARPin MP0310 [NCIt concept]
- FAP/4-1BB-targeting Fusion Protein RO7122290 [NCIt concept]
- FAP/CD40-targeting Agent SHR-7367 [NCIt concept]
- FAP/CD40-targeting DARPin MP0317 [NCIt concept]
- FAPa-targeted CD40 Agonist RO7300490 [NCIt concept]
- FAS Gene [NCIt concept]
- FASTA Format [NCIt concept]
- FASTQ File Name [NCIt concept]
- FASTQ Format [NCIt concept]
- FAT1 Gene [NCIt concept]
- FAT3 Gene [NCIt concept]
- FAT4 Gene [NCIt concept]
- FBLN2 Gene [NCIt concept]
- FBXO11 Gene [NCIt concept]
- FBXW7 Gene [NCIt concept]
- FCGR2B Gene [NCIt concept]
- FCRL4 Gene [NCIt concept]
- FEN1 Gene [NCIt concept]
- FES Gene [NCIt concept]
- FEV Gene [NCIt concept]
- FEV1% REF Post-Bronchodilator [NCIt concept]
- FEV1% REF Pre-Bronchodilator [NCIt concept]
- FEV1/FVC Post-Bronchodilator [NCIt concept]
- FEV1/FVC Pre-Bronchodilator [NCIt concept]
- FFPE Indicator [NCIt concept]
- FFPE MicroRNA Isolation [NCIt concept]
- FGF Receptor Antagonist HGS1036 [NCIt concept]
- FGFR Inhibitor ASP5878 [NCIt concept]
- FGFR Inhibitor CPL304110 [NCIt concept]
- FGFR Inhibitor ET0111 [NCIt concept]
- FGFR/CSF-1R Inhibitor 3D185 [NCIt concept]
- FGFR/VEGFR/PDGFR/FLT3/SRC Inhibitor XL999 [NCIt concept]
- FGFR1 Gene [NCIt concept]
- FGFR1/2/3 Inhibitor HMPL-453 [NCIt concept]
- FGFR1/2/3 Inhibitor TYRA-200 [NCIt concept]
- FGFR2 Gene [NCIt concept]
- FGFR3 Gene [NCIt concept]
- FGFR3 Inhibitor LOXO-435 [NCIt concept]
- FGFR3 Inhibitor TYRA-300 [NCIt concept]
- FGFR4 Antagonist INCB062079 [NCIt concept]
- FGFR4 Gene [NCIt concept]
- FGFR4 Inhibitor BLU 9931 [NCIt concept]
- FGFR4 Inhibitor H3B-6527 [NCIt concept]
- FGFR4 Inhibitor ICP-105 [NCIt concept]
- FGFR4 Inhibitor SY-4798 [NCIt concept]
- FGFR4 Inhibitor SYHX2005 [NCIt concept]
- FH Gene [NCIt concept]
- FHIT Gene [NCIt concept]
- FIGO Stage [NCIt concept]
- FIGO Stage 0 [NCIt concept]
- FIGO Stage I [NCIt concept]
- FIGO Stage IA [NCIt concept]
- FIGO Stage IA1 [NCIt concept]
- FIGO Stage IA2 [NCIt concept]
- FIGO Stage IB [NCIt concept]
- FIGO Stage IB1 [NCIt concept]
- FIGO Stage IB2 [NCIt concept]
- FIGO Stage IC [NCIt concept]
- FIGO Stage IC1 [NCIt concept]
- FIGO Stage IC2 [NCIt concept]
- FIGO Stage IC3 [NCIt concept]
- FIGO Stage II [NCIt concept]
- FIGO Stage IIA [NCIt concept]
- FIGO Stage IIA1 [NCIt concept]
- FIGO Stage IIA2 [NCIt concept]
- FIGO Stage IIB [NCIt concept]
- FIGO Stage III [NCIt concept]
- FIGO Stage IIIA [NCIt concept]
- FIGO Stage IIIA1 [NCIt concept]
- FIGO Stage IIIA1(i) [NCIt concept]
- FIGO Stage IIIA1(ii) [NCIt concept]
- FIGO Stage IIIA2 [NCIt concept]
- FIGO Stage IIIB [NCIt concept]
- FIGO Stage IIIC [NCIt concept]
- FIGO Stage IIIC1 [NCIt concept]
- FIGO Stage IIIC2 [NCIt concept]
- FIGO Stage IV [NCIt concept]
- FIGO Stage IVA [NCIt concept]
- FIGO Stage IVB [NCIt concept]
- FIGO Staging Edition Year [NCIt concept]
- FIP1L1 Gene [NCIt concept]
- FKBP9 Gene [NCIt concept]
- FLCN Gene [NCIt concept]
- FLI1 Gene [NCIt concept]
- FLNA Gene [NCIt concept]
- FLT3 Gene [NCIt concept]
- FLT3 Inhibitor BMF-500 [NCIt concept]
- FLT3 Inhibitor FF-10101 Succinate [NCIt concept]
- FLT3 Inhibitor XY0206 [NCIt concept]
- FLT3 Tyrosine Kinase Inhibitor TTT-3002 [NCIt concept]
- FLT3/ABL/Aurora Kinase Inhibitor KW-2449 [NCIt concept]
- FLT3/CDK4/6 Inhibitor FLX925 [NCIt concept]
- FLT3/FGFR Dual Kinase Inhibitor MAX-40279 [NCIt concept]
- FLT3/KIT Kinase Inhibitor AKN-028 [NCIt concept]
- FLT3/KIT/CSF1R Inhibitor NMS-03592088 [NCIt concept]
- FLT4 Gene [NCIt concept]
- FNBP1 Gene [NCIt concept]
- FOXA1 Gene [NCIt concept]
- FOXL2 Gene [NCIt concept]
- FOXO1 Gene [NCIt concept]
- FOXO3 Gene [NCIt concept]
- FOXO4 Gene [NCIt concept]
- FOXP1 Gene [NCIt concept]
- FOXR1 Gene [NCIt concept]
- FPV Vaccine CV301 [NCIt concept]
- FPV-Brachyury-TRICOM Vaccine [NCIt concept]
- FR Alpha/TRPV6 Bispecific Ligand Drug Conjugate CBP-1008 [NCIt concept]
- FRYL Gene [NCIt concept]
- FSTL3 Gene [NCIt concept]
- FUBP1 Gene [NCIt concept]
- FUS Gene [NCIt concept]
- Facial Muscle Weakness, CTCAE [NCIt concept]
- Facial Nerve Disorder, CTCAE [NCIt concept]
- Facial Pain, CTCAE [NCIt concept]
- Factor VII-targeting Immunoconjugate Protein ICON-1 [NCIt concept]
- Factor VIIa Inhibitor PCI-27483 [NCIt concept]
- Factory Smokestack Smoke Exposure [NCIt concept]
- Fadraciclib [NCIt concept]
- Fadrozole Hydrochloride [NCIt concept]
- Failed [NCIt concept]
- Falbikitug [NCIt concept]
- Falimarev [NCIt concept]
- Falkland Islands (Malvinas) [NCIt concept]
- Fall, CTCAE [NCIt concept]
- Fallopian Tube [NCIt concept]
- Fallopian Tube Anastomotic Leak, CTCAE [NCIt concept]
- Fallopian Tube Obstruction, CTCAE 5.0 [NCIt concept]
- Fallopian Tube Perforation, CTCAE 5.0 [NCIt concept]
- Fallopian Tube Stenosis [NCIt concept]
- Falnidamol [NCIt concept]
- Familial Adenomatous Polyposis [NCIt concept]
- Family Cancer History [NCIt concept]
- Family Cancer History Relative Gender Question [NCIt concept]
- Family Cancer History Relative Primary Diagnosis Question [NCIt concept]
- Family History of BRCA Mutation [NCIt concept]
- Family History of Smoking [NCIt concept]
- Famitinib [NCIt concept]
- Fanconi Anemia [NCIt concept]
- Farletuzumab [NCIt concept]
- Farletuzumab Ecteribulin [NCIt concept]
- Farming, Fishing, and Forestry Occupations [NCIt concept]
- Farnesyl Transferase Inhibitor KO-2806 [NCIt concept]
- Farnesyltransferase/Geranylgeranyltransferase Inhibitor L-778,123 [NCIt concept]
- Faroe Islands [NCIt concept]
- Fas Ligand-treated Allogeneic Mobilized Peripheral Blood Cells [NCIt concept]
- Fas Receptor Agonist APO010 [NCIt concept]
- Fascial Fibroma [NCIt concept]
- Fascial Fibrosarcoma [NCIt concept]
- Fascin Inhibitor NP-G2-044 [NCIt concept]
- Fat Atrophy, CTCAE [NCIt concept]
- Father [NCIt concept]
- Father-in-law [NCIt concept]
- Fatigue, CTCAE 5.0 [NCIt concept]
- Favezelimab [NCIt concept]
- Favezelimab/Pembrolizumab Formulation [NCIt concept]
- Favorable [NCIt concept]
- Fazarabine [NCIt concept]
- Fc Fusion IL-7 Mimetic MDK-703 [NCIt concept]
- Fc-IL-15 Prodrug Fusion Molecule ASKG315 [NCIt concept]
- Fc-VEGFR1 Fusion Protein PB101 [NCIt concept]
- Fc-engineered Anti-CD40 Agonist Antibody 2141-V11 [NCIt concept]
- Febrile Neutropenia, CTCAE [NCIt concept]
- Febuxostat [NCIt concept]
- Fecal Incontinence, CTCAE [NCIt concept]
- Feces [NCIt concept]
- Fedratinib [NCIt concept]
- Fedratinib Hydrochloride [NCIt concept]
- Feladilimab [NCIt concept]
- Felezonexor [NCIt concept]
- Felzartamab [NCIt concept]
- Female [NCIt concept]
- Female Cousin [NCIt concept]
- Female Genital Tract Fistula [NCIt concept]
- Female Genitalia [NCIt concept]
- Female Reproductive System Adenofibroma [NCIt concept]
- Female Sibling of Adopted Child [NCIt concept]
- Feminization Acquired, CTCAE [NCIt concept]
- Femoral Artery [NCIt concept]
- Femoral Lymph Node [NCIt concept]
- Femoral Vein [NCIt concept]
- Femur [NCIt concept]
- Fencabtagene Autoleucel [NCIt concept]
- Fenebrutinib [NCIt concept]
- Fenretinide [NCIt concept]
- Fenretinide Lipid Matrix [NCIt concept]
- Fenretinide Phospholipid Suspension ST-001 [NCIt concept]
- Fetal Growth Retardation, CTCAE [NCIt concept]
- Fetal Rhabdomyoma [NCIt concept]
- Fever [NCIt concept]
- Fever, CTCAE [NCIt concept]
- Few [NCIt concept]
- Fexagratinib [NCIt concept]
- Fianlimab [NCIt concept]
- Fibrillary Astrocytoma [NCIt concept]
- Fibrinogen Decreased, CTCAE [NCIt concept]
- Fibroblast [NCIt concept]
- Fibroblast Activation Protein Alpha-activated Doxorubicin Prodrug AVA6000 [NCIt concept]
- Fibroblastic Liposarcoma [NCIt concept]
- Fibroblastic Osteosarcoma [NCIt concept]
- Fibroblastic Reticular Cell Sarcoma [NCIt concept]
- Fibroepithelial Neoplasm [NCIt concept]
- Fibrofolliculoma [NCIt concept]
- Fibrolamellar Carcinoma [NCIt concept]
- Fibrolipoma [NCIt concept]
- Fibroma [NCIt concept]
- Fibromyalgia [NCIt concept]
- Fibromyxoid Tumor [NCIt concept]
- Fibromyxolipoma [NCIt concept]
- Fibrosarcoma [NCIt concept]
- Fibrosarcomatous Dermatofibrosarcoma Protuberans [NCIt concept]
- Fibrosis [NCIt concept]
- Fibrosis Deep Connective Tissue, CTCAE [NCIt concept]
- Fibrous Histiocytoma [NCIt concept]
- Fibrous Meningioma [NCIt concept]
- Fibula [NCIt concept]
- Ficerafusp Alfa [NCIt concept]
- Ficlatuzumab [NCIt concept]
- Fidasimtamab [NCIt concept]
- Field Burning Smoke Exposure [NCIt concept]
- Fifth [NCIt concept]
- Figitumumab [NCIt concept]
- Fiji [NCIt concept]
- Filanesib [NCIt concept]
- Filgotinib [NCIt concept]
- Filgrastim [NCIt concept]
- Fimaporfin A [NCIt concept]
- Fimepinostat [NCIt concept]
- Financial Clerks [NCIt concept]
- Financial Specialists [NCIt concept]
- Financial and Mathematical Associate Professional [NCIt concept]
- Fine-Needle Aspiration [NCIt concept]
- Finger [NCIt concept]
- Finland [NCIt concept]
- Finotonlimab [NCIt concept]
- Firastotug [NCIt concept]
- Fire Smoke Exposure [NCIt concept]
- First [NCIt concept]
- First Complete Response Occurrence Indicator [NCIt concept]
- First Cousin [NCIt concept]
- First Cousin Once Removed [NCIt concept]
- First Degree Relative [NCIt concept]
- First Patient Visit Date [NCIt concept]
- First Post-treatment Event [NCIt concept]
- First Treatment Date [NCIt concept]
- First Variant Gene Symbol [NCIt concept]
- First-Line Therapy [NCIt concept]
- First-strand Library Sequencing [NCIt concept]
- Firtecan Pegol [NCIt concept]
- Fisetin [NCIt concept]
- Fishery Worker, Hunter and Trapper [NCIt concept]
- Fisogatinib [NCIt concept]
- Five Times Daily [NCIt concept]
- Flank Pain, CTCAE [NCIt concept]
- Flanvotumab [NCIt concept]
- Flashing Lights, CTCAE [NCIt concept]
- Flat Adenoma [NCIt concept]
- Flatulence, CTCAE [NCIt concept]
- Flexible Heteroarotinoid Sulfur Heteroarotinoid A2 [NCIt concept]
- Floaters, CTCAE [NCIt concept]
- Flonoltinib Maleate [NCIt concept]
- Floor of Mouth [NCIt concept]
- Flotetuzumab [NCIt concept]
- Flow Cytometry [NCIt concept]
- Floxuridine [NCIt concept]
- Flt3 Ligand/Anti-CTLA-4 Antibody/IL-12 Engineered Oncolytic Vaccinia Virus RIVAL-01 [NCIt concept]
- Flt3/MerTK Inhibitor MRX-2843 [NCIt concept]
- Flu Like Symptoms, CTCAE [NCIt concept]
- Fluciclovine F18 [NCIt concept]
- Fludarabine [NCIt concept]
- Fludarabine Phosphate [NCIt concept]
- Fluid [NCIt concept]
- Flumatinib Mesylate [NCIt concept]
- Flumbatinib [NCIt concept]
- Fluorescence In Situ Hybridization [NCIt concept]
- Fluorine F 18 Ara-G [NCIt concept]
- Fluorine F 18-AIF-NOTA-pentixather [NCIt concept]
- Fluorodopan [NCIt concept]
- Fluorouracil [NCIt concept]
- Fluorouracil Implant [NCIt concept]
- Fluorouracil-E Therapeutic Implant [NCIt concept]
- Fluoxymesterone [NCIt concept]
- Flushing, CTCAE 5.0 [NCIt concept]
- Flutamide [NCIt concept]
- Fluvastatin [NCIt concept]
- Fluvastatin Sodium [NCIt concept]
- Fms/Trk Tyrosine Kinase Inhibitor PLX7486 Tosylate [NCIt concept]
- Focal [NCIt concept]
- Focal Extracapsular Extention [NCIt concept]
- Folate Receptor Targeted Epothilone BMS753493 [NCIt concept]
- Folate Receptor-Targeted Tubulysin Conjugate EC1456 [NCIt concept]
- Folate Receptor-Targeted Vinca Alkaloid EC0489 [NCIt concept]
- Folate Receptor-Targeted Vinca Alkaloid/Mitomycin C EC0225 [NCIt concept]
- Folate-FITC [NCIt concept]
- Folate-receptor Alpha-targeting Ultrasmall Silica Nanoparticle-drug Conjugate ELU001 [NCIt concept]
- Folic Acid [NCIt concept]
- Folitixorin [NCIt concept]
- Follicular Dendritic Cell Sarcoma [NCIt concept]
- Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type [NCIt concept]
- Follicular Lymphoma [NCIt concept]
- Follicular Variant Thyroid Gland Papillary Carcinoma [NCIt concept]
- Follow-Up [NCIt concept]
- Food Allergy [NCIt concept]
- Food Preparation Assistant [NCIt concept]
- Food Processing and Related Trades Worker [NCIt concept]
- Food and Beverage Serving Workers [NCIt concept]
- Food and Related Products Machine Operator [NCIt concept]
- Foot [NCIt concept]
- Forced Expiratory Volume Decreased, CTCAE [NCIt concept]
- Forearm [NCIt concept]
- Forehead [NCIt concept]
- Forestry and Related Worker [NCIt concept]
- Foretinib [NCIt concept]
- Forimtamig [NCIt concept]
- Foritinib Succinate [NCIt concept]
- Formaldehyde Exposure [NCIt concept]
- Formalin-Fixed Paraffin-Embedded [NCIt concept]
- Formalin-Fixed Paraffin-Embedded DNA [NCIt concept]
- Formalin-Fixed Paraffin-Embedded RNA [NCIt concept]
- Formalin-Fixed Paraffin-Embedded Tissue Sample from Recurrent Disease [NCIt concept]
- Formalin-Fixed Paraffin-Embedded Tissue Scroll [NCIt concept]
- Format [NCIt concept]
- Former Hormonal Contraceptive User [NCIt concept]
- Formestane [NCIt concept]
- Forodesine Hydrochloride [NCIt concept]
- Fosaprepitant [NCIt concept]
- Fosbretabulin [NCIt concept]
- Fosbretabulin Disodium [NCIt concept]
- Fosbretabulin Tromethamine [NCIt concept]
- Foscenvivint [NCIt concept]
- Fosciclopirox [NCIt concept]
- Fosgemcitabine Palabenamide [NCIt concept]
- Fosifloxuridine Nafalbenamide [NCIt concept]
- Foslinanib [NCIt concept]
- Foslinanib Disodium [NCIt concept]
- Fosquidone [NCIt concept]
- Foster Brother [NCIt concept]
- Foster Daughter [NCIt concept]
- Foster Father [NCIt concept]
- Foster Mother [NCIt concept]
- Foster Sister [NCIt concept]
- Foster Son [NCIt concept]
- Fostriecin [NCIt concept]
- Fostroxacitabine Bralpamide [NCIt concept]
- Fotemustine [NCIt concept]
- Fotretamine [NCIt concept]
- FoundationOne Report [NCIt concept]
- Four Point Scale for Staining Intensity [NCIt concept]
- Four Times Daily [NCIt concept]
- Four Tumor Grade Evaluation Tiers [NCIt concept]
- Four or More Positive Lymph Nodes [NCIt concept]
- Fourth [NCIt concept]
- Fractalkine Receptor Antagonist KAND567 [NCIt concept]
- Fracture [NCIt concept]
- Fracture, CTCAE [NCIt concept]
- Frameshift Mutation [NCIt concept]
- France [NCIt concept]
- Fraternal Twin [NCIt concept]
- Fraternal Twin Brother [NCIt concept]
- Fraternal Twin Sister [NCIt concept]
- Free Kappa Light Chain Measurement [NCIt concept]
- Free Lambda Light Chain Measurement [NCIt concept]
- Freezing Method Name [NCIt concept]
- French Guiana [NCIt concept]
- French Polynesia [NCIt concept]
- French-American-British Classification [NCIt concept]
- Frenlosirsen [NCIt concept]
- Fresh Specimen [NCIt concept]
- Fresolimumab [NCIt concept]
- Frontal Lobe [NCIt concept]
- Frontal Lobe Cortex [NCIt concept]
- Frontal Sinus [NCIt concept]
- Frozen Specimen [NCIt concept]
- Fruit Allergy [NCIt concept]
- Fruquintinib [NCIt concept]
- Full Brother [NCIt concept]
- Full Sister [NCIt concept]
- Fulvestrant [NCIt concept]
- Fumagillin-Derived Polymer Conjugate XMT-1107 [NCIt concept]
- Functioning Endocrine Neoplasm [NCIt concept]
- Fundus Uteri [NCIt concept]
- Fundus of the Stomach [NCIt concept]
- Fungal Colonization [NCIt concept]
- Furnace or Boiler Smoke Exposure [NCIt concept]
- Fursultiamine [NCIt concept]
- Fusion Gene Downstream Gene Symbol [NCIt concept]
- Fusion Transcript Sequencing [NCIt concept]
- Futibatinib [NCIt concept]
- Futuximab [NCIt concept]
- Futuximab/Modotuximab Mixture [NCIt concept]
- Fuzheng Yiliu Decoction [NCIt concept]
- Fuzuloparib [NCIt concept]
- G Protein-coupled Estrogen Receptor Agonist LNS8801 [NCIt concept]
- G-Quadruplex Stabilizer BMVC [NCIt concept]
- G-Quadruplex-selective Transcription Inhibitor QN-302 [NCIt concept]
- G1/S-Specific Cyclin-D1 [NCIt concept]
- GAS7 Gene [NCIt concept]
- GATA1 Gene [NCIt concept]
- GATA2 Gene [NCIt concept]
- GATA3 Gene [NCIt concept]
- GBM Antigens and Alloantigens Immunotherapeutic Vaccine [NCIt concept]
- GENIE Report [NCIt concept]
- GGT Increased, CTCAE [NCIt concept]
- GI-4000 Vaccine [NCIt concept]
- GLI1 Gene [NCIt concept]
- GLIS2 Gene [NCIt concept]
- GM-CSF-encoding Oncolytic Adenovirus CGTG-102 [NCIt concept]
- GM-CSF-secreting MVX-2-loaded Capsules/Autologous Irradiated Tumor Cell Vaccine MVX-ONCO-2 [NCIt concept]
- GMPS Gene [NCIt concept]
- GNA11 Gene [NCIt concept]
- GNAQ Gene [NCIt concept]
- GNAQ/GNA11 Antagonist DYP688 [NCIt concept]
- GNAS Gene [NCIt concept]
- GOLGA5 Gene [NCIt concept]
- GOPC Gene [NCIt concept]
- GPC3 Gene [NCIt concept]
- GPC3-targeted Plasmid DNA Vaccine NWRD06 [NCIt concept]
- GPHN Gene [NCIt concept]
- GPRC5D/BCMA/CD3-targeting T-cell Engager IBI3003 [NCIt concept]
- GRIN2A Gene [NCIt concept]
- GRM3 Gene [NCIt concept]
- GS/pan-Notch Inhibitor AL102 [NCIt concept]
- GSK-3 Inhibitor LY2090314 [NCIt concept]
- GSPT1 MGD MRT-2359 [NCIt concept]
- Gabon [NCIt concept]
- Gain [NCIt concept]
- Gait Disturbance, CTCAE [NCIt concept]
- Galamustine [NCIt concept]
- Galarubicin [NCIt concept]
- Galectin-1 Inhibitor OTX008 [NCIt concept]
- Galeterone [NCIt concept]
- Galiximab [NCIt concept]
- Gallbladder [NCIt concept]
- Gallbladder Carcinoma [NCIt concept]
- Gallbladder Fistula, CTCAE [NCIt concept]
- Gallbladder Infection, CTCAE [NCIt concept]
- Gallbladder Intracholecystic Papillary (Tubular) Neoplasm with Intermediate Grade Intraepithelial Neoplasia [NCIt concept]
- Gallbladder Intracholecystic Papillary Neoplasm, Low Grade [NCIt concept]
- Gallbladder Necrosis, CTCAE 5.0 [NCIt concept]
- Gallbladder Obstruction, CTCAE [NCIt concept]
- Gallbladder Pain, CTCAE 5.0 [NCIt concept]
- Gallbladder Perforation, CTCAE 5.0 [NCIt concept]
- Gallium Ga 68-labeled alphaVbeta6 Binding Peptide RAD 301 [NCIt concept]
- Gallium Ga 68/Copper Cu 64-labeled FAPI-XT117 [NCIt concept]
- Gallium-based Bone Resorption Inhibitor AP-002 [NCIt concept]
- Galocitabine [NCIt concept]
- Galunisertib [NCIt concept]
- Gamboge Resin Extract TSB-9-W1 [NCIt concept]
- Gamitrinib [NCIt concept]
- Gamma Heavy Chain Disease [NCIt concept]
- Gamma Knife [NCIt concept]
- Gamma-Enolase [NCIt concept]
- Gamma-Secretase Inhibitor RO4929097 [NCIt concept]
- Gamma-delta Tocotrienol [NCIt concept]
- Gandotinib [NCIt concept]
- Ganetespib [NCIt concept]
- Gangliocytoma [NCIt concept]
- Ganglioglioma [NCIt concept]
- Ganglion [NCIt concept]
- Ganglioneuroblastoma [NCIt concept]
- Ganglioneuroma [NCIt concept]
- Ganglioneuromatosis [NCIt concept]
- Ganglioside GD2 [NCIt concept]
- Ganglioside GM2 [NCIt concept]
- Ganitumab [NCIt concept]
- Ganoderma lucidum Spores Powder Capsule [NCIt concept]
- Garivulimab [NCIt concept]
- Garlic [NCIt concept]
- Garment and Related Trades Worker [NCIt concept]
- Garsorasib [NCIt concept]
- Gartisertib [NCIt concept]
- Gastric Anastomotic Leak, CTCAE [NCIt concept]
- Gastric Carcinoma [NCIt concept]
- Gastric Cardia [NCIt concept]
- Gastric Fistula, CTCAE [NCIt concept]
- Gastric Hemorrhage, CTCAE [NCIt concept]
- Gastric Mucosa [NCIt concept]
- Gastric Necrosis, CTCAE [NCIt concept]
- Gastric Parietal Cell Adenocarcinoma [NCIt concept]
- Gastric Perforation, CTCAE [NCIt concept]
- Gastric Polyp [NCIt concept]
- Gastric Stenosis, CTCAE [NCIt concept]
- Gastric Ulcer, CTCAE [NCIt concept]
- Gastrin Immunotoxin [NCIt concept]
- Gastrin-Producing Neuroendocrine Tumor [NCIt concept]
- Gastritis [NCIt concept]
- Gastritis, CTCAE [NCIt concept]
- Gastroesophageal Junction [NCIt concept]
- Gastroesophageal Junction Involvement Indicator [NCIt concept]
- Gastroesophageal Reflux Disease [NCIt concept]
- Gastroesophageal Reflux Disease, CTCAE [NCIt concept]
- Gastrointestinal [NCIt concept]
- Gastrointestinal Anastomotic Leak, CTCAE [NCIt concept]
- Gastrointestinal Autonomic Nerve Tumor [NCIt concept]
- Gastrointestinal Disorders - Other, Specify, CTCAE [NCIt concept]
- Gastrointestinal Fistula, CTCAE 5.0 [NCIt concept]
- Gastrointestinal Pain, CTCAE [NCIt concept]
- Gastrointestinal Stoma Necrosis, CTCAE [NCIt concept]
- Gastrointestinal Stromal Tumor [NCIt concept]
- Gastrointestinal Stromal Tumor of Uncertain Malignant Potential [NCIt concept]
- Gastrointestinal Tract [NCIt concept]
- Gastroparesis, CTCAE [NCIt concept]
- Gastrosplenic Ligament [NCIt concept]
- Gataparsen Sodium [NCIt concept]
- Gatipotuzumab [NCIt concept]
- Gebasaxturev [NCIt concept]
- Gedatolisib [NCIt concept]
- Gefitinib [NCIt concept]
- Geldanamycin [NCIt concept]
- Gelonin [NCIt concept]
- GemOx Regimen [NCIt concept]
- Gemcitabine [NCIt concept]
- Gemcitabine Elaidate [NCIt concept]
- Gemcitabine Hydrochloride [NCIt concept]
- Gemcitabine Hydrochloride Emulsion [NCIt concept]
- Gemcitabine Prodrug LY2334737 [NCIt concept]
- Gemcitabine-Releasing Intravesical System [NCIt concept]
- Gemistocytic Astrocytoma [NCIt concept]
- Gemtuzumab Ozogamicin [NCIt concept]
- Gender [NCIt concept]
- Gene Amplification Abnormality [NCIt concept]
- Gene Amplification Negative [NCIt concept]
- Gene Amplification Positive [NCIt concept]
- Gene Deletion [NCIt concept]
- Gene Duplication Abnormality [NCIt concept]
- Gene Expression Level Analysis [NCIt concept]
- Gene Fusion Abnormality [NCIt concept]
- Gene Level Copy Number Scores [NCIt concept]
- Gene Product Variation Site [NCIt concept]
- Gene Variant [NCIt concept]
- General Disorders and Administration Site Conditions - Other, Specify, CTCAE [NCIt concept]
- General Equivalency Diploma Completion [NCIt concept]
- General Office Clerk [NCIt concept]
- Generalized Muscle Weakness, CTCAE [NCIt concept]
- Genetic Disorder [NCIt concept]
- Genetic Polymorphism [NCIt concept]
- Genetic Variant Origin Indicator [NCIt concept]
- Genetically Modified Interleukin-12 Transgene-encoding Bifidobacterium longum [NCIt concept]
- Genistein [NCIt concept]
- Genital Edema, CTCAE [NCIt concept]
- Genital Rhabdomyoma [NCIt concept]
- Genitourinary [NCIt concept]
- Genome Variation Format [NCIt concept]
- Genome-Wide DNA Copy Number [NCIt concept]
- GenomePlex Whole Genome Amplification [NCIt concept]
- Genomic Identifier [NCIt concept]
- Genomic Profile [NCIt concept]
- Genotype Match Indicator for Normal/Tumor Matched Tissue Samples [NCIt concept]
- Genotyping Array [NCIt concept]
- Gentuximab [NCIt concept]
- Georgia (Republic) [NCIt concept]
- Geranylgeranyltransferase I Inhibitor [NCIt concept]
- Germ Cell Tumor [NCIt concept]
- Germany [NCIt concept]
- Germline Variation [NCIt concept]
- Gerota Fascia [NCIt concept]
- Gestational Age at Birth [NCIt concept]
- Ghana [NCIt concept]
- Ghost Cell Odontogenic Carcinoma [NCIt concept]
- Giant Cell Angiofibroma [NCIt concept]
- Giant Cell Carcinoma [NCIt concept]
- Giant Cell Fibroblastoma [NCIt concept]
- Giant Cell Glioblastoma [NCIt concept]
- Giant Cell Sarcoma [NCIt concept]
- Giant Cell Tumor [NCIt concept]
- Giant Cell Tumor of Bone [NCIt concept]
- Giant Cell Tumor of Soft Tissue [NCIt concept]
- Giant Cell and Spindle Cell Carcinoma [NCIt concept]
- Giant Congenital Nevus [NCIt concept]
- Gibraltar [NCIt concept]
- Gigantiform Cementoma [NCIt concept]
- Gilbert Syndrome [NCIt concept]
- Giloralimab [NCIt concept]
- Gilteritinib [NCIt concept]
- Gilteritinib Fumarate [NCIt concept]
- Gimatecan [NCIt concept]
- Gimeracil [NCIt concept]
- Gingiva [NCIt concept]
- Gingival Pain, CTCAE [NCIt concept]
- Ginisortamab [NCIt concept]
- Ginsenoside Rg3 Capsule [NCIt concept]
- Giredestrant [NCIt concept]
- Girentuximab [NCIt concept]
- Girodazole [NCIt concept]
- Givastomig [NCIt concept]
- Givinostat [NCIt concept]
- Glandular Papilloma [NCIt concept]
- Glandular Papillomatosis [NCIt concept]
- Glans Penis [NCIt concept]
- Glasdegib [NCIt concept]
- Glasdegib Maleate [NCIt concept]
- Glassy Cell Carcinoma [NCIt concept]
- Glaucarubolone [NCIt concept]
- Glaucoma [NCIt concept]
- Glaucoma, CTCAE [NCIt concept]
- Gleason Grade Group 1 [NCIt concept]
- Gleason Grade Group 2 [NCIt concept]
- Gleason Grade Group 3 [NCIt concept]
- Gleason Grade Group 4 [NCIt concept]
- Gleason Grade Group 5 [NCIt concept]
- Gleason Pattern 1 [NCIt concept]
- Gleason Pattern 2 [NCIt concept]
- Gleason Pattern 3 [NCIt concept]
- Gleason Pattern 4 [NCIt concept]
- Gleason Pattern 5 [NCIt concept]
- Gleason Score for Prostate Cancer [NCIt concept]
- Glecaprevir/Pibrentasvir [NCIt concept]
- Glecirasib [NCIt concept]
- Glembatumumab Vedotin [NCIt concept]
- Glesatinib [NCIt concept]
- Glioblastoma [NCIt concept]
- Glioblastoma Cancer Vaccine ERC1671 [NCIt concept]
- Glioblastoma Multiforme Multipeptide Vaccine IMA950 [NCIt concept]
- Glioblastoma, IDH-Wildtype [NCIt concept]
- Gliofibroma [NCIt concept]
- Glioma [NCIt concept]
- Glioma Lysate Vaccine GBM6-AD [NCIt concept]
- Glioma-associated Peptide-loaded Dendritic Cell Vaccine SL-701 [NCIt concept]
- Gliomatosis Cerebri [NCIt concept]
- Gliosarcoma [NCIt concept]
- Globo H-DT Vaccine OBI-833 [NCIt concept]
- Glofitamab [NCIt concept]
- Glomangioma [NCIt concept]
- Glomangiomyoma [NCIt concept]
- Glomerular Vascular Disorder [NCIt concept]
- Glomus Tumor [NCIt concept]
- Glossectomy [NCIt concept]
- Glossopharyngeal Nerve Disorder, CTCAE [NCIt concept]
- Glottis [NCIt concept]
- Glucarpidase [NCIt concept]
- Glucocorticoid Receptor Antagonist ORIC-101 [NCIt concept]
- Glucose Intolerance, CTCAE [NCIt concept]
- Glucose Measurement [NCIt concept]
- Glufosfamide [NCIt concept]
- Glutamate Carboxypeptidase 2 [NCIt concept]
- Glutaminase-1 Inhibitor IACS-6274 [NCIt concept]
- Glutathione Pegylated Liposomal Doxorubicin Hydrochloride Formulation 2B3-101 [NCIt concept]
- Glyco-engineered Anti-CD20 Monoclonal Antibody CHO H01 [NCIt concept]
- Glycogen Storage Disease [NCIt concept]
- Glycogen-Rich Carcinoma [NCIt concept]
- Glycooptimized Trastuzumab-GEX [NCIt concept]
- GnRH Antagonist SHR7280 [NCIt concept]
- GnRH Antagonist VERU-100 [NCIt concept]
- Goblet Cell Adenocarcinoma [NCIt concept]
- Goiter [NCIt concept]
- Golcadomide [NCIt concept]
- Gold Sodium Thiomalate [NCIt concept]
- Golidocitinib [NCIt concept]
- Golnerminogene Pradenovec [NCIt concept]
- Golotimod [NCIt concept]
- Golvatinib [NCIt concept]
- Gonadal Disorder [NCIt concept]
- Gonadal Polyembryoma [NCIt concept]
- Gonadoblastoma [NCIt concept]
- Gonadotropin-releasing Hormone Analog [NCIt concept]
- Goserelin [NCIt concept]
- Goserelin Acetate [NCIt concept]
- Goserelin Acetate Extended-release Microspheres LY01005 [NCIt concept]
- Goserelin Acetate Extended-release Microspheres LY01022 [NCIt concept]
- Gossypol [NCIt concept]
- Gossypol Acetic Acid [NCIt concept]
- Gotistobart [NCIt concept]
- Gout [NCIt concept]
- Government Regulatory Associate Professional [NCIt concept]
- Grade 1 [NCIt concept]
- Grade 1 Follicular Lymphoma [NCIt concept]
- Grade 1 Nodular Sclerosis Classic Hodgkin Lymphoma [NCIt concept]
- Grade 2 [NCIt concept]
- Grade 2 Follicular Lymphoma [NCIt concept]
- Grade 2 Nodular Sclerosis Classic Hodgkin Lymphoma [NCIt concept]
- Grade 3 [NCIt concept]
- Grade 3 Follicular Lymphoma [NCIt concept]
- Grade 3a Follicular Lymphoma [NCIt concept]
- Grade 3b Follicular Lymphoma [NCIt concept]
- Grade 4 [NCIt concept]
- Grade B [NCIt concept]
- Grade I Neuroendocrine Carcinoma [NCIt concept]
- Grade II Glandular Intraepithelial Neoplasia [NCIt concept]
- Grade II Neuroendocrine Carcinoma [NCIt concept]
- Grade II Squamous Intraepithelial Neoplasia [NCIt concept]
- Grade III Glandular Intraepithelial Neoplasia [NCIt concept]
- Grade III Prostatic Intraepithelial Neoplasia [NCIt concept]
- Grade X [NCIt concept]
- Graduate Studies Completion [NCIt concept]
- Gram per 24 Hours [NCIt concept]
- Gram per Deciliter [NCIt concept]
- Gram per Square Meter [NCIt concept]
- Grandchild [NCIt concept]
- Granddaughter [NCIt concept]
- Grandfather [NCIt concept]
- Grandmother [NCIt concept]
- Grandparent [NCIt concept]
- Grandson [NCIt concept]
- Granular Cell Carcinoma [NCIt concept]
- Granular Cell Tumor [NCIt concept]
- Granular Cell Tumor of the Sellar Region [NCIt concept]
- Granulocyte [NCIt concept]
- Granulocytic Sarcoma [NCIt concept]
- Granulosa Cell Tumor [NCIt concept]
- Granulosa Cell-Theca Cell Tumor [NCIt concept]
- Grapiprant [NCIt concept]
- Graves Disease [NCIt concept]
- Gray [NCIt concept]
- Gray [NCIt concept]
- Gray-Zone Lymphoma [NCIt concept]
- Grease Fire Smoke Exposure [NCIt concept]
- Great Blood Vessel [NCIt concept]
- Great Grandchild [NCIt concept]
- Great Nephew [NCIt concept]
- Great Niece [NCIt concept]
- Greater Curvature of the Stomach [NCIt concept]
- Greater than or Equal to 181 Days [NCIt concept]
- Greatest Dimension Tumor [NCIt concept]
- Greece [NCIt concept]
- Green [NCIt concept]
- Green Tea Extract-based Antioxidant Supplement [NCIt concept]
- Greenland [NCIt concept]
- Grenada [NCIt concept]
- Gresonitamab [NCIt concept]
- Grilling Smoke Exposure [NCIt concept]
- Gross [NCIt concept]
- Gross Extranodal Extension [NCIt concept]
- Gross Total Resection [NCIt concept]
- Gross Tumor Weight [NCIt concept]
- Growth Accelerated, CTCAE [NCIt concept]
- Growth Hormone Abnormal, CTCAE [NCIt concept]
- Growth Suppression, CTCAE [NCIt concept]
- Gruticibart [NCIt concept]
- Guadecitabine [NCIt concept]
- Guadeloupe [NCIt concept]
- Guam [NCIt concept]
- Guanabenz Acetate [NCIt concept]
- Guardian [NCIt concept]
- Guatemala [NCIt concept]
- Guernsey [NCIt concept]
- Guinea [NCIt concept]
- Guinea-Bissau [NCIt concept]
- Gum Infection, CTCAE [NCIt concept]
- Gumarontinib [NCIt concept]
- Gunagratinib [NCIt concept]
- Guretolimod [NCIt concept]
- Guselkumab [NCIt concept]
- Gusperimus Trihydrochloride [NCIt concept]
- Gutolactone [NCIt concept]
- Guyana [NCIt concept]
- Gynecomastia, CTCAE 5.0 [NCIt concept]
- H-ras Antisense Oligodeoxynucleotide ISIS 2503 [NCIt concept]
- H1299 Tumor Cell Lysate Vaccine [NCIt concept]
- H3-3A Gene [NCIt concept]
- H3-3B Gene [NCIt concept]
- H3C2 Gene [NCIt concept]
- H3K27M Long Peptide Vaccine [NCIt concept]
- H4C9 Gene [NCIt concept]
- HAAH Lambda phage Vaccine SNS-301 [NCIt concept]
- HBV Genotype Assay [NCIt concept]
- HCMI Catalog Reference Number [NCIt concept]
- HCV DNA Vaccine INO-8000 [NCIt concept]
- HCV Genotype Assay [NCIt concept]
- HDAC Class I/IIb Inhibitor HG146 [NCIt concept]
- HDAC Inhibitor CKD-581 [NCIt concept]
- HDAC Inhibitor MPT0E028 [NCIt concept]
- HDAC Inhibitor OBP-801 [NCIt concept]
- HDAC Inhibitor REC-2282 [NCIt concept]
- HDAC/EGFR/HER2 Inhibitor CUDC-101 [NCIt concept]
- HDAC6 Inhibitor KA2507 [NCIt concept]
- HDAC8 Inhibitor NBM-BMX [NCIt concept]
- HDM2 Inhibitor MK-8242 [NCIt concept]
- HER-2-positive B-cell Peptide Antigen P467-DT-CRM197/Montanide Vaccine IMU-131 [NCIt concept]
- HER2 ECD+TM Virus-like Replicon Particles Vaccine AVX901 [NCIt concept]
- HER2 Inhibitor BI 1810631 [NCIt concept]
- HER2 Inhibitor CP-724,714 [NCIt concept]
- HER2 Inhibitor DZD1516 [NCIt concept]
- HER2 Inhibitor ELVN-002 [NCIt concept]
- HER2 Inhibitor SPH5030 [NCIt concept]
- HER2 Inhibitor TAS0728 [NCIt concept]
- HER2 Inhibitor ZN-A-1041 [NCIt concept]
- HER2 Tri-specific Natural Killer Cell Engager DF1001 [NCIt concept]
- HER2-targeted DARPin MP0274 [NCIt concept]
- HER2-targeted Hypoxia-stimulated CAR T Cells [NCIt concept]
- HER2-targeted Liposomal Doxorubicin Hydrochloride HF158K1 [NCIt concept]
- HER2-targeted Liposomal Doxorubicin Hydrochloride MM-302 [NCIt concept]
- HER2-targeting Antibody Fc Fragment FS102 [NCIt concept]
- HER2/neu Peptide Vaccine GLSI-100 [NCIt concept]
- HERPUD1 Gene [NCIt concept]
- HEY1 Gene [NCIt concept]
- HHV6 Infection [NCIt concept]
- HHV8 Infection [NCIt concept]
- HIF-1alpha Inhibitor PX-478 [NCIt concept]
- HIF-2alpha Inhibitor AB521 [NCIt concept]
- HIF-2alpha Inhibitor HS-10516 [NCIt concept]
- HIF-2alpha Inhibitor PT2385 [NCIt concept]
- HIF1A Gene [NCIt concept]
- HIF2-alpha Inhibitor NKT2152 [NCIt concept]
- HIF2alpha Inhibitor DFF332 [NCIt concept]
- HIP1 Gene [NCIt concept]
- HIV Infection [NCIt concept]
- HIV Viral Load Measurement [NCIt concept]
- HLA-A Gene [NCIt concept]
- HLA-A*0201 Restricted TERT(572Y)/TERT(572) Peptides Vaccine Vx-001 [NCIt concept]
- HLA-A*2402-Restricted Multipeptide Vaccine S-488410 [NCIt concept]
- HLA-A2-restricted Melanoma-specific Peptides Vaccine GRN-1201 [NCIt concept]
- HLA-DR Antigen [NCIt concept]
- HLF Gene [NCIt concept]
- HM2/MMAE Antibody-Drug Conjugate ALT-P7 [NCIt concept]
- HMG-CoA Reductase Inhibitor [NCIt concept]
- HMGA1 Gene [NCIt concept]
- HMGA2 Gene [NCIt concept]
- HMGB1 Inhibitor SB17170 [NCIt concept]
- HMGB3 Gene [NCIt concept]
- HMGN2P46 Gene [NCIt concept]
- HNF1A Gene [NCIt concept]
- HNRNPA2B1 Gene [NCIt concept]
- HNRNPH1 Gene [NCIt concept]
- HOOK3 Gene [NCIt concept]
- HOXA11 Gene [NCIt concept]
- HOXA13 Gene [NCIt concept]
- HOXA9 Gene [NCIt concept]
- HOXB1 Gene [NCIt concept]
- HOXC11 Gene [NCIt concept]
- HOXC13 Gene [NCIt concept]
- HOXD11 Gene [NCIt concept]
- HOXD13 Gene [NCIt concept]
- HPPH [NCIt concept]
- HPV 16 E6/E7-encoding Arenavirus Vaccine HB-202 [NCIt concept]
- HPV 16 E7 Antigen-expressing Lactobacillis casei Vaccine BLS-ILB-E710c [NCIt concept]
- HPV 16/18 E6/E7 DNA Vaccine pBI-11 [NCIt concept]
- HPV E6/E7 DNA Vaccine GX-188E [NCIt concept]
- HPV E6/E7-encoding Arenavirus Vaccine HB-201 [NCIt concept]
- HPV L1 Virus-like Particles Vaccine NBP615 [NCIt concept]
- HPV Types 16/18 E6/E7-Adenoviral Transduced Autologous Lymphocytes/alpha-Galactosylceramide Vaccine BVAC-C [NCIt concept]
- HPV-16 E6 Peptides Vaccine/Candida albicans Extract [NCIt concept]
- HPV-6-targeting Immunotherapeutic Vaccine INO-3106 [NCIt concept]
- HPV16 E6/7 mRNA Vaccine BNT113 [NCIt concept]
- HPV16 E7-specific HLA-A*02:01-restricted IgG1-Fc Fusion Protein CUE-101 [NCIt concept]
- HPV16 L2/E6/E7 Fusion Protein Vaccine TA-CIN [NCIt concept]
- HPV16 RG1 VLP Vaccine [NCIt concept]
- HPV6/11-targeted DNA Plasmid Vaccine INO-3107 [NCIt concept]
- HRAS Gene [NCIt concept]
- HSD-1 Inhibitor SPI-62 [NCIt concept]
- HSP90 Peptide Vaccine AST-021p [NCIt concept]
- HSP90AA1 Gene [NCIt concept]
- HSP90AB1 Gene [NCIt concept]
- HSV- thymidine Kinase-m2/hGM-CSF Genes-encoding GEN2 [NCIt concept]
- Hafnium Oxide-containing Nanoparticles NBTXR3 [NCIt concept]
- Hairdresser, Beautician and Related Worker [NCIt concept]
- Hairy Cell Leukemia [NCIt concept]
- Hairy Cell Leukemia Variant [NCIt concept]
- Hairy Nevus [NCIt concept]
- Haiti [NCIt concept]
- Half Brother [NCIt concept]
- Half Sibling [NCIt concept]
- Half Sister [NCIt concept]
- Half-brother with Father as Common Parent [NCIt concept]
- Half-brother with Mother as Common Parent [NCIt concept]
- Half-sister with Father as Common Parent [NCIt concept]
- Half-sister with Mother as Common Parent [NCIt concept]
- Halichondrin Analogue E7130 [NCIt concept]
- Halichondrin B [NCIt concept]
- Hallucinations, CTCAE [NCIt concept]
- Halo Nevus [NCIt concept]
- Halofuginone [NCIt concept]
- Halofuginone Hydrobromide [NCIt concept]
- Hand [NCIt concept]
- Hand Assisted Laparoscopic Radical Nephrectomy [NCIt concept]
- Hand Digit 1 [NCIt concept]
- Hand Digit 2 [NCIt concept]
- Hand Digit 3 [NCIt concept]
- Hand Digit 4 [NCIt concept]
- Hand Digit 5 [NCIt concept]
- Hand-Schuller-Christian Disease [NCIt concept]
- Handicraft Worker [NCIt concept]
- Haploidentical Hematopoietic Cell Transplantation [NCIt concept]
- Haptoglobin Decreased, CTCAE [NCIt concept]
- Hard Palate [NCIt concept]
- Hashimoto Thyroiditis [NCIt concept]
- Hashish Smoke Exposure [NCIt concept]
- Hazel [NCIt concept]
- Head Soft Tissue Necrosis, CTCAE [NCIt concept]
- Head and Neck [NCIt concept]
- Head and Neck Lymph Node [NCIt concept]
- Head of the Pancreas [NCIt concept]
- Headache [NCIt concept]
- Headache, CTCAE [NCIt concept]
- Hearing Impaired, CTCAE [NCIt concept]
- Heart [NCIt concept]
- Heart Disorder [NCIt concept]
- Heart Failure, CTCAE [NCIt concept]
- Heat Shock Factor 1 Pathway Inhibitor NXP800 [NCIt concept]
- Heavy Chain Disease [NCIt concept]
- Heavy Drinker [NCIt concept]
- Heavy Truck and Bus Driver [NCIt concept]
- Hec1/Nek2 Inhibitor T-1101 Tosylate [NCIt concept]
- Hedgehog Inhibitor NLM-001 [NCIt concept]
- Helicobacter Pylori Infection [NCIt concept]
- Helicobacter Pylori-Associated Gastritis [NCIt concept]
- Hemangioblastic Meningioma [NCIt concept]
- Hemangioblastoma [NCIt concept]
- Hemangioendothelioma [NCIt concept]
- Hemangioma [NCIt concept]
- Hemangiopericytoma [NCIt concept]
- Hematocrit Measurement [NCIt concept]
- Hematoma, CTCAE [NCIt concept]
- Hematopoietic Cell Transplantation [NCIt concept]
- Hematopoietic Progenitor Cell Antigen CD34 [NCIt concept]
- Hematopoietic System [NCIt concept]
- Hematopoietic and Lymphoid Cell Disorder [NCIt concept]
- Hematopoietic and Lymphoid Cell Neoplasm [NCIt concept]
- Hematosalpinx, CTCAE [NCIt concept]
- Hematoxylin and Eosin Staining Method [NCIt concept]
- Hematuria, CTCAE [NCIt concept]
- Hemiasterlin Analog E7974 [NCIt concept]
- Hemihypertrophy [NCIt concept]
- Hemilaryngectomy [NCIt concept]
- Hemizygosity [NCIt concept]
- Hemochromatosis [NCIt concept]
- Hemodialysis [NCIt concept]
- Hemoglobin Increased, CTCAE [NCIt concept]
- Hemoglobin Measurement [NCIt concept]
- Hemoglobinuria, CTCAE 5.0 [NCIt concept]
- Hemolymphangioma [NCIt concept]
- Hemolysis, CTCAE [NCIt concept]
- Hemolytic Uremic Syndrome [NCIt concept]
- Hemolytic Uremic Syndrome, CTCAE [NCIt concept]
- Hemophilia [NCIt concept]
- Hemorrhagic Cystitis [NCIt concept]
- Hemorrhoidal Hemorrhage, CTCAE [NCIt concept]
- Hemorrhoids, CTCAE 5.0 [NCIt concept]
- Henatinib Maleate [NCIt concept]
- Hepatic [NCIt concept]
- Hepatic Duct [NCIt concept]
- Hepatic Encephalopathy [NCIt concept]
- Hepatic Failure, CTCAE [NCIt concept]
- Hepatic Flexure [NCIt concept]
- Hepatic Hemorrhage, CTCAE [NCIt concept]
- Hepatic Infection, CTCAE [NCIt concept]
- Hepatic Necrosis, CTCAE 5.0 [NCIt concept]
- Hepatic Pain, CTCAE [NCIt concept]
- Hepatic Vein [NCIt concept]
- Hepatitis [NCIt concept]
- Hepatitis A Infection [NCIt concept]
- Hepatitis B DNA Measurement [NCIt concept]
- Hepatitis B Infection [NCIt concept]
- Hepatitis B Surface Antibody Measurement [NCIt concept]
- Hepatitis B Virus Core Antibody Measurement [NCIt concept]
- Hepatitis B Virus Surface Antigen Measurement [NCIt concept]
- Hepatitis C Antibody Measurement [NCIt concept]
- Hepatitis C Infection [NCIt concept]
- Hepatitis C Virus RNA Measurement [NCIt concept]
- Hepatitis Serology [NCIt concept]
- Hepatitis Sustained Virologic Response [NCIt concept]
- Hepatitis Viral, CTCAE [NCIt concept]
- Hepatobiliary Disorders - Other, Specify, CTCAE [NCIt concept]
- Hepatoblastoma [NCIt concept]
- Hepatocellular Adenoma [NCIt concept]
- Hepatocellular Carcinoma [NCIt concept]
- Hepatoid Adenocarcinoma [NCIt concept]
- Hepatosplenic T-Cell Lymphoma [NCIt concept]
- Herba Scutellaria Barbata [NCIt concept]
- Herbimycin [NCIt concept]
- Hereditary Breast Carcinoma [NCIt concept]
- Hereditary Hemorrhagic Telangiectasia [NCIt concept]
- Hereditary Kidney Oncocytoma [NCIt concept]
- Hereditary Leiomyomatosis and Renal Cell Carcinoma [NCIt concept]
- Hereditary Nonpolyposis Colorectal Cancer Syndrome [NCIt concept]
- Hereditary Ovarian Carcinoma [NCIt concept]
- Hereditary Papillary Renal Cell Carcinoma [NCIt concept]
- Hereditary Prostate Carcinoma [NCIt concept]
- Hereditary Renal Cell Carcinoma [NCIt concept]
- Herpes Simplex Virus Infection [NCIt concept]
- Herpes Zoster [NCIt concept]
- Heterodimeric Interleukin-15 [NCIt concept]
- Heterosexual Contact [NCIt concept]
- Heterozygosity [NCIt concept]
- Hexamethylene Bisacetamide [NCIt concept]
- Hexaminolevulinate [NCIt concept]
- Hexylresorcinol [NCIt concept]
- HiChIP [NCIt concept]
- Hibernoma [NCIt concept]
- Hiccups, CTCAE [NCIt concept]
- Hidradenocarcinoma [NCIt concept]
- Hidradenoma [NCIt concept]
- Hidradenoma Papilliferum [NCIt concept]
- Hidrocystoma [NCIt concept]
- Hierarchical Data Format 5 [NCIt concept]
- High [NCIt concept]
- High Grade [NCIt concept]
- High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements [NCIt concept]
- High Grade B-Cell Lymphoma, Not Otherwise Specified [NCIt concept]
- High Grade Dysplasia [NCIt concept]
- High Grade Esophageal Glandular Intraepithelial Neoplasia [NCIt concept]
- High Grade Esophageal Squamous Intraepithelial Neoplasia [NCIt concept]
- High Grade Glandular Intraepithelial Neoplasia [NCIt concept]
- High Grade Liver Dysplastic Nodule [NCIt concept]
- High Grade Prostatic Intraepithelial Neoplasia [NCIt concept]
- High Grade Squamous Intraepithelial Neoplasia [NCIt concept]
- High Grade Surface Osteosarcoma [NCIt concept]
- High Risk [NCIt concept]
- High School Completion [NCIt concept]
- High-Dose Rate Brachytherapy [NCIt concept]
- High-Grade Biliary Intraepithelial Neoplasia [NCIt concept]
- Highly Active Antiretroviral Therapy [NCIt concept]
- Hilar [NCIt concept]
- Hilar Cholangiocarcinoma [NCIt concept]
- Hip [NCIt concept]
- Hip Fracture, CTCAE [NCIt concept]
- Hippocampus [NCIt concept]
- Hirsutism, CTCAE [NCIt concept]
- Hispanic or Latino [NCIt concept]
- Histamine-2 Receptor Antagonist [NCIt concept]
- Histiocytic Sarcoma [NCIt concept]
- Histiocytoma [NCIt concept]
- Histological Progression Type [NCIt concept]
- Histology [NCIt concept]
- Histology ICD-O Morphology Code [NCIt concept]
- Histone [NCIt concept]
- Histone H1 [NCIt concept]
- Histone H2A [NCIt concept]
- Histone H2A-Bbd [NCIt concept]
- Histone H2A.V [NCIt concept]
- Histone H2A.V Isoform 2 [NCIt concept]
- Histone H2A.Z [NCIt concept]
- Histone H2AX [NCIt concept]
- Histone H2B [NCIt concept]
- Histone H3 [NCIt concept]
- Histone H3 Acetyl Lys28 [NCIt concept]
- Histone H3 Methyl Lys4 [NCIt concept]
- Histone H3 Trimethyl Lys28 [NCIt concept]
- Histone H3 Trimethyl Lys36 [NCIt concept]
- Histone H3 Trimethyl Lys4 [NCIt concept]
- Histone H3 Trimethyl Lys9 [NCIt concept]
- Histone H3-Like Centromeric Protein A [NCIt concept]
- Histone H3.1 [NCIt concept]
- Histone H3.1t [NCIt concept]
- Histone H3.2 [NCIt concept]
- Histone H3.3 [NCIt concept]
- Histone H3.3C [NCIt concept]
- Histone H3.X [NCIt concept]
- Histone H3.Y [NCIt concept]
- Histone H4 [NCIt concept]
- Histone Variant [NCIt concept]
- Histone-Lysine N-Methyltransferase EZH2 Inhibitor GSK2816126 [NCIt concept]
- Histoplasmosis [NCIt concept]
- Histrelin Acetate [NCIt concept]
- Hoarseness, CTCAE [NCIt concept]
- Hodgkin Lymphoma [NCIt concept]
- Hodgkin's Antigens-GM-CSF-Expressing Cell Vaccine [NCIt concept]
- Hodgkin's Disease, Nodular Sclerosis, Lymphocyte Depletion [NCIt concept]
- Hodgkin's Disease, Nodular Sclerosis, Lymphocyte Predominance [NCIt concept]
- Hodgkin's Disease, Nodular Sclerosis, Mixed Cellularity [NCIt concept]
- Hodgkin's Granuloma [NCIt concept]
- Hodgkin's Paragranuloma [NCIt concept]
- Hodgkin's Sarcoma [NCIt concept]
- Holmium Ho 166 Poly(L-Lactic Acid) Microspheres [NCIt concept]
- Holy See (Vatican City State) [NCIt concept]
- Home Oxygen Therapy Use Duration Indicator [NCIt concept]
- Home-related Exposure [NCIt concept]
- Homosexual Contact [NCIt concept]
- Homozygosity [NCIt concept]
- Honduras [NCIt concept]
- Hong Kong [NCIt concept]
- Hormonal Contraception [NCIt concept]
- Hormone Replacement Therapy [NCIt concept]
- Hormone Therapy [NCIt concept]
- Hot Flashes, CTCAE [NCIt concept]
- Hotel and Restaurant Manager [NCIt concept]
- How Often Have Alcoholic Drink [NCIt concept]
- Hpk1 Inhibitor BGB-15025 [NCIt concept]
- Hpk1 Inhibitor BGB-26808 [NCIt concept]
- Hpk1 Inhibitor CFI-402411 [NCIt concept]
- Hpk1 Inhibitor FB849 [NCIt concept]
- Hpk1 Inhibitor GRC 54276 [NCIt concept]
- Hpk1 Inhibitor NDI-101150 [NCIt concept]
- Hpk1 Inhibitor PF-07265028 [NCIt concept]
- Hpk1 Inhibitor PRJ1-3024 [NCIt concept]
- Hsp90 Antagonist KW-2478 [NCIt concept]
- Hsp90 Inhibitor AB-010 [NCIt concept]
- Hsp90 Inhibitor BIIB021 [NCIt concept]
- Hsp90 Inhibitor BIIB028 [NCIt concept]
- Hsp90 Inhibitor DS-2248 [NCIt concept]
- Hsp90 Inhibitor Debio 0932 [NCIt concept]
- Hsp90 Inhibitor HSP990 [NCIt concept]
- Hsp90 Inhibitor LAM-003 [NCIt concept]
- Hsp90 Inhibitor LAM-003A [NCIt concept]
- Hsp90 Inhibitor MPT0B640 [NCIt concept]
- Hsp90 Inhibitor NVP-BEP800 [NCIt concept]
- Hsp90 Inhibitor SNX-5422 Mesylate [NCIt concept]
- Hsp90 Inhibitor SNX-5542 Mesylate [NCIt concept]
- Hsp90 Inhibitor TQB3474 [NCIt concept]
- Hsp90 Inhibitor XL888 [NCIt concept]
- Hsp90-targeted Photosensitizer HS-201 [NCIt concept]
- HuaChanSu [NCIt concept]
- Huaier Extract Granule [NCIt concept]
- Huang Lian [NCIt concept]
- Human Chromosome 1 [NCIt concept]
- Human Chromosome 10 [NCIt concept]
- Human Chromosome 11 [NCIt concept]
- Human Chromosome 12 [NCIt concept]
- Human Chromosome 13 [NCIt concept]
- Human Chromosome 14 [NCIt concept]
- Human Chromosome 15 [NCIt concept]
- Human Chromosome 16 [NCIt concept]
- Human Chromosome 17 [NCIt concept]
- Human Chromosome 18 [NCIt concept]
- Human Chromosome 19 [NCIt concept]
- Human Chromosome 2 [NCIt concept]
- Human Chromosome 20 [NCIt concept]
- Human Chromosome 21 [NCIt concept]
- Human Chromosome 22 [NCIt concept]
- Human Chromosome 23 [NCIt concept]
- Human Chromosome 3 [NCIt concept]
- Human Chromosome 4 [NCIt concept]
- Human Chromosome 5 [NCIt concept]
- Human Chromosome 6 [NCIt concept]
- Human Chromosome 7 [NCIt concept]
- Human Chromosome 8 [NCIt concept]
- Human Chromosome 9 [NCIt concept]
- Human Chromosome X [NCIt concept]
- Human Chromosome Y [NCIt concept]
- Human MHC Non-Restricted Cytotoxic T-Cell Line TALL-104 [NCIt concept]
- Human MOAB LICO 28a32 [NCIt concept]
- Human Monoclonal Antibody 216 [NCIt concept]
- Human Monoclonal Antibody B11-hCG Beta Fusion Protein CDX-1307 [NCIt concept]
- Human Papillomavirus 16 E7 Peptide/Padre 965.10 [NCIt concept]
- Human Papillomavirus E6/E7 Protein Measurement [NCIt concept]
- Human Papillomavirus Infection [NCIt concept]
- Human Papillomavirus Test [NCIt concept]
- Human Papillomavirus-16 [NCIt concept]
- Human Papillomavirus-18 [NCIt concept]
- Human Papillomavirus-26 [NCIt concept]
- Human Papillomavirus-31 [NCIt concept]
- Human Papillomavirus-33 [NCIt concept]
- Human Papillomavirus-35 [NCIt concept]
- Human Papillomavirus-39 [NCIt concept]
- Human Papillomavirus-45 [NCIt concept]
- Human Papillomavirus-51 [NCIt concept]
- Human Papillomavirus-52 [NCIt concept]
- Human Papillomavirus-53 [NCIt concept]
- Human Papillomavirus-56 [NCIt concept]
- Human Papillomavirus-58 [NCIt concept]
- Human Papillomavirus-59 [NCIt concept]
- Human Papillomavirus-63 [NCIt concept]
- Human Papillomavirus-66 [NCIt concept]
- Human Papillomavirus-68 [NCIt concept]
- Human Papillomavirus-70 [NCIt concept]
- Human Papillomavirus-73 [NCIt concept]
- Human Papillomavirus-82 [NCIt concept]
- Human Papillomavirus-Independent Cervical Adenocarcinoma, Gastric-Type [NCIt concept]
- Human Papillomavirus-Independent Squamous Cell Carcinoma [NCIt concept]
- Human Papillomavirus-Related Squamous Cell Carcinoma [NCIt concept]
- Human-derived Enterococcus Strain MNC-168 [NCIt concept]
- Humerus [NCIt concept]
- Hungary [NCIt concept]
- Husband [NCIt concept]
- Hyaluronidase-zzxf/Pertuzumab/Trastuzumab [NCIt concept]
- Hybrid Selected Genomic Library [NCIt concept]
- Hycanthone [NCIt concept]
- Hydatidiform Mole [NCIt concept]
- Hydralazine Hydrochloride [NCIt concept]
- Hydroa Vacciniforme Lymphoproliferative Disorder [NCIt concept]
- Hydrocephalus, CTCAE [NCIt concept]
- Hydrocortisone Sodium Succinate [NCIt concept]
- Hydrogel-based Resiquimod STM-416 [NCIt concept]
- Hydrogen Rich Water [NCIt concept]
- Hydroxychloroquine [NCIt concept]
- Hydroxyprogesterone Caproate [NCIt concept]
- Hydroxytyrosol [NCIt concept]
- Hydroxyurea [NCIt concept]
- Hypercalcemia [NCIt concept]
- Hypercalcemia, CTCAE [NCIt concept]
- Hypercholesterolemia [NCIt concept]
- Hypercortisolemia [NCIt concept]
- Hyperdiploid B Acute Lymphoblastic Leukemia [NCIt concept]
- Hyperdiploid B Lymphoblastic Leukemia/Lymphoma [NCIt concept]
- Hyperdiploidy [NCIt concept]
- Hyperestrogenism [NCIt concept]
- Hyperglycemia [NCIt concept]
- Hyperglycemia, CTCAE [NCIt concept]
- Hyperhidrosis, CTCAE [NCIt concept]
- Hypericin [NCIt concept]
- Hyperkalemia, CTCAE [NCIt concept]
- Hyperkeratosis [NCIt concept]
- Hyperlipidemia [NCIt concept]
- Hypermagnesemia, CTCAE [NCIt concept]
- Hypermethylation [NCIt concept]
- Hypernatremia, CTCAE [NCIt concept]
- Hyperparathyroidism [NCIt concept]
- Hyperparathyroidism, CTCAE [NCIt concept]
- Hypersomnia, CTCAE [NCIt concept]
- Hypertension [NCIt concept]
- Hypertension, CTCAE [NCIt concept]
- Hyperthyroidism [NCIt concept]
- Hyperthyroidism, CTCAE [NCIt concept]
- Hypertrichosis, CTCAE [NCIt concept]
- Hypertriglyceridemia, CTCAE [NCIt concept]
- Hyperuricemia, CTCAE [NCIt concept]
- Hypoalbuminemia, CTCAE [NCIt concept]
- Hypocalcemia, CTCAE [NCIt concept]
- Hypodiploid B Lymphoblastic Leukemia/Lymphoma [NCIt concept]
- Hypodiploidy [NCIt concept]
- Hypofractionated Radiation Therapy [NCIt concept]
- Hypoglossal Nerve Disorder, CTCAE [NCIt concept]
- Hypoglycemia, CTCAE [NCIt concept]
- Hypohidrosis, CTCAE [NCIt concept]
- Hypokalemia, CTCAE [NCIt concept]
- Hypomagnesemia, CTCAE [NCIt concept]
- Hyponatremia, CTCAE [NCIt concept]
- Hypoparathyroidism, CTCAE [NCIt concept]
- Hypopharynx [NCIt concept]
- Hypophosphatemia, CTCAE [NCIt concept]
- Hypospadias [NCIt concept]
- Hypotension, CTCAE [NCIt concept]
- Hypothermia, CTCAE [NCIt concept]
- Hypothyroidism [NCIt concept]
- Hypothyroidism, CTCAE [NCIt concept]
- Hypoxia, CTCAE [NCIt concept]
- Hypoxia-activated Prodrug TH-4000 [NCIt concept]
- Hysterectomy [NCIt concept]
- Hysterectomy Margins Involved Indicator [NCIt concept]
- I 131 Antiferritin Immunoglobulin [NCIt concept]
- I 131 Monoclonal Antibody A33 [NCIt concept]
- I 131 Monoclonal Antibody CC49 [NCIt concept]
- I 131 Monoclonal Antibody F19 [NCIt concept]
- I 131 Monoclonal Antibody Lym-1 [NCIt concept]
- IAP Antagonist TQB3728 [NCIt concept]
- IAP Inhibitor HGS1029 [NCIt concept]
- ICD-10 Code [NCIt concept]
- ICD-O-3 Morphology Term Diagnosis Question [NCIt concept]
- ICT-121 Dendritic Cell Vaccine [NCIt concept]
- ID3 Gene [NCIt concept]
- IDAT Format [NCIt concept]
- IDH1 Gene [NCIt concept]
- IDH1 Inhibitor KY100001 [NCIt concept]
- IDH1 Inhibitor TQB3454 [NCIt concept]
- IDH1(R132) Inhibitor IDH305 [NCIt concept]
- IDH1/IDH2 Dual Inhibitor HMPL-306 [NCIt concept]
- IDH1R132H-Specific Peptide Vaccine PEPIDH1M [NCIt concept]
- IDH2 Gene [NCIt concept]
- IDH2 Mutant Inhibitor SH1573 [NCIt concept]
- IDH2 Mutant Inhibitor TQB3455 [NCIt concept]
- IDO Peptide Vaccine IO102 [NCIt concept]
- IDO-1 Inhibitor LY3381916 [NCIt concept]
- IDO/TDO Inhibitor HTI-1090 [NCIt concept]
- IDO/TDO Inhibitor LY-01013 [NCIt concept]
- IDO1 Inhibitor KHK2455 [NCIt concept]
- IDO1 Inhibitor MK-7162 [NCIt concept]
- IDO1 Inhibitor PF-06840003 [NCIt concept]
- IDO1/TDO2 Inhibitor DN1406131 [NCIt concept]
- IDO1/TDO2 Inhibitor M4112 [NCIt concept]
- IGF-1R Inhibition [NCIt concept]
- IGF-1R Inhibitor PL225B [NCIt concept]
- IGF-1R/IR Inhibitor KW-2450 [NCIt concept]
- IGF-methotrexate Conjugate [NCIt concept]
- IGKC Gene [NCIt concept]
- IKBKB Gene [NCIt concept]
- IKKb-matured RNA-loaded Autologous Dendritic Cells DCIKKb [NCIt concept]
- IKZF1 Gene [NCIt concept]
- IKZF2 Protein Degrader DKY709 [NCIt concept]
- IL-10 Immunomodulator MK-1966 [NCIt concept]
- IL-10-armed Anti-CD19 CAR-T Cells Meta10-19 [NCIt concept]
- IL-12-Fc Fusion Protein KGX101 [NCIt concept]
- IL-12-Fc Fusion Protein XmAb662 [NCIt concept]
- IL-12-expressing Exosome CDK-003 [NCIt concept]
- IL-12-expressing HSV-1 NSC 733972 [NCIt concept]
- IL-12-expressing Mesenchymal Stem Cell Vaccine GX-051 [NCIt concept]
- IL-12/Anti-CTLA-4 Monoclonal Antibody-expressing Oncolytic Viral Vector TG6050 [NCIt concept]
- IL-12sc, IL-15sushi, IFNa and GM-CSF mRNA-based Immunotherapeutic Agent SAR441000 [NCIt concept]
- IL-15/IL-15 Receptor alpha Heterodimer NIZ985 [NCIt concept]
- IL-2 Recombinant Fusion Protein ALT-801 [NCIt concept]
- IL-2 Superkine-Recombinant Human Albumin Fusion Protein MDNA11 [NCIt concept]
- IL-2/9/15 Gamma Chain Receptor Inhibitor BNZ-1 [NCIt concept]
- IL-2/Anti-IL-2 Antibody Conjugate SLC-3010 [NCIt concept]
- IL-2/IL-12-based Fusion Protein CLN-617 [NCIt concept]
- IL2 Gene [NCIt concept]
- IL21R Gene [NCIt concept]
- IL6ST Gene [NCIt concept]
- IL7R Gene [NCIt concept]
- ILT-3 Antagonist MK-0482 [NCIt concept]
- IMT-1012 Immunotherapeutic Vaccine [NCIt concept]
- INO-1001 [NCIt concept]
- INO80D Gene [NCIt concept]
- INR Increased, CTCAE [NCIt concept]
- INRG Stage L1 [NCIt concept]
- INRG Stage L2 [NCIt concept]
- INRG Stage M [NCIt concept]
- INRG Stage MS [NCIt concept]
- INSS Stage 1 [NCIt concept]
- INSS Stage 2A [NCIt concept]
- INSS Stage 2B [NCIt concept]
- INSS Stage 3 [NCIt concept]
- INSS Stage 4 [NCIt concept]
- INSS Stage 4S [NCIt concept]
- IRAK4/Ikaros/Aiolos Protein Degrader KT-413 [NCIt concept]
- IRE1 RNase Inhibitor ORIN1001 [NCIt concept]
- IRF4 Gene [NCIt concept]
- IRS Clinical Grouping System [NCIt concept]
- IRS Clinical Staging System [NCIt concept]
- IRS1/IRS2/STAT3 Inhibitor NT219 [NCIt concept]
- IRS4 Gene [NCIt concept]
- ISS 1018 CpG Oligodeoxynucleotide [NCIt concept]
- ISS Stage I Multiple Myeloma [NCIt concept]
- ISS Stage II Multiple Myeloma [NCIt concept]
- ISS Stage III Multiple Myeloma [NCIt concept]
- ISX Gene [NCIt concept]
- ITGAV Gene [NCIt concept]
- ITK Gene [NCIt concept]
- Iadademstat [NCIt concept]
- Ianalumab [NCIt concept]
- Ibandronate Sodium [NCIt concept]
- Ibcasertib [NCIt concept]
- Ibentatug [NCIt concept]
- Iberdomide [NCIt concept]
- Iboctadekin [NCIt concept]
- Ibritumomab Tiuxetan [NCIt concept]
- Ibrutinib [NCIt concept]
- Iceland [NCIt concept]
- Icotinib Hydrochloride [NCIt concept]
- Icrucumab [NCIt concept]
- Idarubicin [NCIt concept]
- Idarubicin Hydrochloride [NCIt concept]
- Idarubicin-Eluting Beads [NCIt concept]
- Idasanutlin [NCIt concept]
- Idecabtagene Vicleucel [NCIt concept]
- Idelalisib [NCIt concept]
- Identical Twin [NCIt concept]
- Identical Twin Brother [NCIt concept]
- Identical Twin Sister [NCIt concept]
- Identifier [NCIt concept]
- Idetrexed [NCIt concept]
- Idiopathic Hypereosinophilic Syndrome [NCIt concept]
- Idiotype-Pulsed Autologous Dendritic Cell Vaccine APC8020 [NCIt concept]
- Idronoxil [NCIt concept]
- Idronoxil Suppository NOX66 [NCIt concept]
- Idroxioleic Acid [NCIt concept]
- Ieramilimab [NCIt concept]
- Ifabotuzumab [NCIt concept]
- Ifebemtinib [NCIt concept]
- Ifetroban [NCIt concept]
- Ifinatamab Deruxtecan [NCIt concept]
- Ifosfamide [NCIt concept]
- Ileal Fistula, CTCAE [NCIt concept]
- Ileal Hemorrhage, CTCAE [NCIt concept]
- Ileal Obstruction, CTCAE [NCIt concept]
- Ileal Perforation, CTCAE 5.0 [NCIt concept]
- Ileal Stenosis, CTCAE [NCIt concept]
- Ileal Ulcer, CTCAE [NCIt concept]
- Ileocecal Valve [NCIt concept]
- Ileum [NCIt concept]
- Ileus, CTCAE [NCIt concept]
- Ilginatinib [NCIt concept]
- Iliac Lymph Node [NCIt concept]
- Ilium [NCIt concept]
- Ilixadencel [NCIt concept]
- Ill-Defined Anatomic Site [NCIt concept]
- Illumina Infinium Methylation BeadChip System [NCIt concept]
- Illumina Sequencing [NCIt concept]
- Iloprost [NCIt concept]
- Ilorasertib [NCIt concept]
- Image Acquisition Date [NCIt concept]
- Image Anatomic Location [NCIt concept]
- Imaging Finding [NCIt concept]
- Imaging Magnification [NCIt concept]
- Imaging Technique [NCIt concept]
- Imalumab [NCIt concept]
- Imaradenant [NCIt concept]
- Imatinib [NCIt concept]
- Imatinib Mesylate [NCIt concept]
- Imetelstat [NCIt concept]
- Imetelstat Sodium [NCIt concept]
- Imexon [NCIt concept]
- Imgatuzumab [NCIt concept]
- Imidazole Mustard [NCIt concept]
- Imidazole-Pyrazole [NCIt concept]
- Imifoplatin [NCIt concept]
- Imipramine Blue [NCIt concept]
- Imiquimod [NCIt concept]
- Imlunestrant [NCIt concept]
- Immature Teratoma [NCIt concept]
- Immediate-release Onapristone [NCIt concept]
- Immediate-release Tablet Afuresertib [NCIt concept]
- Immune System Disorders - Other, Specify, CTCAE [NCIt concept]
- Immunoblastic Lymphoma [NCIt concept]
- Immunocytokine NHS-IL12 [NCIt concept]
- Immunocytokine NHS-IL2-LT [NCIt concept]
- Immunodeficiency-Related Burkitt Lymphoma [NCIt concept]
- Immunofluorescent Staining Method [NCIt concept]
- Immunoglobulin A Measurement [NCIt concept]
- Immunoglobulin G Measurement [NCIt concept]
- Immunoglobulin Heavy Locus [NCIt concept]
- Immunoglobulin Kappa Locus [NCIt concept]
- Immunoglobulin Lambda Locus [NCIt concept]
- Immunoglobulin Light Chain Measurement [NCIt concept]
- Immunoglobulin M Measurement [NCIt concept]
- Immunohistochemistry Staining Method [NCIt concept]
- Immunomodulator OHR/AVR118 [NCIt concept]
- Immunomodulatory Agent CC-11006 [NCIt concept]
- Immunomodulatory Oligonucleotide HYB2055 [NCIt concept]
- Immunoprogression [NCIt concept]
- Immunoresponse [NCIt concept]
- Immunosuppressant [NCIt concept]
- Immunotherapeutic Combination Product CMB305 [NCIt concept]
- Immunotherapy [NCIt concept]
- Immunotherapy Regimen MKC-1106-MT [NCIt concept]
- Immunotoxin CMD-193 [NCIt concept]
- Imvotamab [NCIt concept]
- In Situ Hybridization [NCIt concept]
- In Situ Lesion [NCIt concept]
- Inactivated Oncolytic Virus Particle GEN0101 [NCIt concept]
- Inalimarev [NCIt concept]
- Inavolisib [NCIt concept]
- Incisional Biopsy [NCIt concept]
- Incomplete Terminal Codon Variant [NCIt concept]
- Incomplete Tumor Cell Necrosis [NCIt concept]
- Incyclinide [NCIt concept]
- Indatuximab Ravtansine [NCIt concept]
- Indefinite Dysplasia [NCIt concept]
- Indeterminate [NCIt concept]
- Indeterminate Dendritic Cell Histiocytosis [NCIt concept]
- Index Date [NCIt concept]
- India [NCIt concept]
- Indibulin [NCIt concept]
- Indicine-N-Oxide [NCIt concept]
- Indisulam [NCIt concept]
- Individual Cancer History [NCIt concept]
- Individualized MVA-based Vaccine TG4050 [NCIt concept]
- Indole-3-Carbinol [NCIt concept]
- Indolent Clonal T-Cell Lymphoproliferative Disorder of the Gastrointestinal Tract [NCIt concept]
- Indolent Systemic Mastocytosis [NCIt concept]
- Indomethacin [NCIt concept]
- Indonesia [NCIt concept]
- Indoor Stove or Fireplace Smoke Exposure [NCIt concept]
- Indoximod [NCIt concept]
- Indoximod Prodrug NLG802 [NCIt concept]
- Induced Abortion Finding [NCIt concept]
- Induction Death [NCIt concept]
- Induction Therapy [NCIt concept]
- Indusatumab Vedotin [NCIt concept]
- Inebilizumab [NCIt concept]
- Inecalcitol [NCIt concept]
- Inetetamab [NCIt concept]
- Inezetamab [NCIt concept]
- Infantile Fibrosarcoma [NCIt concept]
- Infantile Hemangioma [NCIt concept]
- Infections and Infestations - Other, Specify, CTCAE [NCIt concept]
- Infectious Disorder [NCIt concept]
- Infective Myositis, CTCAE [NCIt concept]
- Inferior Vena Cava [NCIt concept]
- Infigratinib [NCIt concept]
- Infigratinib Mesylate [NCIt concept]
- Infiltrating Angiolipoma [NCIt concept]
- Infiltrating Lipoma [NCIt concept]
- Inflammation [NCIt concept]
- Inflammatory Atypical Lipomatous Tumor/Well Differentiated Liposarcoma [NCIt concept]
- Inflammatory Bowel Disease [NCIt concept]
- Inflammatory Myofibroblastic Tumor [NCIt concept]
- Infliximab [NCIt concept]
- Information Source for Cause of Death [NCIt concept]
- Information and Communications Technology Operations and User Support Technician [NCIt concept]
- Information and Communications Technology Service Manager [NCIt concept]
- Informed Consent [NCIt concept]
- Infraclavicular Lymph Node [NCIt concept]
- Inframe Deletion [NCIt concept]
- Inframe Insertion [NCIt concept]
- Infusion Related Reaction, CTCAE [NCIt concept]
- Infusion Site Extravasation, CTCAE [NCIt concept]
- Ingenol Mebutate [NCIt concept]
- Ingenol Mebutate Gel [NCIt concept]
- Inguinal Lymph Node [NCIt concept]
- Inguinal Region [NCIt concept]
- Iniparib [NCIt concept]
- Initial Biospecimen Weight [NCIt concept]
- Initial Diagnosis [NCIt concept]
- Initial Genomic Sequencing Date [NCIt concept]
- Initial Neoplastic Disease Extent Indicator [NCIt concept]
- Inixaciclib [NCIt concept]
- Injected Insulin Diabetes Therapy [NCIt concept]
- Injection Site Reaction, CTCAE [NCIt concept]
- Injury To Carotid Artery, CTCAE [NCIt concept]
- Injury To Inferior Vena Cava, CTCAE [NCIt concept]
- Injury To Jugular Vein, CTCAE [NCIt concept]
- Injury To Superior Vena Cava, CTCAE [NCIt concept]
- Injury, Poisoning and Procedural Complications - Other, Specify, CTCAE [NCIt concept]
- Innate Immunostimulator rBBX-01 [NCIt concept]
- Inobrodib [NCIt concept]
- Inodiftagene Vixteplasmid [NCIt concept]
- Inosine 5'-monophosphate Dehydrogenase Inhibitor FF-10501-01 [NCIt concept]
- Inosine Monophosphate Dehydrogenase Inhibitor AVN944 [NCIt concept]
- Inositol [NCIt concept]
- Inotuzumab Ozogamicin [NCIt concept]
- Inproquone [NCIt concept]
- Insertion Mutation [NCIt concept]
- Insomnia, CTCAE 5.0 [NCIt concept]
- Instrument Model [NCIt concept]
- Integrin Alpha V Beta 3-targeting Protein ACT50 [NCIt concept]
- Integrin AlphaVbeta3-targeted Small Molecule-drug Conjugate VIP236 [NCIt concept]
- Integrin Receptor Antagonist GLPG0187 [NCIt concept]
- Integrin alpha-2 Inhibitor E7820 [NCIt concept]
- Intensity-Modulated Radiation Therapy [NCIt concept]
- Intent To Treat [NCIt concept]
- Interdigitating Dendritic Cell Sarcoma [NCIt concept]
- Interferon [NCIt concept]
- Interferon Alfa-2c [NCIt concept]
- Interferon Alfa-N1 [NCIt concept]
- Interferon Alfa-N3 [NCIt concept]
- Interferon Alfacon-1 [NCIt concept]
- Interferon Beta-1A [NCIt concept]
- Interferon Gamma-1b [NCIt concept]
- Interferon-gamma-expressing Adenovirus Vaccine ASN-002 [NCIt concept]
- Intergenic Mutation [NCIt concept]
- Intergroup Rhabdomyosarcoma Group I [NCIt concept]
- Intergroup Rhabdomyosarcoma Group II [NCIt concept]
- Intergroup Rhabdomyosarcoma Group III [NCIt concept]
- Intergroup Rhabdomyosarcoma Group IIIa [NCIt concept]
- Intergroup Rhabdomyosarcoma Group IIIb [NCIt concept]
- Intergroup Rhabdomyosarcoma Group IIa [NCIt concept]
- Intergroup Rhabdomyosarcoma Group IIb [NCIt concept]
- Intergroup Rhabdomyosarcoma Group IIc [NCIt concept]
- Intergroup Rhabdomyosarcoma Group IV [NCIt concept]
- Intergroup Rhabdomyosarcoma Group Ia [NCIt concept]
- Intergroup Rhabdomyosarcoma Group Ib [NCIt concept]
- Interleukin Therapy [NCIt concept]
- Interleukin-12-Fc Fusion Protein DF6002 [NCIt concept]
- Interleukin-15 Agonist Fusion Protein SHR1501 [NCIt concept]
- Interleukin-15 Fusion Protein BJ-001 [NCIt concept]
- Interleukin-15/Interleukin-15 Receptor Alpha Complex-Fc Fusion Protein XmAb24306 [NCIt concept]
- Interleukin-2 Liposome [NCIt concept]
- Interleukin-2 Receptor Subunit Alpha [NCIt concept]
- Interleukin-2/Interleukin-15 Receptor Agonist NL-201 [NCIt concept]
- Intermediate [NCIt concept]
- Intermediate Analysis Archive [NCIt concept]
- Intermediate Grade [NCIt concept]
- Intermediate Immature Teratoma [NCIt concept]
- Intermediate Risk [NCIt concept]
- Intermittent Oxygen Administration [NCIt concept]
- Internal [NCIt concept]
- Internal Mammary Lymph Node [NCIt concept]
- Internal Tandem Duplication Mutation [NCIt concept]
- International Classification of Diseases, Tenth Revision [NCIt concept]
- International Germ Cell Consensus Risk Classification [NCIt concept]
- International Neuroblastoma Pathology Classification [NCIt concept]
- International Neuroblastoma Pathology Classification Histologic Group [NCIt concept]
- International Neuroblastoma Risk Group Staging System [NCIt concept]
- International Neuroblastoma Staging System [NCIt concept]
- International Prognostic Index [NCIt concept]
- International Prognostic Index High Risk Group [NCIt concept]
- International Prognostic Index High-Intermediate Risk Group [NCIt concept]
- International Prognostic Index Low Risk Group [NCIt concept]
- International Prognostic Index Low-Intermediate Risk Group [NCIt concept]
- International Society of Urological Pathology Gleason Grade Group [NCIt concept]
- International Staging System Stage [NCIt concept]
- International Unit per Kilogram [NCIt concept]
- International Unit per Milligram [NCIt concept]
- Interstitial Pneumonia [NCIt concept]
- Interstitial Radiation Therapy [NCIt concept]
- Intervention or Procedure [NCIt concept]
- Intestinal Metaplasia [NCIt concept]
- Intestinal Stoma Leak, CTCAE [NCIt concept]
- Intestinal Stoma Obstruction, CTCAE [NCIt concept]
- Intestinal Stoma Site Bleeding, CTCAE [NCIt concept]
- Intestinal T-Cell Lymphoma [NCIt concept]
- Intestinal-Type Adenocarcinoma [NCIt concept]
- Intestine [NCIt concept]
- Intetumumab [NCIt concept]
- Intimal Sarcoma [NCIt concept]
- Intiquinatine [NCIt concept]
- Intoplicine [NCIt concept]
- Intra-Abdominal Hemorrhage, CTCAE [NCIt concept]
- Intra-Abdominal Lymph Node [NCIt concept]
- Intracompartmental Tumor [NCIt concept]
- Intracranial Hemorrhage, CTCAE [NCIt concept]
- Intraductal Papilloma [NCIt concept]
- Intraductal Papillomatosis [NCIt concept]
- Intraepidermal Epithelioma of Jadassohn [NCIt concept]
- Intraepithelial Neoplasia [NCIt concept]
- Intrahepatic Bile Duct [NCIt concept]
- Intrahepatic Route of Administration [NCIt concept]
- Intramammary Lymph Node [NCIt concept]
- Intramuscular Hemangioma [NCIt concept]
- Intramuscular Lipoma [NCIt concept]
- Intramuscular Route of Administration [NCIt concept]
- Intraneural Perineurioma [NCIt concept]
- Intraoperative Arterial Injury, CTCAE [NCIt concept]
- Intraoperative Breast Injury, CTCAE [NCIt concept]
- Intraoperative Cardiac Injury, CTCAE [NCIt concept]
- Intraoperative Ear Injury, CTCAE [NCIt concept]
- Intraoperative Endocrine Injury, CTCAE [NCIt concept]
- Intraoperative Gastrointestinal Injury, CTCAE [NCIt concept]
- Intraoperative Head and Neck Injury, CTCAE [NCIt concept]
- Intraoperative Hemorrhage, CTCAE [NCIt concept]
- Intraoperative Hepatobiliary Injury, CTCAE [NCIt concept]
- Intraoperative Musculoskeletal Injury, CTCAE [NCIt concept]
- Intraoperative Neurological Injury, CTCAE [NCIt concept]
- Intraoperative Ocular Injury, CTCAE [NCIt concept]
- Intraoperative Renal Injury, CTCAE [NCIt concept]
- Intraoperative Reproductive Tract Injury, CTCAE [NCIt concept]
- Intraoperative Respiratory Injury, CTCAE [NCIt concept]
- Intraoperative Skin Injury [NCIt concept]
- Intraoperative Splenic Injury, CTCAE [NCIt concept]
- Intraoperative Urinary Injury, CTCAE [NCIt concept]
- Intraoperative Venous Injury, CTCAE [NCIt concept]
- Intraperitoneal Route of Administration [NCIt concept]
- Intrathecal Deferoxamine [NCIt concept]
- Intrathecal Route of Administration [NCIt concept]
- Intrathoracic Lymph Node [NCIt concept]
- Intrathyroid Thymic Carcinoma [NCIt concept]
- Intratumoral Route of Administration [NCIt concept]
- Intrauterine Fetal Death [NCIt concept]
- Intravascular Large B-Cell Lymphoma [NCIt concept]
- Intravenous Drug User [NCIt concept]
- Intravenous Route of Administration [NCIt concept]
- Intravesical Route of Administration [NCIt concept]
- Intron of Interest Number [NCIt concept]
- Intronic Mutation [NCIt concept]
- Inulin [NCIt concept]
- Inupadenant [NCIt concept]
- Invasive Breast Carcinoma [NCIt concept]
- Invasive Breast Carcinoma of No Special Type [NCIt concept]
- Invasive Breast Ductal Carcinoma and Lobular Carcinoma [NCIt concept]
- Invasive Breast Ductal Carcinoma and Lobular Carcinoma In Situ [NCIt concept]
- Invasive Breast Lobular Carcinoma [NCIt concept]
- Invasive Breast Lobular Carcinoma, Alveolar Variant [NCIt concept]
- Invasive Breast Lobular Carcinoma, Pleomorphic Variant [NCIt concept]
- Invasive Breast Lobular Carcinoma, Solid Variant [NCIt concept]
- Invasive Breast Lobular Carcinoma, Tubulolobular Variant [NCIt concept]
- Invasive Breast Micropapillary Carcinoma [NCIt concept]
- Invasive Carcinoma [NCIt concept]
- Invasive Clear Cell (Glycogen-Rich) Urothelial Carcinoma [NCIt concept]
- Invasive Encapsulated Follicular Variant Thyroid Gland Papillary Carcinoma [NCIt concept]
- Invasive Hydatidiform Mole [NCIt concept]
- Invasive Lipid-Rich Urothelial Carcinoma [NCIt concept]
- Invasive Lung Mucinous Adenocarcinoma [NCIt concept]
- Invasive Microcystic Urothelial Carcinoma [NCIt concept]
- Invasive Nested Urothelial Carcinoma [NCIt concept]
- Invasive Papillary Adenocarcinoma [NCIt concept]
- Invasive Urothelial Carcinoma with Squamous Differentiation [NCIt concept]
- Invasive Urothelial Carcinoma with Trophoblastic Differentiation [NCIt concept]
- Inversion Mutation Abnormality [NCIt concept]
- Inverted Squamous Papilloma [NCIt concept]
- Inverted Transitional Cell Papilloma [NCIt concept]
- Investigation Description Format [NCIt concept]
- Investigations - Other, Specify, CTCAE [NCIt concept]
- Iobenguane I-131 [NCIt concept]
- Iodine I 124 Monoclonal Antibody A33 [NCIt concept]
- Iodine I 124 Monoclonal Antibody M5A [NCIt concept]
- Iodine I 125-Anti-EGFR-425 Monoclonal Antibody [NCIt concept]
- Iodine I 131 Anti-Fibronectin Antibody Fragment L19-SIP [NCIt concept]
- Iodine I 131 Apamistamab [NCIt concept]
- Iodine I 131 Derlotuximab Biotin [NCIt concept]
- Iodine I 131 Ethiodized Oil [NCIt concept]
- Iodine I 131 IPA [NCIt concept]
- Iodine I 131 Iopofosine [NCIt concept]
- Iodine I 131 MIP-1095 [NCIt concept]
- Iodine I 131 Monoclonal Antibody 81C6 [NCIt concept]
- Iodine I 131 Monoclonal Antibody CC49-deltaCH2 [NCIt concept]
- Iodine I 131 Monoclonal Antibody F16SIP [NCIt concept]
- Iodine I 131 Monoclonal Antibody G-250 [NCIt concept]
- Iodine I 131 Monoclonal Antibody muJ591 [NCIt concept]
- Iodine I 131 Omburtamab [NCIt concept]
- Iodine I 131 Radiation Therapy [NCIt concept]
- Iodine I 131 Rituximab [NCIt concept]
- Iodine I 131 SGMIB-Anti-HER2 CAM-H2 [NCIt concept]
- Iodine I 131 TM-601 [NCIt concept]
- Iodine I 131 Tenatumomab [NCIt concept]
- Iodine I 131 Tositumomab [NCIt concept]
- Iodine I-131 [NCIt concept]
- Ioflubenzamide I-131 [NCIt concept]
- Ion Semiconductor Sequencing [NCIt concept]
- Ionomycin [NCIt concept]
- Ipafricept [NCIt concept]
- Ipatasertib [NCIt concept]
- Ipilimumab [NCIt concept]
- Ipomeanol [NCIt concept]
- Iproplatin [NCIt concept]
- Iran, Islamic Republic of [NCIt concept]
- Iraq [NCIt concept]
- Iratumumab [NCIt concept]
- Ireland [NCIt concept]
- Iridium Ir 192 [NCIt concept]
- Irinotecan [NCIt concept]
- Irinotecan Hydrochloride [NCIt concept]
- Irinotecan Hydrochloride and Floxuridine Liposome LY01616 [NCIt concept]
- Irinotecan Liposome HR070803 [NCIt concept]
- Irinotecan Sucrosofate [NCIt concept]
- Irinotecan-Eluting Beads [NCIt concept]
- Irinotecan/P-glycoprotein Inhibitor HM30181AK Combination Tablet [NCIt concept]
- Irofulven [NCIt concept]
- Iron Overload [NCIt concept]
- Iron Overload, CTCAE [NCIt concept]
- Iroplact [NCIt concept]
- Irosustat [NCIt concept]
- Irpagratinib [NCIt concept]
- Irradiated Allogeneic Human Lung Cancer Cells Expressing OX40L-Ig Vaccine HS-130 [NCIt concept]
- Irregular Menstruation, CTCAE [NCIt concept]
- Irritability, CTCAE [NCIt concept]
- Iruplinalkib [NCIt concept]
- Is Extranodal Tumor Involvement Present [NCIt concept]
- Is Individual Lost to Follow-Up [NCIt concept]
- Is Lymphatic Invasion Present [NCIt concept]
- Is Macroscopic Satellite Nodule Present [NCIt concept]
- Isatuximab [NCIt concept]
- Ischemia Cerebrovascular, CTCAE [NCIt concept]
- Ischemic Heart Disease [NCIt concept]
- Ischium [NCIt concept]
- Ishak Score [NCIt concept]
- Ishak Score 0 [NCIt concept]
- Ishak Score 1-2 [NCIt concept]
- Ishak Score 3-4 [NCIt concept]
- Ishak Score 5 [NCIt concept]
- Ishak Score 6 [NCIt concept]
- Isle of Man [NCIt concept]
- Islet Cell [NCIt concept]
- Islet Cell Adenoma [NCIt concept]
- Islet of Langerhans [NCIt concept]
- Iso-fludelone [NCIt concept]
- Isobrucein B [NCIt concept]
- Isocoumarin NM-3 [NCIt concept]
- Isolated Chemotherapeutic Limb Perfusion [NCIt concept]
- Isosporiasis [NCIt concept]
- Isotope Therapy [NCIt concept]
- Isotretinoin [NCIt concept]
- Ispectamab Debotansine [NCIt concept]
- Ispinesib [NCIt concept]
- Ispinesib Mesylate [NCIt concept]
- Israel [NCIt concept]
- Isthmus Uteri [NCIt concept]
- Istiratumab [NCIt concept]
- Itacitinib [NCIt concept]
- Itacitinib Adipate [NCIt concept]
- Itacnosertib [NCIt concept]
- Italy [NCIt concept]
- Itraconazole [NCIt concept]
- Itraconazole Dispersion In Polymer Matrix [NCIt concept]
- Ivaltinostat [NCIt concept]
- Ivarmacitinib [NCIt concept]
- Ivarmacitinib Sulfate [NCIt concept]
- Ivicentamab [NCIt concept]
- Ivonescimab [NCIt concept]
- Ivosidenib [NCIt concept]
- Ivospemin Hydrochloride [NCIt concept]
- Ivuxolimab [NCIt concept]
- Ixabepilone [NCIt concept]
- Ixazomib [NCIt concept]
- Ixazomib Citrate [NCIt concept]
- Izalontamab [NCIt concept]
- Izastobart [NCIt concept]
- Izeltabart Tapatansine [NCIt concept]
- Izorlisib [NCIt concept]
- JAK Inhibitor [NCIt concept]
- JAK Inhibitor INCB047986 [NCIt concept]
- JAK1 Gene [NCIt concept]
- JAK1 Inhibitor INCB052793 [NCIt concept]
- JAK2 Gene [NCIt concept]
- JAK2 Inhibitor AZD1480 [NCIt concept]
- JAK2 Inhibitor BMS-911543 [NCIt concept]
- JAK2 Inhibitor BS HH 002.SA [NCIt concept]
- JAK2 Inhibitor TQ05105 [NCIt concept]
- JAK2 Inhibitor XL019 [NCIt concept]
- JAK3 Gene [NCIt concept]
- JARID2 Gene [NCIt concept]
- JAZF1 Gene [NCIt concept]
- JNK Inhibitor CC-401 [NCIt concept]
- JNK1 Inhibitor BMS-986360 [NCIt concept]
- JPEG [NCIt concept]
- JPEG 2000 Format [NCIt concept]
- JSON Format [NCIt concept]
- JUN Gene [NCIt concept]
- Jamaica [NCIt concept]
- Japan [NCIt concept]
- Jaw Bone [NCIt concept]
- Jejunal Fistula, CTCAE [NCIt concept]
- Jejunal Hemorrhage, CTCAE [NCIt concept]
- Jejunal Obstruction, CTCAE [NCIt concept]
- Jejunal Perforation, CTCAE [NCIt concept]
- Jejunal Stenosis, CTCAE [NCIt concept]
- Jejunal Ulcer, CTCAE [NCIt concept]
- Jejunum [NCIt concept]
- Jersey [NCIt concept]
- Jianpi Huatan Decoction [NCIt concept]
- Jin Fu Kang [NCIt concept]
- Joint [NCIt concept]
- Joint Effusion, CTCAE 5.0 [NCIt concept]
- Joint Infection, CTCAE [NCIt concept]
- Joint Range of Motion Decreased Cervical Spine, CTCAE [NCIt concept]
- Joint Range of Motion Decreased Lumbar Spine, CTCAE [NCIt concept]
- Joint Range of Motion Decreased, CTCAE [NCIt concept]
- Joint Replacement [NCIt concept]
- Jordan [NCIt concept]
- Jugulotympanic Paraganglioma [NCIt concept]
- Junctional Nevus [NCIt concept]
- Juvenile Breast Fibroadenoma [NCIt concept]
- Juvenile Granulosa Cell Tumor [NCIt concept]
- Juvenile Myelomonocytic Leukemia [NCIt concept]
- Juxtaglomerular Cell Tumor [NCIt concept]
- KAT6 Inhibitor PF-07248144 [NCIt concept]
- KAT6A Gene [NCIt concept]
- KAT6B Gene [NCIt concept]
- KAT7 Gene [NCIt concept]
- KCNJ5 Gene [NCIt concept]
- KDM4 Inhibitor TACH101 [NCIt concept]
- KDM5A Gene [NCIt concept]
- KDM5C Gene [NCIt concept]
- KDM6A Gene [NCIt concept]
- KDR Gene [NCIt concept]
- KDSR Gene [NCIt concept]
- KEAP1 Gene [NCIt concept]
- KIAA1549 Gene [NCIt concept]
- KIF18A Inhibitor VLS-1488 [NCIt concept]
- KIF5B Gene [NCIt concept]
- KIT Gene [NCIt concept]
- KLF4 Gene [NCIt concept]
- KLF6 Gene [NCIt concept]
- KLK2 Gene [NCIt concept]
- KMT2A Gene [NCIt concept]
- KMT2C Gene [NCIt concept]
- KMT2D Gene [NCIt concept]
- KNL1 Gene [NCIt concept]
- KNSTRN Gene [NCIt concept]
- KRAS G12C Inhibitor BEBT-607 [NCIt concept]
- KRAS G12C Inhibitor BI 1823911 [NCIt concept]
- KRAS G12C Inhibitor BPI-421286 [NCIt concept]
- KRAS G12C Inhibitor D3S-001 [NCIt concept]
- KRAS G12C Inhibitor GEC255 [NCIt concept]
- KRAS G12C Inhibitor GH35 [NCIt concept]
- KRAS G12C Inhibitor HBI-2438 [NCIt concept]
- KRAS G12C Inhibitor HS-10370 [NCIt concept]
- KRAS G12C Inhibitor IBI351 [NCIt concept]
- KRAS G12C Inhibitor LY3499446 [NCIt concept]
- KRAS G12C Inhibitor RMC-6291 [NCIt concept]
- KRAS G12C Inhibitor YL-15293 [NCIt concept]
- KRAS G12D Degrader ASP3082 [NCIt concept]
- KRAS G12D Inhibitor HRS-4642 [NCIt concept]
- KRAS G12D Inhibitor MRTX1133 [NCIt concept]
- KRAS G12D Inhibitor RMC-9805 [NCIt concept]
- KRAS Gene [NCIt concept]
- KRAS Inhibitor BI 3706674 [NCIt concept]
- KRAS-G12C Inhibitor LY3537982 [NCIt concept]
- KRASG12C Inhibitor JNJ-74699157 [NCIt concept]
- KRN5500 [NCIt concept]
- KRT20 Gene [NCIt concept]
- KRT7 Gene [NCIt concept]
- KSP Inhibitor AZD4877 [NCIt concept]
- KSP Inhibitor SB-743921 [NCIt concept]
- KTN1 Gene [NCIt concept]
- Kallikrein Inhibitor MDPK67b [NCIt concept]
- Kanglaite [NCIt concept]
- Kanitinib [NCIt concept]
- Kaposi Sarcoma [NCIt concept]
- Kaposiform Hemangioendothelioma [NCIt concept]
- Karnofsky Performance Status [NCIt concept]
- Karnofsky Performance Status 0 [NCIt concept]
- Karnofsky Performance Status 10 [NCIt concept]
- Karnofsky Performance Status 100 [NCIt concept]
- Karnofsky Performance Status 20 [NCIt concept]
- Karnofsky Performance Status 30 [NCIt concept]
- Karnofsky Performance Status 40 [NCIt concept]
- Karnofsky Performance Status 50 [NCIt concept]
- Karnofsky Performance Status 60 [NCIt concept]
- Karnofsky Performance Status 70 [NCIt concept]
- Karnofsky Performance Status 80 [NCIt concept]
- Karnofsky Performance Status 90 [NCIt concept]
- Karyotyping [NCIt concept]
- Kazakhstan [NCIt concept]
- Kenya [NCIt concept]
- Keratinizing Dysplasia [NCIt concept]
- Keratinizing Squamous Cell Carcinoma [NCIt concept]
- Keratitis, CTCAE [NCIt concept]
- Kerosene Smoke Exposure [NCIt concept]
- Ketoconazole [NCIt concept]
- Ketotrexate [NCIt concept]
- Keyboard Operator [NCIt concept]
- Keynatinib [NCIt concept]
- Kidney [NCIt concept]
- Kidney Anastomotic Leak, CTCAE [NCIt concept]
- Kidney Carcinoma [NCIt concept]
- Kidney Disorder [NCIt concept]
- Kidney Infection, CTCAE [NCIt concept]
- Kidney Interpolar Region [NCIt concept]
- Kidney Medullary Carcinoma [NCIt concept]
- Kidney Wilms Tumor [NCIt concept]
- Kilogram per Cubic Meter [NCIt concept]
- Kinase Inhibitor TQB3912 [NCIt concept]
- Kinase Inhibitor UCT-01-097 [NCIt concept]
- Kinase Inhibitor UCT-03-008 [NCIt concept]
- Kiribati [NCIt concept]
- Knee Joint [NCIt concept]
- Korea, Democratic People's Republic of [NCIt concept]
- Korea, Republic of [NCIt concept]
- Kosovo [NCIt concept]
- Kras G12C Inhibitor MK-1084 [NCIt concept]
- Krukenberg Tumor [NCIt concept]
- Kunecatechins Ointment [NCIt concept]
- Kuwait [NCIt concept]
- Kyphosis, CTCAE [NCIt concept]
- Kyrgyzstan [NCIt concept]
- L-Gossypol [NCIt concept]
- L-methylfolate [NCIt concept]
- L1 Acute Lymphoblastic Leukemia [NCIt concept]
- L2 Acute Lymphoblastic Leukemia [NCIt concept]
- LAIR-2 Fusion Protein NC410 [NCIt concept]
- LARP4B Gene [NCIt concept]
- LASP1 Gene [NCIt concept]
- LCK Gene [NCIt concept]
- LCP1 Gene [NCIt concept]
- LEF1 Gene [NCIt concept]
- LHFPL6 Gene [NCIt concept]
- LIFR Gene [NCIt concept]
- LMB-1 Immunotoxin [NCIt concept]
- LMB-2 Immunotoxin [NCIt concept]
- LMB-7 Immunotoxin [NCIt concept]
- LMB-9 Immunotoxin [NCIt concept]
- LMNA Gene [NCIt concept]
- LMO1 Gene [NCIt concept]
- LMO2 Gene [NCIt concept]
- LMP-2:340-349 Peptide Vaccine [NCIt concept]
- LMP-2:419-427 Peptide Vaccine [NCIt concept]
- LMP2-specific IL-12 Secreting T Cell Receptor-transduced T-lymphocytes [NCIt concept]
- LMP2-specific T Cell Receptor-transduced Autologous T-lymphocytes [NCIt concept]
- LMP7 Inhibitor M3258 [NCIt concept]
- LPP Gene [NCIt concept]
- LRIG3 Gene [NCIt concept]
- LRP1B Gene [NCIt concept]
- LRP5 Antagonist BI 905681 [NCIt concept]
- LRP5/6 Antagonist BI 905677 [NCIt concept]
- LSD1 Inhibitor GSK2879552 [NCIt concept]
- LSD1 Inhibitor SYHA1807 [NCIt concept]
- LSD1 Inhibitor TAS1440 [NCIt concept]
- LSD1/HDAC6 Inhibitor JBI-802 [NCIt concept]
- LSM14A Gene [NCIt concept]
- LV.IL-2/B7.1-Transduced AML Blast Vaccine RFUSIN2-AML1 [NCIt concept]
- LYL1 Gene [NCIt concept]
- LZTR1 Gene [NCIt concept]
- Labetuzumab Govitecan [NCIt concept]
- Labium Majus [NCIt concept]
- Labium Minus [NCIt concept]
- Laboratory Procedure [NCIt concept]
- Laboratory Specimen Type [NCIt concept]
- Laboratory Test Result [NCIt concept]
- Lacrimal Gland [NCIt concept]
- Lactate Dehydrogenase Measurement [NCIt concept]
- Lactating Adenoma [NCIt concept]
- Lactation Disorder, CTCAE [NCIt concept]
- Lactotroph Pituitary Neuroendocrine Tumor [NCIt concept]
- Lacutamab [NCIt concept]
- Ladarixin [NCIt concept]
- Ladarixin Sodium [NCIt concept]
- Ladiratuzumab Vedotin [NCIt concept]
- Ladirubicin [NCIt concept]
- Laetrile [NCIt concept]
- Lancastotug [NCIt concept]
- Landogrozumab [NCIt concept]
- Langerhans Cell Histiocytosis [NCIt concept]
- Langerhans Cell Histiocytosis, Disseminated [NCIt concept]
- Langerhans Cell Histiocytosis, Monostotic [NCIt concept]
- Langerhans Cell Histiocytosis, Polyostotic [NCIt concept]
- Langerhans Cell Sarcoma [NCIt concept]
- Laniquidar [NCIt concept]
- Lanreotide Acetate [NCIt concept]
- Lao People's Democratic Republic [NCIt concept]
- Lapachone [NCIt concept]
- Laparoscopic Biopsy [NCIt concept]
- Laparoscopic Partial Nephrectomy [NCIt concept]
- Laparoscopic Radical Nephrectomy [NCIt concept]
- Laparoscopic Radical Prostatectomy [NCIt concept]
- Laparoscopic Radical Prostatectomy with Robotics [NCIt concept]
- Laparoscopy [NCIt concept]
- Laparotomy [NCIt concept]
- Lapatinib [NCIt concept]
- Lapatinib Ditosylate [NCIt concept]
- Laprituximab Emtansine [NCIt concept]
- Lapuleucel-T [NCIt concept]
- Large Cell Carcinoma [NCIt concept]
- Large Cell Medulloblastoma [NCIt concept]
- Large Cell Neuroendocrine Carcinoma [NCIt concept]
- Large Intestinal Anastomotic Leak, CTCAE [NCIt concept]
- Large Intestine [NCIt concept]
- Largest Diameter of Extrapelvic Peritoneal Metastasis [NCIt concept]
- Laromustine [NCIt concept]
- Larotaxel [NCIt concept]
- Larotinib Mesylate [NCIt concept]
- Larotrectinib [NCIt concept]
- Larotrectinib Sulfate [NCIt concept]
- Lartesertib [NCIt concept]
- Laryngeal Carcinoma [NCIt concept]
- Laryngeal Cartilage [NCIt concept]
- Laryngeal Edema, CTCAE [NCIt concept]
- Laryngeal Fistula, CTCAE [NCIt concept]
- Laryngeal Hemorrhage, CTCAE [NCIt concept]
- Laryngeal Inflammation, CTCAE [NCIt concept]
- Laryngeal Mucositis, CTCAE [NCIt concept]
- Laryngeal Obstruction, CTCAE [NCIt concept]
- Laryngeal Stenosis, CTCAE [NCIt concept]
- Laryngitis, CTCAE [NCIt concept]
- Laryngopharyngeal Dysesthesia, CTCAE [NCIt concept]
- Laryngopharyngectomy [NCIt concept]
- Laryngospasm, CTCAE [NCIt concept]
- Larynx [NCIt concept]
- Last Contact Event Occurrence Indicator [NCIt concept]
- Last Known Neoplastic Disease Extent Indicator [NCIt concept]
- Lateral Wall of the Bladder [NCIt concept]
- Lateral Wall of the Nasopharynx [NCIt concept]
- Lateral Wall of the Oropharynx [NCIt concept]
- Laterality [NCIt concept]
- Latikafusp [NCIt concept]
- Latvia [NCIt concept]
- Lavendustin A [NCIt concept]
- Lazertinib [NCIt concept]
- Lead Pb 212 DOTAMTATE [NCIt concept]
- Lead Pb 212 Pentixather [NCIt concept]
- Lead Pb 212 TCMC-trastuzumab [NCIt concept]
- Lead Pb 212 VMT-a-NET [NCIt concept]
- Lead Pb 212-DOTAM-GRPR1 [NCIt concept]
- Lead Pb 212-VMT01 [NCIt concept]
- Lebanon [NCIt concept]
- Lebrikizumab [NCIt concept]
- Lefitolimod [NCIt concept]
- Leflunomide [NCIt concept]
- Left [NCIt concept]
- Left Colectomy [NCIt concept]
- Left Fallopian Tube [NCIt concept]
- Left Ovary [NCIt concept]
- Left Ventricular Systolic Dysfunction, CTCAE 5.0 [NCIt concept]
- Leg [NCIt concept]
- Legacy Project [NCIt concept]
- Legacy Project Archive Indicator [NCIt concept]
- Legal Occupations [NCIt concept]
- Legal, Social and Religious Associate Professional [NCIt concept]
- Legislator and Senior Official [NCIt concept]
- Leiomyoma [NCIt concept]
- Leiomyomatosis [NCIt concept]
- Leiomyosarcoma [NCIt concept]
- Lemzoparlimab [NCIt concept]
- Lenalidomide [NCIt concept]
- Lenalidomide Analog KPG-121 [NCIt concept]
- Lenalidomide Prolonged-release Formulation NEX-20A [NCIt concept]
- Lentigo Maligna [NCIt concept]
- Lentigo Maligna Melanoma [NCIt concept]
- Lentinan [NCIt concept]
- Lenumlostat [NCIt concept]
- Lenvatinib [NCIt concept]
- Lenvatinib Mesylate [NCIt concept]
- Lenzilumab [NCIt concept]
- Lepidic Adenocarcinoma [NCIt concept]
- Leptomeningeal Sarcoma [NCIt concept]
- Leptomeninges [NCIt concept]
- Lerociclib [NCIt concept]
- Lesion with Diameter Greater than 2 cm [NCIt concept]
- Lesion with Diameter Greater than 20 mm [NCIt concept]
- Lesion with Diameter at Least 1 mm and at Most 10 mm [NCIt concept]
- Lesion with Diameter at Least 11 mm and at Most 20 mm [NCIt concept]
- Lesion with Diameter of 2 cm or Less [NCIt concept]
- Lesotho [NCIt concept]
- Lesser Curvature of the Stomach [NCIt concept]
- Lestaurtinib [NCIt concept]
- Letaplimab [NCIt concept]
- Letetresgene Autoleucel [NCIt concept]
- Lethargy, CTCAE [NCIt concept]
- Letolizumab [NCIt concept]
- Letrozole [NCIt concept]
- Letterer-Siwe Disease [NCIt concept]
- Leucovorin [NCIt concept]
- Leucovorin Calcium [NCIt concept]
- Leukemia [NCIt concept]
- Leukemia Secondary To Oncology Chemotherapy, CTCAE [NCIt concept]
- Leukocyte [NCIt concept]
- Leukocyte Count [NCIt concept]
- Leukocytosis, CTCAE [NCIt concept]
- Leukoencephalopathy, CTCAE [NCIt concept]
- Leukosialin [NCIt concept]
- Leuprolide [NCIt concept]
- Leuprolide Acetate [NCIt concept]
- Leuprolide Acetate Sustained-release Microspheres PT105 [NCIt concept]
- Leuprolide Acetate for Injectable Suspension TOL2506 [NCIt concept]
- Leuprolide Mesylate [NCIt concept]
- Leuprolide Mesylate Injectable Suspension [NCIt concept]
- Leurubicin [NCIt concept]
- Levetiracetam [NCIt concept]
- Levoleucovorin Calcium [NCIt concept]
- Levothyroxine [NCIt concept]
- Levothyroxine Sodium [NCIt concept]
- Lexatumumab [NCIt concept]
- Lexibulin [NCIt concept]
- Leydig Cell Tumor [NCIt concept]
- Li-Fraumeni Syndrome [NCIt concept]
- Liarozole [NCIt concept]
- Liarozole Fumarate [NCIt concept]
- Liarozole Hydrochloride [NCIt concept]
- Liberia [NCIt concept]
- Libido Decreased, CTCAE [NCIt concept]
- Libido Increased, CTCAE [NCIt concept]
- Librarians, Curators, and Archivists [NCIt concept]
- Library Sequencing [NCIt concept]
- Library Strand Sequenced [NCIt concept]
- Libya [NCIt concept]
- Licartin [NCIt concept]
- Licorice [NCIt concept]
- Liechtenstein [NCIt concept]
- Lifastuzumab Vedotin [NCIt concept]
- Life Science Technician and Related Associate Professional [NCIt concept]
- Life Scientists [NCIt concept]
- Life Threatening Adverse Event [NCIt concept]
- Lifelong Non-Drinker [NCIt concept]
- Lifileucel [NCIt concept]
- Lifirafenib [NCIt concept]
- Ligament [NCIt concept]
- Ligand Directed Degrader BMS-986460 [NCIt concept]
- Light Chain Deposition Disease [NCIt concept]
- Ligufalimab [NCIt concept]
- Likely Pathogenic Variant [NCIt concept]
- Lilotomab [NCIt concept]
- Limantrafin [NCIt concept]
- Limb Skeletal System [NCIt concept]
- Limonene, (+)- [NCIt concept]
- Limonene, (+/-)- [NCIt concept]
- Linagliptin [NCIt concept]
- Linavonkibart [NCIt concept]
- Lingual Tonsil [NCIt concept]
- Linifanib [NCIt concept]
- Linitis Plastica [NCIt concept]
- Linoleyl Carbonate-Paclitaxel [NCIt concept]
- Linperlisib [NCIt concept]
- Linrodostat [NCIt concept]
- Linsitinib [NCIt concept]
- Lintuzumab [NCIt concept]
- Linvoseltamab [NCIt concept]
- Liothyronine I-131 [NCIt concept]
- Liothyronine Sodium [NCIt concept]
- Lip [NCIt concept]
- Lip Infection, CTCAE [NCIt concept]
- Lip Pain, CTCAE 5.0 [NCIt concept]
- Lipase Increased, CTCAE [NCIt concept]
- Lipid Encapsulated Anti-PLK1 siRNA TKM-PLK1 [NCIt concept]
- Lipid Nanoparticle Encapsulated MYC-targeting mRNA-based Agent OTX-2002 [NCIt concept]
- Lipid Nanoparticle Encapsulated OX40L mRNA-2416 [NCIt concept]
- Lipid Nanoparticle Encapsulated Self-replicating RNA Encoding Human IL-12 JCXH-211 [NCIt concept]
- Lipid Nanoparticle Encapsulated mRNA Encoding Human Single-chain IL-12 ABO2011 [NCIt concept]
- Lipid Nanoparticle Encapsulated mRNAs Encoding Human IL-12A/IL-12B MEDI-1191 [NCIt concept]
- Lipid Nanoparticle Encapsulating Glutathione S-transferase P siRNA NBF-006 [NCIt concept]
- Lipid Nanoparticle Encapsulating mRNAs Encoding Human OX40L/IL-23/IL-36gamma mRNA-2752 [NCIt concept]
- Lipid Nanoparticle-encapsulated EBV mRNA Vaccine mRNA-1189 [NCIt concept]
- Lipid-Rich Carcinoma [NCIt concept]
- Lipoadenoma [NCIt concept]
- Lipoblastoma [NCIt concept]
- Lipoblastomatosis [NCIt concept]
- Lipohypertrophy, CTCAE [NCIt concept]
- Lipoma [NCIt concept]
- Lipoma-Like Atypical Lipomatous Tumor/Well Differentiated Liposarcoma [NCIt concept]
- Lipomatous Neoplasm [NCIt concept]
- Liposarcoma [NCIt concept]
- Liposomal Bcl-2 Antisense Oligonucleotide BP1002 [NCIt concept]
- Liposomal Curcumin [NCIt concept]
- Liposomal Cytarabine [NCIt concept]
- Liposomal Daunorubicin Citrate [NCIt concept]
- Liposomal Docetaxel [NCIt concept]
- Liposomal Eribulin Mesylate [NCIt concept]
- Liposomal HPV-16 E6/E7 Multipeptide Vaccine PDS0101 [NCIt concept]
- Liposomal MUC1/PET-lipid A Vaccine ONT-10 [NCIt concept]
- Liposomal Mitoxantrone Hydrochloride [NCIt concept]
- Liposomal NDDP [NCIt concept]
- Liposomal Rhenium Re 186 [NCIt concept]
- Liposomal SN-38 [NCIt concept]
- Liposomal Topotecan FF-10850 [NCIt concept]
- Liposomal Vinorelbine [NCIt concept]
- Liposomal Vinorelbine Tartrate [NCIt concept]
- Liposomal c-raf Antisense Oligonucleotide [NCIt concept]
- Liposomal iNKT Agonist PORT-2 [NCIt concept]
- Liposome [NCIt concept]
- Liposome-Encapsulated Doxorubicin Citrate [NCIt concept]
- Liposome-encapsulated Daunorubicin-Cytarabine [NCIt concept]
- Liposome-encapsulated OSI-7904 [NCIt concept]
- Liposome-encapsulated RB94 Plasmid DNA Gene Therapy Agent SGT-94 [NCIt concept]
- Liposome-encapsulated TAAs mRNA Vaccine W_ova1 [NCIt concept]
- Liposome-encapsulated miR-34 Mimic MRX34 [NCIt concept]
- Lipustobart [NCIt concept]
- Liquid Biopsy [NCIt concept]
- Liquid Tumor [NCIt concept]
- Liquor [NCIt concept]
- Lirafugratinib [NCIt concept]
- Lirametostat [NCIt concept]
- Lirentelimab [NCIt concept]
- Lirilumab [NCIt concept]
- Lisaftoclax [NCIt concept]
- Lisavanbulin [NCIt concept]
- Lisocabtagene Maraleucel [NCIt concept]
- Listeria monocytogenes-LLO-PSA Vaccine ADXS31-142 [NCIt concept]
- Listeria monocytogenes-LLO-Prostate Cancer Neoantigens Vaccine ADXS-504 [NCIt concept]
- Lithuania [NCIt concept]
- Litronesib [NCIt concept]
- Live Birth [NCIt concept]
- Live-Attenuated Listeria Encoding Human Mesothelin Vaccine CRS-207 [NCIt concept]
- Live-attenuated Listeria monocytogenes-encoding EGFRvIII-NY-ESO-1 Vaccine ADU-623 [NCIt concept]
- Liver [NCIt concept]
- Liver Angiosarcoma [NCIt concept]
- Liver Cancer Neoantigens-sensitized Autoimmune Cells IPM001 [NCIt concept]
- Liver Embryonal Sarcoma [NCIt concept]
- Liver Involvement [NCIt concept]
- Liver and Intrahepatic Bile Duct Carcinoma [NCIt concept]
- Livmoniplimab [NCIt concept]
- Lixumistat Acetate [NCIt concept]
- Lm-tLLO-neoantigens Vaccine ADXS-NEO [NCIt concept]
- LmddA-LLO-chHER2 Fusion Protein-secreting Live-attenuated Listeria Cancer Vaccine OST31-164 [NCIt concept]
- Lobaplatin [NCIt concept]
- Lobectomy [NCIt concept]
- Local-Regional [NCIt concept]
- Localized Disease [NCIt concept]
- Localized Edema, CTCAE [NCIt concept]
- Localized Neoplasm [NCIt concept]
- Locally Advanced Malignant Neoplasm [NCIt concept]
- Locally-acting Temozolomide Formulation SI-053 [NCIt concept]
- Locnartecan [NCIt concept]
- Locomotive Engine Driver and Related Worker [NCIt concept]
- Lodapolimab [NCIt concept]
- Lometrexol [NCIt concept]
- Lometrexol Sodium [NCIt concept]
- Lomustine [NCIt concept]
- Lomvastomig [NCIt concept]
- Lonafarnib [NCIt concept]
- Loncastuximab Tesirine [NCIt concept]
- Long Arm of Chromosome [NCIt concept]
- Long PD-L1 Peptide Vaccine [NCIt concept]
- Long Peptide Vaccine 7 [NCIt concept]
- Long-acting Recombinant Erwinia asparaginase JZP-341 [NCIt concept]
- Long-acting Release Pasireotide [NCIt concept]
- Longest Diameter [NCIt concept]
- Longest Duration of First Symptom Related to Diagnosis [NCIt concept]
- Lontucirev [NCIt concept]
- Lordosis, CTCAE [NCIt concept]
- Lorigerlimab [NCIt concept]
- Lorlatinib [NCIt concept]
- Lorukafusp alfa [NCIt concept]
- Lorvotuzumab Mertansine [NCIt concept]
- Losatuxizumab Vedotin [NCIt concept]
- Losoxantrone [NCIt concept]
- Losoxantrone Hydrochloride [NCIt concept]
- Loss [NCIt concept]
- Lost To Follow-Up [NCIt concept]
- Lovastatin [NCIt concept]
- Low [NCIt concept]
- Low Affinity Immunoglobulin Epsilon Fc Receptor [NCIt concept]
- Low Anterior Resection [NCIt concept]
- Low Grade [NCIt concept]
- Low Grade Appendix Mucinous Neoplasm [NCIt concept]
- Low Grade Biliary Intraepithelial Neoplasia [NCIt concept]
- Low Grade Breast Adenosquamous Carcinoma [NCIt concept]
- Low Grade Central Osteosarcoma [NCIt concept]
- Low Grade Cervical Intraepithelial Neoplasia [NCIt concept]
- Low Grade Dysplasia [NCIt concept]
- Low Grade Endometrioid Stromal Sarcoma [NCIt concept]
- Low Grade Esophageal Glandular Intraepithelial Neoplasia [NCIt concept]
- Low Grade Esophageal Squamous Intraepithelial Neoplasia [NCIt concept]
- Low Grade Fibromyxoid Sarcoma [NCIt concept]
- Low Grade Glandular Intraepithelial Neoplasia [NCIt concept]
- Low Grade Glioma [NCIt concept]
- Low Grade Liver Dysplastic Nodule [NCIt concept]
- Low Grade Myofibroblastic Sarcoma [NCIt concept]
- Low Grade Squamous Intraepithelial Neoplasia [NCIt concept]
- Low Risk [NCIt concept]
- Low-CSD Melanoma [NCIt concept]
- Low-Dose Rate Brachytherapy [NCIt concept]
- Low-Pass Whole Genome Sequencing [NCIt concept]
- Lower Extremity [NCIt concept]
- Lower Gastrointestinal Hemorrhage, CTCAE [NCIt concept]
- Lower Gingiva [NCIt concept]
- Lower Lobe of the Lung [NCIt concept]
- Lower Pole of Kidney [NCIt concept]
- Lower Third of the Esophagus [NCIt concept]
- Lower-Inner Quadrant of the Breast [NCIt concept]
- Lower-Outer Quadrant of the Breast [NCIt concept]
- Lucanthone [NCIt concept]
- Lucatumumab [NCIt concept]
- Lucicebtide [NCIt concept]
- Lucitanib [NCIt concept]
- Lumbar Spine [NCIt concept]
- Luminespib [NCIt concept]
- Luminespib Mesylate [NCIt concept]
- Lumpectomy [NCIt concept]
- Lumretuzumab [NCIt concept]
- Lumrotatug [NCIt concept]
- Lung [NCIt concept]
- Lung Adenocarcinoma [NCIt concept]
- Lung Adenocarcinoma, Mixed Subtype [NCIt concept]
- Lung Carcinoma [NCIt concept]
- Lung Fetal Adenocarcinoma [NCIt concept]
- Lung Infection, CTCAE [NCIt concept]
- Lung Inflammatory Myofibroblastic Tumor [NCIt concept]
- Lung Involvement [NCIt concept]
- Lung Large Cell Carcinoma with Rhabdoid Phenotype [NCIt concept]
- Lung Micropapillary Adenocarcinoma [NCIt concept]
- Lung Mucinous Adenocarcinoma In Situ [NCIt concept]
- Lung Mucosa-Associated Lymphoid Tissue Lymphoma [NCIt concept]
- Lung Non-Mucinous Adenocarcinoma In Situ [NCIt concept]
- Lung Papillary Adenoma [NCIt concept]
- Lung Squamous Cell Carcinoma [NCIt concept]
- Lung-targeted Immunomodulator QBKPN [NCIt concept]
- Lung/Bronchus [NCIt concept]
- Lunresertib [NCIt concept]
- Lupartumab Amadotin [NCIt concept]
- Lupus Erythematosus [NCIt concept]
- Lurbinectedin [NCIt concept]
- Lurtotecan [NCIt concept]
- Lurtotecan Liposome [NCIt concept]
- Luteinizing Hormone Measurement [NCIt concept]
- Lutetium Lu 177 AB-3PRGD2 [NCIt concept]
- Lutetium Lu 177 Anti-CA19-9 Monoclonal Antibody 5B1 [NCIt concept]
- Lutetium Lu 177 DOTA-N3-CTT1403 [NCIt concept]
- Lutetium Lu 177 DOTA-Tetulomab [NCIt concept]
- Lutetium Lu 177 DOTA-biotin [NCIt concept]
- Lutetium Lu 177 Dotatate [NCIt concept]
- Lutetium Lu 177 EB-PSMA-617 [NCIt concept]
- Lutetium Lu 177 LNC1004 [NCIt concept]
- Lutetium Lu 177 Lilotomab-satetraxetan [NCIt concept]
- Lutetium Lu 177 Ludotadipep [NCIt concept]
- Lutetium Lu 177 Monoclonal Antibody CC49 [NCIt concept]
- Lutetium Lu 177 PP-F11N [NCIt concept]
- Lutetium Lu 177 PSMA-10.1 [NCIt concept]
- Lutetium Lu 177 PSMA-EB-01 [NCIt concept]
- Lutetium Lu 177 Rosopatamab Tetraxetan [NCIt concept]
- Lutetium Lu 177 Satoreotide Tetraxetan [NCIt concept]
- Lutetium Lu 177 Vipivotide Tetraxetan [NCIt concept]
- Lutetium Lu 177-DOTA-EB-TATE [NCIt concept]
- Lutetium Lu 177-DTPA-omburtamab [NCIt concept]
- Lutetium Lu 177-EB-LM3 [NCIt concept]
- Lutetium Lu 177-Edotreotide [NCIt concept]
- Lutetium Lu 177-NeoB [NCIt concept]
- Lutetium Lu 177-PNT6555 [NCIt concept]
- Lutetium Lu 177-PSMA-I&T [NCIt concept]
- Lutetium Lu-177 Capromab [NCIt concept]
- Lutetium Lu-177 Girentuximab [NCIt concept]
- Lutetium Lu-177 PNT2002 [NCIt concept]
- Lutetium Lu-177 PSMA-R2 [NCIt concept]
- Lutetium Lu-177 Rituximab [NCIt concept]
- Luveltamab Tazevibulin [NCIt concept]
- Luvixasertib [NCIt concept]
- Luxdegalutamide [NCIt concept]
- Luxembourg [NCIt concept]
- Luxeptinib [NCIt concept]
- Lymph Gland Infection, CTCAE [NCIt concept]
- Lymph Leakage, CTCAE [NCIt concept]
- Lymph Node [NCIt concept]
- Lymph Node Dissection Site [NCIt concept]
- Lymph Node Dissection Type [NCIt concept]
- Lymph Node Involvement [NCIt concept]
- Lymph Node Pain, CTCAE 5.0 [NCIt concept]
- Lymph Node by Anatomic Site [NCIt concept]
- Lymph Node of Inguinal Region or Leg [NCIt concept]
- Lymphadenectomy [NCIt concept]
- Lymphangioleiomyoma [NCIt concept]
- Lymphangioleiomyomatosis [NCIt concept]
- Lymphangioma [NCIt concept]
- Lymphangiosarcoma [NCIt concept]
- Lymphatic Vessel Neoplasm [NCIt concept]
- Lymphedema, CTCAE [NCIt concept]
- Lymphoblast Count [NCIt concept]
- Lymphoblastic Lymphoma [NCIt concept]
- Lymphocele, CTCAE [NCIt concept]
- Lymphocyte [NCIt concept]
- Lymphocyte Count [NCIt concept]
- Lymphocyte Count Decreased, CTCAE [NCIt concept]
- Lymphocyte Count Increased, CTCAE [NCIt concept]
- Lymphocyte Predominant Type Hodgkin's Disease [NCIt concept]
- Lymphocyte-Depleted Classic Hodgkin Lymphoma [NCIt concept]
- Lymphocyte-Rich Classic Hodgkin Lymphoma [NCIt concept]
- Lymphocytic Meningitis [NCIt concept]
- Lymphocytic Thyroiditis [NCIt concept]
- Lymphoepithelioid Variant Peripheral T-Cell Lymphoma, Not Otherwise Specified [NCIt concept]
- Lymphoid Hyperplasia [NCIt concept]
- Lymphoid Leukemia [NCIt concept]
- Lymphoid Tissue [NCIt concept]
- Lymphoma [NCIt concept]
- Lymphomatoid Granulomatosis [NCIt concept]
- Lymphomatoid Papulosis [NCIt concept]
- Lymphoplasmacyte-Rich Meningioma [NCIt concept]
- Lymphoplasmacytic Lymphoma [NCIt concept]
- Lymphoproliferative Disorder [NCIt concept]
- Lymphosarcoma [NCIt concept]
- Lynch Syndrome [NCIt concept]
- Lyophilized Black Raspberry Lozenge [NCIt concept]
- Lyophilized Black Raspberry Saliva Substitute [NCIt concept]
- Lyophilized Human Recombinant Interferon-beta 1a FP-1201 [NCIt concept]
- Lyophilized Inactivated Group A Streptococcus TARA-002 [NCIt concept]
- Lysine-specific Demethylase 1 Inhibitor INCB059872 [NCIt concept]
- Lyso-Thermosensitive Liposome Doxorubicin [NCIt concept]
- M0 TNM Finding [NCIt concept]
- M1 TNM Finding [NCIt concept]
- M1a TNM Finding [NCIt concept]
- M1b TNM Finding [NCIt concept]
- M1c TNM Finding [NCIt concept]
- M1d TNM Finding [NCIt concept]
- MAF Gene [NCIt concept]
- MAFB Gene [NCIt concept]
- MAGE-10.A2 [NCIt concept]
- MAGE-A1-specific T Cell Receptor-transduced Autologous T-cells [NCIt concept]
- MAGE-A3 Peptide Vaccine [NCIt concept]
- MAGE-A3-specific Immunotherapeutic GSK 2132231A [NCIt concept]
- MAGE-A4-specific TCR Gene-transduced Autologous T Lymphocytes TBI-1201 [NCIt concept]
- MAGE-TAB [NCIt concept]
- MALAT1 Gene [NCIt concept]
- MALT1 Gene [NCIt concept]
- MALT1 Inhibitor ABBV-525 [NCIt concept]
- MALT1 Inhibitor MPT-0118 [NCIt concept]
- MALT1 Inhibitor ONO-7018 [NCIt concept]
- MALT1 Inhibitor SGR-1505 [NCIt concept]
- MAML2 Gene [NCIt concept]
- MAML3 Gene [NCIt concept]
- MAP2K1 Gene [NCIt concept]
- MAP2K2 Gene [NCIt concept]
- MAP2K4 Gene [NCIt concept]
- MAP3K1 Gene [NCIt concept]
- MAP3K13 Gene [NCIt concept]
- MAPK1 Gene [NCIt concept]
- MARCKS Protein Inhibitor BIO-11006 [NCIt concept]
- MAT2A Inhibitor AG-270 [NCIt concept]
- MAT2A Inhibitor IDE397 [NCIt concept]
- MAX Gene [NCIt concept]
- MB21D2 Gene [NCIt concept]
- MCL-1 Inhibitor ABBV-467 [NCIt concept]
- MCL1 Inhibitor GS-9716 [NCIt concept]
- MCPyV-LT-encoding Plasmid DNA Vaccine ITI-3000 [NCIt concept]
- MDM2 Antagonist ASTX295 [NCIt concept]
- MDM2 Antagonist RO5045337 [NCIt concept]
- MDM2 Antagonist RO6839921 [NCIt concept]
- MDM2 Degrader KT-253 [NCIt concept]
- MDM2 Gene [NCIt concept]
- MDM2 Inhibitor AMGMDS3 [NCIt concept]
- MDM4 Gene [NCIt concept]
- MDR Modulator CBT-1 [NCIt concept]
- MDS2 Gene [NCIt concept]
- MECOM Gene [NCIt concept]
- MED12 Gene [NCIt concept]
- MEK 1/2 Inhibitor AS703988/MSC2015103B [NCIt concept]
- MEK 1/2 Inhibitor FCN-159 [NCIt concept]
- MEK Inhibitor AZD8330 [NCIt concept]
- MEK Inhibitor CI-1040 [NCIt concept]
- MEK Inhibitor GDC-0623 [NCIt concept]
- MEK Inhibitor IMM-1-104 [NCIt concept]
- MEK Inhibitor PF-07799544 [NCIt concept]
- MEK Inhibitor REC-4881 [NCIt concept]
- MEK Inhibitor RO4987655 [NCIt concept]
- MEK Inhibitor SHR 7390 [NCIt concept]
- MEK Inhibitor WX-554 [NCIt concept]
- MEK inhibitor BI 3011441 [NCIt concept]
- MEK inhibitor CS3006 [NCIt concept]
- MEK-1/MEKK-1 Inhibitor E6201 [NCIt concept]
- MEK/Aurora Kinase Inhibitor BI 847325 [NCIt concept]
- MEK1/2 Inhibitor ABM-168 [NCIt concept]
- MELK Inhibitor OTS167 [NCIt concept]
- MEN1 Gene [NCIt concept]
- MET Gene [NCIt concept]
- MET Kinase Inhibitor OMO-1 [NCIt concept]
- MET Tyrosine Kinase Inhibitor BMS-777607 [NCIt concept]
- MET Tyrosine Kinase Inhibitor EMD 1204831 [NCIt concept]
- MET Tyrosine Kinase Inhibitor PF-04217903 [NCIt concept]
- MET Tyrosine Kinase Inhibitor SAR125844 [NCIt concept]
- MET Tyrosine Kinase Inhibitor SGX523 [NCIt concept]
- METTL-3 Inhibitor STC-15 [NCIt concept]
- MEX Format [NCIt concept]
- MGMT Gene [NCIt concept]
- MIB1 Gene [NCIt concept]
- MITF Gene [NCIt concept]
- MK0731 [NCIt concept]
- MK2 Inhibitor ATI-2231 [NCIt concept]
- MKC-1 [NCIt concept]
- MKNK1 Inhibitor BAY 1143269 [NCIt concept]
- MLF1 Gene [NCIt concept]
- MLH1 Gene [NCIt concept]
- MLLT1 Gene [NCIt concept]
- MLLT10 Gene [NCIt concept]
- MLLT11 Gene [NCIt concept]
- MLLT3 Gene [NCIt concept]
- MLLT6 Gene [NCIt concept]
- MMP Inhibitor S-3304 [NCIt concept]
- MN1 Gene [NCIt concept]
- MNX1 Gene [NCIt concept]
- MOF Compound RiMO-301 [NCIt concept]
- MOv-gamma Chimeric Receptor Gene [NCIt concept]
- MPL Gene [NCIt concept]
- MPS1 Kinase Inhibitor NMS-01940153E [NCIt concept]
- MRTFA Gene [NCIt concept]
- MSH2 Gene [NCIt concept]
- MSH6 Gene [NCIt concept]
- MSI2 Gene [NCIt concept]
- MSN Gene [NCIt concept]
- MTCP1 Gene [NCIt concept]
- MTF-1 Inhibitor APTO-253 HCl [NCIt concept]
- MTOR Gene [NCIt concept]
- MUC-1/WT1 Peptide-primed Autologous Dendritic Cells [NCIt concept]
- MUC1 Gene [NCIt concept]
- MUC1-targeted Peptide GO-203-2C [NCIt concept]
- MUC16 Gene [NCIt concept]
- MUC4 Gene [NCIt concept]
- MUTYH Gene [NCIt concept]
- MVA Tumor-specific Neoantigen Boosting Vaccine MVA-209-FSP [NCIt concept]
- MVA-BN Smallpox Vaccine [NCIt concept]
- MVA-FCU1 TG4023 [NCIt concept]
- MVA-PSA/PAP/STEAP1/5T4 Prostate Cancer Vaccine MVA-PCAQ [NCIt concept]
- MVX-1-loaded Macrocapsule/autologous Tumor Cell Vaccine MVX-ONCO-1 [NCIt concept]
- MX TNM Finding [NCIt concept]
- MYB Gene [NCIt concept]
- MYC Gene [NCIt concept]
- MYC-targeting siRNA DCR-MYC [NCIt concept]
- MYCL Gene [NCIt concept]
- MYCN Gene [NCIt concept]
- MYD88 Gene [NCIt concept]
- MYH11 Gene [NCIt concept]
- MYH9 Gene [NCIt concept]
- MYO5A Gene [NCIt concept]
- MYOD1 Gene [NCIt concept]
- Maackia amurensis Seed Lectin [NCIt concept]
- Macau [NCIt concept]
- Machine Smoke Exposure [NCIt concept]
- Machinery Mechanics and Repairer [NCIt concept]
- Macimorelin [NCIt concept]
- Macitentan [NCIt concept]
- Macrocycle-bridged STING Agonist E7766 [NCIt concept]
- Macroscopic Disease Negative [NCIt concept]
- Macroscopically Positive Parametrial Margin [NCIt concept]
- Madagascar [NCIt concept]
- Maekmoondong-tang [NCIt concept]
- Mafosfamide [NCIt concept]
- Magnesium Valproate [NCIt concept]
- Magnetic Resonance Imaging [NCIt concept]
- Magrolimab [NCIt concept]
- Main Bronchus [NCIt concept]
- Maintenance Therapy [NCIt concept]
- Malabsorption, CTCAE [NCIt concept]
- Malaise, CTCAE [NCIt concept]
- Malaria [NCIt concept]
- Malawi [NCIt concept]
- Malaysia [NCIt concept]
- Maldives [NCIt concept]
- Male [NCIt concept]
- Male Cousin [NCIt concept]
- Male Genitalia [NCIt concept]
- Male Prepuce [NCIt concept]
- Male Sibling of Adopted Child [NCIt concept]
- Mali [NCIt concept]
- Malignancy in Giant Cell Tumor of Bone [NCIt concept]
- Malignant [NCIt concept]
- Malignant Adrenal Cortical Neoplasm [NCIt concept]
- Malignant Adrenal Gland Neoplasm [NCIt concept]
- Malignant Bone Neoplasm [NCIt concept]
- Malignant Brain Neoplasm [NCIt concept]
- Malignant Breast Adenomyoepithelioma [NCIt concept]
- Malignant Cell [NCIt concept]
- Malignant Central Nervous System Neoplasm [NCIt concept]
- Malignant Enteroglucagonoma [NCIt concept]
- Malignant Female Reproductive System Neoplasm [NCIt concept]
- Malignant Gastrinoma [NCIt concept]
- Malignant Gastrointestinal Stromal Tumor [NCIt concept]
- Malignant Giant Cell Neoplasm [NCIt concept]
- Malignant Glioma [NCIt concept]
- Malignant Glomus Tumor [NCIt concept]
- Malignant Granular Cell Tumor [NCIt concept]
- Malignant Granulosa Cell Tumor [NCIt concept]
- Malignant Head and Neck Neoplasm [NCIt concept]
- Malignant Hemangiopericytoma [NCIt concept]
- Malignant Histiocytosis [NCIt concept]
- Malignant Leydig Cell Tumor [NCIt concept]
- Malignant Lymph Node Neoplasm [NCIt concept]
- Malignant Lymphoma Centroblastic, Follicular [NCIt concept]
- Malignant Lymphoma, Convoluted [NCIt concept]
- Malignant Lymphoma, Histiocytic, Diffuse [NCIt concept]
- Malignant Lymphoma, Large Cell Type [NCIt concept]
- Malignant Lymphoma, Large Cell, Cleaved [NCIt concept]
- Malignant Lymphoma, Non-Cleaved Cell Type [NCIt concept]
- Malignant Lymphoma, Non-Cleaved, Diffuse [NCIt concept]
- Malignant Mastocytosis [NCIt concept]
- Malignant Mediastinal Germ Cell Tumor with Associated Hematologic Malignancy [NCIt concept]
- Malignant Melanoma in Precancerous Melanosis [NCIt concept]
- Malignant Melanotic Peripheral Nerve Sheath Tumor [NCIt concept]
- Malignant Melanotic Psammomatous Peripheral Nerve Sheath Tumor [NCIt concept]
- Malignant Mesenchymoma [NCIt concept]
- Malignant Mesothelioma [NCIt concept]
- Malignant Mixed Mesodermal (Mullerian) Tumor [NCIt concept]
- Malignant Mixed Neoplasm [NCIt concept]
- Malignant Mixed Tumor of the Salivary Gland [NCIt concept]
- Malignant Muscle Neoplasm [NCIt concept]
- Malignant Myoepithelioma [NCIt concept]
- Malignant Neoplasm [NCIt concept]
- Malignant Neoplasm, Uncertain Whether Primary or Metastatic [NCIt concept]
- Malignant Odontogenic Neoplasm [NCIt concept]
- Malignant Ossifying Fibromyxoid Tumor [NCIt concept]
- Malignant Ovarian Brenner Tumor [NCIt concept]
- Malignant Ovarian Clear Cell Tumor [NCIt concept]
- Malignant Ovarian Neoplasm [NCIt concept]
- Malignant Ovarian Steroid Cell Tumor [NCIt concept]
- Malignant Ovarian Thecoma [NCIt concept]
- Malignant PEComa [NCIt concept]
- Malignant Pancreatic Glucagonoma [NCIt concept]
- Malignant Pancreatic Insulinoma [NCIt concept]
- Malignant Pericytic Neoplasm [NCIt concept]
- Malignant Peripheral Nerve Sheath Tumor [NCIt concept]
- Malignant Peripheral Nerve Sheath Tumor with Perineurial Differentiation [NCIt concept]
- Malignant Phosphaturic Mesenchymal Tumor [NCIt concept]
- Malignant Phyllodes Tumor [NCIt concept]
- Malignant Sertoli Cell Tumor [NCIt concept]
- Malignant Skin Neoplasm [NCIt concept]
- Malignant Soft Tissue Neoplasm [NCIt concept]
- Malignant Solitary Fibrous Tumor [NCIt concept]
- Malignant Somatostatinoma [NCIt concept]
- Malignant Spindle Cell Neoplasm [NCIt concept]
- Malignant Splenic Neoplasm [NCIt concept]
- Malignant Sweat Gland Neoplasm [NCIt concept]
- Malignant Tenosynovial Giant Cell Tumor [NCIt concept]
- Malignant Teratoma [NCIt concept]
- Malignant Testicular Germ Cell Tumor [NCIt concept]
- Malignant Thymoma [NCIt concept]
- Malignant Triton Tumor [NCIt concept]
- Malignant Trophoblastic Teratoma [NCIt concept]
- Malignant Tumor, Small Cell Type [NCIt concept]
- Malignant Type A Thymoma [NCIt concept]
- Malignant Type AB Thymoma [NCIt concept]
- Malignant Type B1 Thymoma [NCIt concept]
- Malignant Type B2 Thymoma [NCIt concept]
- Malignant Uterine Neoplasm [NCIt concept]
- Malignant Vipoma [NCIt concept]
- Malta [NCIt concept]
- Managing Director and Chief Executive [NCIt concept]
- Mandible [NCIt concept]
- Mandibulectomy [NCIt concept]
- Manelimab [NCIt concept]
- Mania, CTCAE [NCIt concept]
- Mannosulfan [NCIt concept]
- Mannosylerythritol Lipid [NCIt concept]
- Mantle Cell Lymphoma [NCIt concept]
- Mantle Field [NCIt concept]
- Manufacturer [NCIt concept]
- Manufacturing, Mining, Construction and Distribution Manager [NCIt concept]
- Many [NCIt concept]
- Mapatumumab [NCIt concept]
- Maplirpacept [NCIt concept]
- Maraba Oncolytic Virus Expressing Mutant HPV E6/E7 [NCIt concept]
- Marcellomycin [NCIt concept]
- Margetuximab [NCIt concept]
- Marginal Zone Lymphoma [NCIt concept]
- Marijuana [NCIt concept]
- Marijuana Smoke Exposure [NCIt concept]
- Marimastat [NCIt concept]
- Marital Status [NCIt concept]
- Marizomib [NCIt concept]
- Market Gardener and Crop Grower [NCIt concept]
- Married [NCIt concept]
- Marshall Islands [NCIt concept]
- Martinique [NCIt concept]
- Masaoka-Koga Stage [NCIt concept]
- Masaoka-Koga Stage I [NCIt concept]
- Masaoka-Koga Stage III [NCIt concept]
- Masaoka-Koga Stage IIa [NCIt concept]
- Masaoka-Koga Stage IIb [NCIt concept]
- Masaoka-Koga Stage IVa [NCIt concept]
- Masaoka-Koga Stage IVb [NCIt concept]
- Masitinib Mesylate [NCIt concept]
- Masked Annotated Somatic Variation Data [NCIt concept]
- Masked Copy Number Segment Data [NCIt concept]
- Masked Intensity Sequencing Data [NCIt concept]
- Masked Somatic Variation Data [NCIt concept]
- Masofaniten [NCIt concept]
- Masoprocol [NCIt concept]
- Mast Cell Leukemia [NCIt concept]
- Mast Cell Neoplasm [NCIt concept]
- Mast Cell Sarcoma [NCIt concept]
- Mast/Stem Cell Growth Factor Receptor Kit [NCIt concept]
- Mastocytoma [NCIt concept]
- Material Recording and Transport Clerk [NCIt concept]
- Maternal Biological Grandparent [NCIt concept]
- Maternal First Cousin Once Removed [NCIt concept]
- Maternal Great Aunt [NCIt concept]
- Maternal Great Grandparent [NCIt concept]
- Maternal Great Uncle [NCIt concept]
- Maternal Half Sibling [NCIt concept]
- Mathematician, Actuary and Statistician [NCIt concept]
- Matrix Metalloproteinase Inhibitor MMI270 [NCIt concept]
- Mature B-Cell Non-Hodgkin Lymphoma [NCIt concept]
- Mature T-ALL [NCIt concept]
- Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma [NCIt concept]
- Mature Teratoma [NCIt concept]
- Mature miRNA Variant [NCIt concept]
- Matuzumab [NCIt concept]
- Mauritania [NCIt concept]
- Mauritius [NCIt concept]
- Mavelertinib [NCIt concept]
- Maveropepimut-S [NCIt concept]
- Mavorixafor [NCIt concept]
- Maxilla [NCIt concept]
- Maxillary Sinus [NCIt concept]
- Maxillectomy [NCIt concept]
- Maximum Dose Amount [NCIt concept]
- Maximum Tumor Bulk No Known Nodal Involvement [NCIt concept]
- Mayotte [NCIt concept]
- Maytansine [NCIt concept]
- Mcl-1 Inhibitor AZD5991 [NCIt concept]
- Mcl-1 Inhibitor MIK665 [NCIt concept]
- Measurable Residual Disease Assessment [NCIt concept]
- Meat Allergy [NCIt concept]
- Mecbotamab Vedotin [NCIt concept]
- Mechlorethamine [NCIt concept]
- Mechlorethamine Hydrochloride [NCIt concept]
- Mechlorethamine Hydrochloride Gel [NCIt concept]
- Meckel Diverticulum [NCIt concept]
- Mediastinal Hemorrhage, CTCAE [NCIt concept]
- Mediastinal Infection, CTCAE [NCIt concept]
- Mediastinal Lymph Node [NCIt concept]
- Mediastinal Soft Tissue [NCIt concept]
- Mediastinum [NCIt concept]
- Medical Record [NCIt concept]
- Medical and Pharmaceutical Technician [NCIt concept]
- Medically Treated Reflux [NCIt concept]
- Medication Course Number [NCIt concept]
- Medorubicin [NCIt concept]
- Medroxyprogesterone [NCIt concept]
- Medroxyprogesterone Acetate [NCIt concept]
- Medullary Carcinoma, Not Otherwise Specified [NCIt concept]
- Medulloblastoma [NCIt concept]
- Medulloblastoma Molecular Subtypes [NCIt concept]
- Medulloblastoma with Extensive Nodularity [NCIt concept]
- Medulloblastoma, Non-WNT/Non-SHH [NCIt concept]
- Medulloblastoma, Non-WNT/Non-SHH, Group 3 [NCIt concept]
- Medulloblastoma, Non-WNT/Non-SHH, Group 4 [NCIt concept]
- Medulloblastoma, Not Otherwise Specified [NCIt concept]
- Medulloblastoma, SHH-Activated [NCIt concept]
- Medulloblastoma, SHH-Activated, TP53-Mutant [NCIt concept]
- Medulloblastoma, SHH-Activated, TP53-Wildtype [NCIt concept]
- Medulloblastoma, WNT-Activated [NCIt concept]
- Medulloepithelioma Not Otherwise Specified [NCIt concept]
- Medullomyoblastoma [NCIt concept]
- Megestrol Acetate [NCIt concept]
- Megestrol/Tamoxifen Regimen [NCIt concept]
- Melanocytic Medulloblastoma [NCIt concept]
- Melanocytic Nevus [NCIt concept]
- Melanocytoma [NCIt concept]
- Melanoma [NCIt concept]
- Melanoma Arising from Blue Nevus [NCIt concept]
- Melanoma Arising in Giant Congenital Nevus [NCIt concept]
- Melanoma Monoclonal Antibody hIgG2A [NCIt concept]
- Melanoma TRP2 CTL Epitope Vaccine SCIB1 [NCIt concept]
- Melanoma in Junctional Nevus [NCIt concept]
- Melanoma with Known Primary Indicator [NCIt concept]
- Melanotic Neuroectodermal Tumor [NCIt concept]
- Melanotic Neurofibroma [NCIt concept]
- Melanotic Schwannoma [NCIt concept]
- Melphalan [NCIt concept]
- Melphalan Flufenamide [NCIt concept]
- Melphalan Hydrochloride [NCIt concept]
- Melphalan Hydrochloride/Sulfobutyl Ether Beta-Cyclodextrin Complex [NCIt concept]
- Memory Impairment, CTCAE 5.0 [NCIt concept]
- Menatetrenone [NCIt concept]
- Menin Inhibitor BMF-219 [NCIt concept]
- Menin Inhibitor DSP-5336 [NCIt concept]
- Menin-MLL Interaction Inhibitor JNJ-75276617 [NCIt concept]
- Meningeal Melanocytoma [NCIt concept]
- Meningeal Melanocytosis [NCIt concept]
- Meningeal Melanoma [NCIt concept]
- Meningeal Melanomatosis [NCIt concept]
- Meningeal Sarcoma [NCIt concept]
- Meningeal Sarcomatosis [NCIt concept]
- Meninges [NCIt concept]
- Meningioma [NCIt concept]
- Meningiomatosis [NCIt concept]
- Meningismus, CTCAE [NCIt concept]
- Meningitis, CTCAE [NCIt concept]
- Meningothelial Meningioma [NCIt concept]
- Menogaril [NCIt concept]
- Menopause [NCIt concept]
- Menopause Status [NCIt concept]
- Menorrhagia, CTCAE [NCIt concept]
- Mentum [NCIt concept]
- Merbarone [NCIt concept]
- Mercaptopurine [NCIt concept]
- Mercaptopurine Anhydrous [NCIt concept]
- Mercaptopurine Oral Suspension [NCIt concept]
- Merestinib [NCIt concept]
- Merkel Cell Carcinoma [NCIt concept]
- Mesenchymal Chondrosarcoma [NCIt concept]
- Mesenchymoma [NCIt concept]
- Mesenteric Lymph Node [NCIt concept]
- Mesentery [NCIt concept]
- Mesna [NCIt concept]
- Mesonephric Adenocarcinoma [NCIt concept]
- Mesothelial Neoplasm [NCIt concept]
- Mesothelin [NCIt concept]
- Mesothelin/CD3e Tri-specific T-cell Activating Construct HPN536 [NCIt concept]
- Mesothelium [NCIt concept]
- Messenger RNA [NCIt concept]
- MetAP2 Inhibitor APL-1202 [NCIt concept]
- Metabolic Anti-cancer Agent ASCA101 [NCIt concept]
- Metabolic Syndrome [NCIt concept]
- Metabolism and Nutrition Disorders - Other, Specify, CTCAE [NCIt concept]
- Metal Processing and Finishing Plant Operator [NCIt concept]
- Metamelfalan [NCIt concept]
- Metamyelocyte Count [NCIt concept]
- Metanephric Adenofibroma [NCIt concept]
- Metanephric Adenoma [NCIt concept]
- Metanephrine-Secreting [NCIt concept]
- Metaplasia Indicator [NCIt concept]
- Metaplastic Carcinoma [NCIt concept]
- Metaplastic Meningioma [NCIt concept]
- Metarrestin [NCIt concept]
- Metastasectomy [NCIt concept]
- Metastasis Negative [NCIt concept]
- Metastasis Present in Distant Lymph Node [NCIt concept]
- Metastasis Present in Distant Organ [NCIt concept]
- Metastasizing Ameloblastoma [NCIt concept]
- Metastasizing Chondroblastoma [NCIt concept]
- Metastatic Adenocarcinoma [NCIt concept]
- Metastatic Adrenal Gland Pheochromocytoma [NCIt concept]
- Metastatic Carcinoma [NCIt concept]
- Metastatic Diagnosis [NCIt concept]
- Metastatic Extra-Adrenal Paraganglioma [NCIt concept]
- Metastatic Lesion [NCIt concept]
- Metastatic Neoplasm [NCIt concept]
- Metastatic Paraganglioma [NCIt concept]
- Metastatic Pituitary Neuroendocrine Tumor [NCIt concept]
- Metastatic Signet Ring Cell Carcinoma [NCIt concept]
- Metastatic Squamous Cell Carcinoma [NCIt concept]
- Metastatic Tumor Sample [NCIt concept]
- Metatinib Tromethamine [NCIt concept]
- Metformin [NCIt concept]
- Metformin Hydrochloride [NCIt concept]
- Methanol Extraction Residue of BCG [NCIt concept]
- Methazolamide [NCIt concept]
- Methicillin-Resistant Staphylococcus aureus Infection [NCIt concept]
- Methionine Aminopeptidase 2 Inhibitor M8891 [NCIt concept]
- Methionine Aminopeptidase 2 Inhibitor PPI-2458 [NCIt concept]
- Methotrexate [NCIt concept]
- Methotrexate Sodium [NCIt concept]
- Methotrexate-E Therapeutic Implant [NCIt concept]
- Methotrexate-Encapsulating Autologous Tumor-Derived Microparticles [NCIt concept]
- Methoxsalen [NCIt concept]
- Methoxyamine [NCIt concept]
- Methoxyamine Hydrochloride [NCIt concept]
- Methoxytyramine-Secreting [NCIt concept]
- Methyl Bacteriopurpurinimide [NCIt concept]
- Methyl-5-Aminolevulinate Hydrochloride Cream [NCIt concept]
- Methylation [NCIt concept]
- Methylation Beta Value [NCIt concept]
- Methylcantharidimide [NCIt concept]
- Methylene Chloride Exposure [NCIt concept]
- Methylmercaptopurine Riboside [NCIt concept]
- Methylprednisolone [NCIt concept]
- Methylprednisolone Acetate [NCIt concept]
- Methylprednisolone Sodium Succinate [NCIt concept]
- Methylselenocysteine [NCIt concept]
- Methyltestosterone [NCIt concept]
- Metoprine [NCIt concept]
- Mevociclib [NCIt concept]
- Mexico [NCIt concept]
- Mezagitamab [NCIt concept]
- Mezigdomide [NCIt concept]
- Mibefradil [NCIt concept]
- Mibefradil Dihydrochloride [NCIt concept]
- Micellar Nanoparticle-encapsulated Epirubicin [NCIt concept]
- Micro Needle Array-Doxorubicin [NCIt concept]
- MicroRNA [NCIt concept]
- MicroRNA Measurement [NCIt concept]
- MicroRNA Sequencing [NCIt concept]
- Microarray Analysis [NCIt concept]
- Microassay Chip Identifier [NCIt concept]
- Microassay Chip Position Identifier [NCIt concept]
- Microbiome GEN-001 [NCIt concept]
- Microbiome-derived Peptide Vaccine EO2040 [NCIt concept]
- Microbiome-derived Peptide Vaccine EO2401 [NCIt concept]
- Microbiome-derived Peptide Vaccine EO4010 [NCIt concept]
- Microcystic Adenoma [NCIt concept]
- Microcystic Adnexal Carcinoma [NCIt concept]
- Microcystic Meningioma [NCIt concept]
- Microgram [NCIt concept]
- Microgram per Liter [NCIt concept]
- Microgram per Milliliter [NCIt concept]
- Microgram per Square Meter [NCIt concept]
- Microinvasive Squamous Cell Carcinoma [NCIt concept]
- Microkatal per Liter [NCIt concept]
- Micrometastasis Present Indicator [NCIt concept]
- Micromole per Liter [NCIt concept]
- Micronesia, Federated States of [NCIt concept]
- Micropapillary Growth Pattern [NCIt concept]
- Micropapillary Serous Carcinoma [NCIt concept]
- Micropapillary Transitional Cell Carcinoma [NCIt concept]
- Microparticle-encapsulated CYP1B1-encoding DNA Vaccine ZYC300 [NCIt concept]
- Microsatellite Instability [NCIt concept]
- Microsatellite Instability Analysis [NCIt concept]
- Microsatellite Instability Overall Status [NCIt concept]
- Microsatellite Stable [NCIt concept]
- Microscopic [NCIt concept]
- Microscopic Extranodal Extension [NCIt concept]
- Microscopically Positive Parametrial Margin [NCIt concept]
- Microscopy [NCIt concept]
- Microtubule Destabilizer PM534 [NCIt concept]
- Microtubule Inhibitor SCB01A [NCIt concept]
- Microwave Ablation [NCIt concept]
- Middle Ear [NCIt concept]
- Middle Ear Inflammation, CTCAE [NCIt concept]
- Middle Lobe of the Prostate [NCIt concept]
- Middle Lobe of the Right Lung [NCIt concept]
- Middle Third of the Esophagus [NCIt concept]
- Midline [NCIt concept]
- Midostaurin [NCIt concept]
- Mifamurtide [NCIt concept]
- Mifepristone [NCIt concept]
- Milademetan Tosylate [NCIt concept]
- Milataxel [NCIt concept]
- Milatuzumab [NCIt concept]
- Milatuzumab-Doxorubicin Antibody-Drug Conjugate IMMU-110 [NCIt concept]
- Milciclib Maleate [NCIt concept]
- Mild Adverse Event [NCIt concept]
- Mild Dysplasia [NCIt concept]
- Milk Thistle [NCIt concept]
- Millicurie [NCIt concept]
- Milliequivalent [NCIt concept]
- Milligram [NCIt concept]
- Milligram per 24 Hours [NCIt concept]
- Milligram per Deciliter [NCIt concept]
- Milligram per Kilogram [NCIt concept]
- Milligram per Kilogram per Day [NCIt concept]
- Milligram per Square Meter [NCIt concept]
- Milligram per Square Meter per Day [NCIt concept]
- Milligram per Square Meter per Week [NCIt concept]
- Milligram per Week [NCIt concept]
- Milliinternational Unit [NCIt concept]
- Milliliter [NCIt concept]
- Millimeter [NCIt concept]
- Millimole per Liter [NCIt concept]
- Milliunits per Mole Hemoglobin [NCIt concept]
- Milrebrutinib [NCIt concept]
- Miltefosine [NCIt concept]
- Mineralocorticoid Excess [NCIt concept]
- Minimal Response [NCIt concept]
- Minimal Submucosal Invasion [NCIt concept]
- Minimally Invasive Lung Adenocarcinoma [NCIt concept]
- Minimally Invasive Lung Mixed Non-Mucinous and Mucinous Adenocarcinoma [NCIt concept]
- Minimally Invasive Lung Mucinous Adenocarcinoma [NCIt concept]
- Minimally Invasive Lung Non-Mucinous Adenocarcinoma [NCIt concept]
- Minimally Invasive Surgery [NCIt concept]
- Minimum Diameter [NCIt concept]
- Mining and Construction Laborer [NCIt concept]
- Mining and Mineral Processing Plant Operator [NCIt concept]
- Mining, Manufacturing and Construction Supervisor [NCIt concept]
- Minretumomab [NCIt concept]
- Mipasetamab Uzoptirine [NCIt concept]
- Mipicoledine [NCIt concept]
- Mipsagargin [NCIt concept]
- Miptenalimab [NCIt concept]
- Mirabegron [NCIt concept]
- Miransertib [NCIt concept]
- Mirdametinib [NCIt concept]
- Mirvetuximab Soravtansine [NCIt concept]
- Mirzotamab Clezutoclax [NCIt concept]
- Miscellaneous Neoplasm [NCIt concept]
- Misetionamide [NCIt concept]
- Mismatch Repair Gene Mutation [NCIt concept]
- Misonidazole [NCIt concept]
- Missense Mutation [NCIt concept]
- Mistletoe Extract [NCIt concept]
- Mitazalimab [NCIt concept]
- Mitindomide [NCIt concept]
- Mitobronitol [NCIt concept]
- Mitochondrial DNA [NCIt concept]
- Mitochondrial Oxidative Phosphorylation Inhibitor ATR-101 [NCIt concept]
- Mitochondrion [NCIt concept]
- Mitoclomine [NCIt concept]
- Mitoflaxone [NCIt concept]
- Mitoguazone [NCIt concept]
- Mitoguazone Dihydrochloride [NCIt concept]
- Mitolactol [NCIt concept]
- Mitomycin [NCIt concept]
- Mitomycin A [NCIt concept]
- Mitomycin B [NCIt concept]
- Mitomycin C Analog KW-2149 [NCIt concept]
- Mitosis-Karyorrhexis Index [NCIt concept]
- Mitotane [NCIt concept]
- Mitotenamine [NCIt concept]
- Mitotic Count [NCIt concept]
- Mitotic Count Reported Indicator [NCIt concept]
- Mitoxantrone [NCIt concept]
- Mitoxantrone Hydrochloride [NCIt concept]
- Mitozolomide [NCIt concept]
- Mitral Valve Disease, CTCAE [NCIt concept]
- Mivavotinib [NCIt concept]
- Mivebresib [NCIt concept]
- Mivobulin [NCIt concept]
- Mivobulin Isethionate [NCIt concept]
- Mixed Adherent Cells in Suspension [NCIt concept]
- Mixed Bacteria Vaccine [NCIt concept]
- Mixed Cell Adenocarcinoma [NCIt concept]
- Mixed Cell Adenoma [NCIt concept]
- Mixed Cellularity Classic Hodgkin Lymphoma [NCIt concept]
- Mixed Crop and Animal Producer [NCIt concept]
- Mixed Embryonal Carcinoma and Teratoma [NCIt concept]
- Mixed Epithelial and Mesenchymal Hepatoblastoma [NCIt concept]
- Mixed Epithelioid and Spindle Cell Melanoma [NCIt concept]
- Mixed Germ Cell Tumor [NCIt concept]
- Mixed Germ Cell-Sex Cord-Stromal Tumor [NCIt concept]
- Mixed Glioma [NCIt concept]
- Mixed Liposarcoma [NCIt concept]
- Mixed Mesodermal (Mullerian) Tumor [NCIt concept]
- Mixed Neoplasm [NCIt concept]
- Mixed Neuroendocrine Non-Neuroendocrine Neoplasm [NCIt concept]
- Mixed Phenotype Acute Leukemia with BCR-ABL1 Fusion [NCIt concept]
- Mixed Phenotype Acute Leukemia with KMT2A Rearrangement [NCIt concept]
- Mixed Phenotype Acute Leukemia, B/Myeloid [NCIt concept]
- Mixed Phenotype Acute Leukemia, T/Myeloid [NCIt concept]
- Mixed Response [NCIt concept]
- Mixed Teratoma and Seminoma [NCIt concept]
- Mixed Tumor, Not Otherwise Specified [NCIt concept]
- Mobile Plant Operator [NCIt concept]
- Mobitz (Type) II Atrioventricular Block, CTCAE [NCIt concept]
- Mobitz Type I, CTCAE [NCIt concept]
- Mobocertinib [NCIt concept]
- Mobocertinib Succinate [NCIt concept]
- Mocetinostat [NCIt concept]
- Mocravimod Hydrochloride [NCIt concept]
- Modakafusp Alfa [NCIt concept]
- Moderate [NCIt concept]
- Moderate Adverse Event [NCIt concept]
- Moderate Dysplasia [NCIt concept]
- Moderately Differentiated Ovarian Sertoli-Leydig Cell Tumor [NCIt concept]
- Moderately Differentiated Ovarian Sertoli-Leydig Cell Tumor, Variant with Heterologous Elements [NCIt concept]
- Modified Banxia Xiexin Decoction [NCIt concept]
- Modified Conditionally Reprogrammed Cells [NCIt concept]
- Modified Influenza Virus Expressing HPV16 E6/E7 FluBHPVE6E7 [NCIt concept]
- Modified Interleukin-2 DF6215 [NCIt concept]
- Modified Interleukin-2 LTC004 [NCIt concept]
- Modified Radical Mastectomy [NCIt concept]
- Modified Radical Neck Dissection [NCIt concept]
- Modified Vaccinia Ankara-vectored HPV16/18 Vaccine JNJ-65195208 [NCIt concept]
- Modified Vaccinia Virus Ankara Expressing Flt3L/OX40L MQ710 [NCIt concept]
- Modified Vitamin D Binding Protein Macrophage Activator EF-022 [NCIt concept]
- Modotuximab [NCIt concept]
- Mofarotene [NCIt concept]
- Mogamulizumab [NCIt concept]
- Mold or Dust Allergy [NCIt concept]
- Moldova, Republic of [NCIt concept]
- Molecular Analysis [NCIt concept]
- Molecular Glue Degrader GLB-001 [NCIt concept]
- Molecular Sequence Variation [NCIt concept]
- Molecular Sequence Variation Type [NCIt concept]
- Molecular Test Analyte Type [NCIt concept]
- Molibresib [NCIt concept]
- Molibresib Besylate [NCIt concept]
- Momelotinib [NCIt concept]
- Monaco [NCIt concept]
- Monalizumab [NCIt concept]
- Mongolia [NCIt concept]
- Monocarboxylate Transporter 1 Inhibitor AZD3965 [NCIt concept]
- Monoclonal Antibody 105AD7 Anti-idiotype Vaccine [NCIt concept]
- Monoclonal Antibody 11D10 [NCIt concept]
- Monoclonal Antibody 11D10 Anti-Idiotype Vaccine [NCIt concept]
- Monoclonal Antibody 14G2A [NCIt concept]
- Monoclonal Antibody 1F5 [NCIt concept]
- Monoclonal Antibody 3622W94 [NCIt concept]
- Monoclonal Antibody 3F8 [NCIt concept]
- Monoclonal Antibody 3H1 Anti-Idiotype Vaccine [NCIt concept]
- Monoclonal Antibody 4B5 Anti-Idiotype Vaccine [NCIt concept]
- Monoclonal Antibody 7C11 [NCIt concept]
- Monoclonal Antibody 81C6 [NCIt concept]
- Monoclonal Antibody A1G4 Anti-Idiotype Vaccine [NCIt concept]
- Monoclonal Antibody A27.15 [NCIt concept]
- Monoclonal Antibody A33 [NCIt concept]
- Monoclonal Antibody AbGn-7 [NCIt concept]
- Monoclonal Antibody CAL [NCIt concept]
- Monoclonal Antibody CC49-delta CH2 [NCIt concept]
- Monoclonal Antibody CEP-37250/KHK2804 [NCIt concept]
- Monoclonal Antibody D6.12 [NCIt concept]
- Monoclonal Antibody DR-01 [NCIt concept]
- Monoclonal Antibody E2.3 [NCIt concept]
- Monoclonal Antibody F19 [NCIt concept]
- Monoclonal Antibody GD2 Anti-Idiotype Vaccine [NCIt concept]
- Monoclonal Antibody GIM-122 [NCIt concept]
- Monoclonal Antibody HeFi-1 [NCIt concept]
- Monoclonal Antibody Hu3S193 [NCIt concept]
- Monoclonal Antibody HuAFP31 [NCIt concept]
- Monoclonal Antibody HuPAM4 [NCIt concept]
- Monoclonal Antibody IMMU-14 [NCIt concept]
- Monoclonal Antibody L6 [NCIt concept]
- Monoclonal Antibody Lym-1 [NCIt concept]
- Monoclonal Antibody MX35 F(ab')2 [NCIt concept]
- Monoclonal Antibody Me1-14 F(ab')2 [NCIt concept]
- Monoclonal Antibody NEO-201 [NCIt concept]
- Monoclonal Antibody R24 [NCIt concept]
- Monoclonal Antibody RAV12 [NCIt concept]
- Monoclonal Antibody SGN-14 [NCIt concept]
- Monoclonal Antibody SHR-8068 [NCIt concept]
- Monoclonal Antibody TORL-2-307-MAB [NCIt concept]
- Monoclonal Antibody TRK-950 [NCIt concept]
- Monoclonal Antibody m170 [NCIt concept]
- Monoclonal Antibody muJ591 [NCIt concept]
- Monoclonal Cellular Population Present [NCIt concept]
- Monoclonal Gammopathy of Undetermined Significance [NCIt concept]
- Monoclonal Immunoglobulin Deposition Disease [NCIt concept]
- Monoclonal Microbial EDP1503 [NCIt concept]
- Monoclonal Protein Measurement [NCIt concept]
- Monocyte Count [NCIt concept]
- Monocyte Differentiation Antigen CD14 [NCIt concept]
- Monomethyl Auristatin E [NCIt concept]
- Monosomy [NCIt concept]
- Montenegro [NCIt concept]
- Montserrat [NCIt concept]
- More than 5 Mitoses per 50 HPF [NCIt concept]
- Morinda Citrifolia Fruit Extract [NCIt concept]
- Morocco [NCIt concept]
- Morpholinodoxorubicin [NCIt concept]
- Morphologic Architectural Pattern [NCIt concept]
- Mosaicism [NCIt concept]
- Mosedipimod [NCIt concept]
- Mosunetuzumab [NCIt concept]
- Motacabtagene Lurevgedleucel [NCIt concept]
- Motesanib [NCIt concept]
- Motesanib Diphosphate [NCIt concept]
- Motexafin Gadolinium [NCIt concept]
- Motexafin Lutetium [NCIt concept]
- Mother [NCIt concept]
- Mother-in-law [NCIt concept]
- Motixafortide [NCIt concept]
- Motolimod [NCIt concept]
- Motor / Movement Change [NCIt concept]
- Movements Involuntary, CTCAE [NCIt concept]
- Moxetumomab Pasudotox [NCIt concept]
- Mozambique [NCIt concept]
- Mps1 Inhibitor BAY 1217389 [NCIt concept]
- Mps1 Inhibitor BOS172722 [NCIt concept]
- Mu Heavy Chain Disease [NCIt concept]
- Mucin-Producing Adenocarcinoma [NCIt concept]
- Mucin-Producing Carcinoma [NCIt concept]
- Mucinous Adenocarcinoma [NCIt concept]
- Mucinous Adenofibroma [NCIt concept]
- Mucinous Cystadenocarcinoma [NCIt concept]
- Mucinous Cystadenofibroma [NCIt concept]
- Mucinous Cystadenoma [NCIt concept]
- Mucinous Tubular and Spindle Cell Carcinoma of the Kidney [NCIt concept]
- Mucoadhesive Paclitaxel Formulation [NCIt concept]
- Mucoepidermoid Carcinoma [NCIt concept]
- Mucosa of the Lip [NCIt concept]
- Mucosa of the Lower Lip [NCIt concept]
- Mucosa of the Upper Lip [NCIt concept]
- Mucosal Infection, CTCAE [NCIt concept]
- Mucosal Lentiginous Melanoma [NCIt concept]
- Mucositis Oral, CTCAE [NCIt concept]
- Mulnitorsen [NCIt concept]
- Multi-AGC Kinase Inhibitor AT13148 [NCIt concept]
- Multi-Organ Failure, CTCAE [NCIt concept]
- Multi-epitope Anti-folate Receptor Peptide Vaccine TPIV 200 [NCIt concept]
- Multi-epitope HER2 Peptide Vaccine H2NVAC [NCIt concept]
- Multi-epitope HER2 Peptide Vaccine TPIV100 [NCIt concept]
- Multi-glioblastoma-peptide-targeting Autologous Dendritic Cell Vaccine ICT-107 [NCIt concept]
- Multi-kinase Inhbitor AIV001 [NCIt concept]
- Multi-kinase Inhibitor LNK01002 [NCIt concept]
- Multi-kinase Inhibitor ST-1898 [NCIt concept]
- Multi-kinase Inhibitor T-1301 [NCIt concept]
- Multi-mode Kinase Inhibitor EOC317 [NCIt concept]
- Multi-neo-epitope Vaccine OSE 2101 [NCIt concept]
- Multicystic Mesothelioma [NCIt concept]
- Multifocal [NCIt concept]
- Multifocal Lymphomatous Polyposis [NCIt concept]
- Multifunctional/Multitargeted Anticancer Agent OMN54 [NCIt concept]
- Multikinase Inhibitor 4SC-203 [NCIt concept]
- Multikinase Inhibitor AEE788 [NCIt concept]
- Multikinase Inhibitor AT9283 [NCIt concept]
- Multikinase Inhibitor SAR103168 [NCIt concept]
- Multipeptide Vaccine S-588210 [NCIt concept]
- Multiple Adenomatous Polyps [NCIt concept]
- Multiple Endocrine Neoplasia [NCIt concept]
- Multiple Myeloma [NCIt concept]
- Multiple Osteochondromas [NCIt concept]
- Multiplex Sequencing Sample Barcode [NCIt concept]
- Multitargeted Tyrosine Kinase Inhibitor JNJ-26483327 [NCIt concept]
- Mupadolimab [NCIt concept]
- Muparfostat [NCIt concept]
- Mureletecan [NCIt concept]
- Murizatoclax [NCIt concept]
- Muscadine Grape Extract [NCIt concept]
- Muscle [NCIt concept]
- Muscle Tissue [NCIt concept]
- Muscle Weakness Left-Sided, CTCAE [NCIt concept]
- Muscle Weakness Lower Limb, CTCAE [NCIt concept]
- Muscle Weakness Right-Sided, CTCAE [NCIt concept]
- Muscle Weakness Trunk, CTCAE [NCIt concept]
- Muscle Weakness Upper Limb, CTCAE [NCIt concept]
- Musculoskeletal Deformity, CTCAE [NCIt concept]
- Musculoskeletal and Connective Tissue Disorder - Other, Specify, CTCAE [NCIt concept]
- Mushroom-Shaped Lesion [NCIt concept]
- Mutant p53 Activator COTI-2 [NCIt concept]
- Mutant-selective EGFR Inhibitor BDTX-1535 [NCIt concept]
- Mutant-selective EGFR Inhibitor JIN-A02 [NCIt concept]
- Mutant-selective EGFR Inhibitor PF-06459988 [NCIt concept]
- Mutant-selective EGFR Inhibitor TAS3351 [NCIt concept]
- Mutant-selective PI3K-alpha H1047R Inhibitor LOXO-783 [NCIt concept]
- Mutant-selective PI3K-alpha H1047X Inhibitor STX-478 [NCIt concept]
- Mutant-selective PI3K-alpha Inhibitor BPI-21668 [NCIt concept]
- Mutation Abnormality [NCIt concept]
- Mutation Annotation Format [NCIt concept]
- Muzastotug [NCIt concept]
- Myalgia, CTCAE [NCIt concept]
- Myanmar [NCIt concept]
- Myasthenia Gravis [NCIt concept]
- Myasthenia Gravis Foundation of America Class [NCIt concept]
- Myasthenia Gravis Foundation of America Class I [NCIt concept]
- Myasthenia Gravis Foundation of America Class II [NCIt concept]
- Myasthenia Gravis Foundation of America Class III [NCIt concept]
- Myasthenia Gravis Foundation of America Class IV [NCIt concept]
- Myasthenia Gravis Foundation of America Class V [NCIt concept]
- Myc Inhibitor OMO-103 [NCIt concept]
- Myc Inhibitor WBC100 [NCIt concept]
- Mycobacterial Infection [NCIt concept]
- Mycobacterium Avium Complex Lymphadenitis [NCIt concept]
- Mycobacterium Avium Infection [NCIt concept]
- Mycobacterium tuberculosis Arabinomannan Z-100 [NCIt concept]
- Mycobacterium w [NCIt concept]
- Mycophenolic Acid [NCIt concept]
- Mycosis Fungoides [NCIt concept]
- Myelitis, CTCAE [NCIt concept]
- Myeloblast Count [NCIt concept]
- Myelocyte Count [NCIt concept]
- Myelodysplastic Syndrome [NCIt concept]
- Myelodysplastic Syndrome Post Cytotoxic Therapy [NCIt concept]
- Myelodysplastic Syndrome with Excess Blasts [NCIt concept]
- Myelodysplastic Syndrome with Ring Sideroblasts [NCIt concept]
- Myelodysplastic Syndrome with del(5q) [NCIt concept]
- Myelodysplastic Syndrome, CTCAE [NCIt concept]
- Myelodysplastic Syndrome, Not Otherwise Specified [NCIt concept]
- Myelodysplastic Syndrome, Not Otherwise Specified with Multilineage Dysplasia [NCIt concept]
- Myelodysplastic Syndrome, Unclassifiable [NCIt concept]
- Myelodysplastic Syndrome/Acute Myeloid Leukemia [NCIt concept]
- Myelodysplastic/Myeloproliferative Neoplasm with Ring Sideroblasts and Thrombocytosis, Not Otherwise Specified [NCIt concept]
- Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified [NCIt concept]
- Myeloid Cell Leukemia 1 Inhibitor PRT1419 [NCIt concept]
- Myeloid Cell Surface Antigen CD33 [NCIt concept]
- Myeloid Leukemia [NCIt concept]
- Myeloid Leukemia Associated with Down Syndrome [NCIt concept]
- Myeloid Neoplasm Post Cytotoxic Therapy [NCIt concept]
- Myeloid Sarcoma [NCIt concept]
- Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement [NCIt concept]
- Myeloid/Lymphoid Neoplasms with PDGFRA Rearrangement [NCIt concept]
- Myeloid/Lymphoid Neoplasms with PDGFRB Rearrangement [NCIt concept]
- Myeloproliferative Neoplasm [NCIt concept]
- Myeloproliferative Neoplasm, Not Otherwise Specified [NCIt concept]
- Myocardial Infarction [NCIt concept]
- Myocardial Infarction, CTCAE [NCIt concept]
- Myocarditis, CTCAE 5.0 [NCIt concept]
- Myoepithelial Tumor [NCIt concept]
- Myofibroblastoma [NCIt concept]
- Myofibroma [NCIt concept]
- Myofibromatosis [NCIt concept]
- Myolipoma [NCIt concept]
- Myomatous Neoplasm [NCIt concept]
- Myometrium [NCIt concept]
- Myositis, CTCAE 5.0 [NCIt concept]
- Myxofibrosarcoma [NCIt concept]
- Myxoid Leiomyosarcoma [NCIt concept]
- Myxoid Liposarcoma [NCIt concept]
- Myxoinflammatory Fibroblastic Sarcoma [NCIt concept]
- Myxoma [NCIt concept]
- Myxopapillary Ependymoma [NCIt concept]
- Myxosarcoma [NCIt concept]
- N,N-Dibenzyl Daunomycin [NCIt concept]
- N-(5-tert-butyl-3-isoxazolyl)-N-(4-(4-pyridinyl)oxyphenyl) Urea [NCIt concept]
- N-Methylformamide [NCIt concept]
- N-dihydrogalactochitosan [NCIt concept]
- N0 TNM Finding [NCIt concept]
- N1 TNM Finding [NCIt concept]
- N1a TNM Finding [NCIt concept]
- N1b TNM Finding [NCIt concept]
- N1bI Stage Finding [NCIt concept]
- N1bII Stage Finding [NCIt concept]
- N1bIII Stage Finding [NCIt concept]
- N1bIV Stage Finding [NCIt concept]
- N1c TNM Finding [NCIt concept]
- N1mi TNM Finding [NCIt concept]
- N2 TNM Finding [NCIt concept]
- N2a TNM Finding [NCIt concept]
- N2b TNM Finding [NCIt concept]
- N2c TNM Finding [NCIt concept]
- N3 TNM Finding [NCIt concept]
- N3a TNM Finding [NCIt concept]
- N3b TNM Finding [NCIt concept]
- N3c TNM Finding [NCIt concept]
- N4 TNM Finding [NCIt concept]
- N6-Methyladenine Enriched RNA [NCIt concept]
- N6-Methyladenine RNA Analysis [NCIt concept]
- N6-Methyladenine RNA Immunoprecipitation-Sequencing [NCIt concept]
- NA17-A Antigen [NCIt concept]
- NA17.A2 Peptide Vaccine [NCIt concept]
- NAB2 Gene [NCIt concept]
- NACA Gene [NCIt concept]
- NAMPT Inhibitor OT-82 [NCIt concept]
- NAMPT Inhibitor STF-118804 [NCIt concept]
- NBEA Gene [NCIt concept]
- NBN Gene [NCIt concept]
- NCBI Transcript Identifier [NCIt concept]
- NCKIPSD Gene [NCIt concept]
- NCOA1 Gene [NCIt concept]
- NCOA2 Gene [NCIt concept]
- NCOA4 Gene [NCIt concept]
- NCOR1 Gene [NCIt concept]
- NCOR2 Gene [NCIt concept]
- NDRG1 Gene [NCIt concept]
- NEDD8 Activating Enzyme E1 Inhibitor TAS4464 [NCIt concept]
- NF1 Gene [NCIt concept]
- NF2 Gene [NCIt concept]
- NFATC2 Gene [NCIt concept]
- NFE2L2 Gene [NCIt concept]
- NFE2L2/KEAP1/CUL3 Mutant-targeting Agent MGY825 [NCIt concept]
- NFIB Gene [NCIt concept]
- NFKB2 Gene [NCIt concept]
- NFKBIE Gene [NCIt concept]
- NG-nitro-L-arginine [NCIt concept]
- NIN Gene [NCIt concept]
- NKX2-1 Gene [NCIt concept]
- NKp46/CD16-based BCMA-targeted NK Cell Engager SAR445514 [NCIt concept]
- NKp46/CD16-based CD123-targeted NK Cell Engager SAR443579 [NCIt concept]
- NKp46/CD16/CD20/IL-2-variant-specific NK Cell Engager IPH6501 [NCIt concept]
- NLRP3 Agonist BMS-986299 [NCIt concept]
- NLRP3 Inhibitor DFV890 [NCIt concept]
- NMT Inhibitor PCLX-001 [NCIt concept]
- NONO Gene [NCIt concept]
- NOTCH1 Gene [NCIt concept]
- NOTCH2 Gene [NCIt concept]
- NPM1 Gene [NCIt concept]
- NR4A3 Gene [NCIt concept]
- NRAS Gene [NCIt concept]
- NRG1 Gene [NCIt concept]
- NSD1 Gene [NCIt concept]
- NSD2 Gene [NCIt concept]
- NSD2 Inhibitor KTX-1001 [NCIt concept]
- NSD3 Gene [NCIt concept]
- NT5C2 Gene [NCIt concept]
- NTHL1 Gene [NCIt concept]
- NTRK1 Gene [NCIt concept]
- NTRK3 Gene [NCIt concept]
- NUMA1 Gene [NCIt concept]
- NUP214 Gene [NCIt concept]
- NUP98 Gene [NCIt concept]
- NUT Carcinoma [NCIt concept]
- NUTM1 Gene [NCIt concept]
- NUTM2A Gene [NCIt concept]
- NUTM2B Gene [NCIt concept]
- NX TNM Finding [NCIt concept]
- NY-ESO-1 Peptides/Threitolceramide-6-loaded Nanoparticles PORT-3 [NCIt concept]
- NY-ESO-1 Plasmid DNA Cancer Vaccine pPJV7611 [NCIt concept]
- NY-ESO-1-specific TCR Gene-transduced T Lymphocytes TBI-1301 [NCIt concept]
- NY-ESO-1/GLA-SE Vaccine ID-G305 [NCIt concept]
- NY-ESO-B [NCIt concept]
- Nab-paclitaxel [NCIt concept]
- Nab-paclitaxel/Danburstotug Complex AP160 [NCIt concept]
- Nab-paclitaxel/Rituximab-coated Nanoparticle AR160 [NCIt concept]
- Nadofaragene Firadenovec [NCIt concept]
- Nagrestipen [NCIt concept]
- Nail [NCIt concept]
- Nail Discoloration, CTCAE [NCIt concept]
- Nail Infection, CTCAE [NCIt concept]
- Nail Loss, CTCAE [NCIt concept]
- Nail Ridging, CTCAE [NCIt concept]
- Namibia [NCIt concept]
- Namirotene [NCIt concept]
- Namodenoson [NCIt concept]
- Nanafrocin [NCIt concept]
- Nanatinostat [NCIt concept]
- Nanocell-encapsulated miR-16-based microRNA Mimic [NCIt concept]
- Nanoparticle Albumin-Bound Docetaxel [NCIt concept]
- Nanoparticle Albumin-bound Thiocolchicine Dimer nab-5404 [NCIt concept]
- Nanoparticle Formulation CPI-300 [NCIt concept]
- Nanoparticle Paclitaxel Ointment SOR007 [NCIt concept]
- Nanoparticle SN-38-encapsulated Micelle Formulation SNB-101 [NCIt concept]
- Nanoparticle-based Paclitaxel Suspension [NCIt concept]
- Nanoparticle-encapsulated Doxorubicin Hydrochloride [NCIt concept]
- Nanoparticles Encapsulating TLR7 Agonist 1v270 MBS8 [NCIt concept]
- Nanoplexed Poly I:C BO-112 [NCIt concept]
- Nanoscale Coordination Polymer Nanoparticles CPI-100 [NCIt concept]
- Nanosomal Docetaxel Lipid Suspension [NCIt concept]
- Nanrilkefusp Alfa [NCIt concept]
- Napabucasin [NCIt concept]
- Naphthalimide Analogue UNBS5162 [NCIt concept]
- Naporafenib [NCIt concept]
- Naptumomab Estafenatox [NCIt concept]
- Naquotinib [NCIt concept]
- Naratuximab Emtansine [NCIt concept]
- Narazaciclib [NCIt concept]
- Narlumosbart [NCIt concept]
- Narnatumab [NCIt concept]
- Nasal Cavity [NCIt concept]
- Nasal Congestion, CTCAE [NCIt concept]
- Nasal Soft Tissue [NCIt concept]
- Nasal Type Extranodal NK/T-Cell Lymphoma [NCIt concept]
- Nasopharyngeal-Type Undifferentiated Carcinoma [NCIt concept]
- Nasopharynx [NCIt concept]
- Nastorazepide Calcium [NCIt concept]
- Natalizumab [NCIt concept]
- Native Hawaiian or Other Pacific Islander [NCIt concept]
- Natural IFN-alpha OPC-18 [NCIt concept]
- Natural Killer Cells ZRx101 [NCIt concept]
- Nauru [NCIt concept]
- Nausea, CTCAE 5.0 [NCIt concept]
- Navarixin [NCIt concept]
- Navicixizumab [NCIt concept]
- Navitoclax [NCIt concept]
- Navoximod [NCIt concept]
- Navtemadlin [NCIt concept]
- Navy Bean Powder [NCIt concept]
- Naxitamab [NCIt concept]
- Nazartinib [NCIt concept]
- Near Diploidy [NCIt concept]
- Nebratamig [NCIt concept]
- Necitumumab [NCIt concept]
- Neck [NCIt concept]
- Neck Edema, CTCAE [NCIt concept]
- Neck Pain, CTCAE 5.0 [NCIt concept]
- Neck Soft Tissue Necrosis, CTCAE [NCIt concept]
- Neck of the Pancreas [NCIt concept]
- Necrosis Indicator [NCIt concept]
- Necrosis Negative [NCIt concept]
- Necrotic Change [NCIt concept]
- Nectin-4-directed TLR8 Agonist SBT6290 [NCIt concept]
- Necuparanib [NCIt concept]
- Nedaplatin [NCIt concept]
- Nedometinib [NCIt concept]
- Needle Biopsy [NCIt concept]
- Negalstobart [NCIt concept]
- Negative Finding [NCIt concept]
- Negative Lymph Node [NCIt concept]
- Negative Surgical Margin [NCIt concept]
- Nelarabine [NCIt concept]
- Nelipepimut-S [NCIt concept]
- Nelipepimut-S Plus GM-CSF Vaccine [NCIt concept]
- Nelistotug [NCIt concept]
- Nelmastobart [NCIt concept]
- Nemorubicin [NCIt concept]
- Nemorubicin Hydrochloride [NCIt concept]
- Nemtabrutinib [NCIt concept]
- Nemvaleukin Alfa [NCIt concept]
- Nendratareotide Uzatansine [NCIt concept]
- Neoadjuvant Therapy [NCIt concept]
- Neoantigen Heat Shock Protein Vaccine rHSC-DIPGVax [NCIt concept]
- Neoantigen Vaccine GEN-009 [NCIt concept]
- Neoantigen mRNA Personalized Cancer Vaccine SW1115C3 [NCIt concept]
- Neoantigen srRNA Vaccine JCXH-212 [NCIt concept]
- Neoantigen-HSP70 Peptide Cancer Vaccine AGEN2017 [NCIt concept]
- Neoantigen-based Glioblastoma Vaccine [NCIt concept]
- Neoantigen-based Melanoma-Poly-ICLC Vaccine [NCIt concept]
- Neoantigen-based Renal Cell Carcinoma-Poly-ICLC Vaccine [NCIt concept]
- Neoantigen-based Therapeutic Cancer Vaccine GRT-C903 [NCIt concept]
- Neoantigen-based Therapeutic Cancer Vaccine GRT-R904 [NCIt concept]
- Neoplasm [NCIt concept]
- Neoplasm, Uncertain Whether Benign or Malignant [NCIt concept]
- Neoplasms Benign, Malignant and Unspecified (Incl Cysts and Polyps) - Other, Specify, CTCAE [NCIt concept]
- Neoplastic Cell [NCIt concept]
- Nepal [NCIt concept]
- Nephew [NCIt concept]
- Neprilysin [NCIt concept]
- Neratinib [NCIt concept]
- Neratinib Maleate [NCIt concept]
- Nerve [NCIt concept]
- Nerve Sheath Myxoma [NCIt concept]
- Nerve Sheath Neoplasm [NCIt concept]
- Nerve Tissue [NCIt concept]
- Nervous System [NCIt concept]
- Nervous System Disorders - Other, Specify, CTCAE [NCIt concept]
- Nesidioblastosis [NCIt concept]
- Nesuparib [NCIt concept]
- Nesvacumab [NCIt concept]
- Netherlands [NCIt concept]
- Neural Cell Adhesion Molecule 1 [NCIt concept]
- Neuralgia, CTCAE [NCIt concept]
- Neuroblastoma [NCIt concept]
- Neurocysticercosis [NCIt concept]
- Neuroendocrine Carcinoma [NCIt concept]
- Neuroendocrine Neoplasm [NCIt concept]
- Neuroendocrine Tumor [NCIt concept]
- Neuroendocrine Tumor G2 [NCIt concept]
- Neuroepithelial Neoplasm [NCIt concept]
- Neurofibroma [NCIt concept]
- Neurofibromatosis [NCIt concept]
- Neurofibromatosis Type 1 [NCIt concept]
- Neuroma [NCIt concept]
- Neuron Specific Enolase Measurement [NCIt concept]
- Neuronevus [NCIt concept]
- Neurosphere [NCIt concept]
- Neutrophil Band Form Count [NCIt concept]
- Neutrophil Count Decreased, CTCAE [NCIt concept]
- Never [NCIt concept]
- Never Married [NCIt concept]
- Never Smoker [NCIt concept]
- Never Used Hormonal Contraceptives [NCIt concept]
- Nevoid Basal Cell Carcinoma Syndrome [NCIt concept]
- New Caledonia [NCIt concept]
- New Primary Tumor [NCIt concept]
- New Zealand [NCIt concept]
- Next Generation Cancer Model [NCIt concept]
- Next Generation Cancer Model Expanded Under Non-Conforming Conditions [NCIt concept]
- Next Generation Targeted Sequencing [NCIt concept]
- Nezastomig [NCIt concept]
- Nezutatug [NCIt concept]
- Niacinamide [NCIt concept]
- Nicaragua [NCIt concept]
- Niclosamide [NCIt concept]
- Nicotinamide Riboside [NCIt concept]
- Nidanilimab [NCIt concept]
- Niece [NCIt concept]
- Nifurtimox [NCIt concept]
- Niger [NCIt concept]
- Nigeria [NCIt concept]
- Night Blindness, CTCAE [NCIt concept]
- Night Sweats [NCIt concept]
- Nilotinib [NCIt concept]
- Nilotinib Hydrochloride Anhydrous [NCIt concept]
- Nilotinib Hydrochloride Monohydrate [NCIt concept]
- Nilutamide [NCIt concept]
- Nimesulide-Hyaluronic Acid Conjugate CA102N [NCIt concept]
- Nimodipine [NCIt concept]
- Nimotuzumab [NCIt concept]
- Nimustine [NCIt concept]
- Nimustine Hydrochloride [NCIt concept]
- Ningetinib Tosylate [NCIt concept]
- Nintedanib [NCIt concept]
- Nipple [NCIt concept]
- Nipple Adenoma [NCIt concept]
- Nipple Deformity, CTCAE [NCIt concept]
- Niraparib [NCIt concept]
- Niraparib Tosylate Monohydrate [NCIt concept]
- Nirogacestat [NCIt concept]
- Nisevokitug [NCIt concept]
- Nitric Oxide-Releasing Acetylsalicylic Acid Derivative [NCIt concept]
- Nitrogen Mustard Prodrug PR-104 [NCIt concept]
- Nitroglycerin Transdermal Patch [NCIt concept]
- Niue [NCIt concept]
- Nivatrotamab [NCIt concept]
- Nivolumab [NCIt concept]
- Nivolumab/Relatlimab-rmbw [NCIt concept]
- No Effect [NCIt concept]
- No Evidence of Disease [NCIt concept]
- No Matched Normal Low Pass Whole Genome Sequencing Indicator [NCIt concept]
- No Matched Normal Targeted Sequencing Indicator [NCIt concept]
- No Matched Normal Whole Exome Sequencing Indicator [NCIt concept]
- No Matched Normal Whole Genome Sequencing Indicator [NCIt concept]
- No Palliative Benefit [NCIt concept]
- No Response [NCIt concept]
- No Smoke Exposure [NCIt concept]
- Nocardiosis [NCIt concept]
- Nocodazole [NCIt concept]
- Nodal Marginal Zone Lymphoma [NCIt concept]
- Nodular Goiter [NCIt concept]
- Nodular Hidradenoma [NCIt concept]
- Nodular Lymphocyte Predominant B-Cell Lymphoma [NCIt concept]
- Nodular Sclerosis Classic Hodgkin Lymphoma [NCIt concept]
- Nodular Sclerosis Classic Hodgkin Lymphoma, Cellular Phase [NCIt concept]
- Nodular Sclerosis Classic Hodgkin Lymphoma, Syncytial Variant [NCIt concept]
- Nofazinlimab [NCIt concept]
- Nogalamycin [NCIt concept]
- Nogapendekin Alfa [NCIt concept]
- Nolatrexed Dihydrochloride [NCIt concept]
- Non Complete Response/Non Progressive Disease [NCIt concept]
- Non-Cancer Related Death [NCIt concept]
- Non-Cardiac Chest Pain, CTCAE [NCIt concept]
- Non-Coding Gene Exon Mutation [NCIt concept]
- Non-Coding Gene Mutation [NCIt concept]
- Non-Cohesive Pattern [NCIt concept]
- Non-Drinker [NCIt concept]
- Non-Functioning Pancreatic Neuroendocrine Tumor [NCIt concept]
- Non-Hodgkin Lymphoma [NCIt concept]
- Non-Invasive Cribriform Carcinoma [NCIt concept]
- Non-Invasive Papillary Squamous Cell Carcinoma [NCIt concept]
- Non-Invasive Papillary Transitional Cell Carcinoma [NCIt concept]
- Non-Keratinizing Dysplasia [NCIt concept]
- Non-Keratinizing Large Cell Squamous Cell Carcinoma [NCIt concept]
- Non-Keratinizing Small Cell Squamous Cell Carcinoma [NCIt concept]
- Non-Malignant [NCIt concept]
- Non-Metastatic Paraganglioma [NCIt concept]
- Non-Neoplastic Thyroid Gland Disorder [NCIt concept]
- Non-Oncologic Therapeutic Agent [NCIt concept]
- Non-Seminomatous Germ Cell Tumor International Consensus Risk Classification, Good [NCIt concept]
- Non-Seminomatous Germ Cell Tumor International Consensus Risk Classification, Intermediate [NCIt concept]
- Non-Seminomatous Germ Cell Tumor International Consensus Risk Classification, Poor [NCIt concept]
- Non-Sense Mediated Decay Mutation [NCIt concept]
- Non-Small Cell Carcinoma [NCIt concept]
- Non-Small Cell Lung Cancer mRNA-Derived Vaccine CV9201 [NCIt concept]
- Non-Tumor Tissue Area [NCIt concept]
- Non-commissioned Armed Forces Officer [NCIt concept]
- Non-nodal Regional Disease Indicator [NCIt concept]
- Non-nodal Tumor Deposits Indicator [NCIt concept]
- Nonalcoholic Fatty Liver Disease [NCIt concept]
- Nonalcoholic Steatohepatitis [NCIt concept]
- Nonclonal Cellular Population Present [NCIt concept]
- None [NCIt concept]
- Nongerminomatous Germ Cell Tumor [NCIt concept]
- Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation [NCIt concept]
- Nonpigmented Nevus [NCIt concept]
- Nonsense Mutation [NCIt concept]
- Nonstop Mutation [NCIt concept]
- Noraramtide [NCIt concept]
- Norcantharidin Lipid Microspheres [NCIt concept]
- Norepinephrine-Secreting [NCIt concept]
- Norgestrel [NCIt concept]
- Normal [NCIt concept]
- Normal Tissue Sample [NCIt concept]
- Normal and Tumor Sample Distance [NCIt concept]
- Normal or Tumor Sample Pathology Indicator [NCIt concept]
- Normetanephrine-Secreting [NCIt concept]
- North American Ginseng Extract AFX-2 [NCIt concept]
- North Macedonia [NCIt concept]
- Northern Mariana Islands [NCIt concept]
- Nortopixantrone [NCIt concept]
- Norway [NCIt concept]
- Noscapine [NCIt concept]
- Noscapine Hydrochloride [NCIt concept]
- Not Allowed To Collect [NCIt concept]
- Not Applicable [NCIt concept]
- Not Hispanic or Latino [NCIt concept]
- Not Otherwise Specified [NCIt concept]
- Not Performed [NCIt concept]
- Not Reported [NCIt concept]
- Notch Signaling Inhibitor PF-06650808 [NCIt concept]
- Notch Signaling Pathway Inhibitor MK0752 [NCIt concept]
- Nuclear Grade III or IV [NCIt concept]
- Nuclear Staining Method [NCIt concept]
- Nucleic Acid Aliquot Volume [NCIt concept]
- Nucleic Acid Extraction Method [NCIt concept]
- Nucleic RNA Sample [NCIt concept]
- Nucleolin Antagonist IPP-204106N [NCIt concept]
- Nucleoside Analog DFP-10917 [NCIt concept]
- Nucleotide Analogue GS 9219 [NCIt concept]
- Nucleotide Base Caller Name [NCIt concept]
- Nucleotide Base Caller Version [NCIt concept]
- Nucleotide Sequence Read [NCIt concept]
- Nucleotide Sequencing Aliquot Weight [NCIt concept]
- Nucleotide Sequencing Analyte Volume [NCIt concept]
- Nucleotide Sequencing Analyte Weight [NCIt concept]
- Nucleotide Sequencing Date [NCIt concept]
- Nucleotide Sequencing Site Name [NCIt concept]
- Nullizygosity [NCIt concept]
- Number of Cells in Metaphase during Karyotyping [NCIt concept]
- Number of Days Between Index Date and Adverse Event [NCIt concept]
- Number of Days Between Index Date and Best Overall Response [NCIt concept]
- Number of Days Between Index Date and Comorbidity [NCIt concept]
- Number of Days Between Index Date and Death [NCIt concept]
- Number of Days Between Index Date and Diagnosis [NCIt concept]
- Number of Days Between Index Date and Disease Progression [NCIt concept]
- Number of Days Between Index Date and Disease Recurrence [NCIt concept]
- Number of Days Between Index Date and First Event [NCIt concept]
- Number of Days Between Index Date and Imaging Procedure [NCIt concept]
- Number of Days Between Index Date and Laboratory Test [NCIt concept]
- Number of Days Between Index Date and Last Follow Up [NCIt concept]
- Number of Days Between Index Date and Last Known Disease Status [NCIt concept]
- Number of Days Between Index Date and Lost to Follow Up [NCIt concept]
- Number of Days Between Index Date and Nucleotide Sequencing Assay [NCIt concept]
- Number of Days Between Index Date and Participation Consent [NCIt concept]
- Number of Days Between Index Date and Pathology Review [NCIt concept]
- Number of Days Between Index Date and Progression Free Status [NCIt concept]
- Number of Days Between Index Date and Risk Factor Diagnosis [NCIt concept]
- Number of Days Between Index Date and Specimen Collection [NCIt concept]
- Number of Days Between Index Date and Treatment End [NCIt concept]
- Number of Days Between Index Date and Treatment Start [NCIt concept]
- Number of Discontiguous Lesions (New Tumor Event) [NCIt concept]
- Number of Disease-Involved Anatomic Sites [NCIt concept]
- Number of Elapsed Days Between Treatment and Outcome [NCIt concept]
- Number of Gene Copies [NCIt concept]
- Number of Lymph Nodes Examined [NCIt concept]
- Number of Lymph Nodes Positive [NCIt concept]
- Number of Patient Relatives with History of Cancer [NCIt concept]
- Number of Peripancreatic Lymph Nodes Examined [NCIt concept]
- Number of Peripancreatic Lymph Nodes Positive [NCIt concept]
- Number of Pregnancies [NCIt concept]
- Number of Prostatic Chips Examined [NCIt concept]
- Number of Prostatic Chips Positive [NCIt concept]
- Number of RECIST Baseline Target Lesion [NCIt concept]
- Number of Recovered Cells Expected [NCIt concept]
- Number of Sequence Variants [NCIt concept]
- Number of Treated Lesions [NCIt concept]
- Number of Values in Staining Intensity Scale [NCIt concept]
- Number of Years in Occupation [NCIt concept]
- Numerical Clerk [NCIt concept]
- Numidargistat [NCIt concept]
- Nursing and Midwifery Associate Professional [NCIt concept]
- Nursing and Midwifery Professional [NCIt concept]
- Nurulimab [NCIt concept]
- Nut Allergy [NCIt concept]
- Nutraceutical TBL-12 [NCIt concept]
- Nystagmus, CTCAE 5.0 [NCIt concept]
- O-Chloroacetylcarbamoylfumagillol [NCIt concept]
- O6-Benzylguanine [NCIt concept]
- OCT Embedded Indicator [NCIt concept]
- OLIG2 Gene [NCIt concept]
- OMD Gene [NCIt concept]
- OPCs/Green Tea/Spirullina/Curcumin/Antrodia Camphorate/Fermented Soymilk Extract Capsule [NCIt concept]
- Obatoclax Mesylate [NCIt concept]
- Obecabtagene Autoleucel [NCIt concept]
- Obesity [NCIt concept]
- Obesity, CTCAE [NCIt concept]
- Obinutuzumab [NCIt concept]
- Oblimersen Sodium [NCIt concept]
- Obrindatamab [NCIt concept]
- Obstruction Gastric, CTCAE [NCIt concept]
- Ocaratuzumab [NCIt concept]
- Occasional Drinker [NCIt concept]
- Occasionally [NCIt concept]
- Occipital Lobe [NCIt concept]
- Occipital Lobe Cortex [NCIt concept]
- Occipital Lymph Node [NCIt concept]
- Occupation [NCIt concept]
- Occupational Artificial Smoke Machine Smoke Exposure [NCIt concept]
- Occupational Exposure [NCIt concept]
- Occupational Fire Fighting Smoke Exposure [NCIt concept]
- Occupational Foundry Smoke Exposure [NCIt concept]
- Occupational Generator Smoke Exposure [NCIt concept]
- Occupational Military Smoke Exposure [NCIt concept]
- Occupational Paint Baking Smoke Exposure [NCIt concept]
- Occupational Plastics Factory Smoke Exposure [NCIt concept]
- Occupational Plumbing Smoke Exposure [NCIt concept]
- Occupational Soldering/Welding Smoke Exposure [NCIt concept]
- Ocifisertib Fumarate [NCIt concept]
- Ociperlimab [NCIt concept]
- Ocrelizumab [NCIt concept]
- Octreotide [NCIt concept]
- Octreotide Acetate [NCIt concept]
- Octreotide Depot Formulation CAM2029 [NCIt concept]
- Octreotide Pamoate [NCIt concept]
- Octreotide Sustained-release Formulation Debio 4126 [NCIt concept]
- Oculomotor Nerve Disorder, CTCAE [NCIt concept]
- Odetiglucan [NCIt concept]
- Odontoameloblastoma [NCIt concept]
- Odontogenic Carcinoma [NCIt concept]
- Odontogenic Carcinosarcoma [NCIt concept]
- Odontogenic Fibroma [NCIt concept]
- Odontogenic Myxofibroma [NCIt concept]
- Odontogenic Myxoma [NCIt concept]
- Odontogenic Neoplasm [NCIt concept]
- Odontogenic Sarcoma [NCIt concept]
- Odontoma [NCIt concept]
- Odronextamab [NCIt concept]
- Ofatumumab [NCIt concept]
- Offspring [NCIt concept]
- Ofranergene Obadenovec [NCIt concept]
- Oglufanide Disodium [NCIt concept]
- Olaparib [NCIt concept]
- Olaptesed Pegol [NCIt concept]
- Olaratumab [NCIt concept]
- Oleandrin [NCIt concept]
- Oleclumab [NCIt concept]
- Olfactory Nerve [NCIt concept]
- Olfactory Nerve Disorder, CTCAE [NCIt concept]
- Olfactory Neuroblastoma [NCIt concept]
- Olfactory Neurocytoma [NCIt concept]
- Olfactory Neurogenic Tumor [NCIt concept]
- Oligo-fucoidan [NCIt concept]
- Oligoastrocytoma [NCIt concept]
- Oligodendroblastoma [NCIt concept]
- Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted [NCIt concept]
- Oligodendroglioma, Not Otherwise Specified [NCIt concept]
- Oligonucleotide SPC2996 [NCIt concept]
- Oligospermia, CTCAE [NCIt concept]
- Olinvacimab [NCIt concept]
- Olivomycin [NCIt concept]
- Olmutinib [NCIt concept]
- Oltipraz [NCIt concept]
- Olutasidenib [NCIt concept]
- Olverembatinib [NCIt concept]
- Olvimulogene Nanivacirepvec [NCIt concept]
- Omacetaxine [NCIt concept]
- Omacetaxine Mepesuccinate [NCIt concept]
- Oman [NCIt concept]
- Ombrabulin [NCIt concept]
- Omenn Syndrome [NCIt concept]
- Omentectomy [NCIt concept]
- Omentum [NCIt concept]
- Omipalisib [NCIt concept]
- Ompenaclid [NCIt concept]
- Onalespib [NCIt concept]
- Onalespib Lactate [NCIt concept]
- Onametostat [NCIt concept]
- Onartuzumab [NCIt concept]
- Onatasertib [NCIt concept]
- Once Weekly [NCIt concept]
- Once a Week for at Least a Year [NCIt concept]
- Oncocytic Adenocarcinoma [NCIt concept]
- Oncocytic Adenoma [NCIt concept]
- Oncocytic Neoplasm [NCIt concept]
- Oncocytic Variant Thyroid Gland Papillary Carcinoma [NCIt concept]
- Oncolytic Adenovirus AdAPT-001 [NCIt concept]
- Oncolytic Adenovirus Expressing Interferon Beta/CD40 Ligand MEM-288 [NCIt concept]
- Oncolytic Adenovirus Expressing Interferon YSCH-01 [NCIt concept]
- Oncolytic Adenovirus ICOVIR5-infected Allogeneic Mesenchymal Stem Cells [NCIt concept]
- Oncolytic Adenovirus ICVB-1042 [NCIt concept]
- Oncolytic Adenovirus ORCA-010 [NCIt concept]
- Oncolytic HSV-1 C134 [NCIt concept]
- Oncolytic HSV-1 Expressing Anti-PD-1 scFv-Fc/TGFbRII Decoy/IL-12 STI-1386 [NCIt concept]
- Oncolytic HSV-1 Expressing IL-12 and Anti-PD-1 Antibody MVR-C5252 [NCIt concept]
- Oncolytic HSV-1 Expressing IL-12 and Anti-PD-1 Antibody T3011 [NCIt concept]
- Oncolytic HSV-1 Expressing IL-12 and IL-15/IL-15-receptor Alpha VG2025 [NCIt concept]
- Oncolytic HSV-1 Expressing IL-12, IL-15/IL-15-receptor Alpha and PD-L1 Blocking Peptide VG161 [NCIt concept]
- Oncolytic HSV-1 G207 [NCIt concept]
- Oncolytic HSV-1 NV1020 [NCIt concept]
- Oncolytic HSV-1 R130 [NCIt concept]
- Oncolytic HSV-1 rQNestin34.5v.2 [NCIt concept]
- Oncolytic HSV-1 rRp450 [NCIt concept]
- Oncolytic HSV1716 [NCIt concept]
- Oncolytic Herpes Simplex Virus-1 Expressing Anti-CTLA-4 Antibody-like Molecule and GM-CSF RP2 [NCIt concept]
- Oncolytic Herpes Simplex Virus-1 Expressing Anti-CTLA-4 Antibody/CD40L/4-1BBL RP3 [NCIt concept]
- Oncolytic Herpes Simplex Virus-1 ONCR-177 [NCIt concept]
- Oncolytic Influenza A Virus [NCIt concept]
- Oncolytic Measles Virus Encoding Helicobacter pylori Neutrophil-activating Protein [NCIt concept]
- Oncolytic Newcastle Disease Virus MEDI5395 [NCIt concept]
- Oncolytic Newcastle Disease Virus MTH-68H [NCIt concept]
- Oncolytic Newcastle Disease Virus Strain PV701 [NCIt concept]
- Oncolytic RNA Virus IVX037 [NCIt concept]
- Oncolytic Type 2 Herpes Simplex Virus Expressing Anti-PD-L1/CD3 Bispecific Antibody BS-006 [NCIt concept]
- Oncolytic VSV-GP BI 1821736 [NCIt concept]
- Oncolytic Vaccinia Virus Expressing Anti-CD19/CD3 Bispecific Antibody RGV004 [NCIt concept]
- Oncolytic Vaccinia Virus Expressing Anti-CTLA-4 Antibody and GM-CSF BT-001 [NCIt concept]
- Oncolytic Vaccinia Virus OVV-01 [NCIt concept]
- Oncolytic Vaccinia Virus PF-07263689 [NCIt concept]
- Oncolytic Vesicular Stomatitis Virus [NCIt concept]
- Oncolytic Virus ASP9801 [NCIt concept]
- Oncolytic Virus CF33-expressing hNIS/Anti-PD-L1 Antibody [NCIt concept]
- Oncolytic Virus M1-c6v1 [NCIt concept]
- Oncolytic Virus RT-01 [NCIt concept]
- Ondansetron Hydrochloride [NCIt concept]
- One to Three Positive Lymph Nodes [NCIt concept]
- Onfekafusp Alfa [NCIt concept]
- Onilcamotide [NCIt concept]
- Ontorpacept [NCIt concept]
- Ontuxizumab [NCIt concept]
- Onvansertib [NCIt concept]
- Onvatilimab [NCIt concept]
- Onvitrelin Ucalontide [NCIt concept]
- Onzigolide [NCIt concept]
- Oophorectomy [NCIt concept]
- Opaganib [NCIt concept]
- Open [NCIt concept]
- Open Partial Nephrectomy [NCIt concept]
- Open Radical Nephrectomy [NCIt concept]
- Open Radical Prostatectomy [NCIt concept]
- Open Surgical Procedure [NCIt concept]
- Opevesostat [NCIt concept]
- Opioid Growth Factor [NCIt concept]
- Opnurasib [NCIt concept]
- Opolimogene Capmilisbac [NCIt concept]
- Oportuzumab Monatox [NCIt concept]
- Oprozomib [NCIt concept]
- Optic Disc Melanocytoma [NCIt concept]
- Optic Nerve [NCIt concept]
- Optic Nerve Disorder, CTCAE [NCIt concept]
- Optimal Cutting Temperature Compound [NCIt concept]
- Opucolimab [NCIt concept]
- Oral Aminolevulinic Acid Hydrochloride [NCIt concept]
- Oral Azacitidine [NCIt concept]
- Oral Cancer Vaccine V3-OVA [NCIt concept]
- Oral Cavity [NCIt concept]
- Oral Cavity Fistula, CTCAE [NCIt concept]
- Oral Contraceptive [NCIt concept]
- Oral Docetaxel [NCIt concept]
- Oral Dysesthesia, CTCAE [NCIt concept]
- Oral Fludarabine Phosphate [NCIt concept]
- Oral Hemorrhage, CTCAE [NCIt concept]
- Oral Hsp90 Inhibitor IPI-493 [NCIt concept]
- Oral Hypoglycemic Diabetes Therapy [NCIt concept]
- Oral Irinotecan Hydrochloride Formulation VAL-413 [NCIt concept]
- Oral Ixabepilone [NCIt concept]
- Oral Microencapsulated Diindolylmethane [NCIt concept]
- Oral Mucosa [NCIt concept]
- Oral Myoma Vaccine V3-myoma [NCIt concept]
- Oral Pain, CTCAE 5.0 [NCIt concept]
- Oral Pancreatic Cancer Vaccine V3-P [NCIt concept]
- Oral Picoplatin [NCIt concept]
- Oral Route of Administration [NCIt concept]
- Oral Sodium Phenylbutyrate [NCIt concept]
- Oral Topotecan Hydrochloride [NCIt concept]
- Orantinib [NCIt concept]
- Oraxol [NCIt concept]
- Orbit [NCIt concept]
- Orchiectomy [NCIt concept]
- Orchiopexy [NCIt concept]
- Ordesekimab [NCIt concept]
- Oregovomab [NCIt concept]
- Orelabrutinib [NCIt concept]
- Organ Transplantation [NCIt concept]
- Organoid [NCIt concept]
- Original Tumor Cell Sample [NCIt concept]
- Orludodstat [NCIt concept]
- Ormaplatin [NCIt concept]
- Oropharynx [NCIt concept]
- Ortataxel [NCIt concept]
- Orteronel [NCIt concept]
- Orvacabtagene Autoleucel [NCIt concept]
- Osemitamab [NCIt concept]
- Osilodrostat [NCIt concept]
- Osimertinib [NCIt concept]
- Ossifying Fibroma [NCIt concept]
- Ossifying Fibromyxoid Tumor [NCIt concept]
- Ossifying Renal Tumor of Infancy [NCIt concept]
- Osteoarthritis [NCIt concept]
- Osteoblastic Osteosarcoma [NCIt concept]
- Osteoblastoma [NCIt concept]
- Osteochondroma [NCIt concept]
- Osteoid Osteoma [NCIt concept]
- Osteoma [NCIt concept]
- Osteonecrosis of Jaw, CTCAE [NCIt concept]
- Osteopenia [NCIt concept]
- Osteoporosis [NCIt concept]
- Osteoporosis, CTCAE 5.0 [NCIt concept]
- Osteosarcoma [NCIt concept]
- Osteosarcoma Arising in Paget Disease of Bone [NCIt concept]
- Osugacestat [NCIt concept]
- Osunprotafib [NCIt concept]
- Other [NCIt concept]
- Other Clerical Support Worker [NCIt concept]
- Other Craft and Related Worker [NCIt concept]
- Other Elementary Worker [NCIt concept]
- Other Endocrine Glands and Related Structures ICD-O-3 [NCIt concept]
- Other Eye Color [NCIt concept]
- Other Health Associate Professional [NCIt concept]
- Other Health Professional [NCIt concept]
- Other Molecular Analysis [NCIt concept]
- Other Personal Services Worker [NCIt concept]
- Other Sales and Related Workers [NCIt concept]
- Other Services Manager [NCIt concept]
- Other Specified Parts of Pancreas [NCIt concept]
- Other Stationary Plant and Machine Operator [NCIt concept]
- Other Teachers and Instructors [NCIt concept]
- Other and Ill Defined Digestive Organs ICD-O-3 [NCIt concept]
- Other and Ill-Defined Sites ICD-O-3 [NCIt concept]
- Other and Ill-Defined Sites in Lip, Oral Cavity and Pharynx ICD-O-3 [NCIt concept]
- Other and Ill-Defined Sites within Respiratory System and Intrathoracic Organs ICD-O-3 [NCIt concept]
- Other and Unspecified Female Genital Organs ICD-O-3 [NCIt concept]
- Other and Unspecified Major Salivary Glands ICD-O-3 [NCIt concept]
- Other and Unspecified Male Genital Organs ICD-O-3 [NCIt concept]
- Other and Unspecified Parts of Biliary Tract ICD-O-3 [NCIt concept]
- Other and Unspecified Parts of Mouth ICD-O-3 [NCIt concept]
- Other and Unspecified Parts of Tongue ICD-O-3 [NCIt concept]
- Other and Unspecified Urinary Organs ICD-O-3 [NCIt concept]
- Otitis Externa [NCIt concept]
- Otitis Externa, CTCAE [NCIt concept]
- Otitis Media, CTCAE [NCIt concept]
- Otlertuzumab [NCIt concept]
- Outcome of Therapy [NCIt concept]
- Ovapuldencel-T [NCIt concept]
- Ovarian Cancer Stem Cell/hTERT/Survivin mRNAs-loaded Autologous Dendritic Cell Vaccine DC-006 [NCIt concept]
- Ovarian Capsule Fragmented [NCIt concept]
- Ovarian Capsule Intact [NCIt concept]
- Ovarian Capsule Ruptured [NCIt concept]
- Ovarian Capsule Status [NCIt concept]
- Ovarian Clear Cell Adenocarcinofibroma [NCIt concept]
- Ovarian Dysgerminoma [NCIt concept]
- Ovarian Endometrioid Adenocarcinofibroma [NCIt concept]
- Ovarian Endometrioid Adenofibroma [NCIt concept]
- Ovarian Endometrioid Cystadenofibroma [NCIt concept]
- Ovarian Gynandroblastoma [NCIt concept]
- Ovarian Hemorrhage, CTCAE [NCIt concept]
- Ovarian Hilus Cell Tumor [NCIt concept]
- Ovarian Infection, CTCAE [NCIt concept]
- Ovarian Luteinized Thecoma [NCIt concept]
- Ovarian Mucinous Adenocarcinofibroma [NCIt concept]
- Ovarian Rupture, CTCAE [NCIt concept]
- Ovarian Sclerosing Stromal Tumor [NCIt concept]
- Ovarian Seromucinous Carcinoma [NCIt concept]
- Ovarian Serous Adenocarcinofibroma [NCIt concept]
- Ovarian Serous Cystadenocarcinoma [NCIt concept]
- Ovarian Sertoli Cell Tumor with Lipid Storage [NCIt concept]
- Ovarian Sertoli-Leydig Cell Tumor [NCIt concept]
- Ovarian Sertoli-Leydig Cell Tumor with Retiform Elements [NCIt concept]
- Ovarian Sex Cord Tumor with Annular Tubules [NCIt concept]
- Ovarian Sex Cord-Stromal Tumor [NCIt concept]
- Ovarian Small Cell Carcinoma, Hypercalcemic Type [NCIt concept]
- Ovarian Small Cell Carcinoma, Pulmonary-Type [NCIt concept]
- Ovarian Steroid Cell Tumor [NCIt concept]
- Ovarian Stromal Luteoma [NCIt concept]
- Ovarian Stromal Tumor with Minor Sex Cord Elements [NCIt concept]
- Ovarian Surface Involvement Indicator [NCIt concept]
- Ovary [NCIt concept]
- Overlapping/Multiple Zones of Prostate [NCIt concept]
- Ovine Submaxillary Mucin [NCIt concept]
- Ovulation Pain, CTCAE 5.0 [NCIt concept]
- OxPhos Inhibitor VLX600 [NCIt concept]
- Oxaliplatin [NCIt concept]
- Oxaliplatin Eluting Beads [NCIt concept]
- Oxaliplatin-Encapsulated Transferrin-Conjugated N-glutaryl Phosphatidylethanolamine Liposome [NCIt concept]
- Oxcarbazepine [NCIt concept]
- Oxeclosporin [NCIt concept]
- Oxidative Phosphorylation Inhibitor IACS-010759 [NCIt concept]
- Oxidopamine [NCIt concept]
- Oxygen Carrier YQ23 [NCIt concept]
- Ozarelix [NCIt concept]
- Ozekibart [NCIt concept]
- Ozuriftamab Vedotin [NCIt concept]
- P-cadherin Antagonist PF-03732010 [NCIt concept]
- P-cadherin Inhibitor PCA062 [NCIt concept]
- P-cadherin-targeting Agent PF-06671008 [NCIt concept]
- P-p68 Inhibitor RX-5902 [NCIt concept]
- P2RY8 Gene [NCIt concept]
- P30-linked EphA2/CMV pp65/Survivin Peptide Vaccine P30-EPS [NCIt concept]
- PABPC1 Gene [NCIt concept]
- PAFAH1B2 Gene [NCIt concept]
- PAI-1 Inhibitor ACT001 [NCIt concept]
- PAK4 Inhibitor PF-03758309 [NCIt concept]
- PALB2 Gene [NCIt concept]
- PAP/PSA-expressing Arenaviral Vectors HB-302/HB-301 [NCIt concept]
- PARG Inhibitor IDE161 [NCIt concept]
- PARP 1/2 Inhibitor NOV1401 [NCIt concept]
- PARP 1/2 Inhibitor RP12146 [NCIt concept]
- PARP 1/2 Inhibitor SC10914 [NCIt concept]
- PARP 1/2 Inhibitor TQB3823 [NCIt concept]
- PARP Inhibitor AZD2461 [NCIt concept]
- PARP Inhibitor CEP-9722 [NCIt concept]
- PARP Inhibitor E7016 [NCIt concept]
- PARP Inhibitor NMS-03305293 [NCIt concept]
- PARP-1/2 Inhibitor ABT-767 [NCIt concept]
- PARP/Microtubule Polymerization Inhibitor AMXI-5001 [NCIt concept]
- PARP/Tankyrase Inhibitor 2X-121 [NCIt concept]
- PARP1 Inhibitor AZD9574 [NCIt concept]
- PARP1 Inhibitor HS-10502 [NCIt concept]
- PATZ1 Gene [NCIt concept]
- PAX3 Gene [NCIt concept]
- PAX5 Gene [NCIt concept]
- PAX7 Gene [NCIt concept]
- PAX8 Gene [NCIt concept]
- PBRM1 Gene [NCIt concept]
- PBX1 Gene [NCIt concept]
- PCBP1 Gene [NCIt concept]
- PCM1 Gene [NCIt concept]
- PCNA Inhibitor AOH1996 [NCIt concept]
- PCNU [NCIt concept]
- PD-1 Directed Probody CX-188 [NCIt concept]
- PD-1 Targeted IL-15 Mutein Fusion Protein PF-07209960 [NCIt concept]
- PD-1-positive B-cell Peptide Antigen/MVF IMU-201/Montanide Vaccine [NCIt concept]
- PD-L1 Combined Positive Score 20 [NCIt concept]
- PD-L1 Inhibitor ABSK043 [NCIt concept]
- PD-L1 Inhibitor AN4005 [NCIt concept]
- PD-L1 Inhibitor BPI-371153 [NCIt concept]
- PD-L1 Inhibitor GS-4224 [NCIt concept]
- PD-L1 Inhibitor INCB086550 [NCIt concept]
- PD-L1 Inhibitor INCB099280 [NCIt concept]
- PD-L1 Inhibitor INCB099318 [NCIt concept]
- PD-L1/4-1BB/HSA Trispecific Fusion Protein NM21-1480 [NCIt concept]
- PD-L1/PD-L2/VISTA Antagonist CA-170 [NCIt concept]
- PD1 Inhibitor [NCIt concept]
- PDCD1LG2 Gene [NCIt concept]
- PDE4DIP Gene [NCIt concept]
- PDGFB Gene [NCIt concept]
- PDGFR alpha/KIT Mutant-specific Inhibitor NB003 [NCIt concept]
- PDGFRA Gene [NCIt concept]
- PDGFRB Gene [NCIt concept]
- PDK1 Inhibitor AR-12 [NCIt concept]
- PDPN Gene [NCIt concept]
- PE/HPV16 E7/KDEL Fusion Protein/GPI-0100 TVGV-1 [NCIt concept]
- PEG-PEI-cholesterol Lipopolymer-encased IL-12 DNA Plasmid Vector IMNN-001 [NCIt concept]
- PEG-interleukin-2 [NCIt concept]
- PEG-modified/Site-mutated IL-2 SHR-1916 [NCIt concept]
- PEOX-based Polymer Encapsulated Paclitaxel FID-007 [NCIt concept]
- PEP-3-KLH Conjugate Vaccine [NCIt concept]
- PER1 Gene [NCIt concept]
- PERK Inhibitor HC-5404-FU [NCIt concept]
- PERK Inhibitor NMS-03597812 [NCIt concept]
- PGLA/PEG Copolymer-Based Paclitaxel [NCIt concept]
- PGR Gene [NCIt concept]
- PH20 Hyaluronidase-expressing Adenovirus VCN-01 [NCIt concept]
- PHF23 Gene [NCIt concept]
- PHF6 Gene [NCIt concept]
- PHOX2B Gene [NCIt concept]
- PI3K Alpha/Beta Inhibitor BAY1082439 [NCIt concept]
- PI3K Alpha/mTOR Inhibitor PWT33597 Mesylate [NCIt concept]
- PI3K Inhibitor BGT226 [NCIt concept]
- PI3K Inhibitor GSK1059615 [NCIt concept]
- PI3K Inhibitor TL117 [NCIt concept]
- PI3K Inhibitor WX-037 [NCIt concept]
- PI3K Inhibitor ZSTK474 [NCIt concept]
- PI3K alpha/delta Inhibitor TQ-B3525 [NCIt concept]
- PI3K p110beta/delta Inhibitor KA2237 [NCIt concept]
- PI3K-alpha Inhibitor HS-10352 [NCIt concept]
- PI3K-alpha Inhibitor TOS-358 [NCIt concept]
- PI3K-beta Inhibitor GSK2636771 [NCIt concept]
- PI3K-beta Inhibitor SAR260301 [NCIt concept]
- PI3K-delta Inhibitor AMG 319 [NCIt concept]
- PI3K-delta Inhibitor BGB-10188 [NCIt concept]
- PI3K-delta Inhibitor SHC014748M [NCIt concept]
- PI3K-gamma Inhibitor HS248 [NCIt concept]
- PI3K-gamma Inhibitor ZX-4081 [NCIt concept]
- PI3K/BET Inhibitor LY294002 [NCIt concept]
- PI3K/HDAC Inhibitor BEBT-908 [NCIt concept]
- PI3K/mTOR Inhibitor CLL442 [NCIt concept]
- PI3K/mTOR Inhibitor HEC 68498 [NCIt concept]
- PI3K/mTOR Kinase Inhibitor DS-7423 [NCIt concept]
- PI3K/mTOR Kinase Inhibitor PF-04691502 [NCIt concept]
- PI3K/mTOR Kinase Inhibitor VS-5584 [NCIt concept]
- PI3K/mTOR Kinase Inhibitor WXFL10030390 [NCIt concept]
- PI3K/mTORC1/mTORC2 Inhibitor DCBCI0901 [NCIt concept]
- PI3Ka/mTOR Inhibitor PKI-179 [NCIt concept]
- PI3Kalpha Inhibitor AZD8835 [NCIt concept]
- PI3Kbeta Inhibitor AZD8186 [NCIt concept]
- PI3Kdelta Inhibitor GS-9901 [NCIt concept]
- PI3Kdelta/gamma Inhibitor ZX-101A [NCIt concept]
- PICALM Gene [NCIt concept]
- PIERCE2 Gene [NCIt concept]
- PIK3CA Gene [NCIt concept]
- PIK3CB Gene [NCIt concept]
- PIK3R1 Gene [NCIt concept]
- PIM Kinase Inhibitor LGH447 [NCIt concept]
- PIM Kinase Inhibitor SGI-1776 [NCIt concept]
- PIM Kinase Inhibitor TP-3654 [NCIt concept]
- PIM/FLT3 Kinase Inhibitor SEL24 [NCIt concept]
- PIM1 Gene [NCIt concept]
- PIM3 Gene [NCIt concept]
- PKA Regulatory Subunit RIalpha Mixed-Backbone Antisense Oligonucleotide GEM 231 [NCIt concept]
- PKC-beta Inhibitor MS-553 [NCIt concept]
- PLAG1 Gene [NCIt concept]
- PLCG1 Gene [NCIt concept]
- PLK1 Inhibitor TAK-960 [NCIt concept]
- PLZ4-coated Paclitaxel-loaded Micelle Formulation [NCIt concept]
- PML Gene [NCIt concept]
- PMS1 Gene [NCIt concept]
- PMS2 Gene [NCIt concept]
- POLD1 Gene [NCIt concept]
- POLE Gene [NCIt concept]
- POLG Gene [NCIt concept]
- POLQ Gene [NCIt concept]
- POT1 Gene [NCIt concept]
- POU2AF1 Gene [NCIt concept]
- POU5F1 Gene [NCIt concept]
- PPAR Alpha Antagonist TPST-1120 [NCIt concept]
- PPAR Gamma Inhibitor FX-909 [NCIt concept]
- PPARG Gene [NCIt concept]
- PPFIBP1 Gene [NCIt concept]
- PPM1D Gene [NCIt concept]
- PPP2R1A Gene [NCIt concept]
- PPP6C Gene [NCIt concept]
- PR1 Leukemia Peptide Vaccine [NCIt concept]
- PRAME-targeting T-cell Receptor/Inducible Caspase 9 BPX-701 [NCIt concept]
- PRC2 Inhibitor ORIC-944 [NCIt concept]
- PRCC Gene [NCIt concept]
- PRDM1 Gene [NCIt concept]
- PRDM16 Gene [NCIt concept]
- PRDM2 Gene [NCIt concept]
- PREX2 Gene [NCIt concept]
- PRF1 Gene [NCIt concept]
- PRKACA Gene [NCIt concept]
- PRKAR1A Gene [NCIt concept]
- PRKCB Gene [NCIt concept]
- PRMT1 Inhibitor GSK3368715 [NCIt concept]
- PRMT5 Inhibitor AMG 193 [NCIt concept]
- PRMT5 Inhibitor AUR-105 [NCIt concept]
- PRMT5 Inhibitor AZD3470 [NCIt concept]
- PRMT5 Inhibitor PRT811 [NCIt concept]
- PRMT5 Inhibitor SH3765 [NCIt concept]
- PRMT5 Inhibitor SKL27969 [NCIt concept]
- PRMT5 Inhibitor SYHX2001 [NCIt concept]
- PRMT5 Inhibitor TNG462 [NCIt concept]
- PRMT5 Inhibitor TNG908 [NCIt concept]
- PRMT5-MTA Inhibitor MRTX1719 [NCIt concept]
- PRPF40B Gene [NCIt concept]
- PRRX1 Gene [NCIt concept]
- PSA/IL-2/GM-CSF Vaccine [NCIt concept]
- PSA/PSMA DNA Plasmid INO-5150 [NCIt concept]
- PSA/PSMA/PSCA-encoding DNA Plasmid Vaccine PF-06755990 [NCIt concept]
- PSIP1 Gene [NCIt concept]
- PSMA-specific Targeting Module TMpPSMA [NCIt concept]
- PSMA-targeted Docetaxel Nanoparticles BIND-014 [NCIt concept]
- PSMA-targeted Tubulysin B-containing Conjugate EC1169 [NCIt concept]
- PSMA-targeting Fluorescent Imaging Agent MDX1201-A488 [NCIt concept]
- PSMA-targeting T-cell Redirecting Agent JNJ-80038114 [NCIt concept]
- PSMA/CD3 Tri-specific T-cell Activating Construct HPN424 [NCIt concept]
- PTCH1 Gene [NCIt concept]
- PTEN Gene [NCIt concept]
- PTGS2 Gene [NCIt concept]
- PTK6 Gene [NCIt concept]
- PTP4A1 Gene [NCIt concept]
- PTPN11 Gene [NCIt concept]
- PTPN13 Gene [NCIt concept]
- PTPN6 Gene [NCIt concept]
- PTPRB Gene [NCIt concept]
- PTPRC Gene [NCIt concept]
- PTPRK Gene [NCIt concept]
- PTPRT Gene [NCIt concept]
- PVA Microporous Hydrospheres [NCIt concept]
- PVA Microporous Hydrospheres/Doxorubicin Hydrochloride [NCIt concept]
- PWWP2A Gene [NCIt concept]
- Pacanalotamab [NCIt concept]
- Pacinian Neurofibroma [NCIt concept]
- Pack Year [NCIt concept]
- Paclitaxel [NCIt concept]
- Paclitaxel Ceribate [NCIt concept]
- Paclitaxel Injection Concentrate for Nanodispersion [NCIt concept]
- Paclitaxel Liposome [NCIt concept]
- Paclitaxel PPE Microspheres [NCIt concept]
- Paclitaxel Poliglumex [NCIt concept]
- Paclitaxel Polymeric Micelle Formulation NANT-008 [NCIt concept]
- Paclitaxel Trevatide [NCIt concept]
- Paclitaxel Vitamin E-Based Emulsion [NCIt concept]
- Paclitaxel and Hyaluronic Acid [NCIt concept]
- Paclitaxel-Loaded Polymeric Micelle [NCIt concept]
- Paclitaxel-conjugated CXCR4 Peptide Antagonist MB1707 [NCIt concept]
- Paclitaxel-loaded Tumor Penetrating Microparticles [NCIt concept]
- Pacmilimab [NCIt concept]
- Pacritinib [NCIt concept]
- Pacritinib Citrate [NCIt concept]
- Padeliporfin [NCIt concept]
- Padnarsertib [NCIt concept]
- Padoporfin [NCIt concept]
- Pagetoid Reticulosis [NCIt concept]
- Pain [NCIt concept]
- Pain In Extremity, CTCAE [NCIt concept]
- Pain of Skin, CTCAE [NCIt concept]
- Pain, CTCAE [NCIt concept]
- Painter, Building Structure Cleaner and Related Trades Worker [NCIt concept]
- Paired End Reads Indicator [NCIt concept]
- Pakistan [NCIt concept]
- Palate [NCIt concept]
- Palatectomy [NCIt concept]
- Palatine Tonsil [NCIt concept]
- Palau [NCIt concept]
- Palazestrant [NCIt concept]
- Palbociclib [NCIt concept]
- Palbociclib Isethionate [NCIt concept]
- Palifosfamide [NCIt concept]
- Palifosfamide Tromethamine [NCIt concept]
- Palladium Pd-103 [NCIt concept]
- Palliative [NCIt concept]
- Palliative Therapy [NCIt concept]
- Palmar-Plantar Erythrodysesthesia Syndrome, CTCAE [NCIt concept]
- Palonosetron Hydrochloride [NCIt concept]
- Palpitations, CTCAE [NCIt concept]
- Paltimatrectinib [NCIt concept]
- Paltusotine [NCIt concept]
- Palupiprant [NCIt concept]
- Pamidronate Disodium [NCIt concept]
- Pamidronic Acid [NCIt concept]
- Pamiparib [NCIt concept]
- Pamrevlumab [NCIt concept]
- Pamvatamig [NCIt concept]
- Pan HER/VEGFR2 Receptor Tyrosine Kinase Inhibitor BMS-690514 [NCIt concept]
- Pan-AKT Inhibitor ARQ751 [NCIt concept]
- Pan-AKT Inhibitor LY2503029 [NCIt concept]
- Pan-AKT Kinase Inhibitor GSK690693 [NCIt concept]
- Pan-FGFR Inhibitor ABSK-121 [NCIt concept]
- Pan-FGFR Inhibitor LY2874455 [NCIt concept]
- Pan-HER Inhibitor FCN-411 [NCIt concept]
- Pan-KRAS Inhibitor BI 1701963 [NCIt concept]
- Pan-KRAS Inhibitor YL-17231 [NCIt concept]
- Pan-LOX Inhibitor PXS-5505 [NCIt concept]
- Pan-Mutant-IDH1 Inhibitor Bay-1436032 [NCIt concept]
- Pan-RAF Inhibitor LY3009120 [NCIt concept]
- Pan-RAR Agonist/AP-1 Inhibitor LGD 1550 [NCIt concept]
- Pan-TRK Inhibitor ONO-7579 [NCIt concept]
- Pan-VEGFR/TIE2 Tyrosine Kinase Inhibitor CEP-11981 [NCIt concept]
- Pan-mutant-selective PI3K-alpha Inhibitor RLY-2608 [NCIt concept]
- Pan-mutant-selective PI3K-alpha Inhibitor RLY-5836 [NCIt concept]
- Pan-variant KIT Inhibitor THE-630 [NCIt concept]
- Panama [NCIt concept]
- Pancratistatin [NCIt concept]
- Pancreas [NCIt concept]
- Pancreas Infection, CTCAE [NCIt concept]
- Pancreatectomy [NCIt concept]
- Pancreatic Acinar Cell Cystadenocarcinoma [NCIt concept]
- Pancreatic Anastomotic Leak, CTCAE [NCIt concept]
- Pancreatic Beta Cell Adenoma [NCIt concept]
- Pancreatic Carcinoma [NCIt concept]
- Pancreatic Duct [NCIt concept]
- Pancreatic Duct Stenosis, CTCAE [NCIt concept]
- Pancreatic Enzymes Decreased, CTCAE [NCIt concept]
- Pancreatic Fistula, CTCAE [NCIt concept]
- Pancreatic Glucagonoma [NCIt concept]
- Pancreatic Hemorrhage, CTCAE [NCIt concept]
- Pancreatic Insulinoma [NCIt concept]
- Pancreatic Intraductal Papillary Mucinous Neoplasm, Oncocytic-Type [NCIt concept]
- Pancreatic Intraductal Papillary-Mucinous Neoplasm [NCIt concept]
- Pancreatic Intraductal Papillary-Mucinous Neoplasm with an Associated Invasive Carcinoma [NCIt concept]
- Pancreatic Intraductal Papillary-Mucinous Neoplasm, High Grade [NCIt concept]
- Pancreatic Intraductal Tubulopapillary Neoplasm [NCIt concept]
- Pancreatic Mixed Acinar-Ductal Carcinoma [NCIt concept]
- Pancreatic Mixed Adenoneuroendocrine Carcinoma [NCIt concept]
- Pancreatic Mixed Ductal-Neuroendocrine Carcinoma [NCIt concept]
- Pancreatic Mucinous-Cystic Neoplasm with Intermediate Grade Dysplasia [NCIt concept]
- Pancreatic Mucinous-Cystic Neoplasm, High Grade [NCIt concept]
- Pancreatic Necrosis, CTCAE [NCIt concept]
- Pancreatic Neuroendocrine Carcinoma [NCIt concept]
- Pancreatic Neuroendocrine Microtumor [NCIt concept]
- Pancreatic Neuroendocrine Neoplasm [NCIt concept]
- Pancreatic Neuroendocrine Tumor [NCIt concept]
- Pancreatic Non-Invasive Mucinous Cystadenocarcinoma [NCIt concept]
- Pancreatitis [NCIt concept]
- Pancreatitis, CTCAE 5.0 [NCIt concept]
- Pancreatoblastoma [NCIt concept]
- Panitumumab [NCIt concept]
- Panobinostat [NCIt concept]
- Panobinostat Lactate [NCIt concept]
- Panobinostat Nanoparticle Formulation MTX110 [NCIt concept]
- Panulisib [NCIt concept]
- Pap Smear [NCIt concept]
- Papillary Adenocarcinoma [NCIt concept]
- Papillary Adenofibroma [NCIt concept]
- Papillary Adenoma [NCIt concept]
- Papillary Carcinoma [NCIt concept]
- Papillary Carcinoma In Situ [NCIt concept]
- Papillary Craniopharyngioma [NCIt concept]
- Papillary Cystadenocarcinoma [NCIt concept]
- Papillary Cystadenoma [NCIt concept]
- Papillary Cystic Neoplasm [NCIt concept]
- Papillary Eccrine Adenoma [NCIt concept]
- Papillary Eccrine Carcinoma [NCIt concept]
- Papillary Ependymoma [NCIt concept]
- Papillary Glioneuronal Tumor [NCIt concept]
- Papillary Growth Pattern [NCIt concept]
- Papillary Intralymphatic Angioendothelioma [NCIt concept]
- Papillary Meningioma [NCIt concept]
- Papillary Mucinous Cystadenocarcinoma [NCIt concept]
- Papillary Mucinous Cystadenoma [NCIt concept]
- Papillary Renal Cell Carcinoma [NCIt concept]
- Papillary Serous Cystadenocarcinoma [NCIt concept]
- Papillary Serous Cystadenoma [NCIt concept]
- Papillary Squamous Cell Carcinoma [NCIt concept]
- Papillary Transitional Cell Carcinoma [NCIt concept]
- Papillary Tumor of the Pineal Region [NCIt concept]
- Papillary Urothelial Neoplasm of Low Malignant Potential [NCIt concept]
- Papilledema, CTCAE [NCIt concept]
- Papilloma [NCIt concept]
- Papillomatosis [NCIt concept]
- Papua New Guinea [NCIt concept]
- Papulopustular Rash, CTCAE [NCIt concept]
- Para-Spinal Ganglion [NCIt concept]
- Paraaortic Lymph Node [NCIt concept]
- Paracentesis [NCIt concept]
- Parachordoma [NCIt concept]
- Paraganglioma [NCIt concept]
- Paraguay [NCIt concept]
- Paramedic [NCIt concept]
- Parametrium [NCIt concept]
- Paranasal Sinus [NCIt concept]
- Parasympathetic Paraganglioma [NCIt concept]
- Parathyroid Gland [NCIt concept]
- Parathyroid Gland Chief Cell Adenoma [NCIt concept]
- Parathyroid Gland Water-Clear Cell Adenoma [NCIt concept]
- Parenchyma [NCIt concept]
- Parent [NCIt concept]
- Parent with Radiation Exposure Indicator [NCIt concept]
- Paresthesia, CTCAE [NCIt concept]
- Paricalcitol [NCIt concept]
- Parietal Lobe [NCIt concept]
- Paronychia, CTCAE [NCIt concept]
- Parosteal Osteosarcoma [NCIt concept]
- Parotid Gland [NCIt concept]
- Parotid Gland Lymph Node [NCIt concept]
- Parotidectomy [NCIt concept]
- Paroxysmal Atrial Tachycardia, CTCAE [NCIt concept]
- Parsaclisib [NCIt concept]
- Parsaclisib Hydrochloride [NCIt concept]
- Parsatuzumab [NCIt concept]
- Partial DNA Methylation [NCIt concept]
- Partial Hepatectomy [NCIt concept]
- Partial Hydatidiform Mole [NCIt concept]
- Partial Laryngectomy [NCIt concept]
- Partial Maxillectomy [NCIt concept]
- Partial Nephrectomy [NCIt concept]
- Partial Remission [NCIt concept]
- Partial Resection [NCIt concept]
- Partially Engineered T-regulatory Cell Donor Graft TRGFT-201 [NCIt concept]
- Partially HLA-matched Multiple TAA-specific Allogeneic T-lymphocytes [NCIt concept]
- Parvovirus H-1 [NCIt concept]
- Pasireotide [NCIt concept]
- Pasotuxizumab [NCIt concept]
- Pass [NCIt concept]
- Passage Number [NCIt concept]
- Passive Smoke Exposure [NCIt concept]
- Patella [NCIt concept]
- Paternal Biological Grandparent [NCIt concept]
- Paternal First Cousin Once Removed [NCIt concept]
- Paternal Great Aunt [NCIt concept]
- Paternal Great Grandparent [NCIt concept]
- Paternal Great Uncle [NCIt concept]
- Paternal Half Sibling [NCIt concept]
- Pathogenic Variant [NCIt concept]
- Pathogenicity [NCIt concept]
- Pathologic ENSAT Staging Finding v7 [NCIt concept]
- Pathologic Examination [NCIt concept]
- Pathologic Lymph Nodes ENSAT Staging Finding v7 [NCIt concept]
- Pathologic Primary Tumor ENSAT Staging Finding v7 [NCIt concept]
- Pathology [NCIt concept]
- Pathology Report [NCIt concept]
- Pathology Report UUID [NCIt concept]
- Patidegib [NCIt concept]
- Patidegib Topical Gel [NCIt concept]
- Patritumab [NCIt concept]
- Patritumab Deruxtecan [NCIt concept]
- Patupilone [NCIt concept]
- Pavunalimab [NCIt concept]
- Pavurutamab [NCIt concept]
- Paxalisib [NCIt concept]
- Pazopanib [NCIt concept]
- Pazopanib Hydrochloride [NCIt concept]
- Pegargiminase [NCIt concept]
- Pegaspargase [NCIt concept]
- Pegcrisantaspase [NCIt concept]
- Pegdinetanib [NCIt concept]
- Pegenzileukin [NCIt concept]
- Pegfilgrastim [NCIt concept]
- Pegilodecakin [NCIt concept]
- Peginterferon Alfa-2a [NCIt concept]
- Peginterferon Alfa-2b [NCIt concept]
- Pegsitacianine [NCIt concept]
- Pegtomarginase [NCIt concept]
- Pegvisomant [NCIt concept]
- Pegvorhyaluronidase Alfa [NCIt concept]
- Pegylated CD25/CD122-selective Interleukin-2 Mutein STK-012 [NCIt concept]
- Pegylated Deoxycytidine Analogue DFP-14927 [NCIt concept]
- Pegylated IL-2 8MW2311 [NCIt concept]
- Pegylated Interferon Alfa [NCIt concept]
- Pegylated Liposomal Belotecan [NCIt concept]
- Pegylated Liposomal Doxorubicin Hydrochloride [NCIt concept]
- Pegylated Liposomal Irinotecan [NCIt concept]
- Pegylated Liposomal Mitomycin C Lipid-based Prodrug [NCIt concept]
- Pegylated Liposomal Mitoxantrone Hydrochloride [NCIt concept]
- Pegylated Liposomal Nanoparticle-based Docetaxel Prodrug MNK-010 [NCIt concept]
- Pegylated Orthogonal IL-2 STK-009 [NCIt concept]
- Pegylated Paclitaxel [NCIt concept]
- Pegylated Recombinant Human Arginase I BCT-100 [NCIt concept]
- Pegylated SN-38 Conjugate PLX038 [NCIt concept]
- Pegylated TOP1 Inhibitor PEEL-224 [NCIt concept]
- Pegzilarginase [NCIt concept]
- Pelabresib Anhydrous [NCIt concept]
- Pelareorep [NCIt concept]
- Peldesine [NCIt concept]
- Pelitinib [NCIt concept]
- Pelitrexol [NCIt concept]
- Pelvic Floor Muscle Weakness, CTCAE [NCIt concept]
- Pelvic Infection, CTCAE [NCIt concept]
- Pelvic Lymph Node [NCIt concept]
- Pelvic Pain, CTCAE 5.0 [NCIt concept]
- Pelvic Peritoneum [NCIt concept]
- Pelvic Soft Tissue Necrosis, CTCAE [NCIt concept]
- Pelvis [NCIt concept]
- Pembrolizumab [NCIt concept]
- Pembrolizumab/Quavonlimab MK-1308A [NCIt concept]
- Pemetrexed [NCIt concept]
- Pemetrexed Disodium [NCIt concept]
- Pemigatinib [NCIt concept]
- Pemlimogene Merolisbac [NCIt concept]
- Pemrametostat [NCIt concept]
- Penberol [NCIt concept]
- Penclomedine [NCIt concept]
- Pending [NCIt concept]
- Penicillamine [NCIt concept]
- Penile Carcinoma In Situ [NCIt concept]
- Penile Infection, CTCAE [NCIt concept]
- Penile Pain, CTCAE 5.0 [NCIt concept]
- Penis [NCIt concept]
- Penpulimab [NCIt concept]
- Pentamethylmelamine [NCIt concept]
- Pentamustine [NCIt concept]
- Pentostatin [NCIt concept]
- Pentoxifylline [NCIt concept]
- Pepinemab [NCIt concept]
- Peplomycin [NCIt concept]
- Peplomycin Sulfate [NCIt concept]
- Peposertib [NCIt concept]
- Peptic Ulcer [NCIt concept]
- Peptichemio [NCIt concept]
- Peptide 946 Melanoma Vaccine [NCIt concept]
- Peptide 946-Tetanus Peptide Conjugate Melanoma Vaccine [NCIt concept]
- Peptide Receptor Radionuclide Therapy [NCIt concept]
- Peptide-drug Conjugate OPD5 [NCIt concept]
- Percent Follicular Component [NCIt concept]
- Percent Follicular Component Greater than 10 Percent [NCIt concept]
- Percent Follicular Component Less than or Equal to 10 Percent [NCIt concept]
- Percent G/C [NCIt concept]
- Percent Gleason Patterns 4 and 5 [NCIt concept]
- Percent Inflammatory Marker Positive [NCIt concept]
- Percent Prostatic Involvement [NCIt concept]
- Percent Rhabdoid Features [NCIt concept]
- Percent Sarcomatoid Features [NCIt concept]
- Percent Tumor Cell Nuclei [NCIt concept]
- Percent Tumor Invasion [NCIt concept]
- Percent Unit [NCIt concept]
- Percent of Eosinophils [NCIt concept]
- Percent of Epithelioid Melanocytes [NCIt concept]
- Percent of Granulocytes [NCIt concept]
- Percent of Lymphocytes [NCIt concept]
- Percent of Monocytes [NCIt concept]
- Percent of Morphologically Normal Cells [NCIt concept]
- Percent of Necrosis [NCIt concept]
- Percent of Neutrophils [NCIt concept]
- Percent of Nucleotide Markers Exhibiting Instability [NCIt concept]
- Percent of Spindle-Shaped Melanocytes [NCIt concept]
- Percent of Stromal Cells [NCIt concept]
- Percent of Tumor Cells [NCIt concept]
- Perenostobart [NCIt concept]
- Peretinoin [NCIt concept]
- Perflenapent Emulsion [NCIt concept]
- Perforation Bile Duct, CTCAE [NCIt concept]
- Performed Procedure [NCIt concept]
- Perfosfamide [NCIt concept]
- Periapical Cemento-Osseous Dysplasia [NCIt concept]
- Pericardial Effusion, CTCAE [NCIt concept]
- Pericardial Tamponade, CTCAE [NCIt concept]
- Pericarditis, CTCAE [NCIt concept]
- Pericardium [NCIt concept]
- Perifollicular Fibroma [NCIt concept]
- Perifosine [NCIt concept]
- Perihilar Lymph Node [NCIt concept]
- Perillyl Alcohol [NCIt concept]
- Perimenopausal [NCIt concept]
- Perineal Pain, CTCAE 5.0 [NCIt concept]
- Perinephric Fat [NCIt concept]
- Perineum [NCIt concept]
- Perineural Invasion Assessment [NCIt concept]
- Perineurioma [NCIt concept]
- Periodontal Disease, CTCAE [NCIt concept]
- Periorbital Edema, CTCAE [NCIt concept]
- Periorbital Infection, CTCAE [NCIt concept]
- Periorbital Soft Tissue [NCIt concept]
- Periosteal Chondroma [NCIt concept]
- Periosteal Chondrosarcoma [NCIt concept]
- Periosteal Fibroma [NCIt concept]
- Periosteal Fibrosarcoma [NCIt concept]
- Periosteal Osteosarcoma [NCIt concept]
- Peripheral Blood [NCIt concept]
- Peripheral Blood Components [NCIt concept]
- Peripheral Ischemia, CTCAE [NCIt concept]
- Peripheral Lung Parenchyma Tumor [NCIt concept]
- Peripheral Motor Neuropathy, CTCAE [NCIt concept]
- Peripheral Nerve Infection, CTCAE [NCIt concept]
- Peripheral Nervous System [NCIt concept]
- Peripheral Neuropathy [NCIt concept]
- Peripheral Odontogenic Fibroma [NCIt concept]
- Peripheral Primitive Neuroectodermal Tumor [NCIt concept]
- Peripheral Sensory Neuropathy, CTCAE [NCIt concept]
- Peripheral T-Cell Lymphoma, Large Cell [NCIt concept]
- Peripheral T-Cell Lymphoma, Not Otherwise Specified [NCIt concept]
- Peripheral Vascular Disorder [NCIt concept]
- Peripheral Zone of Prostate [NCIt concept]
- Peritoneal Cavity [NCIt concept]
- Peritoneal Cytology [NCIt concept]
- Peritoneal Effusion [NCIt concept]
- Peritoneal Fluid [NCIt concept]
- Peritoneal Infection, CTCAE [NCIt concept]
- Peritoneal Lavage [NCIt concept]
- Peritoneal Multicystic Mesothelioma [NCIt concept]
- Peritoneal Necrosis, CTCAE [NCIt concept]
- Peritoneal Wash Cytology Results Indicator [NCIt concept]
- Peritoneum [NCIt concept]
- Peritoneum and Retroperitoneum [NCIt concept]
- Peritumoral [NCIt concept]
- Persistent Disease [NCIt concept]
- Persistent Distant Metastasis [NCIt concept]
- Persistent Locoregional Disease [NCIt concept]
- Personal Care Workers in Health Service [NCIt concept]
- Personal History Neoplasm Type Question [NCIt concept]
- Personal History of Acute Myeloid Leukemia with Induction Failure [NCIt concept]
- Personal History of Central Nervous System Rhabdoid Tumor [NCIt concept]
- Personal History of Colorectal Cancer [NCIt concept]
- Personal History of Liver Toxicity due to Non-Infectious Cause [NCIt concept]
- Personal History of Low Grade Glioma [NCIt concept]
- Personal History of Other Cancer Within 5 Years [NCIt concept]
- Personal History of Other Central Nervous System Tumor [NCIt concept]
- Personal History of Other Hematologic Disorder [NCIt concept]
- Personal History of Other Leukemia [NCIt concept]
- Personal History of Other Nonmalignant Systemic Disease [NCIt concept]
- Personal History of Other Pulmonary Complications [NCIt concept]
- Personal History of Pheochromocytoma or Paraganglioma [NCIt concept]
- Personal History of Renal Failure Requiring Dialysis [NCIt concept]
- Personality Change, CTCAE [NCIt concept]
- Personalized ALL-specific Multi-HLA-binding Peptide Vaccine [NCIt concept]
- Personalized Cancer Neoantigen Vaccine GAd-PEV [NCIt concept]
- Personalized Cancer Neoantigen Vaccine MVA-PEV [NCIt concept]
- Personalized Liposomal Neoantigen-based Peptide Vaccine EVX-01 [NCIt concept]
- Personalized Neoantigen Cancer Vaccine VB10.NEO [NCIt concept]
- Personalized Neoantigen DNA Vaccine GNOS-PV01 [NCIt concept]
- Personalized Neoantigen DNA Vaccine GNOS-PVO2 [NCIt concept]
- Personalized Neoantigen Follicular Lymphoma Vaccine [NCIt concept]
- Personalized Neoantigen Ovarian Cancer Vaccine [NCIt concept]
- Personalized Neoantigen Peptide Vaccine iNeo-Vac-P01 [NCIt concept]
- Personalized Neoantigen Plasmid DNA Melanoma Vaccine EVX-02 [NCIt concept]
- Personalized Neoantigen Vaccine NECVAX NEO1 [NCIt concept]
- Personalized Neoepitope Yeast Vaccine YE-NEO-001 [NCIt concept]
- Personalized Peptide Cancer Vaccine NEO-PV-01 [NCIt concept]
- Personalized and Adjusted Neoantigen Peptide Vaccine PANDA-VAC [NCIt concept]
- Pertuzumab [NCIt concept]
- Pertuzumab Zuvotolimod [NCIt concept]
- Peru [NCIt concept]
- Pesticide Exposure [NCIt concept]
- Petroleum Hydrocarbon Compound Exposure [NCIt concept]
- Peutz-Jeghers Syndrome [NCIt concept]
- Pevonedistat [NCIt concept]
- Pexastimogene Devacirepvec [NCIt concept]
- Pexidartinib [NCIt concept]
- Pexmetinib [NCIt concept]
- Phaleria macrocarpa Extract DLBS-1425 [NCIt concept]
- Phantom Pain, CTCAE 5.0 [NCIt concept]
- Pharmacologic Substance [NCIt concept]
- Pharmacological Ascorbate [NCIt concept]
- Pharmacotherapy [NCIt concept]
- Pharyngeal Anastomotic Leak, CTCAE [NCIt concept]
- Pharyngeal Fistula, CTCAE [NCIt concept]
- Pharyngeal Hemorrhage, CTCAE [NCIt concept]
- Pharyngeal Mucositis, CTCAE [NCIt concept]
- Pharyngeal Necrosis, CTCAE [NCIt concept]
- Pharyngeal Stenosis, CTCAE [NCIt concept]
- Pharyngeal Tonsil [NCIt concept]
- Pharyngitis, CTCAE [NCIt concept]
- Pharyngolaryngeal Pain, CTCAE [NCIt concept]
- Pharynx [NCIt concept]
- Phellodendron amurense Bark Extract [NCIt concept]
- Phenesterin [NCIt concept]
- Phenethyl Isothiocyanate [NCIt concept]
- Phenethyl Isothiocyanate-containing Watercress Juice [NCIt concept]
- Phenyl Acetate [NCIt concept]
- Phenytoin Sodium [NCIt concept]
- Philippines [NCIt concept]
- Phlebitis Infective, CTCAE [NCIt concept]
- Phlebitis, CTCAE [NCIt concept]
- Phosphatidylcholine-Bound Silybin [NCIt concept]
- Phosphoramide Mustard [NCIt concept]
- Phosphorodiamidate Morpholino Oligomer AVI-4126 [NCIt concept]
- Phosphorus P-32 [NCIt concept]
- Photodynamic Compound TLD-1433 [NCIt concept]
- Photon Beam Radiation Therapy [NCIt concept]
- Photophobia, CTCAE 5.0 [NCIt concept]
- Photosensitivity, CTCAE [NCIt concept]
- Photosensitizer Agent REM-001 [NCIt concept]
- Phyllodes Tumor [NCIt concept]
- Physical Examination [NCIt concept]
- Physical Examination Finding [NCIt concept]
- Physical and Earth Science Professional [NCIt concept]
- Physical and Engineering Science Technician [NCIt concept]
- Physician [NCIt concept]
- Phytochlorin Sodium-Polyvinylpyrrolidone Complex [NCIt concept]
- Pibenzimol [NCIt concept]
- Pibrozelesin [NCIt concept]
- Pibrozelesin Hydrobromide [NCIt concept]
- Picibanil [NCIt concept]
- Picoplatin [NCIt concept]
- Picrasinoside H [NCIt concept]
- Picropodophyllin [NCIt concept]
- Pictilisib [NCIt concept]
- Pictilisib Bismesylate [NCIt concept]
- Pidilizumab [NCIt concept]
- Pidnarulex [NCIt concept]
- Pifusertib [NCIt concept]
- Pigmented Adrenal Cortical Adenoma [NCIt concept]
- Pigmented Dermatofibrosarcoma Protuberans [NCIt concept]
- Pigmented Nevus [NCIt concept]
- Pigmented Spindle Cell Nevus [NCIt concept]
- Pilaralisib [NCIt concept]
- Pilocytic Astrocytoma [NCIt concept]
- Pilomatrical Carcinoma [NCIt concept]
- Pilomatricoma [NCIt concept]
- Pilomyxoid Astrocytoma [NCIt concept]
- Pimasertib [NCIt concept]
- Pimicotinib [NCIt concept]
- Pimitespib [NCIt concept]
- Pimivalimab [NCIt concept]
- Pimurutamab [NCIt concept]
- Pinatuzumab Vedotin [NCIt concept]
- Pineal Gland [NCIt concept]
- Pineal Parenchymal Tumor of Intermediate Differentiation [NCIt concept]
- Pineal Region Neoplasm [NCIt concept]
- Pineoblastoma [NCIt concept]
- Pineocytoma [NCIt concept]
- Pingyangmycin [NCIt concept]
- Pinometostat [NCIt concept]
- Pioglitazone [NCIt concept]
- Pioglitazone Hydrochloride [NCIt concept]
- Pipe [NCIt concept]
- Pipendoxifene [NCIt concept]
- Piperazinedione [NCIt concept]
- Piperine Extract (Standardized) [NCIt concept]
- Pipobroman [NCIt concept]
- Piposulfan [NCIt concept]
- Pirarubicin [NCIt concept]
- Pirarubicin Hydrochloride [NCIt concept]
- Pirfenidone [NCIt concept]
- Piritrexim [NCIt concept]
- Piritrexim Isethionate [NCIt concept]
- Pirotinib [NCIt concept]
- Piroxantrone [NCIt concept]
- Piroxantrone Hydrochloride [NCIt concept]
- Pirtobrutinib [NCIt concept]
- Pituicytoma [NCIt concept]
- Pituitary Gland [NCIt concept]
- Pituitary Gland Acidophil Adenoma [NCIt concept]
- Pituitary Gland Acidophil Carcinoma [NCIt concept]
- Pituitary Gland Basophil Adenoma [NCIt concept]
- Pituitary Gland Chromophobe Adenoma [NCIt concept]
- Pituitary Gland Mixed Acidophil-Basophil Adenoma [NCIt concept]
- Pituitary Gland Mixed Acidophil-Basophil Carcinoma [NCIt concept]
- Pituitary Neuroendocrine Tumor [NCIt concept]
- Pivekimab Sunirine [NCIt concept]
- Pixantrone [NCIt concept]
- Pixantrone Dimaleate [NCIt concept]
- Pixatimod [NCIt concept]
- Placebo [NCIt concept]
- Placenta [NCIt concept]
- Placental Hemangioma [NCIt concept]
- Placental Site Trophoblastic Tumor [NCIt concept]
- Pladienolide Derivative E7107 [NCIt concept]
- Plain Text Data Format [NCIt concept]
- Plamotamab [NCIt concept]
- Plasma [NCIt concept]
- Plasma Cell Leukemia [NCIt concept]
- Plasma Cell Neoplasm [NCIt concept]
- Plasmablastic Lymphoma [NCIt concept]
- Plasmacytoma [NCIt concept]
- Plasmid DNA Vaccine pING-hHER3FL [NCIt concept]
- Plastic Embolic Bead [NCIt concept]
- Platelet Count [NCIt concept]
- Platelet Count Decreased, CTCAE [NCIt concept]
- Platinum [NCIt concept]
- Platinum Acetylacetonate-Titanium Dioxide Nanoparticles [NCIt concept]
- Platinum Compound [NCIt concept]
- Platinum-Resistant Disease [NCIt concept]
- Pleomorphic Adenoma [NCIt concept]
- Pleomorphic Carcinoma [NCIt concept]
- Pleomorphic Hepatocellular Carcinoma [NCIt concept]
- Pleomorphic Lipoma [NCIt concept]
- Pleomorphic Liposarcoma [NCIt concept]
- Pleomorphic Rhabdomyosarcoma [NCIt concept]
- Pleomorphic Xanthoastrocytoma [NCIt concept]
- Pleura [NCIt concept]
- Pleural Effusion [NCIt concept]
- Pleural Effusion, CTCAE [NCIt concept]
- Pleural Fluid [NCIt concept]
- Pleural Hemorrhage, CTCAE [NCIt concept]
- Pleural Infection, CTCAE [NCIt concept]
- Pleural Solitary Fibrous Tumor [NCIt concept]
- Pleuritic Pain, CTCAE 5.0 [NCIt concept]
- Pleurodesis [NCIt concept]
- Pleuropulmonary Blastoma [NCIt concept]
- Plevitrexed [NCIt concept]
- Plexiform Fibrohistiocytic Tumor [NCIt concept]
- Plexiform Neurofibroma [NCIt concept]
- Plexiform Schwannoma [NCIt concept]
- Plicamycin [NCIt concept]
- Plinabulin [NCIt concept]
- Plitidepsin [NCIt concept]
- Plixorafenib [NCIt concept]
- Plk1 Inhibitor BI 2536 [NCIt concept]
- Plocabulin [NCIt concept]
- Plogosertib [NCIt concept]
- Ploidy [NCIt concept]
- Plozalizumab [NCIt concept]
- Pneumocystis Pneumonia [NCIt concept]
- Pneumonectomy [NCIt concept]
- Pneumonia [NCIt concept]
- Pneumonitis, CTCAE [NCIt concept]
- Pneumothorax, CTCAE [NCIt concept]
- Pol Theta Inhibitor ART4215 [NCIt concept]
- Poland [NCIt concept]
- Polar Spongioblastoma [NCIt concept]
- Polatuzumab Vedotin [NCIt concept]
- Polidocanol [NCIt concept]
- Poliglusam [NCIt concept]
- Polo-like Kinase 1 Inhibitor GSK461364 [NCIt concept]
- Polo-like Kinase 1 Inhibitor MK1496 [NCIt concept]
- Poly (ADP-Ribose) Polymerase Inhibitor [NCIt concept]
- Poly-T Enriched Genomic Library [NCIt concept]
- Poly-alendronate Dextran-Guanidine Conjugate [NCIt concept]
- Poly-gamma Glutamic Acid [NCIt concept]
- Polyamine Analog SL11093 [NCIt concept]
- Polyamine Analogue PG11047 [NCIt concept]
- Polyamine Transport Inhibitor AMXT-1501 Dicaprate [NCIt concept]
- Polyandrol [NCIt concept]
- Polycystic Ovary Syndrome [NCIt concept]
- Polycythemia Vera [NCIt concept]
- Polyethylene Glycol Recombinant Endostatin [NCIt concept]
- Polyethyleneglycol-7-ethyl-10-hydroxycamptothecin DFP-13318 [NCIt concept]
- Polygonal Cell Carcinoma [NCIt concept]
- Polymer-conjugated IL-15 Receptor Agonist NKTR-255 [NCIt concept]
- Polymer-encapsulated Luteolin Nanoparticle [NCIt concept]
- Polymerase Chain Reaction [NCIt concept]
- Polymeric Camptothecin Prodrug XMT-1001 [NCIt concept]
- Polymeric Nanoparticle-conjugated Camptothecin DAN-222 [NCIt concept]
- Polymorphic Post-Transplant Lymphoproliferative Disorder [NCIt concept]
- Polypodium leucotomos Extract [NCIt concept]
- Polysaccharide-K [NCIt concept]
- Polysialic Acid [NCIt concept]
- Polyunsaturated Fatty Acid [NCIt concept]
- Polyvalent Melanoma Vaccine [NCIt concept]
- Polzastobart [NCIt concept]
- Pomalidomide [NCIt concept]
- Pomegranate Juice [NCIt concept]
- Pomegranate Liquid Extract [NCIt concept]
- Ponatinib [NCIt concept]
- Ponatinib Hydrochloride [NCIt concept]
- Poorly Differentiated [NCIt concept]
- Poorly Differentiated Lesion [NCIt concept]
- Poorly Differentiated Neuroblastoma [NCIt concept]
- Poorly Differentiated Neuroendocrine Lesion [NCIt concept]
- Poorly Differentiated Ovarian Sertoli-Leydig Cell Tumor [NCIt concept]
- Poorly Differentiated Ovarian Sertoli-Leydig Cell Tumor, Variant with Heterologous Elements [NCIt concept]
- Poorly Differentiated Thyroid Gland Carcinoma [NCIt concept]
- Popliteal Fossa [NCIt concept]
- Popliteal Lymph Node [NCIt concept]
- Porcupine Inhibitor CGX1321 [NCIt concept]
- Porcupine Inhibitor ETC-1922159 [NCIt concept]
- Porcupine Inhibitor WNT974 [NCIt concept]
- Porcupine Inhibitor Wnt-C59 [NCIt concept]
- Porcupine Inhibitor XNW7201 [NCIt concept]
- Porfimer Sodium [NCIt concept]
- Porfiromycin [NCIt concept]
- Porocarcinoma [NCIt concept]
- Poroma [NCIt concept]
- Portable Document Format [NCIt concept]
- Portal Hypertension, CTCAE [NCIt concept]
- Portal Vein Thrombosis, CTCAE [NCIt concept]
- Portugal [NCIt concept]
- Porustobart [NCIt concept]
- Positive Finding [NCIt concept]
- Positive Lymph Node [NCIt concept]
- Positive Surgical Margin [NCIt concept]
- Positron Emission Tomography [NCIt concept]
- Post Neoadjuvant Therapy Sample [NCIt concept]
- Post-Adjuvant Therapy [NCIt concept]
- Post-Transplant Lymphoproliferative Disorder [NCIt concept]
- Post-secondary Therapy [NCIt concept]
- Postcricoid Region [NCIt concept]
- Posterior Mediastinum [NCIt concept]
- Posterior Wall of the Bladder [NCIt concept]
- Posterior Wall of the Hypopharynx [NCIt concept]
- Posterior Wall of the Nasopharynx [NCIt concept]
- Posterior Wall of the Oropharynx [NCIt concept]
- Postmenopausal [NCIt concept]
- Postnasal Drip, CTCAE [NCIt concept]
- Postoperative [NCIt concept]
- Postoperative Hemorrhage, CTCAE [NCIt concept]
- Postoperative Thoracic Procedure Complication, CTCAE [NCIt concept]
- Postsecondary Teachers [NCIt concept]
- Pouch [NCIt concept]
- Poziotinib [NCIt concept]
- Poziotinib Hydrochloride [NCIt concept]
- Pracinostat [NCIt concept]
- Pradusinstobart [NCIt concept]
- Pralatrexate [NCIt concept]
- Pralsetinib [NCIt concept]
- Praluzatamab Ravtansine [NCIt concept]
- Pravastatin Sodium [NCIt concept]
- Pre T-ALL [NCIt concept]
- Pre-B Acute Lymphoblastic Leukemia [NCIt concept]
- Pre-Diagnosis [NCIt concept]
- Pre-Pre-B Acute Lymphoblastic Leukemia [NCIt concept]
- Pre-Procurement [NCIt concept]
- Pre-Registration [NCIt concept]
- Pre-Therapy [NCIt concept]
- Pre-extracted DNA Received by TSS Indicator [NCIt concept]
- Precancerous Melanosis [NCIt concept]
- Precocious Puberty, CTCAE 5.0 [NCIt concept]
- Predicted Maximum Read Length of Sequenced Fragment [NCIt concept]
- Predicted Mean Read Length of Sequenced Fragment [NCIt concept]
- Predicted Minimum Read Length of Sequenced Fragment [NCIt concept]
- Prednimustine [NCIt concept]
- Prednisolone [NCIt concept]
- Prednisolone Acetate [NCIt concept]
- Prednisolone Sodium Phosphate [NCIt concept]
- Prednisone [NCIt concept]
- Pregnancy Outcome [NCIt concept]
- Pregnancy, Puerperium and Perinatal Conditions - Other, Specify, CTCAE [NCIt concept]
- Pregnant [NCIt concept]
- Pregnant at Diagnosis Indicator [NCIt concept]
- Premalignant Neoplasm [NCIt concept]
- Premature Birth Indicator [NCIt concept]
- Premature Delivery, CTCAE [NCIt concept]
- Premature Menopause, CTCAE [NCIt concept]
- Premenopausal [NCIt concept]
- Preoperative [NCIt concept]
- Prepared Amount [NCIt concept]
- Prepuce [NCIt concept]
- Prescribed Dose [NCIt concept]
- Presence of Clear Cytoplasm Less than or Equal to 25 Percent [NCIt concept]
- Presence of Extravascular Matrix Patterns [NCIt concept]
- Present [NCIt concept]
- Preservation Procedure [NCIt concept]
- Presyncope, CTCAE [NCIt concept]
- Preventive Intervention [NCIt concept]
- Prexasertib [NCIt concept]
- Prexigebersen [NCIt concept]
- Primary Amyloidosis [NCIt concept]
- Primary Cell Culture [NCIt concept]
- Primary Cutaneous Anaplastic Large Cell Lymphoma [NCIt concept]
- Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder [NCIt concept]
- Primary Cutaneous CD4-Positive Small/Medium T-Cell Lymphoproliferative Disorder [NCIt concept]
- Primary Cutaneous CD8-Positive Aggressive Epidermotropic Cytotoxic T-Cell Lymphoma [NCIt concept]
- Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type [NCIt concept]
- Primary Cutaneous Follicle Center Lymphoma [NCIt concept]
- Primary Cutaneous Gamma-Delta T-Cell Lymphoma [NCIt concept]
- Primary Cutaneous Lymphoma [NCIt concept]
- Primary Cutaneous Marginal Zone Lymphoproliferative Disorder [NCIt concept]
- Primary Cutaneous T-Cell Non-Hodgkin Lymphoma [NCIt concept]
- Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System [NCIt concept]
- Primary Effusion Lymphoma [NCIt concept]
- Primary Gleason Pattern [NCIt concept]
- Primary Immune Thrombocytopenia [NCIt concept]
- Primary Induction Failure [NCIt concept]
- Primary Mediastinal Large B-Cell Lymphoma [NCIt concept]
- Primary Myelofibrosis [NCIt concept]
- Primary Neoplasm [NCIt concept]
- Primary Peritoneal Serous Papillary Adenocarcinoma [NCIt concept]
- Primary Pulmonary Myxoid Sarcoma with EWSR1-CREB1 Fusion [NCIt concept]
- Primary School and Early Childhood Teacher [NCIt concept]
- Primary Sclerosing Cholangitis [NCIt concept]
- Primary Site Unknown [NCIt concept]
- Primary Site of Disease [NCIt concept]
- Primary Tumor Field [NCIt concept]
- Primary Tumor Site [NCIt concept]
- Prime Cancer Vaccine MVA-BN-CV301 [NCIt concept]
- Primitive Neuroectodermal Tumor [NCIt concept]
- Prinomastat [NCIt concept]
- Printing Workers [NCIt concept]
- Prior Therapy [NCIt concept]
- Prizloncabtagene Autoleucel [NCIt concept]
- Proapoptotic Sulindac Analog CP-461 [NCIt concept]
- Procarbazine [NCIt concept]
- Procarbazine Hydrochloride [NCIt concept]
- Procaspase Activating Compound-1 VO-100 [NCIt concept]
- Process Control Technician [NCIt concept]
- Processed Food Allergy [NCIt concept]
- Processed Project [NCIt concept]
- Processing [NCIt concept]
- Proctitis, CTCAE [NCIt concept]
- Prodencel [NCIt concept]
- Prodrug PARP Inhibitor TSL-1502 [NCIt concept]
- Production Manager in Agriculture, Forestry and Fishery [NCIt concept]
- Productive Cough, CTCAE [NCIt concept]
- Professional Doctorate Degree Completion [NCIt concept]
- Professional Services Manager [NCIt concept]
- Progestational Intrauterine Device [NCIt concept]
- Progesterone Only Hormone Replacement Therapy [NCIt concept]
- Progestin Only Hormonal Contraception [NCIt concept]
- Proglumide [NCIt concept]
- Progression of Disease at Recurrence [NCIt concept]
- Progression or Recurrence Type [NCIt concept]
- Progressive Disease [NCIt concept]
- Progressive Multifocal Leukoencephalopathy [NCIt concept]
- Progressive or Recurrent Disease Anatomic Site [NCIt concept]
- Progressive or Recurrent Disease Indicator [NCIt concept]
- Prohibitin-Targeting Peptide 1 [NCIt concept]
- Project Data Submission Enabled Indicator [NCIt concept]
- Project Name [NCIt concept]
- Project Release Request Indicator [NCIt concept]
- Project Reviewed by AWG Indicator [NCIt concept]
- Project Submission Status [NCIt concept]
- Prolapse of Intestinal Stoma, CTCAE [NCIt concept]
- Prolapse of Urostomy, CTCAE [NCIt concept]
- Prolgolimab [NCIt concept]
- Proliferating Cell Count [NCIt concept]
- Proliferating Trichilemmal Tumor [NCIt concept]
- Proliferative Nodules in Congenital Melanocytic Nevus [NCIt concept]
- Prolymphocyte Count [NCIt concept]
- Prolymphocytic Leukemia [NCIt concept]
- Promonocyte Count [NCIt concept]
- Promyelocyte Count [NCIt concept]
- Propane Smoke Exposue [NCIt concept]
- Proportion Covered at Read Depth of 10X [NCIt concept]
- Proportion Covered at Read Depth of 30X [NCIt concept]
- Proportion Targets with No Coverage [NCIt concept]
- Proportion of Duplicated Reads Data [NCIt concept]
- Proportion of Mapped Reads Data [NCIt concept]
- Prospective Tissue Collection [NCIt concept]
- Prostate Acinar Sarcomatoid Carcinoma [NCIt concept]
- Prostate Bed [NCIt concept]
- Prostate Cancer Vaccine ONY-P1 [NCIt concept]
- Prostate Carcinoma [NCIt concept]
- Prostate Gland [NCIt concept]
- Prostate Health Cocktail Dietary Supplement [NCIt concept]
- Prostate Infection, CTCAE [NCIt concept]
- Prostate Level Disease Origin Indicator [NCIt concept]
- Prostate Zone of Disease Origin [NCIt concept]
- Prostate-Specific Antigen [NCIt concept]
- Prostatic Acid Phosphatase-Sargramostim Fusion Protein PA2024 [NCIt concept]
- Prostatic Hemorrhage, CTCAE [NCIt concept]
- Prostatic Obstruction, CTCAE [NCIt concept]
- Prostatic Pain, CTCAE 5.0 [NCIt concept]
- Protease-activated Anti-EGFR/Anti-CD3 Bispecific Antibody Prodrug CX-904 [NCIt concept]
- Proteasome Inhibitor TQB3602 [NCIt concept]
- Protective Service Occupations [NCIt concept]
- Protein [NCIt concept]
- Protein Arginine Methyltransferase 5 Inhibitor PF-06939999 [NCIt concept]
- Protein Arginine Methyltransferase 5 Inhibitor PRT543 [NCIt concept]
- Protein Expression Analysis [NCIt concept]
- Protein Isoform Measurement [NCIt concept]
- Protein Overexpression [NCIt concept]
- Protein Phosphatase 2A Inhibitor LB-100 [NCIt concept]
- Protein Stabilized Liposomal Docetaxel Nanoparticles [NCIt concept]
- Protein-engineered Interleukin-12 XTX301 [NCIt concept]
- Protein-engineered Interleukin-2 XTX202 [NCIt concept]
- Proteinuria, CTCAE 5.0 [NCIt concept]
- Proteomic Profiling [NCIt concept]
- Prothrombin Time [NCIt concept]
- Protocol Identifier [NCIt concept]
- Protocol Treatment Arm [NCIt concept]
- Proton Beam Radiation Therapy [NCIt concept]
- Proton Pump Inhibitor [NCIt concept]
- Protoplasmic Astrocytoma [NCIt concept]
- Proxalutamide [NCIt concept]
- Pruritus, CTCAE [NCIt concept]
- Psammomatous Meningioma [NCIt concept]
- Pseudoglandular Squamous Cell Carcinoma [NCIt concept]
- Pseudoisocytidine [NCIt concept]
- Pseudomyxoma Peritonei [NCIt concept]
- Pseudoprogression [NCIt concept]
- Pseudoresponse [NCIt concept]
- Psoriasis [NCIt concept]
- Psychiatric Disorders - Other, Specify, CTCAE [NCIt concept]
- Psychosis, CTCAE [NCIt concept]
- Pterostilbene [NCIt concept]
- Pucotenlimab [NCIt concept]
- Puerto Rico [NCIt concept]
- Pulmonary Adenomatosis [NCIt concept]
- Pulmonary Artery Intimal Sarcoma [NCIt concept]
- Pulmonary Blastoma [NCIt concept]
- Pulmonary Edema, CTCAE [NCIt concept]
- Pulmonary Embolism [NCIt concept]
- Pulmonary Fibrosis [NCIt concept]
- Pulmonary Fibrosis, CTCAE [NCIt concept]
- Pulmonary Fistula, CTCAE [NCIt concept]
- Pulmonary Hemorrhage [NCIt concept]
- Pulmonary Hypertension, CTCAE [NCIt concept]
- Pulmonary Mucinous Cystic Tumor of Borderline Malignancy [NCIt concept]
- Pulmonary Valve Disease, CTCAE [NCIt concept]
- Pulocimab [NCIt concept]
- Pulrodemstat [NCIt concept]
- Pumitepa [NCIt concept]
- Punch Biopsy [NCIt concept]
- Puquitinib [NCIt concept]
- Puquitinib Mesylate [NCIt concept]
- Pure Erythroid Leukemia [NCIt concept]
- Purine Analogue NSC 750854 [NCIt concept]
- Purinostat Mesylate [NCIt concept]
- Puromycin [NCIt concept]
- Puromycin Hydrochloride [NCIt concept]
- Purpura, CTCAE [NCIt concept]
- Pylorus [NCIt concept]
- Pyramidal Tract Syndrome, CTCAE [NCIt concept]
- Pyrazinamide [NCIt concept]
- Pyrazoloacridine [NCIt concept]
- Pyridyl Cyanoguanidine CHS 828 [NCIt concept]
- Pyriform Sinus [NCIt concept]
- Pyrotinib [NCIt concept]
- Pyrotinib Dimaleate [NCIt concept]
- Pyroxamide [NCIt concept]
- Pyruvate Kinase Inhibitor TLN-232 [NCIt concept]
- Pyruvate Kinase M2 Isoform Activator TP-1454 [NCIt concept]
- QKI Gene [NCIt concept]
- Qatar [NCIt concept]
- Qilisheng Immunoregulatory Oral Solution [NCIt concept]
- Quadrivalent Human Papillomavirus (types 6, 11, 16, 18) Recombinant Vaccine [NCIt concept]
- Quarfloxin [NCIt concept]
- Quavonlimab [NCIt concept]
- Quemliclustat [NCIt concept]
- Quick Freeze [NCIt concept]
- Quinacrine Hydrochloride [NCIt concept]
- Quinine [NCIt concept]
- Quisinostat [NCIt concept]
- Quizartinib [NCIt concept]
- R-(-)-Gossypol Acetic Acid [NCIt concept]
- R-CHOP Regimen [NCIt concept]
- RABEP1 Gene [NCIt concept]
- RAC1 Gene [NCIt concept]
- RAD21 Gene [NCIt concept]
- RAD51B Gene [NCIt concept]
- RAF Kinase Inhibitor L-779450 [NCIt concept]
- RAF Kinase Inhibitor XL281 [NCIt concept]
- RAF1 Gene [NCIt concept]
- RALGDS Gene [NCIt concept]
- RANBP2 Gene [NCIt concept]
- RAP1GDS1 Gene [NCIt concept]
- RARA Gene [NCIt concept]
- RARalpha Agonist IRX5183 [NCIt concept]
- RAS Inhibitor RMC-6236 [NCIt concept]
- RAS Peptide Cancer Vaccine TG01 [NCIt concept]
- RB1 Gene [NCIt concept]
- RBCs-Anti-PD1 Antibody Conjugate WTX212 [NCIt concept]
- RBM10 Gene [NCIt concept]
- RBM15 Gene [NCIt concept]
- RECIST Baseline Target Lesion Sum [NCIt concept]
- RECQL4 Gene [NCIt concept]
- REL Gene [NCIt concept]
- REPLI-g Pooled DNA [NCIt concept]
- REPLI-g Whole Genome Amplification [NCIt concept]
- REPLI-g X DNA [NCIt concept]
- RET Gene [NCIt concept]
- RET Inhibitor APS03118 [NCIt concept]
- RET Inhibitor EP0031 [NCIt concept]
- RET Inhibitor FHND5071 [NCIt concept]
- RET Inhibitor HS-10365 [NCIt concept]
- RET Inhibitor KL590586 [NCIt concept]
- RET Inhibitor LOXO-260 [NCIt concept]
- RET Inhibitor SY-5007 [NCIt concept]
- RET Inhibitor TY-1091 [NCIt concept]
- RFT5-dgA Immunotoxin IMTOX25 [NCIt concept]
- RGPD3 Gene [NCIt concept]
- RGS7 Gene [NCIt concept]
- RHOA Gene [NCIt concept]
- RHOH Gene [NCIt concept]
- RIPK1 Inhibitor GSK3145095 [NCIt concept]
- RMI2 Gene [NCIt concept]
- RNA Integrity Number [NCIt concept]
- RNA Transcription Modulator AU-409 [NCIt concept]
- RNA-lipoplex Cancer Vaccine BNT116 [NCIt concept]
- RNF213 Gene [NCIt concept]
- RNF43 Gene [NCIt concept]
- RNR Inhibitor COH29 [NCIt concept]
- RNR Subunits Interaction Inhibitor TAS1553 [NCIt concept]
- ROBO1-targeted BiCAR-NKT Cells [NCIt concept]
- ROBO2 Gene [NCIt concept]
- ROS1 Gene [NCIt concept]
- ROS1/TRK/ALK Inhibitor TY-2136b [NCIt concept]
- RPL10 Gene [NCIt concept]
- RPL22 Gene [NCIt concept]
- RPL5 Gene [NCIt concept]
- RPN1 Gene [NCIt concept]
- RPS15 Gene [NCIt concept]
- RSK1-4 Inhibitor PMD-026 [NCIt concept]
- RSPO2 Gene [NCIt concept]
- RSPO3 Gene [NCIt concept]
- RUNX1 Gene [NCIt concept]
- RUNX1T1 Gene [NCIt concept]
- RXR-alpha Variant-targeting Agent NM6603 [NCIt concept]
- Rabusertib [NCIt concept]
- Rac/Cdc42 Inhibitor MBQ-167 [NCIt concept]
- Race [NCIt concept]
- Racemetyrosine/Methoxsalen/Phenytoin/Sirolimus [NCIt concept]
- Racotumomab [NCIt concept]
- Radgocitabine [NCIt concept]
- Radgocitabine Hydrochloride [NCIt concept]
- Radiation Boost [NCIt concept]
- Radiation Exposure [NCIt concept]
- Radiation Recall Reaction (Dermatologic), CTCAE [NCIt concept]
- Radiation Therapy [NCIt concept]
- Radical Hysterectomy [NCIt concept]
- Radical Neck Dissection [NCIt concept]
- Radical Nephrectomy [NCIt concept]
- Radical Prostatectomy [NCIt concept]
- Radiculitis, CTCAE [NCIt concept]
- Radioactive Iodine [NCIt concept]
- Radioactive Iodine Therapy [NCIt concept]
- Radioembolization [NCIt concept]
- Radiofrequency Ablation [NCIt concept]
- Radiographic Progressive Disease [NCIt concept]
- Radiolabeled CC49 [NCIt concept]
- Radiologic Examination [NCIt concept]
- Radiosensitizing Agent [NCIt concept]
- Radiosensitizing Agent Used Indicator [NCIt concept]
- Radiosurgery [NCIt concept]
- Radium Ra 223 Dichloride [NCIt concept]
- Radium Ra 224-labeled Calcium Carbonate Microparticles [NCIt concept]
- Radix Angelicae Sinensis/Radix Astragali Herbal Supplement [NCIt concept]
- Radon Exposure [NCIt concept]
- Radotinib Hydrochloride [NCIt concept]
- Ragifilimab [NCIt concept]
- Ralaniten Acetate [NCIt concept]
- Ralimetinib Mesylate [NCIt concept]
- Raloxifene [NCIt concept]
- Raloxifene Hydrochloride [NCIt concept]
- Raltitrexed [NCIt concept]
- Raludotatug Deruxtecan [NCIt concept]
- Ralzapastotug [NCIt concept]
- Ramucirumab [NCIt concept]
- Randomly Selected Genomic Library [NCIt concept]
- Ranibizumab [NCIt concept]
- Ranimustine [NCIt concept]
- Ranolazine [NCIt concept]
- Ranpirnase [NCIt concept]
- Ras Inhibitor [NCIt concept]
- Ras Inhibitor LUNA18 [NCIt concept]
- Ras Inhibitor RSC-1255 [NCIt concept]
- Ras Peptide ASP [NCIt concept]
- Ras Peptide CYS [NCIt concept]
- Ras Peptide VAL [NCIt concept]
- Rasdegafusp Alfa [NCIt concept]
- Rash Acneiform, CTCAE [NCIt concept]
- Rash Maculo-Papular, CTCAE [NCIt concept]
- Rash Pustular, CTCAE [NCIt concept]
- Ravoxertinib [NCIt concept]
- Raw CpG Island Variation Data [NCIt concept]
- Raw Intensity Sequencing Data [NCIt concept]
- Raw Sequencing Data [NCIt concept]
- Raw Somatic Variation Data [NCIt concept]
- Razoxane [NCIt concept]
- Read Depth [NCIt concept]
- Read Group Adapter Content Quality Control Indicator [NCIt concept]
- Read Group Basic Statistics Quality Control Indicator [NCIt concept]
- Read Group Kmer Content Quality Control Indicator [NCIt concept]
- Read Group Name [NCIt concept]
- Read Group Overrepresented Sequences Quality Control Indicator [NCIt concept]
- Read Group Pairs on Different Chromosomes Data [NCIt concept]
- Read Group Per Base N Content Quality Control Indicator [NCIt concept]
- Read Group Per Base Sequence Content Quality Control Indicator [NCIt concept]
- Read Group Per Base Sequence Quality Indicator [NCIt concept]
- Read Group Per Sequence G/C Content Quality Control Indicator [NCIt concept]
- Read Group Per Sequence Quality Score Indicator [NCIt concept]
- Read Group Per Tile Sequence Quality Indicator [NCIt concept]
- Read Group Sequence Duplication Levels Quality Control Indicator [NCIt concept]
- Read Group Sequence Length Distribution Quality Control Indicator [NCIt concept]
- Read Length [NCIt concept]
- Read Pair 1 [NCIt concept]
- Read Pair 2 [NCIt concept]
- Read Pair Number [NCIt concept]
- Realgar-Indigo naturalis Formulation [NCIt concept]
- Reason Off Treatment [NCIt concept]
- Reason Treatment Not Administered [NCIt concept]
- Rebastinib Tosylate [NCIt concept]
- Rebeccamycin [NCIt concept]
- Rebemadlin [NCIt concept]
- Rebimastat [NCIt concept]
- Receptor Tyrosine Kinase Inhibitor R1530 [NCIt concept]
- Receptor-Type Tyrosine-Protein Phosphatase C [NCIt concept]
- Recombinant Adenovirus-p53 SCH-58500 [NCIt concept]
- Recombinant Albumin-binding IL-12 SON-1010 [NCIt concept]
- Recombinant Anti-WT1 Immunotherapeutic GSK2302024A [NCIt concept]
- Recombinant Bacterial Minicells VAX014 [NCIt concept]
- Recombinant Bispecific Single-Chain Antibody rM28 [NCIt concept]
- Recombinant CD40-Ligand [NCIt concept]
- Recombinant Erythropoietin [NCIt concept]
- Recombinant Fas Ligand [NCIt concept]
- Recombinant Fractalkine [NCIt concept]
- Recombinant Granulocyte-Macrophage Colony-Stimulating Factor [NCIt concept]
- Recombinant Growth Factor [NCIt concept]
- Recombinant Human 6Ckine [NCIt concept]
- Recombinant Human Adenovirus Type 5 H101 [NCIt concept]
- Recombinant Human Apolipoprotein(a) Kringle V MG1102 [NCIt concept]
- Recombinant Human EGF-rP64K/Montanide ISA 51 Vaccine [NCIt concept]
- Recombinant Human Endostatin [NCIt concept]
- Recombinant Human GM-CSF-encoding Oncolytic Adenovirus SynOV1.1 [NCIt concept]
- Recombinant Human Hsp110-gp100 Chaperone Complex Vaccine [NCIt concept]
- Recombinant Human Hyaluronidase and Pembrolizumab [NCIt concept]
- Recombinant Human Papillomavirus 11-valent Vaccine [NCIt concept]
- Recombinant Human Papillomavirus 14-valent Vaccine SCT1000 [NCIt concept]
- Recombinant Human Papillomavirus Bivalent Vaccine [NCIt concept]
- Recombinant Human Papillomavirus Nonavalent Vaccine [NCIt concept]
- Recombinant Human Plasminogen Kringle 5 Domain ABT 828 [NCIt concept]
- Recombinant Humanized Anti-HER-2 Bispecific Monoclonal Antibody MBS301 [NCIt concept]
- Recombinant Interferon [NCIt concept]
- Recombinant Interferon Alfa [NCIt concept]
- Recombinant Interferon Alfa-1b [NCIt concept]
- Recombinant Interferon Alfa-2a [NCIt concept]
- Recombinant Interferon Alfa-2b [NCIt concept]
- Recombinant Interferon Alpha 2b-like Protein [NCIt concept]
- Recombinant Interferon Beta [NCIt concept]
- Recombinant Interferon Gamma [NCIt concept]
- Recombinant Interleukin-13 [NCIt concept]
- Recombinant Interleukin-2 [NCIt concept]
- Recombinant Interleukin-6 [NCIt concept]
- Recombinant KSA Glycoprotein CO17-1A [NCIt concept]
- Recombinant Leukocyte Interleukin [NCIt concept]
- Recombinant Leukoregulin [NCIt concept]
- Recombinant Luteinizing Hormone [NCIt concept]
- Recombinant MAGE-3.1 Antigen [NCIt concept]
- Recombinant Macrophage Colony-Stimulating Factor [NCIt concept]
- Recombinant Modified Vaccinia Ankara-5T4 Vaccine [NCIt concept]
- Recombinant Newcastle Disease Virus-encoding Interleukin-12 MEDI9253 [NCIt concept]
- Recombinant Newcastle Disease Virus-encoding Interleukin-12 V938 [NCIt concept]
- Recombinant Oncolytic Poliovirus PVS-RIPO [NCIt concept]
- Recombinant PRAME Protein Plus AS15 Adjuvant GSK2302025A [NCIt concept]
- Recombinant Saccharomyces Cerevisia-CEA(610D)-Expressing Vaccine GI-6207 [NCIt concept]
- Recombinant Super-compound Interferon [NCIt concept]
- Recombinant Thyroglobulin [NCIt concept]
- Recombinant Thyrotropin Alfa [NCIt concept]
- Recombinant Transforming Growth Factor-Beta [NCIt concept]
- Recombinant Transforming Growth Factor-Beta-2 [NCIt concept]
- Recombinant Tumor Necrosis Factor Alpha-Thymosin Alpha 1 Fusion Protein [NCIt concept]
- Recombinant Tumor Necrosis Factor-Alpha [NCIt concept]
- Recombinant Tyrosinase-Related Protein-2 [NCIt concept]
- Recombinant Vesicular Stomatitis Virus-expressing Human Interferon Beta and Sodium-Iodide Symporter [NCIt concept]
- Recreational Fire Smoke Exposure [NCIt concept]
- Rectal Anastomotic Leak, CTCAE [NCIt concept]
- Rectal Carcinoma [NCIt concept]
- Rectal Fistula, CTCAE [NCIt concept]
- Rectal Hemorrhage, CTCAE [NCIt concept]
- Rectal Mucositis, CTCAE [NCIt concept]
- Rectal Necrosis, CTCAE [NCIt concept]
- Rectal Obstruction, CTCAE [NCIt concept]
- Rectal Pain, CTCAE 5.0 [NCIt concept]
- Rectal Perforation, CTCAE 5.0 [NCIt concept]
- Rectal Stenosis, CTCAE [NCIt concept]
- Rectal Ulcer, CTCAE [NCIt concept]
- Rectosigmoid Region [NCIt concept]
- Rectum [NCIt concept]
- Recurrent Disease [NCIt concept]
- Recurrent Disease, Distant Site [NCIt concept]
- Recurrent Laryngeal Nerve Palsy, CTCAE [NCIt concept]
- Recurrent Neoplasm [NCIt concept]
- Recurrent Pyogenic Cholangitis [NCIt concept]
- Red [NCIt concept]
- Red and Violet [NCIt concept]
- Redaporfin [NCIt concept]
- Refametinib [NCIt concept]
- Reflux Treatment Type Indicator [NCIt concept]
- Refractory Anemia [NCIt concept]
- Refractory Anemia with Excess Blasts in Transformation [NCIt concept]
- Refractory Cytopenia of Childhood [NCIt concept]
- Refractory Disease [NCIt concept]
- Refractory Neutropenia [NCIt concept]
- Refractory Thrombocytopenia [NCIt concept]
- Refusal of Treatment by Patient [NCIt concept]
- Refuse Worker [NCIt concept]
- Regional Disease [NCIt concept]
- Regional Lymph Node [NCIt concept]
- Regional Metastasis Present [NCIt concept]
- Regional Site Receiving Treatment [NCIt concept]
- Regorafenib [NCIt concept]
- Regorafenib Hydrate [NCIt concept]
- Regressing Melanoma [NCIt concept]
- Regressing Nevus [NCIt concept]
- Regulatory Region Amplification [NCIt concept]
- Regulatory Region Deletion [NCIt concept]
- Regulatory Region Mutation [NCIt concept]
- Relacorilant [NCIt concept]
- Relationship Type [NCIt concept]
- Relatlimab [NCIt concept]
- Relmacabtagene Autoleucel [NCIt concept]
- Relugolix [NCIt concept]
- Remetinostat [NCIt concept]
- Renal Calculi, CTCAE [NCIt concept]
- Renal Capsule [NCIt concept]
- Renal Cell Carcinoma [NCIt concept]
- Renal Cell Carcinoma Peptides Vaccine IMA901 [NCIt concept]
- Renal Cell Carcinoma with MiT Translocations [NCIt concept]
- Renal Cell Carcinoma, Not Otherwise Specified [NCIt concept]
- Renal Colic, CTCAE [NCIt concept]
- Renal Failure [NCIt concept]
- Renal Hemorrhage, CTCAE [NCIt concept]
- Renal Involvement [NCIt concept]
- Renal Pelvis [NCIt concept]
- Renal Sinus [NCIt concept]
- Renal Vein [NCIt concept]
- Renal and Urinary Disorders - Other, Specify, CTCAE [NCIt concept]
- Renomedullary Interstitial Cell Tumor [NCIt concept]
- Renvistobart [NCIt concept]
- Reozalimab [NCIt concept]
- Reparixin [NCIt concept]
- Repetitive Sequence [NCIt concept]
- Reported Average Base Quality [NCIt concept]
- Repotrectinib [NCIt concept]
- Reproductive System and Breast Disorders - Other, Specify, CTCAE [NCIt concept]
- Request for Submission Indicator [NCIt concept]
- Resection [NCIt concept]
- Residual Disease [NCIt concept]
- Residual Tumor Size Measurement [NCIt concept]
- Resigratinib [NCIt concept]
- Resin Fume Exposure [NCIt concept]
- Resiquimod [NCIt concept]
- Resiquimod Hydrogel-based Sustained-release formulation [NCIt concept]
- Resiquimod Topical Gel [NCIt concept]
- Resistant Starch [NCIt concept]
- Resminostat [NCIt concept]
- Respirable Crystalline Silica Exposure [NCIt concept]
- Respiratory Failure, CTCAE [NCIt concept]
- Respiratory, Thoracic and Mediastinal Disorders - Other, Specify, CTCAE [NCIt concept]
- Responsive Disease [NCIt concept]
- Restlessness, CTCAE [NCIt concept]
- Restriction Endonuclease [NCIt concept]
- Restrictive Cardiomyopathy, CTCAE [NCIt concept]
- Resveratrol [NCIt concept]
- Resveratrol Formulation SRT501 [NCIt concept]
- Retail and Wholesale Trade Manager [NCIt concept]
- Retaspimycin [NCIt concept]
- Retaspimycin Hydrochloride [NCIt concept]
- Rete Ovarii Adenocarcinoma [NCIt concept]
- Retelliptine [NCIt concept]
- Reticuloendothelial System [NCIt concept]
- Reticulosarcoma [NCIt concept]
- Retifanlimab [NCIt concept]
- Retina [NCIt concept]
- Retinal Detachment, CTCAE 5.0 [NCIt concept]
- Retinal Tear, CTCAE [NCIt concept]
- Retinal Vascular Disorder, CTCAE [NCIt concept]
- Retinoblastoma [NCIt concept]
- Retinocytoma [NCIt concept]
- Retinoic Acid Agent Ro 16-9100 [NCIt concept]
- Retinoic Acid Syndrome, CTCAE [NCIt concept]
- Retinoid 9cUAB30 [NCIt concept]
- Retinol [NCIt concept]
- Retinopathy, CTCAE [NCIt concept]
- Retinyl Acetate [NCIt concept]
- Retinyl Palmitate [NCIt concept]
- Retlirafusp Alfa [NCIt concept]
- Retro-Orbital Region [NCIt concept]
- Retromolar Trigone [NCIt concept]
- Retroperitoneal Hemorrhage, CTCAE 5.0 [NCIt concept]
- Retroperitoneal Lymph Node [NCIt concept]
- Retroperitoneal Lymph Node Involvement [NCIt concept]
- Retroperitoneum [NCIt concept]
- Retrospective Tissue Collection [NCIt concept]
- Retrovector Encoding Mutant Anti-Cyclin G1 [NCIt concept]
- Reunion [NCIt concept]
- Revdofilimab [NCIt concept]
- Reverse Phase Protein Array [NCIt concept]
- Reverse Transcriptase-Polymerase Chain Reaction [NCIt concept]
- Reversible Posterior Leukoencephalopathy Syndrome, CTCAE [NCIt concept]
- Review [NCIt concept]
- Revumenib [NCIt concept]
- Rexinoid NRX 194204 [NCIt concept]
- Rezetamig [NCIt concept]
- Rezivertinib [NCIt concept]
- Rezorstobart [NCIt concept]
- Rezvilutamide [NCIt concept]
- Rhabdoid Indicator [NCIt concept]
- Rhabdoid Meningioma [NCIt concept]
- Rhabdoid Tumor [NCIt concept]
- Rhabdoid Tumor of the Kidney [NCIt concept]
- Rhabdomyoma [NCIt concept]
- Rhabdomyosarcoma [NCIt concept]
- Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features [NCIt concept]
- Rhenium Re 186 Etidronate [NCIt concept]
- Rhenium Re 188 BMEDA-labeled Liposomes [NCIt concept]
- Rhenium Re-188 Ethiodized Oil [NCIt concept]
- Rhenium Re-188 Etidronate [NCIt concept]
- Rheumatoid Arthritis [NCIt concept]
- Rheumatologic Disorder [NCIt concept]
- Rhinitis Infective, CTCAE [NCIt concept]
- Rhizoxin [NCIt concept]
- Rib [NCIt concept]
- Ribociclib [NCIt concept]
- Ribociclib/Letrozole [NCIt concept]
- Ribocytokine IL-2 BNT153 [NCIt concept]
- Ribocytokine IL-7 BNT152 [NCIt concept]
- Ribonuclease QBI-139 [NCIt concept]
- Ribonucleic Acid [NCIt concept]
- Ribozyme RPI.4610 [NCIt concept]
- Rice Bran [NCIt concept]
- Ricolinostat [NCIt concept]
- Ridaforolimus [NCIt concept]
- Right [NCIt concept]
- Right Colectomy [NCIt concept]
- Right Fallopian Tube [NCIt concept]
- Right Ovary [NCIt concept]
- Right Ventricular Dysfunction, CTCAE [NCIt concept]
- Rigosertib [NCIt concept]
- Rigosertib Sodium [NCIt concept]
- Rilimogene Galvacirepvec [NCIt concept]
- Rilimogene Galvacirepvec/Rilimogene Glafolivec [NCIt concept]
- Rilimogene Glafolivec [NCIt concept]
- Rilotumumab [NCIt concept]
- Rilunermin Alfa [NCIt concept]
- Rilvegostomig [NCIt concept]
- Rindopepimut [NCIt concept]
- Rineterkib [NCIt concept]
- Rintodestrant [NCIt concept]
- Ripertamab [NCIt concept]
- Ripretinib [NCIt concept]
- Risk Factor [NCIt concept]
- Risk Factor Diagnostic Method [NCIt concept]
- Risk Factor History Negative [NCIt concept]
- Risk Factor Treatment Indicator [NCIt concept]
- Risk Factors for HIV Infection [NCIt concept]
- Risovalisib [NCIt concept]
- Risperidone Formulation in Rumenic Acid [NCIt concept]
- Ritrosulfan [NCIt concept]
- Rituximab [NCIt concept]
- Rituximab Conjugate CON-4619 [NCIt concept]
- Rituximab and Hyaluronidase Human [NCIt concept]
- Rivaroxaban [NCIt concept]
- Riviciclib [NCIt concept]
- Rivoceranib [NCIt concept]
- Rivoceranib Mesylate [NCIt concept]
- Robatumumab [NCIt concept]
- Roblitinib [NCIt concept]
- Rocakinogene Sifuplasmid [NCIt concept]
- Rocapuldencel-T [NCIt concept]
- Rociletinib [NCIt concept]
- Rodorubicin [NCIt concept]
- Roducitabine [NCIt concept]
- Rofecoxib [NCIt concept]
- Roflumilast [NCIt concept]
- Rogaratinib [NCIt concept]
- Rogletimide [NCIt concept]
- Rolinsatamab Talirine [NCIt concept]
- Romania [NCIt concept]
- Romidepsin [NCIt concept]
- Roneparstat [NCIt concept]
- Roniciclib [NCIt concept]
- Root Directory [NCIt concept]
- Ropeginterferon Alfa-2B [NCIt concept]
- Ropidoxuridine [NCIt concept]
- Ropocamptide [NCIt concept]
- Roquinimex [NCIt concept]
- Rosabulin [NCIt concept]
- Rose Bengal Solution PV-10 [NCIt concept]
- Rosette-Forming Glioneuronal Tumor [NCIt concept]
- Rosiglitazone Maleate [NCIt concept]
- Rosmantuzumab [NCIt concept]
- Rosopatamab [NCIt concept]
- Rosuvastatin [NCIt concept]
- Round Cell Liposarcoma [NCIt concept]
- Round Ligament [NCIt concept]
- Route of Administration [NCIt concept]
- Rovalpituzumab Tesirine [NCIt concept]
- Rubber, Plastic and Paper Products Machine Operator [NCIt concept]
- Rubella Infection [NCIt concept]
- Rubinstein-Taybi Syndrome [NCIt concept]
- Rubitecan [NCIt concept]
- Rucaparib [NCIt concept]
- Rucaparib Camsylate [NCIt concept]
- Rucaparib Phosphate [NCIt concept]
- Rucosopasem Manganese [NCIt concept]
- Rulonilimab [NCIt concept]
- Run Metadata [NCIt concept]
- Runimotamab [NCIt concept]
- Ruserontinib [NCIt concept]
- Russian Federation [NCIt concept]
- Ruthenium Ru-106 [NCIt concept]
- Ruthenium-based Small Molecule Therapeutic BOLD-100 [NCIt concept]
- Ruthenium-based Transferrin Targeting Agent NKP-1339 [NCIt concept]
- Ruxolitinib [NCIt concept]
- Ruxolitinib Phosphate [NCIt concept]
- Ruxotemitide [NCIt concept]
- Rwanda [NCIt concept]
- S-Adenosylmethionine [NCIt concept]
- S-equol [NCIt concept]
- S100A7 Gene [NCIt concept]
- SALL4 Gene [NCIt concept]
- SBDS Gene [NCIt concept]
- SBIL-2 [NCIt concept]
- SDC4 Gene [NCIt concept]
- SDF-1 Receptor Antagonist PTX-9908 [NCIt concept]
- SDHA Gene [NCIt concept]
- SDHAF2 Gene [NCIt concept]
- SDHB Gene [NCIt concept]
- SDHC Gene [NCIt concept]
- SDHD Gene [NCIt concept]
- SEPTIN5 Gene [NCIt concept]
- SEPTIN6 Gene [NCIt concept]
- SEPTIN9 Gene [NCIt concept]
- SERD SHR9549 [NCIt concept]
- SERD ZB-716 [NCIt concept]
- SERD ZN-c5 [NCIt concept]
- SERPINA9 Gene [NCIt concept]
- SET Gene [NCIt concept]
- SETBP1 Gene [NCIt concept]
- SETD1A Gene [NCIt concept]
- SETD2 Gene [NCIt concept]
- SETD2 Inhibitor EZM0414 [NCIt concept]
- SF3B1 Gene [NCIt concept]
- SFPQ Gene [NCIt concept]
- SFRP4 Gene [NCIt concept]
- SGK1 Gene [NCIt concept]
- SH2B3 Gene [NCIt concept]
- SH3GL1 Gene [NCIt concept]
- SHP-1 Agonist SC-43 [NCIt concept]
- SHP2 Inhibitor BBP-398 [NCIt concept]
- SHP2 Inhibitor ERAS-601 [NCIt concept]
- SHP2 Inhibitor ET0038 [NCIt concept]
- SHP2 Inhibitor HBI-2376 [NCIt concept]
- SHP2 Inhibitor HS-10381 [NCIt concept]
- SHP2 Inhibitor JAB-3068 [NCIt concept]
- SHP2 Inhibitor JAB-3312 [NCIt concept]
- SHP2 Inhibitor PF-07284892 [NCIt concept]
- SHP2 Inhibitor RLY-1971 [NCIt concept]
- SHP2 Inhibitor SH3809 [NCIt concept]
- SHTN1 Gene [NCIt concept]
- SIK3 Inhibitor OMX-0407 [NCIt concept]
- SIOP/COG/NWTSG Stage I [NCIt concept]
- SIOP/COG/NWTSG Stage II [NCIt concept]
- SIOP/COG/NWTSG Stage III [NCIt concept]
- SIOP/COG/NWTSG Stage IV [NCIt concept]
- SIRP-alpha Fc Fusion Protein IMM01 [NCIt concept]
- SIRPA Gene [NCIt concept]
- SIRPa-4-1BBL Fusion Protein DSP107 [NCIt concept]
- SIRPa-Fc-CD40L Fusion Protein SL-172154 [NCIt concept]
- SKI Gene [NCIt concept]
- SLC34A2 Gene [NCIt concept]
- SLC45A3 Gene [NCIt concept]
- SLC66A2 Gene [NCIt concept]
- SLFN12-PDE3A Complex Inducer BAY 2666605 [NCIt concept]
- SMAC Mimetic BI 891065 [NCIt concept]
- SMAD2 Gene [NCIt concept]
- SMAD3 Gene [NCIt concept]
- SMAD4 Gene [NCIt concept]
- SMARCA2 Degrader PRT3789 [NCIt concept]
- SMARCA4 Gene [NCIt concept]
- SMARCB1 Gene [NCIt concept]
- SMARCD1 Gene [NCIt concept]
- SMARCE1 Gene [NCIt concept]
- SMC1A Gene [NCIt concept]
- SMO Gene [NCIt concept]
- SMO Protein Inhibitor ZSP1602 [NCIt concept]
- SMRT Sequencing [NCIt concept]
- SN-38-Loaded Polymeric Micelles NK012 [NCIt concept]
- SND1 Gene [NCIt concept]
- SNS01-T Nanoparticles [NCIt concept]
- SNX29 Gene [NCIt concept]
- SOCS1 Gene [NCIt concept]
- SOS1 Inhibitor MRTX0902 [NCIt concept]
- SOX2 Gene [NCIt concept]
- SPECC1 Gene [NCIt concept]
- SPEN Gene [NCIt concept]
- SPOP Gene [NCIt concept]
- SR-BP1/HSI Inhibitor SR31747A [NCIt concept]
- SR-T100 Gel [NCIt concept]
- SRA-XML Format [NCIt concept]
- SRC Gene [NCIt concept]
- SRC/YES1 Kinase Inhibitor NXP900 [NCIt concept]
- SRGAP3 Gene [NCIt concept]
- SRSF2 Gene [NCIt concept]
- SRSF3 Gene [NCIt concept]
- SS18 Gene [NCIt concept]
- SS18L1 Gene [NCIt concept]
- SSX1 Gene [NCIt concept]
- SSX2 Gene [NCIt concept]
- SSX4 Gene [NCIt concept]
- STAG1 Gene [NCIt concept]
- STAG2 Gene [NCIt concept]
- STAT Inhibitor OPB-111077 [NCIt concept]
- STAT3 Degrader KT-333 [NCIt concept]
- STAT3 Gene [NCIt concept]
- STAT3 Inhibitor C-188-9 [NCIt concept]
- STAT3 Inhibitor DSP-0337 [NCIt concept]
- STAT3 Inhibitor OPB-31121 [NCIt concept]
- STAT3 Inhibitor OPB-51602 [NCIt concept]
- STAT3 Inhibitor WP1066 [NCIt concept]
- STAT5B Gene [NCIt concept]
- STAT6 Gene [NCIt concept]
- STIL Gene [NCIt concept]
- STING Agonist BI 1387446 [NCIt concept]
- STING Agonist BI 1703880 [NCIt concept]
- STING Agonist BMS-986301 [NCIt concept]
- STING Agonist CRD3874 [NCIt concept]
- STING Agonist GSK3745417 [NCIt concept]
- STING Agonist IMSA101 [NCIt concept]
- STING Agonist KL340399 [NCIt concept]
- STING Agonist MK-2118 [NCIt concept]
- STING Agonist SB 11285 [NCIt concept]
- STING Agonist SNX281 [NCIt concept]
- STING Agonist-containing PTGFRN-expressing Exosomes CDK002 [NCIt concept]
- STING-activating Cyclic Dinucleotide Agonist MIW815 [NCIt concept]
- STING-expressing E. coli SYNB1891 [NCIt concept]
- STK11 Gene [NCIt concept]
- STRN Gene [NCIt concept]
- SUFU Gene [NCIt concept]
- SUZ12 Gene [NCIt concept]
- SYK Gene [NCIt concept]
- SYP Gene [NCIt concept]
- Sabarubicin [NCIt concept]
- Sabatolimab [NCIt concept]
- Sabizabulin [NCIt concept]
- Sacituzumab Govitecan [NCIt concept]
- Sacituzumab Tirumotecan [NCIt concept]
- Sacrum [NCIt concept]
- Sacubitril/Valsartan [NCIt concept]
- Safimaltib [NCIt concept]
- Safingol [NCIt concept]
- Safusidenib [NCIt concept]
- Sagopilone [NCIt concept]
- Saint Helena, Ascension and Tristan da Cunha [NCIt concept]
- Saint Kitts and Nevis [NCIt concept]
- Saint Lucia [NCIt concept]
- Saint Pierre and Miquelon [NCIt concept]
- Saint Vincent and the Grenadines [NCIt concept]
- Sales and Purchasing Agent and Broker [NCIt concept]
- Sales, Marketing and Development Manager [NCIt concept]
- Sales, Marketing and Public Relations Professional [NCIt concept]
- Salesperson [NCIt concept]
- Salirasib [NCIt concept]
- Saliva [NCIt concept]
- Saliva Sample [NCIt concept]
- Salivary Duct Carcinoma [NCIt concept]
- Salivary Duct Inflammation, CTCAE [NCIt concept]
- Salivary Gland [NCIt concept]
- Salivary Gland Basal Cell Adenocarcinoma [NCIt concept]
- Salivary Gland Canalicular Adenoma [NCIt concept]
- Salivary Gland Fistula, CTCAE [NCIt concept]
- Salivary Gland Infection, CTCAE [NCIt concept]
- Salivary Gland Intraductal Carcinoma [NCIt concept]
- Salivary Gland Monomorphic Adenoma [NCIt concept]
- Salivary Gland Polymorphous Adenocarcinoma [NCIt concept]
- Salmonella Septicemia [NCIt concept]
- Salmonella VNP20009 [NCIt concept]
- Salmonella enterica Serotype Typhimurium Expressing L-methioninase SGN1 [NCIt concept]
- Salpingectomy [NCIt concept]
- Salpingo-Oophorectomy [NCIt concept]
- Salt-inducible Kinase Inhibitor GRN-300 [NCIt concept]
- Sam68 Modulator CWP232291 [NCIt concept]
- Samalizumab [NCIt concept]
- Samarium Sm 153-DOTMP [NCIt concept]
- Samoa [NCIt concept]
- Samotolisib [NCIt concept]
- Sample Anatomic Site [NCIt concept]
- Sample Derived from New Primary [NCIt concept]
- Sample Procurement Date [NCIt concept]
- Sample and Data Relationship Format [NCIt concept]
- Samrotamab Vedotin [NCIt concept]
- Samuraciclib [NCIt concept]
- San Marino [NCIt concept]
- San Zhong Kui Jian Tang [NCIt concept]
- Sao Tome and Principe [NCIt concept]
- Sapacitabine [NCIt concept]
- Sapanisertib [NCIt concept]
- Sapitinib [NCIt concept]
- SarCNU [NCIt concept]
- Saracatinib [NCIt concept]
- Saracatinib Difumarate [NCIt concept]
- Sarcoidosis [NCIt concept]
- Sarcoma [NCIt concept]
- Sarcomatoid Carcinoma [NCIt concept]
- Sarcomatoid Features [NCIt concept]
- Sarcomatoid Hepatocellular Carcinoma [NCIt concept]
- Sarcomatoid Mesothelioma [NCIt concept]
- Sarcomatoid Renal Cell Carcinoma [NCIt concept]
- Sarcomatoid Transitional Cell Carcinoma [NCIt concept]
- Sarcomatosis [NCIt concept]
- Sardomozide [NCIt concept]
- Sargramostim [NCIt concept]
- Saruparib [NCIt concept]
- Sasanlimab [NCIt concept]
- Satraplatin [NCIt concept]
- Saudi Arabia [NCIt concept]
- Savolitinib [NCIt concept]
- Scalene Lymph Node [NCIt concept]
- Scalp [NCIt concept]
- Scalp Pain, CTCAE 5.0 [NCIt concept]
- Scapula [NCIt concept]
- Scheduling Issue [NCIt concept]
- Schwannoma [NCIt concept]
- Schwannomatosis [NCIt concept]
- Sciatic Nerve [NCIt concept]
- Scientific Data Type [NCIt concept]
- Scirrhous Adenocarcinoma [NCIt concept]
- Scirrhous Hepatocellular Carcinoma [NCIt concept]
- Scleral Disorder, CTCAE [NCIt concept]
- Sclerosing Atypical Lipomatous Tumor/Well Differentiated Liposarcoma [NCIt concept]
- Sclerosing Epithelioid Fibrosarcoma [NCIt concept]
- Sclerosing Rhabdomyosarcoma [NCIt concept]
- Sclerosis [NCIt concept]
- Scoliosis, CTCAE [NCIt concept]
- Scopoletin [NCIt concept]
- Scrotal Infection, CTCAE [NCIt concept]
- Scrotal Pain, CTCAE 5.0 [NCIt concept]
- Scrotum [NCIt concept]
- Seasonal Allergic Rhinitis [NCIt concept]
- Sebaceous Adenoma [NCIt concept]
- Sebaceous Carcinoma [NCIt concept]
- Sec61 Inhibitor KZR-261 [NCIt concept]
- Seclidemstat [NCIt concept]
- Second [NCIt concept]
- Second Exon of Interest Number [NCIt concept]
- Second Primary Malignant Neoplasm [NCIt concept]
- Second-strand Library Sequencing [NCIt concept]
- Secondary Carcinoma [NCIt concept]
- Secondary Education Teacher [NCIt concept]
- Secondary Exposure Indicator [NCIt concept]
- Secondary Gleason Pattern [NCIt concept]
- Secondary Myelofibrosis [NCIt concept]
- Secondary Neoplasm [NCIt concept]
- Secondhand Smoke Exposure as a Child [NCIt concept]
- Secretary (General) [NCIt concept]
- Secretory Meningioma [NCIt concept]
- Sedoxantrone Trihydrochloride [NCIt concept]
- Segmented Neutrophil Count [NCIt concept]
- Seizure [NCIt concept]
- Seizure Disorder [NCIt concept]
- Seizure, CTCAE 5.0 [NCIt concept]
- Selatinib Ditosilate [NCIt concept]
- Select Exposure Types [NCIt concept]
- Selected Normal Low Pass Whole Genome Sequencing Indicator [NCIt concept]
- Selected Normal Targeted Sequencing Sample Aliquot Indicator [NCIt concept]
- Selected Normal Whole Exome Sequencing Indicator [NCIt concept]
- Selected Normal Whole Genome Sequencing Indicator [NCIt concept]
- Selective Cytokine Inhibitory Drug CC-1088 [NCIt concept]
- Selective Estrogen Receptor Covalent Antagonist TQB3915 [NCIt concept]
- Selective Estrogen Receptor Degrader AND019 [NCIt concept]
- Selective Estrogen Receptor Degrader AZD9496 [NCIt concept]
- Selective Estrogen Receptor Degrader LSZ102 [NCIt concept]
- Selective Estrogen Receptor Degrader LX-039 [NCIt concept]
- Selective Estrogen Receptor Degrader SRN-927 [NCIt concept]
- Selective Estrogen Receptor Modulator CC-8490 [NCIt concept]
- Selective Estrogen Receptor Modulator TAS-108 [NCIt concept]
- Selective Human Estrogen-receptor Alpha Partial Agonist TTC-352 [NCIt concept]
- Seliciclib [NCIt concept]
- Selicrelumab [NCIt concept]
- Selinexor [NCIt concept]
- Selitrectinib [NCIt concept]
- Selonsertib [NCIt concept]
- Selpercatinib [NCIt concept]
- Selumetinib [NCIt concept]
- Selumetinib Sulfate [NCIt concept]
- Semaxanib [NCIt concept]
- Seminal Vesicle [NCIt concept]
- Seminoma [NCIt concept]
- Seminoma International Germ Cell Tumor Consensus Risk Classification, Good [NCIt concept]
- Seminoma International Germ Cell Tumor Consensus Risk Classification, Intermediate [NCIt concept]
- Semuloparin [NCIt concept]
- Semustine [NCIt concept]
- Senaparib [NCIt concept]
- Seneca Valley Virus-001 [NCIt concept]
- Senegal [NCIt concept]
- Sensory Change [NCIt concept]
- Seocalcitol [NCIt concept]
- Sepantronium Bromide [NCIt concept]
- Separated [NCIt concept]
- Sepsis, CTCAE [NCIt concept]
- Sequence Alignment Workflow [NCIt concept]
- Sequence Analysis [NCIt concept]
- Sequence Read Count [NCIt concept]
- Sequencing Adapter Name [NCIt concept]
- Sequencing Adapter Nucleic Acid Sequence [NCIt concept]
- Sequencing Data [NCIt concept]
- Sequencing Flow Cell Barcode [NCIt concept]
- Sequencing Lane Identifier [NCIt concept]
- Sequencing Library Name [NCIt concept]
- Sequencing Library Preparation Kit Catalog Number [NCIt concept]
- Sequencing Library Preparation Kit Name [NCIt concept]
- Sequencing Library Preparation Kit Vendor Name [NCIt concept]
- Sequencing Library Preparation Kit Version [NCIt concept]
- Sequencing Size Selection Range [NCIt concept]
- Serabelisib [NCIt concept]
- Serbia [NCIt concept]
- Serclutamab Talirine [NCIt concept]
- Serdemetan [NCIt concept]
- Sergiolide [NCIt concept]
- Seribantumab [NCIt concept]
- Serine/Threonine Kinase Inhibitor CBP501 [NCIt concept]
- Serine/Threonine Kinase Inhibitor XL418 [NCIt concept]
- Seroma, CTCAE [NCIt concept]
- Serous Adenofibroma [NCIt concept]
- Serous Cystadenocarcinoma [NCIt concept]
- Serous Cystadenoma [NCIt concept]
- Serous Endometrial Intraepithelial Carcinoma [NCIt concept]
- Serous Surface Papillary Carcinoma [NCIt concept]
- Serous Surface Papilloma [NCIt concept]
- Serous Tubal Intraepithelial Carcinoma [NCIt concept]
- Serplulimab [NCIt concept]
- Serrated Lesions and Polyps [NCIt concept]
- Sertoli Cell Tumor [NCIt concept]
- Serum [NCIt concept]
- Serum Amylase Increased, CTCAE [NCIt concept]
- Serum Mesothelin Measurement [NCIt concept]
- Serum Sickness, CTCAE 5.0 [NCIt concept]
- Setanaxib [NCIt concept]
- Seventh [NCIt concept]
- Severe Adverse Event [NCIt concept]
- Severe Dysplasia [NCIt concept]
- Seviteronel [NCIt concept]
- Sex Cord-Stromal Tumor [NCIt concept]
- Seychelles [NCIt concept]
- Sezary Syndrome [NCIt concept]
- Shared Anti-Idiotype-AB-S006 [NCIt concept]
- Shared Anti-Idiotype-AB-S024A [NCIt concept]
- Shark Cartilage [NCIt concept]
- Shark Cartilage Extract AE-941 [NCIt concept]
- Sheet and Structural Metal Worker, Molder and Welder, and Related Worker [NCIt concept]
- Shellfish Allergy [NCIt concept]
- Shenqi Fuzheng Injection SQ001 [NCIt concept]
- Ship and Aircraft Controller and Technician [NCIt concept]
- Ships' Deck Crew and Related Worker [NCIt concept]
- Sho-Saiko-To [NCIt concept]
- Short Arm of Chromosome [NCIt concept]
- Short Hairpin RNA-IL-6 Gene Silencing Anti-CD19 CAR T Cells [NCIt concept]
- Short Site Name [NCIt concept]
- Shoulder [NCIt concept]
- Shu Yu Wan Formula [NCIt concept]
- Sialadenitis [NCIt concept]
- Sialoblastoma [NCIt concept]
- Sialyl Tn Antigen [NCIt concept]
- Sialyl Tn-KLH Vaccine [NCIt concept]
- Sibling [NCIt concept]
- Sibrotuzumab [NCIt concept]
- Sick Sinus Syndrome, CTCAE [NCIt concept]
- Sierra Leone [NCIt concept]
- Sigmoid Colon [NCIt concept]
- Sigmoidectomy [NCIt concept]
- Signet Ring Cell Carcinoma [NCIt concept]
- Silatecan AR-67 [NCIt concept]
- Silent Mutation [NCIt concept]
- Silent Stop Codon Mutation [NCIt concept]
- Silibinin [NCIt concept]
- Silicon Phthalocyanine 4 [NCIt concept]
- Silmitasertib [NCIt concept]
- Silmitasertib Sodium [NCIt concept]
- Siltuximab [NCIt concept]
- Simalikalactone D [NCIt concept]
- Simeprevir [NCIt concept]
- Simlukafusp Alfa [NCIt concept]
- Simmitinib [NCIt concept]
- Simotaxel [NCIt concept]
- Simridarlimab [NCIt concept]
- Simtuzumab [NCIt concept]
- Simurosertib [NCIt concept]
- Singapore [NCIt concept]
- Single Cell ATAC-Seq [NCIt concept]
- Single Cell Data [NCIt concept]
- Single Cell Library Construction Kit Identifier [NCIt concept]
- Single Cell RNA Sequencing [NCIt concept]
- Sinonasal Inverted Papilloma [NCIt concept]
- Sinonasal Non-Keratinizing Squamous Cell Carcinoma [NCIt concept]
- Sinonasal Oncocytic Papilloma [NCIt concept]
- Sinonasal Papilloma [NCIt concept]
- Sintilimab [NCIt concept]
- Sinus [NCIt concept]
- Sinus Bradycardia, CTCAE [NCIt concept]
- Sinus Disorder, CTCAE [NCIt concept]
- Sinus Pain, CTCAE 5.0 [NCIt concept]
- Sinus Tachycardia, CTCAE 5.0 [NCIt concept]
- Sinusitis, CTCAE [NCIt concept]
- Sinusoidal Infiltration [NCIt concept]
- Siplizumab [NCIt concept]
- Sipuleucel-T [NCIt concept]
- Siremadlin [NCIt concept]
- Sirexatamab [NCIt concept]
- Sirolimus [NCIt concept]
- Sirolimus Albumin-bound Nanoparticles [NCIt concept]
- Sirolimus Topical Gel NPC-12Y [NCIt concept]
- Sirolimus Topical Gel PTX-022 [NCIt concept]
- Sirpiglenastat [NCIt concept]
- Sirtratumab Vedotin [NCIt concept]
- Sister [NCIt concept]
- Sister-in-law [NCIt concept]
- Site Specific Immunomodulator QBECO [NCIt concept]
- Site of Metastasis at Diagnosis [NCIt concept]
- Site of Resection or Biopsy [NCIt concept]
- Sitimagene Ceradenovec [NCIt concept]
- Sitravatinib [NCIt concept]
- Sivifene [NCIt concept]
- Six TAAs-specific Autologous T-cells MT-601 [NCIt concept]
- Sixth [NCIt concept]
- Sizofiran [NCIt concept]
- Sjogren Syndrome [NCIt concept]
- Skeletal Muscle Tissue [NCIt concept]
- Skene Gland [NCIt concept]
- Skin [NCIt concept]
- Skin Adenoid Basal Cell Carcinoma [NCIt concept]
- Skin Appendage Adenoma [NCIt concept]
- Skin Appendage Neoplasm [NCIt concept]
- Skin Atrophy, CTCAE 5.0 [NCIt concept]
- Skin Basal Cell Carcinoma [NCIt concept]
- Skin Basal Cell Carcinoma with Sebaceous Differentiation [NCIt concept]
- Skin Basosquamous Cell Carcinoma [NCIt concept]
- Skin Fibroepithelial Basal Cell Carcinoma [NCIt concept]
- Skin Fibrous Histiocytoma [NCIt concept]
- Skin Hyperpigmentation, CTCAE [NCIt concept]
- Skin Hypopigmentation, CTCAE [NCIt concept]
- Skin Induration, CTCAE [NCIt concept]
- Skin Infection, CTCAE [NCIt concept]
- Skin Infiltrating Basal Cell Carcinoma [NCIt concept]
- Skin Metatypical Carcinoma [NCIt concept]
- Skin Micronodular Basal Cell Carcinoma [NCIt concept]
- Skin Nodular Basal Cell Carcinoma [NCIt concept]
- Skin Nodulo-Ulcerative Basal Cell Carcinoma [NCIt concept]
- Skin Pigmented Basal Cell Carcinoma [NCIt concept]
- Skin Rash [NCIt concept]
- Skin Sclerosing/Morphoeic Basal Cell Carcinoma [NCIt concept]
- Skin Tattoo [NCIt concept]
- Skin Ulceration, CTCAE [NCIt concept]
- Skin and Subcutaneous Tissue Disorders - Other, Specify, CTCAE [NCIt concept]
- Skin of the Face [NCIt concept]
- Skin of the Lip [NCIt concept]
- Skin of the Lower Extremity [NCIt concept]
- Skin of the Lower Limb and Hip [NCIt concept]
- Skin of the Scalp and Neck [NCIt concept]
- Skin of the Trunk [NCIt concept]
- Skin of the Upper Extremity [NCIt concept]
- Skin of the Upper Limb and Shoulder [NCIt concept]
- Skull [NCIt concept]
- Sleep Apnea [NCIt concept]
- Sleep Apnea, CTCAE [NCIt concept]
- Slide Image [NCIt concept]
- Slide Section Anatomic Site [NCIt concept]
- Slovakia [NCIt concept]
- Slovenia [NCIt concept]
- Smac Mimetic BGB-24714 [NCIt concept]
- Smac Mimetic GDC-0152 [NCIt concept]
- Smac Mimetic GDC-0917 [NCIt concept]
- Smac Mimetic LCL161 [NCIt concept]
- Small Cell Carcinoma, Fusiform Cell Type [NCIt concept]
- Small Cell Intermediate Cell Carcinoma [NCIt concept]
- Small Cell Neuroendocrine Carcinoma [NCIt concept]
- Small Cell Osteosarcoma [NCIt concept]
- Small Cell Sarcoma [NCIt concept]
- Small Congenital Melanocytic Nevus [NCIt concept]
- Small Intestinal Anastomotic Leak, CTCAE [NCIt concept]
- Small Intestinal Mucosa [NCIt concept]
- Small Intestinal Mucositis, CTCAE [NCIt concept]
- Small Intestinal Obstruction, CTCAE [NCIt concept]
- Small Intestinal Perforation, CTCAE 5.0 [NCIt concept]
- Small Intestinal Stenosis, CTCAE [NCIt concept]
- Small Intestine [NCIt concept]
- Small Intestine Infection, CTCAE [NCIt concept]
- Small Intestine Ulcer, CTCAE [NCIt concept]
- Small Lymphocytic Lymphoma [NCIt concept]
- Smoke Exposure [NCIt concept]
- Smokehouse Smoke Exposure [NCIt concept]
- Smokeless Tobacco [NCIt concept]
- Smokeless Tobacco Exposure [NCIt concept]
- Smokeless Tobacco Use [NCIt concept]
- Smoking [NCIt concept]
- Smoking Cessation Year [NCIt concept]
- Smoking Onset Year [NCIt concept]
- Smoking Status [NCIt concept]
- Smoking Status Not Documented [NCIt concept]
- Smoking at Diagnosis [NCIt concept]
- Smooth Muscle Neoplasm [NCIt concept]
- Smoothened Antagonist BMS-833923 [NCIt concept]
- Smoothened Antagonist IPI-609 [NCIt concept]
- Smoothened Antagonist LDE225 Topical [NCIt concept]
- Smoothened Antagonist LEQ506 [NCIt concept]
- Smoothened Antagonist TAK-441 [NCIt concept]
- Sneezing, CTCAE [NCIt concept]
- Sobuzoxane [NCIt concept]
- Socazolimab [NCIt concept]
- Social Circumstances - Other, Specify, CTCAE [NCIt concept]
- Social Drinker [NCIt concept]
- Social Security Death Index [NCIt concept]
- Social Setting-related Exposure [NCIt concept]
- Social and Religious Professional [NCIt concept]
- Sodium Borate Exposure [NCIt concept]
- Sodium Borocaptate [NCIt concept]
- Sodium Butyrate [NCIt concept]
- Sodium Dichloroacetate [NCIt concept]
- Sodium Fluoride [NCIt concept]
- Sodium Iodide I-131 [NCIt concept]
- Sodium Metaarsenite [NCIt concept]
- Sodium Pentaborate Pentahydrate [NCIt concept]
- Sodium Phenylbutyrate [NCIt concept]
- Sodium Salicylate [NCIt concept]
- Sodium Selenite [NCIt concept]
- Sodium Stibogluconate [NCIt concept]
- Sodium-Potassium Adenosine Triphosphatase Inhibitor RX108 [NCIt concept]
- Sofituzumab Vedotin [NCIt concept]
- Soft Palate [NCIt concept]
- Soft Tissue [NCIt concept]
- Soft Tissue Infection, CTCAE [NCIt concept]
- Soft Tissue Necrosis Lower Limb, CTCAE [NCIt concept]
- Soft Tissue Necrosis Upper Limb, CTCAE [NCIt concept]
- Soft Tissue Perineurioma [NCIt concept]
- Soft Tissue Sarcoma [NCIt concept]
- Software and Applications Developer and Analyst [NCIt concept]
- Solid Carcinoma [NCIt concept]
- Solid Growth Pattern [NCIt concept]
- Solid Pseudopapillary Carcinoma of the Pancreas [NCIt concept]
- Solid Pseudopapillary Neoplasm [NCIt concept]
- Solid Pseudopapillary Neoplasm of the Pancreas [NCIt concept]
- Solid Tissue Specimen [NCIt concept]
- Solid/Trabecular Variant Thyroid Gland Papillary Carcinoma [NCIt concept]
- Solitary Fibrous Tumor [NCIt concept]
- Solitary Mastocytoma of the Skin [NCIt concept]
- Solitary Plasmacytoma [NCIt concept]
- Solitary Plasmacytoma of Bone [NCIt concept]
- Solitary Reticulohistiocytoma [NCIt concept]
- Solitomab [NCIt concept]
- Solomon Islands [NCIt concept]
- Solvent Exposure [NCIt concept]
- Somalia [NCIt concept]
- Somatic Cytogenetic Abnormality Analysis [NCIt concept]
- Somatic Variation [NCIt concept]
- Somatic Variation Rate [NCIt concept]
- Somatostatin-Producing Neuroendocrine Tumor [NCIt concept]
- Some College Completion [NCIt concept]
- Some High School, No Diploma [NCIt concept]
- Somnolence, CTCAE [NCIt concept]
- Son [NCIt concept]
- Son-in-law [NCIt concept]
- Sonepcizumab [NCIt concept]
- Sonidegib [NCIt concept]
- Sonographic Examination [NCIt concept]
- Sonolisib [NCIt concept]
- Sonrotoclax [NCIt concept]
- Sontuzumab [NCIt concept]
- Soquelitinib [NCIt concept]
- Sorafenib [NCIt concept]
- Sorafenib Tosylate [NCIt concept]
- Sore Throat, CTCAE [NCIt concept]
- Sorghum bicolor Supplement [NCIt concept]
- Sorted Cells [NCIt concept]
- Sotevtamab [NCIt concept]
- Sotiburafusp Alfa [NCIt concept]
- Sotigalimab [NCIt concept]
- Sotorasib [NCIt concept]
- Sotrastaurin [NCIt concept]
- Sotrastaurin Acetate [NCIt concept]
- Sotuletinib [NCIt concept]
- Sotuletinib Dihydrochloride [NCIt concept]
- Source Site Name [NCIt concept]
- South Africa [NCIt concept]
- South Sudan [NCIt concept]
- Southern Blotting [NCIt concept]
- Sovilnesib [NCIt concept]
- Sovipostobart [NCIt concept]
- Sovleplenib [NCIt concept]
- Soy Isoflavones [NCIt concept]
- Soy Protein Isolate [NCIt concept]
- Spain [NCIt concept]
- Spanlecortemlocel [NCIt concept]
- Sparfosate Sodium [NCIt concept]
- Sparfosic Acid [NCIt concept]
- Spartalizumab [NCIt concept]
- Spasticity, CTCAE [NCIt concept]
- Spebrutinib [NCIt concept]
- Special Diet Therapy [NCIt concept]
- Specify HPV Genotype [NCIt concept]
- Spectral View Settings Format [NCIt concept]
- Spectrophotometry [NCIt concept]
- Spermatic Cord [NCIt concept]
- Spermatic Cord Anastomotic Leak, CTCAE [NCIt concept]
- Spermatic Cord Hemorrhage, CTCAE [NCIt concept]
- Spermatic Cord Obstruction, CTCAE 5.0 [NCIt concept]
- Sphenoid Sinus [NCIt concept]
- Spherical Nucleic Acid Nanoparticle NU-0129 [NCIt concept]
- Spike-In Concentration [NCIt concept]
- Spike-In FASTA File Name [NCIt concept]
- Spike-In Inclusion Indicator [NCIt concept]
- Spinal Cord [NCIt concept]
- Spinal Fracture, CTCAE [NCIt concept]
- Spinal Meninges [NCIt concept]
- Spinal Muscular Atrophy [NCIt concept]
- Spindle Cell Hemangioma [NCIt concept]
- Spindle Cell Lipoma [NCIt concept]
- Spindle Cell Melanoma [NCIt concept]
- Spindle Cell Oncocytoma [NCIt concept]
- Spindle Cell Rhabdomyosarcoma [NCIt concept]
- Spindle Cell Sarcoma [NCIt concept]
- Spindle Cell Squamous Carcinoma [NCIt concept]
- Spindle Cell Synovial Sarcoma [NCIt concept]
- Spindle-Cell Predominant Trichodiscoma [NCIt concept]
- Spiradenocarcinoma [NCIt concept]
- Spiradenoma [NCIt concept]
- Spirogermanium [NCIt concept]
- Spiromustine [NCIt concept]
- Spiroplatin [NCIt concept]
- Spitz Nevus [NCIt concept]
- Spleen [NCIt concept]
- Splenic B-Cell Lymphoma/Leukemia, Unclassifiable [NCIt concept]
- Splenic Diffuse Red Pulp Small B-Cell Lymphoma [NCIt concept]
- Splenic Disorder [NCIt concept]
- Splenic Flexure [NCIt concept]
- Splenic Infection, CTCAE [NCIt concept]
- Splenic Lymph Node [NCIt concept]
- Splenic Marginal Zone Lymphoma [NCIt concept]
- Splice Junction Measurement [NCIt concept]
- Splice-Site Mutation [NCIt concept]
- Splicing Inhibitor H3B-8800 [NCIt concept]
- Spongioneuroblastoma [NCIt concept]
- Spongistatin [NCIt concept]
- Spontaneous Abortion [NCIt concept]
- Spontaneous Descent of Undescended Testis [NCIt concept]
- Spontaneously Regressed Retinoblastoma [NCIt concept]
- Sporadic Burkitt Lymphoma [NCIt concept]
- Sports and Fitness Worker [NCIt concept]
- Spouse [NCIt concept]
- Sputum [NCIt concept]
- Squalamine Lactate [NCIt concept]
- Squamous Cell Carcinoma [NCIt concept]
- Squamous Cell Carcinoma Antigen Measurement [NCIt concept]
- Squamous Cell Carcinoma In Situ with Questionable Stromal Invasion [NCIt concept]
- Squamous Cell Carcinoma with Horn Formation [NCIt concept]
- Squamous Cell Carcinoma, Clear Cell Type [NCIt concept]
- Squamous Cell Neoplasm [NCIt concept]
- Squamous Metaplasia [NCIt concept]
- Squamous Odontogenic Tumor [NCIt concept]
- Squamous Papilloma [NCIt concept]
- Squamous Papillomatosis [NCIt concept]
- Square Millimeter [NCIt concept]
- Squeezed Red Blood Cells Expressing HPV16 Epitopes SQZ-AAC-HPV [NCIt concept]
- Src Kinase Inhibitor AP 23846 [NCIt concept]
- Src Kinase Inhibitor M475271 [NCIt concept]
- Src/Abl Kinase Inhibitor AZD0424 [NCIt concept]
- Src/tubulin Inhibitor KX2-361 [NCIt concept]
- Sri Lanka [NCIt concept]
- St. John's Wort [NCIt concept]
- Stable [NCIt concept]
- Stable Disease [NCIt concept]
- Stage 0 [NCIt concept]
- Stage 0 Cervical Cancer AJCC v6 [NCIt concept]
- Stage 0 Cutaneous Melanoma AJCC v6 and v7 [NCIt concept]
- Stage 0 Squamous Cell Carcinoma [NCIt concept]
- Stage 0 Transitional Cell Carcinoma [NCIt concept]
- Stage 0 Vaginal Cancer AJCC v6 [NCIt concept]
- Stage 0 Vaginal Cancer AJCC v7 [NCIt concept]
- Stage 0 Vulvar Cancer AJCC v6 [NCIt concept]
- Stage 0a [NCIt concept]
- Stage 0is [NCIt concept]
- Stage I [NCIt concept]
- Stage IA [NCIt concept]
- Stage IA1 [NCIt concept]
- Stage IA2 [NCIt concept]
- Stage IA3 [NCIt concept]
- Stage IB [NCIt concept]
- Stage IB1 [NCIt concept]
- Stage IB2 [NCIt concept]
- Stage IC [NCIt concept]
- Stage II [NCIt concept]
- Stage IIA [NCIt concept]
- Stage IIA1 [NCIt concept]
- Stage IIA2 [NCIt concept]
- Stage IIB [NCIt concept]
- Stage IIC [NCIt concept]
- Stage III [NCIt concept]
- Stage IIIA [NCIt concept]
- Stage IIIA1 [NCIt concept]
- Stage IIIA2 [NCIt concept]
- Stage IIIB [NCIt concept]
- Stage IIIC [NCIt concept]
- Stage IIIC1 [NCIt concept]
- Stage IIIC2 [NCIt concept]
- Stage IIID [NCIt concept]
- Stage IS [NCIt concept]
- Stage IV [NCIt concept]
- Stage IVA [NCIt concept]
- Stage IVB [NCIt concept]
- Stage IVC [NCIt concept]
- Stage M2 [NCIt concept]
- Stage R [NCIt concept]
- Stage R0 [NCIt concept]
- Stage R1 [NCIt concept]
- Stage R2 [NCIt concept]
- Stage RX [NCIt concept]
- Stage X [NCIt concept]
- Staining Intensity [NCIt concept]
- Staining Intensity 0 [NCIt concept]
- Staining Intensity 1+ [NCIt concept]
- Staining Intensity 2+ [NCIt concept]
- Staining Intensity 3+ [NCIt concept]
- Staining Intensity 4+ [NCIt concept]
- Staining Intensity Value Reported Indicator [NCIt concept]
- Staining Method [NCIt concept]
- Stallimycin [NCIt concept]
- Standard Deviation for Read Length of Sequenced Fragments [NCIt concept]
- Standardized Uptake Value [NCIt concept]
- Standardized Uptake Value Maximum [NCIt concept]
- Staphylococcal Enterotoxin A [NCIt concept]
- Staphylococcal Enterotoxin B [NCIt concept]
- Staphylococcal Osteomyelitis [NCIt concept]
- Staphylococcus aureus Infection [NCIt concept]
- Start Lost Mutation [NCIt concept]
- State of Palestine [NCIt concept]
- Staurosporine [NCIt concept]
- Steatosis [NCIt concept]
- Stem Cell Therapy [NCIt concept]
- Stenosis of Gastrointestinal Stoma, CTCAE [NCIt concept]
- Step Child [NCIt concept]
- Step Father [NCIt concept]
- Step Sibling [NCIt concept]
- Stepbrother [NCIt concept]
- Stepdaughter [NCIt concept]
- Stepmother [NCIt concept]
- Stepsister [NCIt concept]
- Stepson [NCIt concept]
- Stereotactic Radiosurgery [NCIt concept]
- Sternum [NCIt concept]
- Steroid Therapy [NCIt concept]
- Stevens-Johnson Syndrome, CTCAE [NCIt concept]
- Stillbirth [NCIt concept]
- Stoma Site Infection, CTCAE [NCIt concept]
- Stomach [NCIt concept]
- Stomach Pain, CTCAE 5.0 [NCIt concept]
- Stomal Ulcer, CTCAE 5.0 [NCIt concept]
- Street Vendor (Excluding Food) [NCIt concept]
- Street and Market Salesperson [NCIt concept]
- Street and Related Service Worker [NCIt concept]
- Streptonigrin [NCIt concept]
- Streptozocin [NCIt concept]
- Stridor, CTCAE [NCIt concept]
- Stringent Complete Response [NCIt concept]
- Stroke [NCIt concept]
- Stroke, CTCAE [NCIt concept]
- Stromal Neoplasm [NCIt concept]
- Stromal Sarcoma [NCIt concept]
- Strontium Chloride Sr-89 [NCIt concept]
- Struma Ovarii [NCIt concept]
- Strumal Carcinoid [NCIt concept]
- Study Medication Completed [NCIt concept]
- Subasumstat [NCIt concept]
- Subcarinal Lymph Node [NCIt concept]
- Subcutaneous Panniculitis-Like T-Cell Lymphoma [NCIt concept]
- Subcutaneous Route of Administration [NCIt concept]
- Subcutis [NCIt concept]
- Subependymal Giant Cell Astrocytoma [NCIt concept]
- Subependymoma [NCIt concept]
- Subepidermal Nodular Fibrosis [NCIt concept]
- Subglottis [NCIt concept]
- Subject Consent Type [NCIt concept]
- Sublingual Salivary Gland [NCIt concept]
- Submandibular Lymph Node [NCIt concept]
- Submandibular Salivary Gland [NCIt concept]
- Submicron Particle Paclitaxel Sterile Suspension [NCIt concept]
- Submission [NCIt concept]
- Submitter Reviewing Project Indicator [NCIt concept]
- Submucosal Invasion Depth [NCIt concept]
- Subsistence Crop Farmer [NCIt concept]
- Subsistence Fisherman, Hunter, Trapper and Gatherer [NCIt concept]
- Subsistence Livestock Farmer [NCIt concept]
- Subsistence Mixed Crop and Livestock Farmer [NCIt concept]
- Substance Use Per Day [NCIt concept]
- Subtotal Prostatectomy [NCIt concept]
- Succinate Dehydrogenase-Deficient Renal Cell Carcinoma [NCIt concept]
- Sudan [NCIt concept]
- Sudden Death NOS, CTCAE [NCIt concept]
- Sudocetaxel Zendusortide [NCIt concept]
- Sugemalimab [NCIt concept]
- Suicidal Ideation, CTCAE [NCIt concept]
- Suicide Attempt, CTCAE [NCIt concept]
- Sulanemadlin [NCIt concept]
- Sulfatinib [NCIt concept]
- Sulfonylurea Antidiabetic Agent [NCIt concept]
- Sulforaphane [NCIt concept]
- Sulindac [NCIt concept]
- Sulofenur [NCIt concept]
- Sunitinib [NCIt concept]
- Sunitinib Malate [NCIt concept]
- Sunvozertinib [NCIt concept]
- Super Enhancer Inhibitor GZ17-6.02 [NCIt concept]
- Superficial Atypical Lipomatous Tumor/Well Differentiated Liposarcoma [NCIt concept]
- Superficial Lesion [NCIt concept]
- Superficial Multifocal Basal Cell Carcinoma [NCIt concept]
- Superficial Parotidectomy [NCIt concept]
- Superficial Soft Tissue Fibrosis, CTCAE [NCIt concept]
- Superficial Spreading Adenocarcinoma [NCIt concept]
- Superficial Thrombophlebitis, CTCAE [NCIt concept]
- Superior Vena Cava Syndrome, CTCAE [NCIt concept]
- Superior Wall of the Nasopharynx [NCIt concept]
- Supplement [NCIt concept]
- Supportive Care [NCIt concept]
- Supracervical Hysterectomy [NCIt concept]
- Supraclavicular Lymph Node [NCIt concept]
- Supracricoid Laryngectomy [NCIt concept]
- Supraglottic Laryngectomy [NCIt concept]
- Supraglottis [NCIt concept]
- Supratentorial Embryonal Tumor, Not Otherwise Specified [NCIt concept]
- Supratentorial Ependymoma, ZFTA-RELA Fusion-Positive [NCIt concept]
- Supratentorial Tumor Site [NCIt concept]
- Supraventricular Tachycardia, CTCAE [NCIt concept]
- Suramin [NCIt concept]
- Suramin Sodium [NCIt concept]
- Suratadenoturev [NCIt concept]
- Surface Immunoglobulin [NCIt concept]
- Surface Immunoglobulin Light Chain Kappa [NCIt concept]
- Surface Immunoglobulin Light Chain Lambda [NCIt concept]
- Surgical Complication [NCIt concept]
- Surgical Margins Status [NCIt concept]
- Surgical Procedure [NCIt concept]
- Surgical and Medical Procedures - Other, Specify, CTCAE [NCIt concept]
- Suriname [NCIt concept]
- Surveillance [NCIt concept]
- Survivin Antigen [NCIt concept]
- Survivin mRNA Antagonist EZN-3042 [NCIt concept]
- Survivin-expressing CVD908ssb-TXSVN Vaccine [NCIt concept]
- Survivin-targeted Vaccine OVM-200 [NCIt concept]
- Surzebiclimab [NCIt concept]
- Suspected Reason for Disease Response [NCIt concept]
- Suspension Culture [NCIt concept]
- Sustained-release Lipid Inhaled Cisplatin [NCIt concept]
- Sustained-release Mitomycin C Hydrogel Formulation UGN-101 [NCIt concept]
- Sustained-release Mitomycin C Hydrogel Formulation UGN-102 [NCIt concept]
- Sutetinib Maleate [NCIt concept]
- Suvemcitug [NCIt concept]
- Svalbard and Jan Mayen [NCIt concept]
- Sweat Gland Adenoma [NCIt concept]
- Sweat Gland Carcinoma [NCIt concept]
- Sweat Gland Neoplasm [NCIt concept]
- Sweden [NCIt concept]
- Switzerland [NCIt concept]
- Sympathetic Paraganglioma [NCIt concept]
- Symptomatic Presentation [NCIt concept]
- Synchronous Lesion [NCIt concept]
- Synchrotope TA2M Plasmid DNA Vaccine [NCIt concept]
- Synchrovax SEM Plasmid DNA Vaccine [NCIt concept]
- Syncope, CTCAE 5.0 [NCIt concept]
- Syndecan-1 [NCIt concept]
- Syngeneic Stem Cell Transplantation [NCIt concept]
- Synovial Membrane [NCIt concept]
- Synovial Sarcoma [NCIt concept]
- Synthetic Alkaloid PM00104 [NCIt concept]
- Synthetic Glioblastoma Mutated Tumor-specific Peptides Vaccine Therapy APVAC2 [NCIt concept]
- Synthetic Glioblastoma Tumor-associated Peptides Vaccine Therapy APVAC1 [NCIt concept]
- Synthetic Hypericin [NCIt concept]
- Synthetic Long E6 Peptide-Toll-like Receptor Ligand Conjugate Vaccine ISA201 [NCIt concept]
- Synthetic Long E6/E7 Peptides Vaccine HPV-01 [NCIt concept]
- Synthetic Long HPV16 E6/E7 Peptides Vaccine ISA101b [NCIt concept]
- Synthetic Plumbagin PCUR-101 [NCIt concept]
- Synthetic hTERT DNA Vaccine INO-1400 [NCIt concept]
- Synthetic hTERT DNA Vaccine INO-1401 [NCIt concept]
- Syphilis [NCIt concept]
- Syrian Arab Republic [NCIt concept]
- Syringocystadenoma Papilliferum [NCIt concept]
- Syringofibroadenoma [NCIt concept]
- Syringoma [NCIt concept]
- Systemic EBV-Positive T-Cell Lymphoma of Childhood [NCIt concept]
- Systemic Mastocytosis [NCIt concept]
- Systemic Mastocytosis with an Associated Myeloid Neoplasm [NCIt concept]
- Systemic Radiation Therapy [NCIt concept]
- T Acute Lymphoblastic Leukemia [NCIt concept]
- T Lymphoblastic Leukemia/Lymphoma [NCIt concept]
- T Lymphoblastic Lymphoma [NCIt concept]
- T-Cell Antigen CD7 [NCIt concept]
- T-Cell Large Granular Lymphocyte Leukemia [NCIt concept]
- T-Cell Non-Hodgkin Lymphoma [NCIt concept]
- T-Cell Prolymphocytic Leukemia [NCIt concept]
- T-Cell Receptor Alpha Locus [NCIt concept]
- T-Cell Receptor Beta Locus [NCIt concept]
- T-Cell Receptor Delta Locus [NCIt concept]
- T-Cell Surface Glycoprotein CD5 [NCIt concept]
- T-Cell/Histiocyte-Rich Large B-Cell Lymphoma [NCIt concept]
- T-Zone Variant Peripheral T-Cell Lymphoma [NCIt concept]
- T-cell-redirecting Antibody JNJ-80948543 [NCIt concept]
- T-regulatory Cell-enriched Donor Cells [NCIt concept]
- T0 TNM Finding [NCIt concept]
- T1 TNM Finding [NCIt concept]
- T1a TNM Finding [NCIt concept]
- T1a1 Stage Finding [NCIt concept]
- T1a2 Stage Finding [NCIt concept]
- T1b TNM Finding [NCIt concept]
- T1b1 TNM Finding [NCIt concept]
- T1b2 TNM Finding [NCIt concept]
- T1c TNM Finding [NCIt concept]
- T1mi TNM Finding [NCIt concept]
- T2 TNM Finding [NCIt concept]
- T2a TNM Finding [NCIt concept]
- T2a1 TNM Finding [NCIt concept]
- T2a2 TNM Finding [NCIt concept]
- T2b TNM Finding [NCIt concept]
- T2c TNM Finding [NCIt concept]
- T2d TNM Finding [NCIt concept]
- T3 TNM Finding [NCIt concept]
- T3a TNM Finding [NCIt concept]
- T3b TNM Finding [NCIt concept]
- T3c TNM Finding [NCIt concept]
- T3d TNM Finding [NCIt concept]
- T4 TNM Finding [NCIt concept]
- T4a TNM Finding [NCIt concept]
- T4b TNM Finding [NCIt concept]
- T4c TNM Finding [NCIt concept]
- T4d TNM Finding [NCIt concept]
- T4e TNM Finding [NCIt concept]
- T900607 [NCIt concept]
- TACC3 Protein-Protein Interaction Inhibitor AO-252 [NCIt concept]
- TAF15 Gene [NCIt concept]
- TAG-72 Antigen [NCIt concept]
- TAL1 Gene [NCIt concept]
- TAL2 Gene [NCIt concept]
- TAM/c-Met Inhibitor RXDX-106 [NCIt concept]
- TAR Format [NCIt concept]
- TARGET Data Coordinating Center Archive [NCIt concept]
- TARGZ Format [NCIt concept]
- TBI Format [NCIt concept]
- TBL1XR1 Gene [NCIt concept]
- TBX3 Gene [NCIt concept]
- TCEA1 Gene [NCIt concept]
- TCF12 Gene [NCIt concept]
- TCF3 Gene [NCIt concept]
- TCF7L2 Gene [NCIt concept]
- TCGA Analyte Type Identifier [NCIt concept]
- TCGA BCR Tumor Code Identifier [NCIt concept]
- TCGA BCR Tumor Code Name [NCIt concept]
- TCGA Data Coordinating Center Archive [NCIt concept]
- TCGA Sample Type Identifier [NCIt concept]
- TCL1A Gene [NCIt concept]
- TCR-engineered T-cells HRYZ-T101 [NCIt concept]
- TEAD Inhibitor BPI-460372 [NCIt concept]
- TEAD Inhibitor IK-930 [NCIt concept]
- TEAD Inhibitor VT3989 [NCIt concept]
- TEC Gene [NCIt concept]
- TENT5C Gene [NCIt concept]
- TERT Gene [NCIt concept]
- TET1 Gene [NCIt concept]
- TET2 Gene [NCIt concept]
- TFE3 Gene [NCIt concept]
- TFEB Gene [NCIt concept]
- TFG Gene [NCIt concept]
- TFPT Gene [NCIt concept]
- TFRC Gene [NCIt concept]
- TGF-beta Receptor 1 Inhibitor GFH018 [NCIt concept]
- TGF-beta Receptor 1 Inhibitor PF-06952229 [NCIt concept]
- TGF-beta Receptor 1 Kinase Inhibitor SH3051 [NCIt concept]
- TGF-beta Receptor 1 Kinase Inhibitor YL-13027 [NCIt concept]
- TGF-beta2 Antisense Oligonucleotide TASO-001 [NCIt concept]
- TGFBR2 Gene [NCIt concept]
- TGFa-PE38 Immunotoxin [NCIt concept]
- TGFbeta Inhibitor LY3200882 [NCIt concept]
- TGFbeta Inhibitor TU2218 [NCIt concept]
- TGFbeta Receptor Ectodomain-IgG Fc Fusion Protein BMS-986416 [NCIt concept]
- THL-P [NCIt concept]
- THRAP3 Gene [NCIt concept]
- TIFF [NCIt concept]
- TIGIT/PD-L1 Inhibitor AUR-106 [NCIt concept]
- TLC ELL-12 [NCIt concept]
- TLR Agonist BDB001 [NCIt concept]
- TLR Agonist BSG-001 [NCIt concept]
- TLR Agonist CADI-05 [NCIt concept]
- TLR Agonist Decoy20 [NCIt concept]
- TLR-Directed Cationic Lipid-DNA Complex JVRS-100 [NCIt concept]
- TLR1/2 Agonist Pam3Cys-GDPKHPKSF [NCIt concept]
- TLR2 Gene [NCIt concept]
- TLR7 Agonist 852A [NCIt concept]
- TLR7 Agonist APR003 [NCIt concept]
- TLR7 Agonist CAN1012 [NCIt concept]
- TLR7 Agonist JNJ-64794964 [NCIt concept]
- TLR7 Agonist LHC165 [NCIt concept]
- TLR7 Agonist RO7119929 [NCIt concept]
- TLR7 Agonist SHR2150 [NCIt concept]
- TLR7 agonist BNT411 [NCIt concept]
- TLR8 Agonist DN1508052 [NCIt concept]
- TLR9 Agonist SD-101 [NCIt concept]
- TLX1 Gene [NCIt concept]
- TLX3 Gene [NCIt concept]
- TM4SF1-CAR/EpCAM-CAR-expressing Autologous T Cells [NCIt concept]
- TMEM127 Gene [NCIt concept]
- TMPRSS2 Gene [NCIt concept]
- TNC Gene [NCIt concept]
- TNFAIP3 Gene [NCIt concept]
- TNFRSF14 Gene [NCIt concept]
- TNFRSF17 Gene [NCIt concept]
- TOP1 Gene [NCIt concept]
- TOP2B Gene [NCIt concept]
- TORC1/2 Kinase Inhibitor DS-3078a [NCIt concept]
- TP40 Immunotoxin [NCIt concept]
- TP53 Gene [NCIt concept]
- TP63 Gene [NCIt concept]
- TPM3 Gene [NCIt concept]
- TPM4 Gene [NCIt concept]
- TPR Gene [NCIt concept]
- TRAF7 Gene [NCIt concept]
- TRIM24 Gene [NCIt concept]
- TRIM27 Gene [NCIt concept]
- TRIM33 Gene [NCIt concept]
- TRIP11 Gene [NCIt concept]
- TRK Inhibitor AZD6918 [NCIt concept]
- TRK Inhibitor TQB3558 [NCIt concept]
- TRK Inhibitor TQB3811 [NCIt concept]
- TRK Inhibitor VC004 [NCIt concept]
- TRK/ROS1/ALK Inhibitor SIM1803-1A [NCIt concept]
- TRPM8 Agonist D-3263 [NCIt concept]
- TRPV6 Calcium Channel Inhibitor SOR-C13 [NCIt concept]
- TRRAP Gene [NCIt concept]
- TSC1 Gene [NCIt concept]
- TSC2 Gene [NCIt concept]
- TSHR Gene [NCIt concept]
- TSP-1 Mimetic ABT-510 [NCIt concept]
- TSP-1 Mimetic Fusion Protein CVX-045 [NCIt concept]
- TTK/PLK1 Inhibitor BAL0891 [NCIt concept]
- TX TNM Finding [NCIt concept]
- Tab-Separated Value Format [NCIt concept]
- Tabalumab [NCIt concept]
- Tabelecleucel [NCIt concept]
- Tacaciclib [NCIt concept]
- Tacedinaline [NCIt concept]
- Tafasitamab [NCIt concept]
- Tagitanlimab [NCIt concept]
- Tagraxofusp-erzs [NCIt concept]
- Tagtociclib [NCIt concept]
- Tail of the Pancreas [NCIt concept]
- Taiwan [NCIt concept]
- Tajikistan [NCIt concept]
- Talabostat [NCIt concept]
- Talabostat Mesylate [NCIt concept]
- Talacotuzumab [NCIt concept]
- Talactoferrin Alfa [NCIt concept]
- Taladegib [NCIt concept]
- Talampanel [NCIt concept]
- Talaporfin Sodium [NCIt concept]
- Talazoparib [NCIt concept]
- Talc Poudrage [NCIt concept]
- Taletrectinib [NCIt concept]
- Taletrectinib Adipate [NCIt concept]
- Talimogene Laherparepvec [NCIt concept]
- Tall Cell Variant Thyroid Gland Papillary Carcinoma [NCIt concept]
- Tallimustine [NCIt concept]
- Talmapimod [NCIt concept]
- Talotrexin [NCIt concept]
- Talotrexin Ammonium [NCIt concept]
- Talquetamab [NCIt concept]
- Taltobulin [NCIt concept]
- Tamgiblimab [NCIt concept]
- Tamibarotene [NCIt concept]
- Taminadenant [NCIt concept]
- Tamoxifen [NCIt concept]
- Tamoxifen Citrate [NCIt concept]
- Tamrintamab Pamozirine [NCIt concept]
- Tandutinib [NCIt concept]
- Tanespimycin [NCIt concept]
- Taniraleucel [NCIt concept]
- Tanomastat [NCIt concept]
- Tanycytic Ependymoma [NCIt concept]
- Tanzania, United Republic of [NCIt concept]
- Tapotoclax [NCIt concept]
- Taragarestrant [NCIt concept]
- Tarenflurbil [NCIt concept]
- Tarextumab [NCIt concept]
- Target Capture Kit Identifier [NCIt concept]
- Targeted Anatomic Site [NCIt concept]
- Targeted Molecular Therapy [NCIt concept]
- Tariquidar [NCIt concept]
- Tarlatamab [NCIt concept]
- Tasadenoturev [NCIt concept]
- Taselisib [NCIt concept]
- Tasidotin [NCIt concept]
- Tasisulam [NCIt concept]
- Tasisulam Sodium [NCIt concept]
- Tasquinimod [NCIt concept]
- Tasurgratinib [NCIt concept]
- Taurolidine [NCIt concept]
- Tauromustine [NCIt concept]
- Taurultam [NCIt concept]
- Tavokinogene Telseplasmid [NCIt concept]
- Tavolimab [NCIt concept]
- Taxane Analogue TPI 287 [NCIt concept]
- Taxane Compound [NCIt concept]
- Taxol Analogue SID 530 [NCIt concept]
- Tazarotene [NCIt concept]
- Tazemetostat [NCIt concept]
- Tebentafusp [NCIt concept]
- Tebotelimab [NCIt concept]
- Tecaginlimab [NCIt concept]
- Technology Platform Version [NCIt concept]
- Teclistamab [NCIt concept]
- Tecogalan Sodium [NCIt concept]
- Tefinostat [NCIt concept]
- Tegafur [NCIt concept]
- Tegafur-Gimeracil-Oteracil Potassium-Leucovorin Calcium Oral Formulation [NCIt concept]
- Tegafur-Uracil [NCIt concept]
- Tegafur-gimeracil-oteracil Potassium [NCIt concept]
- Tegavivint [NCIt concept]
- Teglarinad [NCIt concept]
- Teglarinad Chloride [NCIt concept]
- Telaglenastat [NCIt concept]
- Telaglenastat Hydrochloride [NCIt concept]
- Telangiectasia, CTCAE 5.0 [NCIt concept]
- Telangiectatic Osteosarcoma [NCIt concept]
- Telapristone [NCIt concept]
- Telapristone Acetate [NCIt concept]
- Telatinib Mesylate [NCIt concept]
- Telecommunications and Broadcasting Technician [NCIt concept]
- Telisotuzumab [NCIt concept]
- Telisotuzumab Vedotin [NCIt concept]
- Telomerase Inhibitor FJ5002 [NCIt concept]
- Teloxantrone [NCIt concept]
- Teloxantrone Hydrochloride [NCIt concept]
- Telratolimod [NCIt concept]
- Temarotene [NCIt concept]
- Temoporfin [NCIt concept]
- Temozolomide [NCIt concept]
- Temporal Lobe [NCIt concept]
- Temporal Lobe Cortex [NCIt concept]
- Temsirolimus [NCIt concept]
- Temuterkib [NCIt concept]
- Temuterkib Mesylate [NCIt concept]
- Tenalisib [NCIt concept]
- Tendon [NCIt concept]
- Tenifatecan [NCIt concept]
- Teniposide [NCIt concept]
- Tenosynovial Giant Cell Tumor [NCIt concept]
- Tepoditamab [NCIt concept]
- Tepotinib [NCIt concept]
- Teprotumumab [NCIt concept]
- Terameprocol [NCIt concept]
- Teratoma [NCIt concept]
- Teratoma with Somatic-Type Malignancy [NCIt concept]
- Terfluranol [NCIt concept]
- Tergenpumatucel-L [NCIt concept]
- Teroxirone [NCIt concept]
- Tertiary Gleason Pattern [NCIt concept]
- Tertomotide [NCIt concept]
- Tesetaxel [NCIt concept]
- Tesevatinib [NCIt concept]
- Tesidolumab [NCIt concept]
- Test Result Report [NCIt concept]
- Test Site Domain Name [NCIt concept]
- Test Value Percent Range [NCIt concept]
- Test Value Reported Indicator [NCIt concept]
- Testicular Disorder, CTCAE [NCIt concept]
- Testicular Germ Cell Neoplasia In Situ [NCIt concept]
- Testicular Hemorrhage, CTCAE [NCIt concept]
- Testicular Large Cell Calcifying Sertoli Cell Tumor [NCIt concept]
- Testicular Mixed Germ Cell-Sex Cord-Stromal Tumor, Unclassified [NCIt concept]
- Testicular Mixed Sex Cord-Stromal Tumor [NCIt concept]
- Testicular Pain, CTCAE 5.0 [NCIt concept]
- Testicular Seminoma with High Mitotic Index [NCIt concept]
- Testicular Sex Cord-Stromal Tumor, Not Otherwise Specified [NCIt concept]
- Testicular Spermatocytic Tumor [NCIt concept]
- Testis [NCIt concept]
- Testolactone [NCIt concept]
- Testosterone Enanthate [NCIt concept]
- Tetanus Toxoid Vaccine [NCIt concept]
- Tetra-specific Antibody GNC-039 [NCIt concept]
- Tetrachloroethylene Exposure [NCIt concept]
- Tetradecanoylphorbol Acetate [NCIt concept]
- Tetrahydrouridine [NCIt concept]
- Tetraploidy [NCIt concept]
- Tetrathiomolybdate [NCIt concept]
- Textile, Fur and Leather Products Machine Operator [NCIt concept]
- Tezacitabine [NCIt concept]
- Tezacitabine Anhydrous [NCIt concept]
- Tezemlimogene Daxadenorepvec [NCIt concept]
- Thailand [NCIt concept]
- Thalicarpine [NCIt concept]
- Thalidomide [NCIt concept]
- The Gambia [NCIt concept]
- Thecoma [NCIt concept]
- Theramide [NCIt concept]
- Therapeutic Agent Category [NCIt concept]
- Therapeutic Agent Level Achieved Indicator [NCIt concept]
- Therapeutic Agent Targeted Administration Concentration [NCIt concept]
- Therapeutic Angiotensin-(1-7) [NCIt concept]
- Therapeutic Breast/Ovarian/Prostate Peptide Cancer Vaccine DPX-0907 [NCIt concept]
- Therapeutic Cancer Vaccine ATP128 [NCIt concept]
- Therapeutic Effect [NCIt concept]
- Therapeutic Effect Indicator [NCIt concept]
- Therapeutic Estradiol [NCIt concept]
- Therapeutic Glucocorticoid [NCIt concept]
- Therapeutic Hydrocortisone [NCIt concept]
- Therapeutic Insulin [NCIt concept]
- Therapeutic Liver Cancer Peptide Vaccine IMA970A [NCIt concept]
- Therapeutic Oxygen Use Indicator [NCIt concept]
- Therapeutic Procedure [NCIt concept]
- Therapeutic Prostate Cancer Peptide Vaccine TENDU [NCIt concept]
- Thiarabine [NCIt concept]
- Thiazolidinedione Antidiabetic Agent [NCIt concept]
- Thigh [NCIt concept]
- Thiodiglycol [NCIt concept]
- Thioguanine [NCIt concept]
- Thioguanine Anhydrous [NCIt concept]
- Thioinosine [NCIt concept]
- Thioredoxin-1 Inhibitor PX-12 [NCIt concept]
- Thiostrepton [NCIt concept]
- Thiotepa [NCIt concept]
- Thioureidobutyronitrile [NCIt concept]
- Third [NCIt concept]
- Thoracentesis [NCIt concept]
- Thoracic Esophagus [NCIt concept]
- Thoracic Spine [NCIt concept]
- Thoracoscopic Biopsy [NCIt concept]
- Thorax [NCIt concept]
- Thorium Th 227 Anetumab Corixetan [NCIt concept]
- Thorium Th 227 Pelgifatamab Corixetan [NCIt concept]
- Thorium Th 227 Trastuzumab Corixetan [NCIt concept]
- Thousand Cells per Microliter [NCIt concept]
- Three Point Scale for Staining Intensity [NCIt concept]
- Three Times Daily [NCIt concept]
- Three Tumor Grade Evaluation Tiers [NCIt concept]
- Throat [NCIt concept]
- Throat Carcinoma [NCIt concept]
- Thromboembolic Event, CTCAE [NCIt concept]
- Thromboembolism [NCIt concept]
- Thrombotic Thrombocytopenic Purpura [NCIt concept]
- Thrombotic Thrombocytopenic Purpura, CTCAE [NCIt concept]
- Thymic Carcinoma [NCIt concept]
- Thymidylate Synthase Inhibitor CX1106 [NCIt concept]
- Thymidylate Synthase Inhibitor DFP-11207 [NCIt concept]
- Thymoma [NCIt concept]
- Thymoma Type A [NCIt concept]
- Thymoma Type AB [NCIt concept]
- Thymoma Type B1 [NCIt concept]
- Thymoma Type B2 [NCIt concept]
- Thymoma Type B3 [NCIt concept]
- Thymopentin [NCIt concept]
- Thymus Gland [NCIt concept]
- Thyroid Carcinoma Arising in Struma Ovarii [NCIt concept]
- Thyroid Extract [NCIt concept]
- Thyroid Gland [NCIt concept]
- Thyroid Gland Carcinoma [NCIt concept]
- Thyroid Gland Follicular Adenoma [NCIt concept]
- Thyroid Gland Follicular Carcinoma [NCIt concept]
- Thyroid Gland Follicular Carcinoma, Encapsulated Angioinvasive [NCIt concept]
- Thyroid Gland Follicular Carcinoma, Minimally Invasive [NCIt concept]
- Thyroid Gland Hyalinizing Trabecular Tumor [NCIt concept]
- Thyroid Gland Isthmus [NCIt concept]
- Thyroid Gland Macrofollicular Adenoma [NCIt concept]
- Thyroid Gland Medullary Carcinoma [NCIt concept]
- Thyroid Gland Medullary Carcinoma with Amyloid Stroma [NCIt concept]
- Thyroid Gland Microfollicular Adenoma [NCIt concept]
- Thyroid Gland Mixed Medullary and Follicular Carcinoma [NCIt concept]
- Thyroid Gland Mixed Medullary and Papillary Carcinoma [NCIt concept]
- Thyroid Gland Nodule [NCIt concept]
- Thyroid Gland Noninvasive Follicular Neoplasm with Papillary-Like Nuclear Features [NCIt concept]
- Thyroid Gland Oncocytic Adenoma [NCIt concept]
- Thyroid Gland Oncocytic Neoplasm [NCIt concept]
- Thyroid Gland Papillary Carcinoma [NCIt concept]
- Thyroid Gland Papillary Microcarcinoma [NCIt concept]
- Thyroid Gland Papillary and Follicular Carcinoma [NCIt concept]
- Thyroid Gland Spindle Epithelial Tumor with Thymus-Like Elements [NCIt concept]
- Thyroid Gland Well-Differentiated Tumor of Uncertain Malignant Potential [NCIt concept]
- Thyrointegrin AlphaVBeta3 Antagonist fb-PMT [NCIt concept]
- Tiazofurin [NCIt concept]
- Tibia [NCIt concept]
- Tibial Adamantinoma [NCIt concept]
- Tidutamab [NCIt concept]
- Tifcemalimab [NCIt concept]
- Tigapotide [NCIt concept]
- Tigatuzumab [NCIt concept]
- Tigilanol Tiglate [NCIt concept]
- Tigozertinib [NCIt concept]
- Tilarginine [NCIt concept]
- Tilogotamab [NCIt concept]
- Tilsotolimod Sodium [NCIt concept]
- Tilvestamab [NCIt concept]
- Time Between Waking and First Smoke [NCIt concept]
- Time Between Waking and First Smoke - After 60 Minutes [NCIt concept]
- Time Between Waking and First Smoke - Between 31 and 60 Minutes [NCIt concept]
- Time Between Waking and First Smoke - Between 6 and 30 Minutes [NCIt concept]
- Time Between Waking and First Smoke - Within 5 Minutes [NCIt concept]
- Time of Exposure of Six Weeks or More [NCIt concept]
- Timepoint Event Category [NCIt concept]
- Timonacic [NCIt concept]
- Timor-Leste [NCIt concept]
- Tin Ethyl Etiopurpurin [NCIt concept]
- Tinengotinib [NCIt concept]
- Tinlorafenib [NCIt concept]
- Tinnitus, CTCAE 5.0 [NCIt concept]
- Tinodasertib [NCIt concept]
- Tinostamustine [NCIt concept]
- Tinurilimab [NCIt concept]
- Tinzaparin Sodium [NCIt concept]
- Tiomolibdate Choline [NCIt concept]
- Tiomolibdate Diammonium [NCIt concept]
- Tipapkinogene Sovacivec [NCIt concept]
- Tipifarnib [NCIt concept]
- Tipiracil [NCIt concept]
- Tipiracil Hydrochloride [NCIt concept]
- Tirabrutinib [NCIt concept]
- Tiragolumab [NCIt concept]
- Tirapazamine [NCIt concept]
- Tirbanibulin [NCIt concept]
- Tisagenlecleucel [NCIt concept]
- Tislelizumab [NCIt concept]
- Tisotumab Vedotin [NCIt concept]
- Tissue [NCIt concept]
- Tissue Microarray Image [NCIt concept]
- Tissue Microassay Array Position Identifier [NCIt concept]
- Tissue Sample [NCIt concept]
- Tissue Slide [NCIt concept]
- Tissue or Organ of Origin [NCIt concept]
- Tivantinib [NCIt concept]
- Tivozanib [NCIt concept]
- Tivumecirnon [NCIt concept]
- Tizaterkib [NCIt concept]
- Tobacco [NCIt concept]
- Tobacco Pipe Smoke Exposure [NCIt concept]
- Tobacco Smoke Related Exposure [NCIt concept]
- Tobacco Smoking [NCIt concept]
- Tobacco Type Used [NCIt concept]
- Tobacco Use [NCIt concept]
- Tobemstomig [NCIt concept]
- Tocilizumab [NCIt concept]
- Tocladesine [NCIt concept]
- Tocotrienol [NCIt concept]
- Tocotrienol-rich Fraction [NCIt concept]
- Togo [NCIt concept]
- Tokelau [NCIt concept]
- Tolebrutinib [NCIt concept]
- Tolinapant [NCIt concept]
- Toll-like Receptor 7/8 Agonist BDB018 [NCIt concept]
- Tolnidamine [NCIt concept]
- Toluene Exposure [NCIt concept]
- Tomaralimab [NCIt concept]
- Tomato-Soy Juice [NCIt concept]
- Tomivosertib [NCIt concept]
- Tonga [NCIt concept]
- Tongue [NCIt concept]
- Tongue Carcinoma [NCIt concept]
- Tonsil [NCIt concept]
- Tonsillar Carcinoma [NCIt concept]
- Tonsillar Fossa [NCIt concept]
- Tonsillar Pillar [NCIt concept]
- Tonsillectomy [NCIt concept]
- Too Early [NCIt concept]
- Tooth Development Disorder, CTCAE [NCIt concept]
- Tooth Discoloration, CTCAE [NCIt concept]
- Tooth Infection, CTCAE [NCIt concept]
- Toothache, CTCAE [NCIt concept]
- Topical AKT Inhibitor SM-020 [NCIt concept]
- Topical Betulinic Acid [NCIt concept]
- Topical Celecoxib [NCIt concept]
- Topical Fluorouracil [NCIt concept]
- Topical Gemcitabine Hydrochloride [NCIt concept]
- Topical Potassium Dobesilate [NCIt concept]
- Topical Tirbanibulin [NCIt concept]
- Topical Trichloroacetic Acid [NCIt concept]
- Topixantrone [NCIt concept]
- Topoisomerase I Inhibitor Genz-644282 [NCIt concept]
- Topoisomerase I Inhibitor LMP400 [NCIt concept]
- Topoisomerase I Inhibitor LMP776 [NCIt concept]
- Topoisomerase I/II Inhibitor NEV-801 [NCIt concept]
- Topoisomerase-1 Inhibitor LMP744 [NCIt concept]
- Topoisomerase-II Inhibitor Racemic XK469 [NCIt concept]
- Topoisomerase-II-beta Inhibitor Racemic XK469 [NCIt concept]
- Topotecan [NCIt concept]
- Topotecan Hydrochloride [NCIt concept]
- Topotecan Hydrochloride Liposomes [NCIt concept]
- Topotecan Sustained-release Episcleral Plaque [NCIt concept]
- Topsalysin [NCIt concept]
- Toremifene [NCIt concept]
- Toremifene Citrate [NCIt concept]
- Toripalimab [NCIt concept]
- Tosedostat [NCIt concept]
- Tositumomab [NCIt concept]
- Total Androgen Blockade [NCIt concept]
- Total Area of Mitotic Index Ratio Analysis [NCIt concept]
- Total Bilirubin Measurement [NCIt concept]
- Total Colectomy [NCIt concept]
- Total Hepatectomy [NCIt concept]
- Total Hysterectomy [NCIt concept]
- Total Laryngectomy [NCIt concept]
- Total Mastectomy [NCIt concept]
- Total Maxillectomy [NCIt concept]
- Total Nephrectomy [NCIt concept]
- Total Number of Genetic Loci Assayed [NCIt concept]
- Total Number of Nucleotide Sequences Processed [NCIt concept]
- Total Number of Radiotherapy Dose Fractions Received [NCIt concept]
- Total Pancreatectomy [NCIt concept]
- Total Proctocolectomy [NCIt concept]
- Total Protein Measurement [NCIt concept]
- Total RNA [NCIt concept]
- Total Testosterone Measurement [NCIt concept]
- Total Years Have Smoked Cigarettes [NCIt concept]
- Tovetumab [NCIt concept]
- Tovorafenib [NCIt concept]
- Toxic Epidermal Necrolysis, CTCAE [NCIt concept]
- Toxicity [NCIt concept]
- Toxoplasmosis [NCIt concept]
- Tozasertib Lactate [NCIt concept]
- Trabectedin [NCIt concept]
- Trabecular Adenocarcinoma [NCIt concept]
- Trabecular Adenoma [NCIt concept]
- Trabedersen [NCIt concept]
- Tracer [NCIt concept]
- Trachea [NCIt concept]
- Trachea and Bronchus [NCIt concept]
- Tracheal Fistula, CTCAE [NCIt concept]
- Tracheal Hemorrhage, CTCAE [NCIt concept]
- Tracheal Mucositis, CTCAE [NCIt concept]
- Tracheal Obstruction, CTCAE [NCIt concept]
- Tracheal Stenosis, CTCAE [NCIt concept]
- Tracheitis, CTCAE [NCIt concept]
- Tracheostomy Site Bleeding, CTCAE [NCIt concept]
- Traditional Serrated Adenoma [NCIt concept]
- Traditional and Complementary Medicine Associate Professional [NCIt concept]
- Traditional and Complementary Medicine Professional [NCIt concept]
- Trained Immunity Natural Killer Cells IBR900 [NCIt concept]
- Trametinib [NCIt concept]
- Trametinib Dimethyl Sulfoxide [NCIt concept]
- Trans Sodium Crocetinate [NCIt concept]
- TransCon IL-2 Beta/Gamma [NCIt concept]
- Transcription Factor Binding Site Amplification [NCIt concept]
- Transcription Factor Binding Site Deletion Mutation [NCIt concept]
- Transcription Factor Binding Site Mutation [NCIt concept]
- Transcription Factor Protein SON-DP [NCIt concept]
- Transcriptomics [NCIt concept]
- Transdermal 17beta-Estradiol Gel BHR-200 [NCIt concept]
- Transdermal 4-Hydroxytestosterone [NCIt concept]
- Transferrin Receptor-Targeted Anti-RRM2 siRNA CALAA-01 [NCIt concept]
- Transferrin Receptor-Targeted Liposomal p53 cDNA [NCIt concept]
- Transferrin-CRM107 [NCIt concept]
- Transfusion Recipient [NCIt concept]
- Transglottic Extension of Laryngeal Tumor [NCIt concept]
- Transient Abnormal Myelopoiesis Associated with Down Syndrome [NCIt concept]
- Transient Ischemic Attack [NCIt concept]
- Transient Ischemic Attacks, CTCAE [NCIt concept]
- Transition Zone of Prostate [NCIt concept]
- Transitional Cell Carcinoma [NCIt concept]
- Transitional Cell Papilloma [NCIt concept]
- Transitional Meningioma [NCIt concept]
- Transoral Laser Microsurgery [NCIt concept]
- Transplantation [NCIt concept]
- Transplanted Kidney Complication [NCIt concept]
- Transport and Storage Laborer [NCIt concept]
- Transurethral Prostatic Resection [NCIt concept]
- Transurethral Resection of Bladder Tumor [NCIt concept]
- Transverse Colectomy [NCIt concept]
- Transverse Colon [NCIt concept]
- Tranylcypromine Sulfate [NCIt concept]
- Trapoxin [NCIt concept]
- Trastuzumab [NCIt concept]
- Trastuzumab Botidotin [NCIt concept]
- Trastuzumab Conjugate BI-CON-02 [NCIt concept]
- Trastuzumab Deruxtecan [NCIt concept]
- Trastuzumab Duocarmazine [NCIt concept]
- Trastuzumab Emtansine [NCIt concept]
- Trastuzumab Imbotolimod [NCIt concept]
- Trastuzumab Rezetecan [NCIt concept]
- Trastuzumab Vedotin [NCIt concept]
- Trastuzumab/Hyaluronidase-oysk [NCIt concept]
- Trastuzumab/MMAF Antibody-drug Conjugate IKS014 [NCIt concept]
- Trastuzumab/Tesirine Antibody-drug Conjugate ADCT-502 [NCIt concept]
- Travel Attendant, Conductor and Guide [NCIt concept]
- Treatment Duration in Days [NCIt concept]
- Treatment Ongoing [NCIt concept]
- Treatment Regimen [NCIt concept]
- Treatment Related Secondary Malignancy, CTCAE [NCIt concept]
- Treatment Terminated Due to Toxicity [NCIt concept]
- Treatment not Administered per the Discretion of the Health Care Provider [NCIt concept]
- Trebananib [NCIt concept]
- Tremelimumab [NCIt concept]
- Tremor, CTCAE 5.0 [NCIt concept]
- Treosulfan [NCIt concept]
- Treponemal Infection [NCIt concept]
- Tretazicar [NCIt concept]
- Tretinoin [NCIt concept]
- Tretinoin Liposome [NCIt concept]
- Tri-specific NK Cell Engager CC-92328 [NCIt concept]
- Triamcinolone Acetonide [NCIt concept]
- Triamcinolone Hexacetonide [NCIt concept]
- Triapine [NCIt concept]
- Triazene Derivative CB10-277 [NCIt concept]
- Triazene Derivative TriN2755 [NCIt concept]
- Triazinate [NCIt concept]
- Triaziquone [NCIt concept]
- Tributyrin [NCIt concept]
- Trichilemmal Carcinoma [NCIt concept]
- Trichilemmoma [NCIt concept]
- Trichoblastoma [NCIt concept]
- Trichofolliculoma [NCIt concept]
- Triciribine Phosphate [NCIt concept]
- Tricuspid Valve Disease, CTCAE [NCIt concept]
- Trientine Hydrochloride [NCIt concept]
- Triethylenemelamine [NCIt concept]
- Trifluridine [NCIt concept]
- Trifluridine and Tipiracil Hydrochloride [NCIt concept]
- Trigeminal Nerve Disorder, CTCAE [NCIt concept]
- Trilaciclib [NCIt concept]
- Trim Adapter Sequence Indicator [NCIt concept]
- Trimelamol [NCIt concept]
- Trimeric GITRL-Fc OMP-336B11 [NCIt concept]
- Trimethylcolchicinic Acid [NCIt concept]
- Trimetrexate [NCIt concept]
- Trimetrexate Glucuronate [NCIt concept]
- Trinidad and Tobago [NCIt concept]
- Trioxifene [NCIt concept]
- Triplatin Tetranitrate [NCIt concept]
- Triptolide Analog [NCIt concept]
- Triptorelin [NCIt concept]
- Triptorelin Pamoate [NCIt concept]
- Tris-acryl Gelatin Microspheres [NCIt concept]
- Trismus, CTCAE [NCIt concept]
- Trisomy [NCIt concept]
- Trispecific Antibody JNJ-79635322 [NCIt concept]
- Tritylcysteine [NCIt concept]
- TrkA Inhibitor VMD-928 [NCIt concept]
- Trochlear Nerve Disorder, CTCAE [NCIt concept]
- Trodusquemine [NCIt concept]
- Trofosfamide [NCIt concept]
- Troglitazone [NCIt concept]
- Trophoblastic Tumor [NCIt concept]
- Troriluzole [NCIt concept]
- Trotabresib [NCIt concept]
- Troxacitabine [NCIt concept]
- True Histiocytic Lymphoma [NCIt concept]
- Truncation Mutation [NCIt concept]
- Trunk [NCIt concept]
- Tubercidin [NCIt concept]
- Tuberculosis [NCIt concept]
- Tuberculosis Infection [NCIt concept]
- Tuberous Sclerosis [NCIt concept]
- Tubular Adenocarcinoma [NCIt concept]
- Tubular Adenoma [NCIt concept]
- Tubular Pattern [NCIt concept]
- Tubulin Inhibitor ALB 109564 Dihydrochloride [NCIt concept]
- Tubulin Inhibitor ALB-109564 [NCIt concept]
- Tubulin Polymerization Inhibitor AB8939 [NCIt concept]
- Tubulin Polymerization Inhibitor AEZS 112 [NCIt concept]
- Tubulin-Binding Agent SSR97225 [NCIt concept]
- Tubulocystic Renal Cell Carcinoma [NCIt concept]
- Tubulointerstitial Disease [NCIt concept]
- Tubulovillous Adenoma [NCIt concept]
- Tucatinib [NCIt concept]
- Tucidinostat [NCIt concept]
- Tucotuzumab Celmoleukin [NCIt concept]
- Tufted Angioma [NCIt concept]
- Tulmimetostat [NCIt concept]
- Tumor Burden [NCIt concept]
- Tumor Capsule Invasion Present [NCIt concept]
- Tumor Classification [NCIt concept]
- Tumor Debulking [NCIt concept]
- Tumor Depth Descriptor [NCIt concept]
- Tumor Embolism [NCIt concept]
- Tumor Focality [NCIt concept]
- Tumor Free [NCIt concept]
- Tumor Grade Evaluation Tier Number [NCIt concept]
- Tumor Infiltrating Lymphocytes Finding Indicator [NCIt concept]
- Tumor Infiltrating Macrophages Finding Indicator [NCIt concept]
- Tumor Length [NCIt concept]
- Tumor Lysis Syndrome, CTCAE 5.0 [NCIt concept]
- Tumor Markers Normalized [NCIt concept]
- Tumor Measurement Method [NCIt concept]
- Tumor Necrosis Factor Receptor Superfamily Member 8 [NCIt concept]
- Tumor Pain, CTCAE 5.0 [NCIt concept]
- Tumor Ploidy [NCIt concept]
- Tumor Progression [NCIt concept]
- Tumor Regression Grade [NCIt concept]
- Tumor Regression Score 0 [NCIt concept]
- Tumor Regression Score 1 [NCIt concept]
- Tumor Regression Score 2 [NCIt concept]
- Tumor Regression Score 3 [NCIt concept]
- Tumor Resection [NCIt concept]
- Tumor Shape Observed Descriptor [NCIt concept]
- Tumor Thickness [NCIt concept]
- Tumor Tissue Sample [NCIt concept]
- Tumor Width [NCIt concept]
- Tumor-Adjacent Normal Post Neoadjuvant Therapy Sample [NCIt concept]
- Tumor-Associated Lymphocytosis [NCIt concept]
- Tumorlet [NCIt concept]
- Tunisia [NCIt concept]
- Tunlametinib [NCIt concept]
- Tuparstobart [NCIt concept]
- Turban Tumor [NCIt concept]
- Turcot Syndrome [NCIt concept]
- Turkey [NCIt concept]
- Turkmenistan [NCIt concept]
- Tusamitamab Ravtansine [NCIt concept]
- Tuspetinib [NCIt concept]
- Tuvalu [NCIt concept]
- Tuvusertib [NCIt concept]
- Tuxobertinib [NCIt concept]
- Twice Daily [NCIt concept]
- Twice Weekly [NCIt concept]
- Twin [NCIt concept]
- Type [NCIt concept]
- Type 1 Diabetes Mellitus [NCIt concept]
- Type 1 Papillary Renal Cell Carcinoma [NCIt concept]
- Type 2 Diabetes Mellitus [NCIt concept]
- Type 2 Papillary Renal Cell Carcinoma [NCIt concept]
- Type A Spindle Cell Melanoma [NCIt concept]
- Type B Spindle Cell Melanoma [NCIt concept]
- Typhlitis, CTCAE 5.0 [NCIt concept]
- Tyroserleutide [NCIt concept]
- Tyrosinase Peptide [NCIt concept]
- Tyrosinase-KLH [NCIt concept]
- Tyrosinase:146-156 Peptide [NCIt concept]
- Tyrosine Kinase Inhibitor [NCIt concept]
- Tyrosine Kinase Inhibitor IDRX-42 [NCIt concept]
- Tyrosine Kinase Inhibitor OSI-930 [NCIt concept]
- Tyrosine Kinase Inhibitor SU5402 [NCIt concept]
- Tyrosine Kinase Inhibitor XL228 [NCIt concept]
- Tyrosinemia [NCIt concept]
- U2AF1 Gene [NCIt concept]
- UAE Inhibitor TAK-243 [NCIt concept]
- UBB Gene [NCIt concept]
- UBR5 Gene [NCIt concept]
- UICC Clinical M Category [NCIt concept]
- UICC Clinical N Category [NCIt concept]
- UICC Clinical Stage [NCIt concept]
- UICC Clinical T Category [NCIt concept]
- UICC Pathologic M Category [NCIt concept]
- UICC Pathologic N Category [NCIt concept]
- UICC Pathologic Stage [NCIt concept]
- UICC Pathologic T Category [NCIt concept]
- UICC Staging System Manual [NCIt concept]
- ULK1/2 Inhibitor DCC-3116 [NCIt concept]
- USP1 Inhibitor ISM3091 [NCIt concept]
- USP1 Inhibitor TNG348 [NCIt concept]
- USP1 inhibitor KSQ-4279 [NCIt concept]
- USP14/UCHL5 Inhibitor VLX1570 [NCIt concept]
- USP6 Gene [NCIt concept]
- USP8 Gene [NCIt concept]
- Ubamatamab [NCIt concept]
- Ubenimex [NCIt concept]
- Ubidecarenone Nanodispersion BPM31510n [NCIt concept]
- Ublituximab [NCIt concept]
- Uganda [NCIt concept]
- Ukraine [NCIt concept]
- Ulcer Indicator [NCIt concept]
- Ulcerative Colitis [NCIt concept]
- Ulevostinag [NCIt concept]
- Uliledlimab [NCIt concept]
- Ulinastatin [NCIt concept]
- Ulixertinib [NCIt concept]
- Ulocuplumab [NCIt concept]
- Ultrasound Imaging [NCIt concept]
- Ultrasound-Guided Biopsy [NCIt concept]
- Umbilical Cord [NCIt concept]
- Umbilical Cord Blood-derived CD16-expressing Natural Killer Cells AB-101 [NCIt concept]
- Umbilical Cord Blood-derived MAK Immune Cells [NCIt concept]
- Umbralisib [NCIt concept]
- Umbralisib Tosylate [NCIt concept]
- Unaligned Sequence Read [NCIt concept]
- Uncaria tomentosa Extract [NCIt concept]
- Unchanged [NCIt concept]
- Uncle [NCIt concept]
- Undescended Testes [NCIt concept]
- Undescended Testis Corrected Indicator [NCIt concept]
- Undescended Testis Corrected Method [NCIt concept]
- Undescended Testis History Indicator [NCIt concept]
- Undescended Testis Laterality [NCIt concept]
- Undifferentiated Carcinoma [NCIt concept]
- Undifferentiated Carcinoma with Osteoclast-Like Giant Cells [NCIt concept]
- Undifferentiated Epithelioid Sarcoma [NCIt concept]
- Undifferentiated High Grade Pleomorphic Sarcoma of Bone [NCIt concept]
- Undifferentiated Neuroblastoma [NCIt concept]
- Undifferentiated Pleomorphic Sarcoma [NCIt concept]
- Undifferentiated Pleomorphic Sarcoma with Osteoclast-Like Giant Cells [NCIt concept]
- Undifferentiated Retinoblastoma [NCIt concept]
- Undifferentiated Round Cell Sarcoma [NCIt concept]
- Undifferentiated Soft Tissue Sarcoma [NCIt concept]
- Undifferentiated Spindle Cell Sarcoma [NCIt concept]
- Unecritinib [NCIt concept]
- Unequal Limb Length, CTCAE [NCIt concept]
- Unesbulin [NCIt concept]
- Unfavorable [NCIt concept]
- Unifocal [NCIt concept]
- Unilateral [NCIt concept]
- Unintended Pregnancy [NCIt concept]
- Unit Per Gram Hemoglobin [NCIt concept]
- Unit for Functional Test Results [NCIt concept]
- Unit of Length [NCIt concept]
- Unit per Liter [NCIt concept]
- Unit per Milliliter [NCIt concept]
- United Arab Emirates [NCIt concept]
- United Kingdom [NCIt concept]
- United States [NCIt concept]
- Universal Anti-CD7 CAR T Cells RD13-01 [NCIt concept]
- Universal Donor Expanded TGF-beta-imprinted NK Cells [NCIt concept]
- Unknown [NCIt concept]
- Unknown Tumor Status [NCIt concept]
- Unknown Tumor Zone [NCIt concept]
- Unrelated [NCIt concept]
- Unsatisfactory [NCIt concept]
- Unspecified [NCIt concept]
- Unstranded Library Sequencing [NCIt concept]
- Upamostat [NCIt concept]
- Upinitatug [NCIt concept]
- Upinitatug Rilsodotin [NCIt concept]
- Upper Extremity [NCIt concept]
- Upper Gastrointestinal Hemorrhage, CTCAE [NCIt concept]
- Upper Gingiva [NCIt concept]
- Upper Lobe of the Lung [NCIt concept]
- Upper Pole of Kidney [NCIt concept]
- Upper Respiratory Infection, CTCAE [NCIt concept]
- Upper Respiratory System [NCIt concept]
- Upper Third of the Esophagus [NCIt concept]
- Upper-Inner Quadrant of the Breast [NCIt concept]
- Upper-Outer Quadrant of the Breast [NCIt concept]
- Uprevstobart [NCIt concept]
- Uproleselan [NCIt concept]
- Uprosertib [NCIt concept]
- Urabrelimab [NCIt concept]
- Urachal Carcinoma [NCIt concept]
- Urachus [NCIt concept]
- Uracil Ointment [NCIt concept]
- Urelumab [NCIt concept]
- Ureter [NCIt concept]
- Ureteric Anastomotic Leak, CTCAE [NCIt concept]
- Ureteric Orifice [NCIt concept]
- Urethra [NCIt concept]
- Urethral Anastomotic Leak, CTCAE [NCIt concept]
- Urethral Infection, CTCAE [NCIt concept]
- Urinary Fistula, CTCAE [NCIt concept]
- Urinary Frequency, CTCAE [NCIt concept]
- Urinary Incontinence, CTCAE 5.0 [NCIt concept]
- Urinary Retention, CTCAE [NCIt concept]
- Urinary System [NCIt concept]
- Urinary Tract [NCIt concept]
- Urinary Tract Infection [NCIt concept]
- Urinary Tract Infection, CTCAE [NCIt concept]
- Urinary Tract Obstruction, CTCAE [NCIt concept]
- Urinary Tract Pain, CTCAE [NCIt concept]
- Urinary Urgency, CTCAE [NCIt concept]
- Urine [NCIt concept]
- Urine Discoloration, CTCAE [NCIt concept]
- Urine Output Decreased, CTCAE [NCIt concept]
- Uroacitides [NCIt concept]
- Urokinase-Derived Peptide A6 [NCIt concept]
- Urostomy Leak, CTCAE [NCIt concept]
- Urostomy Obstruction, CTCAE [NCIt concept]
- Urostomy Site Bleeding, CTCAE [NCIt concept]
- Urostomy Stenosis, CTCAE [NCIt concept]
- Urothelial Carcinoma [NCIt concept]
- Urothelial Papilloma [NCIt concept]
- Ursolic Acid [NCIt concept]
- Urticaria Pigmentosa/Maculopapular Cutaneous Mastocytosis [NCIt concept]
- Urticaria, CTCAE [NCIt concept]
- Uruguay [NCIt concept]
- Utatrectinib [NCIt concept]
- Uterine Anastomotic Leak, CTCAE [NCIt concept]
- Uterine Corpus Adenomyosis [NCIt concept]
- Uterine Corpus Carcinofibroma [NCIt concept]
- Uterine Corpus Epithelioid Leiomyoma [NCIt concept]
- Uterine Corpus High Grade Endometrial Stromal Sarcoma [NCIt concept]
- Uterine Corpus Leiomyoma [NCIt concept]
- Uterine Corpus Low Grade Endometrial Stromal Sarcoma [NCIt concept]
- Uterine Corpus Metastasizing Leiomyoma [NCIt concept]
- Uterine Corpus Smooth Muscle Tumor of Uncertain Malignant Potential [NCIt concept]
- Uterine Corpus Undifferentiated Sarcoma [NCIt concept]
- Uterine Fistula, CTCAE [NCIt concept]
- Uterine Hemorrhage, CTCAE [NCIt concept]
- Uterine Infection, CTCAE [NCIt concept]
- Uterine Obstruction, CTCAE [NCIt concept]
- Uterine Pain, CTCAE 5.0 [NCIt concept]
- Uterine Perforation, CTCAE [NCIt concept]
- Uterus [NCIt concept]
- Utidelone [NCIt concept]
- Utomilumab [NCIt concept]
- Uveitis, CTCAE [NCIt concept]
- Uvula [NCIt concept]
- Uzansertib [NCIt concept]
- Uzbekistan [NCIt concept]
- V930 Vaccine [NCIt concept]
- VAV1 Gene [NCIt concept]
- VEGF/HGF-targeting DARPin MP0250 [NCIt concept]
- VEGFR Inhibitor KRN951 [NCIt concept]
- VEGFR-2 DNA Vaccine VXM01 [NCIt concept]
- VEGFR/FGFR Inhibitor ODM-203 [NCIt concept]
- VEGFR/PDGFR Tyrosine Kinase Inhibitor TAK-593 [NCIt concept]
- VEGFR2 Tyrosine Kinase Inhibitor PF-00337210 [NCIt concept]
- VEGFR2/PDGFR/c-Kit/Flt-3 Inhibitor SU014813 [NCIt concept]
- VEGFR3 Inhibitor EVT801 [NCIt concept]
- VGEF Mixed-Backbone Antisense Oligonucleotide GEM 220 [NCIt concept]
- VGEFR/c-kit/PDGFR Tyrosine Kinase Inhibitor XL820 [NCIt concept]
- VHL Gene [NCIt concept]
- VIP-Producing Neuroendocrine Tumor [NCIt concept]
- VSV-GP BI 1831169 [NCIt concept]
- VSV-GP-based Cancer Vaccine VSV-GP128 [NCIt concept]
- VTI1A Gene [NCIt concept]
- Vaccine-Sensitized Draining Lymph Node Cells [NCIt concept]
- Vaccinium myrtillus/Macleaya cordata/Echinacea angustifolia Extract Granules [NCIt concept]
- Vactosertib [NCIt concept]
- Vadacabtagene Leraleucel [NCIt concept]
- Vadastuximab Talirine [NCIt concept]
- Vadimezan [NCIt concept]
- Vagina [NCIt concept]
- Vaginal Anastomotic Leak, CTCAE [NCIt concept]
- Vaginal Discharge, CTCAE [NCIt concept]
- Vaginal Dryness, CTCAE 5.0 [NCIt concept]
- Vaginal Fistula, CTCAE [NCIt concept]
- Vaginal Hemorrhage, CTCAE [NCIt concept]
- Vaginal Infection, CTCAE [NCIt concept]
- Vaginal Inflammation, CTCAE [NCIt concept]
- Vaginal Obstruction, CTCAE 5.0 [NCIt concept]
- Vaginal Pain, CTCAE 5.0 [NCIt concept]
- Vaginal Perforation, CTCAE 5.0 [NCIt concept]
- Vaginal Stricture, CTCAE [NCIt concept]
- Vaginismus [NCIt concept]
- Vagus Nerve Disorder, CTCAE [NCIt concept]
- Valecobulin [NCIt concept]
- Valemetostat [NCIt concept]
- Validation [NCIt concept]
- Vallecula [NCIt concept]
- Valproic Acid [NCIt concept]
- Valrubicin [NCIt concept]
- Valspodar [NCIt concept]
- Vamotinib [NCIt concept]
- Vandetanib [NCIt concept]
- Vandetanib-eluting Radiopaque Bead BTG-002814 [NCIt concept]
- Vandortuzumab Vedotin [NCIt concept]
- Vantictumab [NCIt concept]
- Vanuatu [NCIt concept]
- Vanucizumab [NCIt concept]
- Vapreotide [NCIt concept]
- Variant Benign [NCIt concept]
- Variant Call File Format [NCIt concept]
- Variant Codon Position Number [NCIt concept]
- Variant Likely Benign [NCIt concept]
- Variant of Unknown Significance [NCIt concept]
- Varicella Zoster Infection [NCIt concept]
- Varlilumab [NCIt concept]
- Varlitinib [NCIt concept]
- Varlitinib Tosylate [NCIt concept]
- Varnimcabtagene Autoleucel [NCIt concept]
- Vas Deferens [NCIt concept]
- Vas Deferens Anastomotic Leak, CTCAE [NCIt concept]
- Vascular Access Complication, CTCAE [NCIt concept]
- Vascular Disorder [NCIt concept]
- Vascular Disorders - Other, Specify, CTCAE [NCIt concept]
- Vascular Disrupting Agent BNC105 [NCIt concept]
- Vascular Disrupting Agent BNC105P [NCIt concept]
- Vascular Disrupting Agent ZD6126 [NCIt concept]
- Vascular Invasion Assessment [NCIt concept]
- Vascular Invasion Descriptor [NCIt concept]
- Vascular Invasion Negative [NCIt concept]
- Vasculitis, CTCAE [NCIt concept]
- Vasovagal Reaction, CTCAE [NCIt concept]
- Vatalanib [NCIt concept]
- Vatalanib Succinate [NCIt concept]
- Vebreltinib [NCIt concept]
- Vecabrutinib [NCIt concept]
- Vector-peptide Conjugated Paclitaxel [NCIt concept]
- Vedolizumab [NCIt concept]
- Vehicle, Window, Laundry and Other Hand Cleaning Worker [NCIt concept]
- Vein [NCIt concept]
- Veligrotug [NCIt concept]
- Veliparib [NCIt concept]
- Veltuzumab [NCIt concept]
- Vemurafenib [NCIt concept]
- Vena Cava Involvement or Thrombus [NCIt concept]
- Venetoclax [NCIt concept]
- Venezuela, Bolivarian Republic of [NCIt concept]
- Venomous Ant Bite Allergy [NCIt concept]
- Venous [NCIt concept]
- Venous Hemangioma [NCIt concept]
- Venous Injury, CTCAE [NCIt concept]
- Venous Invasion [NCIt concept]
- Ventricular Arrhythmia, CTCAE 5.0 [NCIt concept]
- Ventricular Fibrillation, CTCAE 5.0 [NCIt concept]
- Ventricular Tachycardia, CTCAE 5.0 [NCIt concept]
- Vepafestinib [NCIt concept]
- Vepdegestrant [NCIt concept]
- Vepsitamab [NCIt concept]
- Verapamil [NCIt concept]
- Verpasep Caltespen [NCIt concept]
- Verrucous Carcinoma [NCIt concept]
- Verrucous Hemangioma [NCIt concept]
- Verrucous Papilloma [NCIt concept]
- Vertebra [NCIt concept]
- Vertebral Canal [NCIt concept]
- Vertebral Column [NCIt concept]
- Vertigo, CTCAE [NCIt concept]
- Verubulin [NCIt concept]
- Verubulin Hydrochloride [NCIt concept]
- Very Good Partial Response [NCIt concept]
- Verzistobart [NCIt concept]
- Vesencumab [NCIt concept]
- Vesigenurtucel-L [NCIt concept]
- Vestibular Disorder, CTCAE [NCIt concept]
- Vestibular Schwannoma [NCIt concept]
- Vestibule of Mouth [NCIt concept]
- Veterinarian [NCIt concept]
- Veterinary Staff [NCIt concept]
- Vevoctadekin [NCIt concept]
- Viagenpumatucel-L [NCIt concept]
- Vibecotamab [NCIt concept]
- Vibostolimab [NCIt concept]
- Vibostolimab/Pembrolizumab MK-7684A [NCIt concept]
- Vidutolimod [NCIt concept]
- Viet Nam [NCIt concept]
- Vilamakitug [NCIt concept]
- Vilaprisan [NCIt concept]
- Villoglandular Endometrial Endometrioid Adenocarcinoma [NCIt concept]
- Villous Adenocarcinoma [NCIt concept]
- Villous Adenoma [NCIt concept]
- Vimseltinib [NCIt concept]
- Vinblastine [NCIt concept]
- Vinblastine Sulfate [NCIt concept]
- Vincristine [NCIt concept]
- Vincristine Liposomal [NCIt concept]
- Vincristine Sulfate [NCIt concept]
- Vincristine Sulfate Liposome [NCIt concept]
- Vindesine [NCIt concept]
- Vinepidine [NCIt concept]
- Vinflunine [NCIt concept]
- Vinflunine Ditartrate [NCIt concept]
- Vinfosiltine [NCIt concept]
- Vinorelbine [NCIt concept]
- Vinorelbine Tartrate [NCIt concept]
- Vinorelbine Tartrate Emulsion [NCIt concept]
- Vinorelbine Tartrate Oral [NCIt concept]
- Vintafolide [NCIt concept]
- Vinzolidine [NCIt concept]
- Vinzolidine Sulfate [NCIt concept]
- Viral Vector-based Cancer Vaccine VAC85135 [NCIt concept]
- Virgin Islands, British [NCIt concept]
- Virgin Islands, U.S. [NCIt concept]
- Virilization, CTCAE [NCIt concept]
- Virulizin [NCIt concept]
- Visceral Arterial Ischemia, CTCAE [NCIt concept]
- Vismodegib [NCIt concept]
- Vistusertib [NCIt concept]
- Visual Change [NCIt concept]
- Visugromab [NCIt concept]
- Vital Capacity Abnormal, CTCAE [NCIt concept]
- Vital Status [NCIt concept]
- Vitamin D3 Analogue ILX23-7553 [NCIt concept]
- Vitamin E Compound [NCIt concept]
- Vitespen [NCIt concept]
- Vitreous Hemorrhage, CTCAE 5.0 [NCIt concept]
- Vixtimotamab [NCIt concept]
- Vobramitamab Duocarmazine [NCIt concept]
- Vocational Education Teacher [NCIt concept]
- Vocational Program Completion [NCIt concept]
- Vocimagene Amiretrorepvec [NCIt concept]
- Vociprotafib [NCIt concept]
- Vodobatinib [NCIt concept]
- Vodudeutentan Sodium [NCIt concept]
- Vofatamab [NCIt concept]
- Voice Alteration, CTCAE [NCIt concept]
- Volasertib [NCIt concept]
- Volcanic Smoke Exposure [NCIt concept]
- Volociximab [NCIt concept]
- Volrustomig [NCIt concept]
- Vomiting, CTCAE [NCIt concept]
- Von Hippel Lindau Syndrome [NCIt concept]
- Vonlerolizumab [NCIt concept]
- Vopikitug [NCIt concept]
- Vopratelimab [NCIt concept]
- Vorasidenib [NCIt concept]
- Vorbipiprant [NCIt concept]
- Vorinostat [NCIt concept]
- Vorolanib [NCIt concept]
- Vorsetzumab Mafodotin [NCIt concept]
- Vosaroxin [NCIt concept]
- Vosilasarm [NCIt concept]
- Voxalatamab [NCIt concept]
- Voxtalisib [NCIt concept]
- Vudalimab [NCIt concept]
- Vulinacimab [NCIt concept]
- Vulva [NCIt concept]
- Vulval Infection, CTCAE [NCIt concept]
- Vulvar Intraepithelial Neoplasia, HPV-Independent [NCIt concept]
- Vusolimogene Oderparepvec [NCIt concept]
- WAGR Syndrome [NCIt concept]
- WAS Gene [NCIt concept]
- WDCP Gene [NCIt concept]
- WEISS Criteria [NCIt concept]
- WEISS System [NCIt concept]
- WHO Central Nervous System Grade [NCIt concept]
- WHO Central Nervous System Grade 1 [NCIt concept]
- WHO Central Nervous System Grade 2 [NCIt concept]
- WHO Central Nervous System Grade 3 [NCIt concept]
- WHO Central Nervous System Grade 4 [NCIt concept]
- WHO Neuroendocrine Tumor Grade [NCIt concept]
- WIF1 Gene [NCIt concept]
- WNK2 Gene [NCIt concept]
- WRN Gene [NCIt concept]
- WT1 Gene [NCIt concept]
- WT1 Peptide Vaccine OCV-501 [NCIt concept]
- WT1 Peptide Vaccine WT2725 [NCIt concept]
- WT1 Protein-derived Peptide Vaccine DSP-7888 [NCIt concept]
- WT1-A10/AS01B Immunotherapeutic GSK2130579A [NCIt concept]
- WT1-targeted IL-2-based Fusion Protein CUE-102 [NCIt concept]
- WT1/PSMA/hTERT-encoding Plasmid DNA INO-5401 [NCIt concept]
- WWTR1 Gene [NCIt concept]
- W_pro1 Cancer Vaccine [NCIt concept]
- Wafer Dosing Unit [NCIt concept]
- Waldenstrom Macroglobulinemia [NCIt concept]
- Waldeyer Ring [NCIt concept]
- Wallis and Futuna [NCIt concept]
- Ward [NCIt concept]
- Warfarin Sodium [NCIt concept]
- Warning [NCIt concept]
- Warthin Tumor [NCIt concept]
- Was Lymph Node Dissection Performed [NCIt concept]
- Wasp Venom Allergy [NCIt concept]
- Wasting Syndrome [NCIt concept]
- Water-Clear Cell Adenocarcinoma [NCIt concept]
- Watering Eyes, CTCAE [NCIt concept]
- Wedge Excision [NCIt concept]
- Wee1 Kinase Inhibitor Debio 0123 [NCIt concept]
- Wee1 Kinase Inhibitor IMP7068 [NCIt concept]
- Weekly Drinker [NCIt concept]
- Weight Gain, CTCAE [NCIt concept]
- Weight Loss [NCIt concept]
- Weight Loss, CTCAE [NCIt concept]
- Welgenaleucel [NCIt concept]
- Well Differentiated [NCIt concept]
- Well Differentiated Neuroendocrine Lesion [NCIt concept]
- Well Differentiated Ovarian Sertoli-Leydig Cell Tumor [NCIt concept]
- Western Sahara [NCIt concept]
- What is the First Presenting Symptom Related to Disease [NCIt concept]
- What is the Hormonal Contraceptive Use Status [NCIt concept]
- Wheezing, CTCAE [NCIt concept]
- Whipple Procedure [NCIt concept]
- White [NCIt concept]
- White Blood Cell Decreased, CTCAE [NCIt concept]
- White Carrot [NCIt concept]
- White Matter [NCIt concept]
- Whole Blood [NCIt concept]
- Whole Bone Marrow [NCIt concept]
- Whole Exome Sequencing [NCIt concept]
- Whole Genome Sequencing [NCIt concept]
- Whole Genome Sequencing Read Depth [NCIt concept]
- Whole Transcriptome Sequencing [NCIt concept]
- Widowed [NCIt concept]
- Wife [NCIt concept]
- Wilms Tumor [NCIt concept]
- Wilms Tumor Histologic Subtype [NCIt concept]
- Wine [NCIt concept]
- With Tumor [NCIt concept]
- Withdrawal by Subject [NCIt concept]
- Within 3 Months of Surgery [NCIt concept]
- Wnt Signaling Inhibitor SM04755 [NCIt concept]
- Wnt Signaling Pathway Inhibitor SM08502 [NCIt concept]
- Wnt-5a Mimic Hexapeptide Foxy-5 [NCIt concept]
- Wobe-Mugos E [NCIt concept]
- Wolff-Parkinson-White Syndrome [NCIt concept]
- Wolffian Tumor [NCIt concept]
- Wood Dust Exposure [NCIt concept]
- Wood Processing and Papermaking Plant Operator [NCIt concept]
- Wood Treater, Cabinet-maker and Related Trades Worker [NCIt concept]
- Wood-Burning Factory Smoke Exposure [NCIt concept]
- Wood-Burning Indoor Stove or Fireplace Smoke Exposure [NCIt concept]
- Work-Related Smoke Exposure [NCIt concept]
- Wound Complication, CTCAE [NCIt concept]
- Wound Dehiscence, CTCAE [NCIt concept]
- Wound Infection, CTCAE [NCIt concept]
- Wrist Fracture, CTCAE [NCIt concept]
- Wrist Joint [NCIt concept]
- XBP1-US/XBP1-SP/CD138/CS1 Multipeptide Vaccine PVX-410 [NCIt concept]
- XELOX Regimen [NCIt concept]
- XIAP Antisense Oligonucleotide AEG35156 [NCIt concept]
- XPA Gene [NCIt concept]
- XPC Gene [NCIt concept]
- XPO1 Gene [NCIt concept]
- XPO1 Inhibitor WJ01024 [NCIt concept]
- XPO1 Inhibitor WJ01075 [NCIt concept]
- Xaluritamig [NCIt concept]
- Xanthohumol [NCIt concept]
- Xenograft [NCIt concept]
- Xentuzumab [NCIt concept]
- Xevinapant [NCIt concept]
- Xiaoai Jiedu Decoction [NCIt concept]
- Xiliertinib [NCIt concept]
- Xirestomig [NCIt concept]
- Y 90 Monoclonal Antibody CC49 [NCIt concept]
- Y 90 Monoclonal Antibody HMFG1 [NCIt concept]
- Y 90 Monoclonal Antibody Lym-1 [NCIt concept]
- Y 90 Monoclonal Antibody M195 [NCIt concept]
- Y 90 Monoclonal Antibody m170 [NCIt concept]
- YAP/TEAD Interaction Inhibitor IAG933 [NCIt concept]
- YWHAE Gene [NCIt concept]
- Yang Yin Fu Zheng [NCIt concept]
- Yangzheng Xiaoji Extract [NCIt concept]
- Year of Death [NCIt concept]
- Year of Initial Cancer Diagnosis [NCIt concept]
- Year of Last Follow Up [NCIt concept]
- Year of Pancreatitis Onset [NCIt concept]
- Yemen [NCIt concept]
- Yes [NCIt concept]
- Yiqi-yangyin-jiedu Herbal Decoction [NCIt concept]
- Yolk Sac Tumor [NCIt concept]
- Yttrium Y 90 Anti-CD19 Monoclonal Antibody BU12 [NCIt concept]
- Yttrium Y 90 Anti-CD45 Monoclonal Antibody AHN-12 [NCIt concept]
- Yttrium Y 90 Anti-CD45 Monoclonal Antibody BC8 [NCIt concept]
- Yttrium Y 90 Anti-CDH3 Monoclonal Antibody FF-21101 [NCIt concept]
- Yttrium Y 90 Anti-CEA Monoclonal Antibody cT84.66 [NCIt concept]
- Yttrium Y 90 Basiliximab [NCIt concept]
- Yttrium Y 90 Carbon Microspheres [NCIt concept]
- Yttrium Y 90 Colloid [NCIt concept]
- Yttrium Y 90 DOTA Anti-CEA Monoclonal Antibody M5A [NCIt concept]
- Yttrium Y 90 Daclizumab [NCIt concept]
- Yttrium Y 90 Glass Microspheres [NCIt concept]
- Yttrium Y 90 Monoclonal Antibody B3 [NCIt concept]
- Yttrium Y 90 Monoclonal Antibody BrE-3 [NCIt concept]
- Yttrium Y 90 Monoclonal Antibody Hu3S193 [NCIt concept]
- Yttrium Y 90 Monoclonal Antibody MN-14 [NCIt concept]
- Yttrium Y 90 Resin Microspheres [NCIt concept]
- Yttrium Y 90 Tabituximab Barzuxetan [NCIt concept]
- Yttrium Y 90-DOTA-Biotin [NCIt concept]
- Yttrium Y 90-DOTA-di-HSG Peptide IMP-288 [NCIt concept]
- Yttrium Y 90-Edotreotide [NCIt concept]
- Yttrium Y-90 Clivatuzumab Tetraxetan [NCIt concept]
- Yttrium Y-90 Epratuzumab Tetraxetan [NCIt concept]
- Yttrium Y-90 Ibritumomab Tiuxetan [NCIt concept]
- Yttrium Y-90 Tacatuzumab Tetraxetan [NCIt concept]
- Yttrium-90 Polycarbonate Brachytherapy Plaque [NCIt concept]
- ZBTB16 Gene [NCIt concept]
- ZCCHC8 Gene [NCIt concept]
- ZEB1 Gene [NCIt concept]
- ZEB2 Gene [NCIt concept]
- ZFHX3 Gene [NCIt concept]
- ZMYM2 Gene [NCIt concept]
- ZMYM3 Gene [NCIt concept]
- ZNF331 Gene [NCIt concept]
- ZNF384 Gene [NCIt concept]
- ZNF429 Gene [NCIt concept]
- ZNF444 Gene [NCIt concept]
- ZNF479 Gene [NCIt concept]
- ZNF521 Gene [NCIt concept]
- ZNRF3 Gene [NCIt concept]
- ZRSR2 Gene [NCIt concept]
- Zabadinostat [NCIt concept]
- Zalcitabine [NCIt concept]
- Zalifrelimab [NCIt concept]
- Zalutumumab [NCIt concept]
- Zamaporvint [NCIt concept]
- Zambia [NCIt concept]
- Zamtocabtagene Autoleucel [NCIt concept]
- Zandelisib [NCIt concept]
- Zanidatamab [NCIt concept]
- Zanolimumab [NCIt concept]
- Zanubrutinib [NCIt concept]
- Zanzalintinib [NCIt concept]
- Zebularine [NCIt concept]
- Zebutinib [NCIt concept]
- Zegocractin [NCIt concept]
- Zelavespib [NCIt concept]
- Zelenectide Pevedotin [NCIt concept]
- Zeluvalimab [NCIt concept]
- Zenocutuzumab [NCIt concept]
- Zeripatamig [NCIt concept]
- Zero [NCIt concept]
- Zeteletinib [NCIt concept]
- Zevorcabtagene Autoleucel [NCIt concept]
- Zibotentan [NCIt concept]
- Zidesamtinib [NCIt concept]
- Zifcasiran [NCIt concept]
- Zifcasiran Sodium [NCIt concept]
- Zigakibart [NCIt concept]
- Zilovertamab [NCIt concept]
- Zilovertamab Vedotin [NCIt concept]
- Zimbabwe [NCIt concept]
- Zimberelimab [NCIt concept]
- Zinc Finger Nuclease ZFN-603 [NCIt concept]
- Zinc Finger Nuclease ZFN-758 [NCIt concept]
- Zinostatin [NCIt concept]
- Zinostatin Stimalamer [NCIt concept]
- Zipalertinib [NCIt concept]
- Zirconium Zr 89 Panitumumab [NCIt concept]
- Ziv-Aflibercept [NCIt concept]
- Zolbetuximab [NCIt concept]
- Zoledronic Acid [NCIt concept]
- Zoligratinib [NCIt concept]
- Zoptarelin Doxorubicin [NCIt concept]
- Zorifertinib [NCIt concept]
- Zorubicin [NCIt concept]
- Zorubicin Hydrochloride [NCIt concept]
- Zotatifin [NCIt concept]
- Zotiraciclib Citrate [NCIt concept]
- Zotizalkib [NCIt concept]
- Zuclomiphene Citrate [NCIt concept]
- Zurletrectinib [NCIt concept]
- Zygosity [NCIt concept]
- c-Met Inhibitor ABN401 [NCIt concept]
- c-Met Inhibitor AL2846 [NCIt concept]
- c-Met Inhibitor AMG 208 [NCIt concept]
- c-Met Inhibitor AMG 337 [NCIt concept]
- c-Met Inhibitor DO-2 [NCIt concept]
- c-Met Inhibitor GST-HG161 [NCIt concept]
- c-Met Inhibitor HS-10241 [NCIt concept]
- c-Met Inhibitor JNJ-38877605 [NCIt concept]
- c-Met Inhibitor MK2461 [NCIt concept]
- c-Met Inhibitor MK8033 [NCIt concept]
- c-Met Inhibitor SPH3348 [NCIt concept]
- c-Met/FLT3/TRK/CDK8/19 Inhibitor TSN084 [NCIt concept]
- c-Myb mRNA Degrader REM-422 [NCIt concept]
- c-raf Antisense Oligonucleotide ISIS 5132 [NCIt concept]
- cDNA Library Construction [NCIt concept]
- cEt KRAS Antisense Oligonucleotide AZD4785 [NCIt concept]
- cFMS Tyrosine Kinase Inhibitor ARRY-382 [NCIt concept]
- cM0 (i+) TNM Finding [NCIt concept]
- cM0 ENSAT Staging Finding v7 [NCIt concept]
- cM1 ENSAT Staging Finding v7 [NCIt concept]
- cPLA2 Inhibiting Silicone-based Gel AVX001 [NCIt concept]
- cis-Urocanic Acid [NCIt concept]
- dUTPase/DPD Inhibitor TAS-114 [NCIt concept]
- dbGaP Accession Number [NCIt concept]
- eIF4E Antisense Oligonucleotide ISIS 183750 [NCIt concept]
- hTERT Multipeptide/Montanide ISA-51 VG/Imiquimod Vaccine GX 301 [NCIt concept]
- hTERT Vaccine V934/V935 [NCIt concept]
- hTERT-encoding DNA Vaccine INVAC-1 [NCIt concept]
- huBC1-huIL12 Fusion Protein AS1409 [NCIt concept]
- iNKT Cell Agonist ABX196 [NCIt concept]
- iNOS Dimerization Inhibitor FK-330 [NCIt concept]
- iPSC-derived Anti-BCMA CAR/CD16/IL-15RF-expressing CD38-eliminated NK Cells FT576 [NCIt concept]
- iPSC-derived Anti-CD19 CAR/CD16/IL-15RF/ADR-expressing CD38-eliminated NK Cells FT522 [NCIt concept]
- iPSC-derived CD16-expressing Natural Killer Cells FT516 [NCIt concept]
- iPSC-derived CD16/IL-15RF-expressing Anti-CD19 CAR-NK Cells FT596 [NCIt concept]
- iPSC-derived CD16/IL-15RF-expressing CD38-eliminated NK Cells FT538 [NCIt concept]
- iPSC-derived Natural Killer Cells FT500 [NCIt concept]
- mRNA-Derived Prostate Cancer Vaccine CV9103 [NCIt concept]
- mRNA-based Personalized Cancer Vaccine NCI-4650 [NCIt concept]
- mRNA-based Personalized Cancer Vaccine mRNA-4157 [NCIt concept]
- mRNA-based TriMix Melanoma Vaccine ECI-006 [NCIt concept]
- mRNA-based Tumor-specific Neoantigen Boosting Vaccine GRT-R902 [NCIt concept]
- mRNA-derived IDO/PD-L1-targeted Vaccine mRNA-4359 [NCIt concept]
- mRNA-derived KRAS-targeted Vaccine V941 [NCIt concept]
- mRNA-derived Lung Cancer Vaccine BI 1361849 [NCIt concept]
- mRNA-derived Prostate Cancer Vaccine CV9104 [NCIt concept]
- mRNA-encoded Anti-CD3/Anti-CLDN6 Bispecific Antibody BNT142 [NCIt concept]
- mRNA-encoded Anti-Claudin18.2 Monoclonal Antibody BNT141 [NCIt concept]
- mTOR Inhibitor GDC-0349 [NCIt concept]
- mTOR Kinase Inhibitor AZD8055 [NCIt concept]
- mTOR Kinase Inhibitor CERC-006 [NCIt concept]
- mTOR Kinase Inhibitor PP242 [NCIt concept]
- mTOR1/2 Kinase Inhibitor ME-344 [NCIt concept]
- mTORC 1/2 Inhibitor LXI-15029 [NCIt concept]
- mTORC1 Kinase Inhibitor RMC-5552 [NCIt concept]
- mTORC1/2 Kinase Inhibitor BI 860585 [NCIt concept]
- mTORC1/mTORC2/DHFR Inhibitor ABTL0812 [NCIt concept]
- miR-221 LNA Inhibitor LNA-i-miR-221 [NCIt concept]
- miRNA 193a-3p Mimic INT-1B3 [NCIt concept]
- miRNA Size Fractionated Genomic Library [NCIt concept]
- mirVana RNA Isolation [NCIt concept]
- mtRTK Inhibitor WM-S1-030 [NCIt concept]
- p38 MAPK Inhibitor LY3007113 [NCIt concept]
- p53 Mutant Reactivator APR-548 [NCIt concept]
- p53 Peptide Vaccine MPS-128 [NCIt concept]
- p53 Y220C Mutant Reactivator PC14586 [NCIt concept]
- p53-HDM2 Interaction Inhibitor MI-773 [NCIt concept]
- p53/HDM2 Interaction Inhibitor CGM097 [NCIt concept]
- p70S6K Inhibitor LY2584702 [NCIt concept]
- p70S6K/Akt Inhibitor M-2698 [NCIt concept]
- p97 Inhibitor CB-5083 [NCIt concept]
- p97 Inhibitor CB-5339 [NCIt concept]
- p97 Inhibitor CB-5339 Tosylate [NCIt concept]
- pDNA-encoding Emm55 Autologous Cancer Cell Vaccine IFx-Hu2.0 [NCIt concept]
- pH Low Insertion Peptide-exatecan Conjugate CBX-12 [NCIt concept]
- pN0 (i+) TNM Finding [NCIt concept]
- pN0 (i-) TNM Finding [NCIt concept]
- pN0 (mol+) TNM Finding [NCIt concept]
- pN0 (mol-) TNM Finding [NCIt concept]
- pN0 ENSAT Staging Finding v7 [NCIt concept]
- pN1 ENSAT Staging Finding v7 [NCIt concept]
- pNGVL4a-CRT-E6E7L2 DNA Vaccine [NCIt concept]
- pNGVL4a-Sig/E7(detox)/HSP70 DNA and HPV16 L2/E6/E7 Fusion Protein TA-CIN Vaccine PVX-2 [NCIt concept]
- pT1 ENSAT Staging Finding v7 [NCIt concept]
- pT2 ENSAT Staging Finding v7 [NCIt concept]
- pT3 ENSAT Staging Finding v7 [NCIt concept]
- pT4 ENSAT Staging Finding v7 [NCIt concept]
- pTa TNM Finding [NCIt concept]
- pTis TNM Finding [NCIt concept]
- pan FGFR Inhibitor PRN1371 [NCIt concept]
- pan-HER Kinase Inhibitor AC480 [NCIt concept]
- pan-PI3K Inhibitor CLR457 [NCIt concept]
- pan-PI3K/mTOR Inhibitor SF1126 [NCIt concept]
- pan-PIM Kinase Inhibitor AZD1208 [NCIt concept]
- pan-PIM Kinase Inhibitor GDC-0570 [NCIt concept]
- pan-PIM Kinase Inhibitor NVP-LGB-321 [NCIt concept]
- pan-RAF Inhibitor JZP815 [NCIt concept]
- pan-RAF Inhibitor QLH11906 [NCIt concept]
- pan-RAF Inhibitor TR128 [NCIt concept]
- pan-RAF Inhibitor XP-102 [NCIt concept]
- pan-RAF Kinase Inhibitor CCT3833 [NCIt concept]
- pan-TRK/ROS1 Dual Inhibitor XZP-5955 [NCIt concept]
- pbi-shRNA STMN1 Lipoplex [NCIt concept]
- rRNA Depleted Genomic Library [NCIt concept]
- siG12D LODER [NCIt concept]
- siRNA-transfected Peripheral Blood Mononuclear Cells APN401 [NCIt concept]
- ssRNA-based Immunomodulator CV8102 [NCIt concept]
- t(10;11)(p11.2;q23) [NCIt concept]
- t(11;19)(q23.3;p13.1) [NCIt concept]
- t(3;5)(q25;q34) [NCIt concept]
- t(6;11)(q27;q23) [NCIt concept]
- t(6;9) [NCIt concept]
- t(8;21) [NCIt concept]
- t(9;11)(p21.3;q23.3) [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients